<SEC-DOCUMENT>0001493152-22-007150.txt : 20220317
<SEC-HEADER>0001493152-22-007150.hdr.sgml : 20220317
<ACCEPTANCE-DATETIME>20220317160538
ACCESSION NUMBER:		0001493152-22-007150
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		69
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220317
DATE AS OF CHANGE:		20220317

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Viewbix Inc.
		CENTRAL INDEX KEY:			0000797542
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		IRS NUMBER:				680080601
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-15746
		FILM NUMBER:		22748482

	BUSINESS ADDRESS:	
		STREET 1:		14 ARYEH SHENKAR STREET
		CITY:			HERZLIYA
		STATE:			L3
		ZIP:			4672514
		BUSINESS PHONE:		855-879-8439

	MAIL ADDRESS:	
		STREET 1:		14 ARYEH SHENKAR STREET
		CITY:			HERZLIYA
		STATE:			L3
		ZIP:			4672514

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Virtual Crypto Technologies, Inc.
		DATE OF NAME CHANGE:	20180312

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Emerald Medical Applications Corp.
		DATE OF NAME CHANGE:	20151006

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZAXIS INTERNATIONAL INC
		DATE OF NAME CHANGE:	19950916
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>form10-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:VBIX="http://corp.viewbix.com/20211231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_033_VBIX_corp.viewbix.com_20211231 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20210101_20211231 -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0000797542 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_076_XDX_form10%2Dk.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_063_NIS_0_iso4217%2D%2DILS -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityCentralIndexKey">0000797542</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0131" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0150" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossOnSaleOfBusiness" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0152" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VBIX:FinancingProvidedByParentCompanyAcquisition" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0189" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0204" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0205" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0230" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0232" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0237" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0238" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VBIX:GainFromSaleOfSubsidiary" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0266" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Depreciation" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0269" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0296" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0299" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0305" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromShortTermDebt" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0308" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0311" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-01-012021-12-31_custom_SalariesandRelatedExpenseMember" id="xdx2ixbrl0525" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2021-01-012021-12-31_custom_SalariesandRelatedExpenseMember" id="xdx2ixbrl0541" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Depreciation" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0563" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VBIX:FinancingIncomeExpensesNet" contextRef="From2020-01-012020-12-31_custom_InterestExpensesMember" id="xdx2ixbrl0586" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2021-12-31" id="xdx2ixbrl0620" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2020-12-31" id="xdx2ixbrl0621" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="vbix-20211231.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-01-01to2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-17">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-01-27_custom_VirtualCryptoIsraelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">VBIX:VirtualCryptoIsraelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-01-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-02-07_custom_ShareExchangeAgreementMember_custom_ViewbixLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">VBIX:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VBIX:ViewbixLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-02-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-172020-12-18_custom_StockSubscriptionAgreementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">VBIX:StockSubscriptionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-17</xbrli:startDate>
        <xbrli:endDate>2020-12-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-18_custom_StockSubscriptionAgreementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">VBIX:StockSubscriptionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-18_us-gaap_InvestorMember_custom_LoanAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">VBIX:LoanAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-172020-12-18_custom_LoanAgreementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">VBIX:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-17</xbrli:startDate>
        <xbrli:endDate>2020-12-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_GixLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VBIX:GixLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-122022-02-13_custom_GixLoanMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">VBIX:GixLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-12</xbrli:startDate>
        <xbrli:endDate>2022-02-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-18_custom_LoanAndStockSubscriptionAgreementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">VBIX:LoanAndStockSubscriptionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-18_custom_LoanAndStockSubscriptionAgreementMember_custom_InvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">VBIX:LoanAndStockSubscriptionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">VBIX:InvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-172020-12-18_custom_LoanAndStockSubscriptionAgreementMember_custom_InvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">VBIX:LoanAndStockSubscriptionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">VBIX:InvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-17</xbrli:startDate>
        <xbrli:endDate>2020-12-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-172020-12-18_custom_StockSubscriptionAgreementMember_custom_InvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">VBIX:StockSubscriptionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">VBIX:InvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-17</xbrli:startDate>
        <xbrli:endDate>2020-12-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-18_custom_LoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">VBIX:LoanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-18_custom_SharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">VBIX:SharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-172020-12-18_custom_GixLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VBIX:GixLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-17</xbrli:startDate>
        <xbrli:endDate>2020-12-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_ClassHWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VBIX:ClassHWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_ClassIWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VBIX:ClassIWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_ClassGWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VBIX:ClassGWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ClassJWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VBIX:ClassJWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ClassJWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VBIX:ClassJWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ClassKWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VBIX:ClassKWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ClassKWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VBIX:ClassKWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_IndividualSubscriptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">VBIX:IndividualSubscriptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_IndividualSubscriptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">VBIX:IndividualSubscriptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EnterpriseSubscriptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">VBIX:EnterpriseSubscriptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EnterpriseSubscriptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">VBIX:EnterpriseSubscriptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SalariesandRelatedExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">VBIX:SalariesandRelatedExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SalariesandRelatedExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">VBIX:SalariesandRelatedExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SubcontractorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">VBIX:SubcontractorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SubcontractorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">VBIX:SubcontractorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">VBIX:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">VBIX:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_BankFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">VBIX:BankFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_BankFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">VBIX:BankFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ExchangeRateDifferencesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">VBIX:ExchangeRateDifferencesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_ExchangeRateDifferencesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">VBIX:ExchangeRateDifferencesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_InterestExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">VBIX:InterestExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_InterestExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">VBIX:InterestExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_IsraelTaxAuthorityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_IsraelTaxAuthorityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ViewbixIsraelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">VBIX:ViewbixIsraelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="NIS">
      <xbrli:measure>iso4217:ILS</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="xdx2ixbrl0230" toRefs="Footnote000255"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.15pt; text-align: center; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.15pt; text-align: center; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: center; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.15pt; text-align: center; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_902_edei--DocumentType_c20210101__20211231_zMcx7OEDLYa7"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 12pt; text-align: justify; text-indent: -0.5pt"><span id="xdx_905_edei--DocumentAnnualReport_c20210101__20211231_zd38v49vy26c"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleantrue" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 6.55pt; text-align: center; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal year ended <span id="xdx_90A_edei--DocumentPeriodEndDate_c20210101__20211231_zXgm7QQ9I1lk"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><span id="xdx_90D_edei--CurrentFiscalYearEndDate_c20210101__20211231_zlQQZd1UCgna"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate">December 31</ix:nonNumeric></span>, <span id="xdx_90D_edei--DocumentFiscalYearFocus_c20210101__20211231_z6Rr2ZiK5Gzc"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:DocumentFiscalYearFocus">2021</ix:nonNumeric></span></ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--DocumentTransitionReport_c20210101__20211231_ziJdx8csyz52"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span>
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 6.55pt; text-align: center; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
file number <span id="xdx_906_edei--EntityFileNumber_c20210101__20211231_z51Kp0XB5Y62"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityFileNumber">000-15746</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.15pt; text-align: center; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90D_edei--EntityRegistrantName_c20210101__20211231_z94zh1McibEd"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityRegistrantName">VIEWBIX
INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 6.55pt; text-align: center; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant As Specified In Its Charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20210101__20211231_zF069NrWQ43h"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20210101__20211231_zfZii1UF6fDj"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityTaxIdentificationNumber">68-0080601</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    of Incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--EntityAddressAddressLine1_c20210101__20211231_zT1TAZRQIrV8"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressAddressLine1">11
    Derech Menachem Begin Street</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressCityOrTown_c20210101__20211231_zwBzCaIRAvc4"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressCityOrTown">Ramat Gan</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressCountry_c20210101__20211231_zCDmTxFDACSl"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">Israel</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--EntityAddressPostalZipCode_c20210101__20211231_ziXfJMBFOOLf"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressPostalZipCode">5268104</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of Principal Executive Offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ZIP
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 6.55pt; text-align: center; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
Telephone Number, Including Area Code: <span id="xdx_901_edei--CityAreaCode_c20210101__20211231_zFAg3HxTnzhb"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:CityAreaCode">+972</ix:nonNumeric></span> <span id="xdx_90C_edei--LocalPhoneNumber_c20210101__20211231_zDMvEnnR6lKi"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:LocalPhoneNumber">9-774-1505</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 42%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--Security12bTitle_c20210101__20211231_zkrTH9tBM9Pd"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:Security12bTitle">Common
    Stock, Par Value $0.0001</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--TradingSymbol_c20210101__20211231_zeKvlRwYfaPi"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:TradingSymbol">VBIX</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>OTCQB</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#9744; <span id="xdx_90E_edei--EntityWellKnownSeasonedIssuer_c20210101__20211231_zxnzB517udR2"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span>
&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes &#9744; <span id="xdx_905_edei--EntityVoluntaryFilers_c20210101__20211231_zF9FaT8ssiX6"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span>
&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. <span id="xdx_90E_edei--EntityCurrentReportingStatus_c20210101__20211231_zwaIUuhP08x5"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> &#9746;  No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes   &#9744; <span id="xdx_90D_edei--EntityInteractiveDataCurrent_c20210101__20211231_zrxwjp4nXju8"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityInteractiveDataCurrent">No</ix:nonNumeric></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;,
&#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityFilerCategory_c20210101__20211231_zAmW69177Zaa"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-Accelerated
    filer</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--EntitySmallBusiness_c20210101__20211231_zJQQnnOCaTfj"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">Emerging growth company</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20210101__20211231_zM7ngOJj4tC5"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes &#9744;
No &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report. Yes   &#9744; No<span id="xdx_90E_edei--IcfrAuditorAttestationFlag_c20210101__20211231_zjvYV1lcV3ai"> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleantrue" name="dei:IcfrAuditorAttestationFlag">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes &#9744; <span id="xdx_908_edei--EntityShellCompany_c20210101__20211231_z4PhAAvbaXed"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span>
&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate market value of the registrant&#8217;s common stock held by non-affiliates of the registrant was $<span id="xdx_90D_edei--EntityPublicFloat_iI_c20210630_zyFV0qLDUR1d"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">815,277</ix:nonFraction></span> as of June 30, 2021,
based upon the closing price of the common stock on that date, which was $0.0401.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 17, 2022, there were <span id="xdx_900_edei--EntityCommonStockSharesOutstanding_iI_pid_c20220317_zcFCf7sDNxo1"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-03-17" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,753,669</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, par value $0.0001 per
share (&#8220;Common Stock&#8221;) outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 4pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: center; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#a_001">PART I</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_002">DESCRIPTION OF BUSINESS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    1A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_003">RISK FACTORS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">7</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    1B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_004">UNRESOLVED STAFF COMMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">18</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_005">PROPERTIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">18</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_006">LEGAL PROCEEDINGS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">18</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_007">MINE SAFETY DISCLOSURES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#a_008">PART II</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_009">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASE OF EQUITY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    6.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_010">SELECTED FINANCIAL DATA</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    7.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_011">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND PLAN OF OPERATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    7A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_012">QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    8.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_013">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    9.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_014">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    9A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_015">CONTROLS AND PROCEDURES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    9B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_016">OTHER INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#a_017">PART III</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    10.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_018">DIRECTORS EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">27</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    11.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_019">EXECUTIVE COMPENSATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    12.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_020">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">29</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    13.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_021">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    14.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_022">PRINCIPAL ACCOUNTING FEES AND SERVICES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#a_023">PART IV</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    15.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_024">EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">31</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: center; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cautionary
Statement regarding Forward-Looking Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Annual Report on Form 10-K includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended. The Registrant has based these forward-looking statements on its
current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties
and assumptions about the Registrant that may cause its actual results, levels of activity, performance or achievements to be materially
different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements.
In some cases, you can identify forward-looking statements by terminology such as &#8220;may&#8221;, &#8220;will&#8221;, &#8220;should&#8221;,
&#8220;could&#8221;, &#8220;would&#8221;, &#8220;expect&#8221;, &#8220;plan&#8221;, &#8220;anticipate&#8221;, &#8220;believe&#8221;,
&#8220;estimate&#8221;, &#8220;continue&#8221;, or the negative of such terms or other similar expressions. Factors that might cause
or contribute to such a discrepancy include, but are not limited to, those described in this Annual Report on Form 10-K and in the Registrant&#8217;s
other Securities and Exchange Commission filings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: center; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_001"></span>PART
I</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_002"></span>ITEM
1. DESCRIPTION OF BUSINESS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Overview
and recent developments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Viewbix
Inc. (f/k/a Virtual Crypto Technologies, Inc., f/k/a Emerald Medical Applications Corp.) (the &#8220;Registrant&#8221;, &#8220;Viewbix&#8221;
or the &#8220;Company&#8221;) was incorporated in the State of Ohio in 1989 under a predecessor name, Zaxis International, Inc. (&#8220;Zaxis&#8221;).
On August 25, 1995, Zaxis merged with a subsidiary of The InFerGene Company, a Delaware corporation, which entity changed its name to
Zaxis International, Inc. and the Company was reincorporated in Delaware under the name of Zaxis International, Inc. On December 30,
2014, Zaxis entered into an agreement with Emerald Medical Applications Ltd., a private limited liability company organized under the
laws of the State of Israel (&#8220;Emerald Israel&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 16, 2015, Zaxis and Emerald Israel executed a share exchange agreement, which closed on July 14, 2015, and Emerald Israel became
the Company&#8217;s wholly-owned subsidiary. Emerald Israel was engaged in the business of developing Emerald Israel&#8217;s DermaCompare
technology and the development, sale and service of imaging solutions utilizing its DermaCompare software for use in derma imaging and
analytics for the detection of skin cancer. On January 29, 2018, the Company ceased the DermaCompare operations of its former subsidiary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 17, 2018, the Company formed a new wholly-owned subsidiary under the laws of the State of Israel, Virtual Crypto Technologies
Ltd. (the &#8220;VCT Israel&#8221;), to develop and market software and hardware products facilitating and supporting the purchase and/or
sale of cryptocurrencies through ATMs, tablets, personal computers (&#8220;PCs&#8221;) and/or mobile devices. On February 12, 2018, the
Registrant filed a definitive information statement to change its name from Emerald Medical Applications Corp. to Virtual Crypto Technologies,
Inc. to reflect its new operations and business focus, and, effective as of March 7, 2018, the Financial Industry Regulatory Authority
(&#8220;FINRA&#8221;) approved the Registrant&#8217;s name change and its trading symbol was changed from &#8220;MRLA&#8221; to &#8220;VRCP&#8221;
on the OTCQB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transaction
with Gix Internet Ltd.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 7, 2019, the Registrant entered into a share exchange agreement (the &#8220;Share Exchange Agreement&#8221;) with Gix Internet
Ltd., formerly known as Algomizer Ltd. (TASE:GIX), a company organized under the laws of the State of Israel (&#8220;Gix Internet&#8221;
or &#8220;Parent Company&#8221;), pursuant to which on July 25, 2019 (the &#8220;Closing Date&#8221;) Gix Internet assigned, transferred
and delivered its 99.83% holdings in Viewbix Ltd. (&#8220;Viewbix Israel&#8221;) to the Company in exchange for shares of restricted
Common Stock, representing 65% of the issued and outstanding share capital of the Company on a fully diluted basis as of the Closing
Date, following the conversion of certain convertible notes of the Company and excluding certain warrants to purchase shares of the Common
Stock expiring in 2020 and additional warrants as further described below (the &#8220;Fully Diluted Share Capital&#8221;). In addition,
upon the earlier of: (a) the launch of a live video product to an American consumer in the United States by Viewbix Israel, or (b) the
launch of an interactive television product to an American consumer in the United States by Viewbix Israel, the Company will issue to
Gix Internet an additional 1,642,193 shares of restricted Common Stock of the Company representing 5% of the Fully Diluted Share Capital
immediately following the Closing Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 24, 2019, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of Delaware
reflecting its name change from Virtual Crypto Technologies, Inc. to Viewbix Inc. to reflect its new operations and business focus and,
effective on August 7, 2019, FINRA approved the Registrant&#8217;s name change and its trading symbol was changed from &#8220;VRCP&#8221;
to &#8220;VBIX&#8221; on the OTCQB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the Closing Date, (i) the Company issued 20,281,085 shares of its Common Stock to Gix Internet in exchange for consideration consisting
of 99.83% holdings in Viewbix Israel, and (ii) convertible notes representing 3,434,889 shares of Common Stock then currently issued
to holders were converted. The shares of Common Stock were issued under Regulation S. The Company also issued a total of 7,298,636 warrants
to Gix Internet to purchase shares of Common Stock, whereby (i) 3,649,318 of such warrants were issued with an exercise price of $0.48,
and (ii) 3,649,318 of such warrants were issued with an exercise price of $0.80.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the Closing Date, Viewbix Israel became a subsidiary of the Registrant. Viewbix Israel was incorporated in February 2006 in Israel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: 34.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 27, 2020, VCT Israel was sold to a third party for NIS 50,000 ($14,459).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Merger
with Gix Media Ltd.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 5, 2021, the Company entered into a certain Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with Gix Media
Ltd., an Israeli company and the majority-owned subsidiary of Gix Internet, in the field of MarTech (Marketing Technology) solutions,
primarily search and content monetization (&#8220;Gix Media&#8221;) and Vmedia Merger Sub Ltd., an Israeli company and wholly-owned subsidiary
of the Company (&#8220;Merger Sub&#8221;), pursuant to which, following the Merger (as defined herein), and upon satisfaction of additional
closing conditions, Merger Sub will merge with and into Gix Media, with Gix Media being the surviving entity and wholly-owned subsidiary
of the Company (the &#8220;Gix Merger&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms and conditions of the Merger Agreement, at the Merger Effective Date (as defined in the Merger Agreement) all outstanding
ordinary shares of Gix Media, having no par value (the &#8220;Gix Media Shares&#8221;) will be converted into shares of Common Stock,
such that immediately following the Gix Merger, holders of Gix Media Shares will hold 90% of the Company&#8217;s capital stock on a fully
diluted basis. <span style="background-color: white">The Merger Agreement also contains customary representations, warranties and covenants
made by each of the Company, Gix Media and Merger Sub.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 28.35pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the Gix Merger, the board of directors of the Company is expected to consist of six (6) directors and will be comprised of four (4) new
directors to be appointed by Gix Media, who will join the Company&#8217;s two currently-serving directors, Amihay Hadad and Alon Dayan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 28.35pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 21, 2021, the shareholders of each of Gix Media and Merger Sub approved the Merger Agreement. Consummation of the Gix Merger
is subject to certain additional closing conditions, including, among other things, (i) the Company filing an amendment to its certificate
of incorporation to change the Company&#8217;s name to &#8220;Gix Media, Inc.&#8221;, (ii) obtaining approval from certain third parties,
including the approval of Bank Leumi due to certain liens registered in its favor against ordinary shares of Gix Media; (iii) conversion
of the Company&#8217;s outstanding convertible instruments into restricted shares of Common Stock and (iv) obtaining a tax pre-ruling
from the Israeli Tax Authority relating to the Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with Gix Merger, on February 13, 2022, the requisite majority of the Company&#8217;s stockholders approved certain amendments
to the Company&#8217;s certificate of incorporation, including, but not limited to (i) a name change from &#8220;Viewbix Inc.&#8221;
to &#8220;Gix Media, Inc.&#8221;, (ii) a reverse stock split of the Company&#8217;s common Stock at a ratio of 1-for-28 (the &#8220;Planned
Reverse Split&#8221;), (iii) a staggered board structure, and (iv) certain other provisions therein. The Company intends to effect the
foregoing amended and restated certificate of incorporation upon the closing of the Gix Merger. Additionally, on February 25, 2022, the
Company filed a Schedule 14C Information Statement with the SEC, whereby it reported the foregoing approvals by the requisite majority
of the Company&#8217;s stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Viewbix
Business Overview</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Viewbix
is an interactive video technology and data platform that provides its client with deep insights into their video marketing performance
as well as the effectiveness of its messaging. Viewbix allows companies to add a layer of interactive content on top of a video that
allows viewers to engage and interact with the video. The platform measures exactly when a viewer takes an action while watching a video
and collects and reports the results to the client.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Viewbix
developed the interactive video platform based on a Software as a Service (&#8220;SaaS&#8221;) business model with interactive
elements, and the ability to collect and analyze information about each interactive action performed during the viewing of the video
clip. The interactive elements and information gathered allows the client to analyze user viewing habits and optimize in real-time
throughout the campaign, while increasing the effectiveness of online and live video marketing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Viewbix
has adapted its technology platform to work on most nonproprietary platforms on the Internet, including, but not limited to, online video
campaigns, brand and image videos, online tutorials, live and real-time video streaming (e.g. music concerts and sporting events), video
presentations, and more. Using the Viewbix platform, video creators can integrate advances features into their videos, specifically the
inclusion of &#8220;click&#8221; buttons that trigger a particular action, into a given video, like the insertion of a smart form for
retrieving the contact information of the viewer. Viewbix then collects all the data around the cross section of the viewing data and
engagement data and offers its clients the opportunity to download and analyze the results. Viewbix also offers a full service option
where the Viewbix account managers will analyze the data and report results and suggestions to its clients.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: 27.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, the Company initiated certain cost reduction measures during fiscal year-ended December 31, 2020. On January 1, 2020,
each of the Company&#8217;s former Chief Executive Officer and Chief Operating Officer tendered their resignations from their respective
positions. Moreover, due to the Company&#8217;s failure to meet predetermined sales targets set forth in the Share Exchange Agreement,
the Company determined to reduce the size of its sales team and, likewise, the R&amp;D team was replaced with a more cost-effective consultant.
These decisions, and future decisions related to cost-reduction measures, may impact the Company&#8217;s ability to sell and support
its products in the future and, accordingly, may materially impact the Company&#8217;s business operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Industry
Overview</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: 27.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Video
marketing remains one of the fastest growing industries, and, accordingly is increasingly crowded with competition. According to a study
published by Cisco, by 2022 online videos will represent 82% of online consumer traffic. Globally, three trillion minutes (or five million
years) of video content will cross the Internet each month by 2022, which is the equivalent of 1.1 million minutes of video streamed
or downloaded every second.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: 27.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to an additional study published by Statista, ad spending is expected to show an annual growth rate of 11%, resulting in a projected
market volume of $162,242 million by 2026. In the video advertising segment, it is expected that $136,486 million will be generated
through mobile in 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: 27.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Competition</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
there are many companies that offer hosting and streaming services, Viewbix focuses on providing expanded value to its clients that reaches
beyond the hosting and streaming platforms. Viewbix has several direct competitors, including Hapyak, which operates primarily via websites,
and Innovid, which focuses on advertisements. Additionally, video hosting companies, such as Wistia and Vidyard, both offer certain interactive
elements similar to Viewbix. However, Viewbix&#8217;s proprietary component is its focus on interactivity and deep data, whose
results can thereafter be analyzed and applied.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: 27.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Intellectual
Property and Other Proprietary Rights</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
commercial success depends, in part, on obtaining and maintaining patent and other intellectual property protection, in the United States
and internationally, for the technologies used in our products. We cannot be sure that any of our patents will be commercially useful
in protecting our technology. Our commercial success also depends in part on our non-infringement of the patents or proprietary rights
of third parties. The patent positions can be highly uncertain and involve complex and evolving legal and factual questions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have four patents that have been granted to us in the U.S. which we consider material to our business and operating success, including
the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    Patent No. 10,467,684: the granted patent relates to novel techniques implemented by Viewbix which enables businesses to configure
    their video players to incorporate interactivity functions, such as call-to-actions, into their video publishing and delivery workflows;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    Patent No. 8,706,562: the granted patent relates to video e-commerce networking, modules and methods used to configure a video or
    playlist that is delivered to viewers where the content displayed in the video player is dynamic and can be automatically customized
    based on the publisher site;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    Patent No. 8,706,558: the granted patent relates video e-commerce networking, modules and methods to display a video or playlist
    that is delivered to a viewer where the content displayed in the video player is dynamic and automatically customized based on the
    publisher site; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    Patent No. 9,792,645: the granted patent provides a unique method to facilitate video interactions between a publisher and end users,
    and measures the data produced through that interaction.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also protect our proprietary technology and processes, in part, by confidentiality and invention assignment agreements with our employees,
consultants, scientific advisors and other contractors. These agreements may be breached, and we may not have adequate remedies for any
breach. We also rely on trade secrets to protect our product candidates. However, our trade secrets may otherwise become known or be
independently discovered by competitors. To the extent that our employees, consultants, scientific advisors or other contractors use
intellectual property owned by others in their work for us, disputes may arise as to the rights in related or resulting know-how and
inventions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Product
Development</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Viewbix
focuses its R&amp;D efforts on the expansion of its interactive live capabilities by collecting the engagement data for each session
and relating back to a live stream, which is aimed to enhance clients&#8217; feedback on its stream for both real time and future stream
optimizations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Employees</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, Viewbix has two employees in management and finance in Israel. Additionally, Viewbix retains the services of two
R&amp;D service providers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_003"></span>ITEM
1A. RISK FACTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
shares of our Common Stock are highly speculative in nature, involve a high degree of risk and should be purchased only by persons who
can afford to lose their entire amount invested in the Common Stock. Accordingly, prospective investors should carefully consider, along
with other matters referred to herein, the following risk factors in evaluating our business before purchasing any shares of Common Stock.
If any of the following risks actually occurs, our business, financial condition or operating results could be materially adversely affected.
In such case, you may lose all or part of your investment. You should carefully consider the risks described below and the other information
in this Prospectus before investing in our Common Stock.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
Risk Factors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is subject to numerous risks and uncertainties, including those highlighted in the section titled &#8220;Risk Factors&#8221;
immediately following this prospectus summary. These risks include, among others, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    initiated certain cost-reduction measures during the previous fiscal year, which could have long-term adverse effects on our business
    and we may not realize the operational or financial benefits from such actions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    COVID-19 pandemic may adversely affect our business, financial condition, liquidity and results of operations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    success depends, in part, upon the continued demand of video as an integral part of corporate marketing and internal communications
    plans and the continued growth and acceptance of videos as effective alternatives to traditional online and offline marketing products
    and services;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    to our evolving business model and rapid changes in the Internet and the nature of services, it is difficult to accurately predict
    our future performance and may be difficult to increase revenue or profitability;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    customers may reduce or terminate their business relationship with us at any time. If customers representing a significant portion
    of our revenue reduce or terminate their relationship with us, it could have a material adverse effect on our business, results of
    operations and financial condition;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    and established internet and technology companies, such as Google and Facebook, play a substantial role in the digital advertising
    market and may significantly impair our ability to operate in this industry;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    advertising/marketing industry is highly competitive. If we cannot compete effectively in this market, our revenues are likely to
    decline;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we cannot enforce and protect our intellectual property rights, our business could be adversely affected;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may in the future be, subject to claims of intellectual property infringement that could adversely affect our business;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent
    terms may be inadequate to protect our competitive position for an adequate amount of time;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be able to protect our systems, technology and infrastructure from cyberattacks;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    business depends on our ability to collect and use data, and any limitation on the collection and use of this data could significantly
    diminish the value of our platform and cause us to lose customers and revenue;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of Common Stock issuable upon the conversion of warrants may substantially increase the number of shares of Common Stock available
    for sale in the public market and depress the price of our Common Stock;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Our
    Planned Reverse Split may not result in a proportional increase in the per share price of our Common Stock;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are subject to compliance with securities law, which exposes us to potential liabilities, including potential rescission rights;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    availability of a large number of authorized but unissued shares of Common Stock may, upon their issuance, lead to dilution of existing
    stockholders;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have never paid cash dividends and do not anticipate doing so in the foreseeable future;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Common Stock is subject to the &#8220;Penny Stock&#8221; rules of the SEC and the trading market in our stock is limited, which makes
    transactions in our stock cumbersome and may reduce the value of an investment;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
    our Common Stock is thinly traded, sale of your holding may take a considerable amount of time;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of Common Stock eligible for future sale may adversely affect the market;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we fail to maintain effective internal controls over financial reporting, the price of our Common Stock may be adversely affected;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are required to comply with certain provisions of Section 404 of the Sarbanes-Oxley Act of 2002 and if we fail to comply in a timely
    manner, our business could be harmed and our stock price could decline;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    annual and quarterly results may fluctuate, which may cause substantial fluctuations in our Common Stock price;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware
    law contains provisions that could discourage, delay or prevent a change in control of our company, prevent attempts to replace or
    remove current management and reduce the market price of our stock;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Political,
    economic and military instability in Israel may impede our ability to operate and harm our financial results; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    rate fluctuations between foreign currencies and the U.S. Dollar may negatively affect our earnings.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Associated with Our Business and Industry</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
initiated certain cost-reduction measures during the previous fiscal year, which could have long-term adverse effects on our business
and we may not realize the operational or financial benefits from such actions.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 19.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
initiated certain cost-reduction measures during the previous fiscal year, and we may engage in similar activities in the future. This
decision may distract management, could slow improvements in our platform and limit our ability to attract customers. It remains unclear
how and to what extent this decision will impact our future business and operating success.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
COVID-19 pandemic may negatively impact the global economy in a significant manner for an extended period of time, and also adversely
affect our business and operating result</i></b>s.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
COVID-19 pandemic has resulted in a widespread health crisis that has adversely affected businesses, economies and financial markets
worldwide, placed constraints on the operations of businesses, decreased consumer mobility and activity, and caused significant economic
volatility in the United States, Israel and international capital markets. The COVID-19 pandemic has caused an economic recession, high
unemployment rates and other disruptions, both in the United States, Israel and the rest of the world. The COVID-19 pandemic has not
yet currently adversely affected our business, however, any of these impacts, including the prolonged continuation of these impacts,
could in the future, adversely affect our business and operating results and heighten many of the other risks described in these &#8220;Risk
Factors.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
success depends, in part, upon the continued demand of video as an integral part of corporate marketing and internal communications plans
and the continued growth and acceptance of videos as effective alternatives to traditional online and offline marketing products and
services.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
provide a platform that allows companies to understand what messages are resonating with their video viewers and how to leverage that
data to enrich and empower a more effective video experience. Our revenues are derived from the sale of our platform. If the demand for
video advertising does not continue to grow or customers do not embrace our platform, this could have a material adverse effect on our
business and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success also depends, in part, on our ability to compete for a share of available video advertising/marketing expenditures as more traditional
offline and emerging media companies continue to enter the online advertising/marketing market, as well as on the continued growth and
acceptance of online advertising generally. If for any reason online advertising is not perceived as effective (relative to traditional
advertising), web browsers, software programs and/or other applications that limit or prevent advertising from being displayed become
commonplace and/or the industry fails to effectively manage click fraud, the market for online advertising will be negatively impacted.
Any lack of growth in the market for online advertising/marketing (particularly for paid listings) could adversely affect our business,
financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Due
to our evolving business model and rapid changes in the Internet and the nature of services, it is difficult to accurately predict our
future performance and may be difficult to increase revenue or profitability.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
developed our platform based on a SaaS business model. We do not have an extensive history of ongoing operations in using our
business model from which to predict our future performance, and making such predictions, particularly with regard to the effect of our
efforts to aggressively increase the distribution and profitability is very complex and challenging. If we are unable to continuously
improve our platform, this could have a negative effect on our competitiveness and ability to service and attract customers. If we are
unsuccessful in doing so in a timely fashion, we may not be able to achieve revenue growth or increase our profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 27.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
customers may reduce or terminate their business relationship with us at any time. If customers representing a significant portion of
our revenue reduce or terminate their relationship with us, it could have a material adverse effect on our business, results of operations
and financial condition.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 27.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
generally engage with two types of customers: small companies who change from time to time and a number of large companies with whom
the engagement is for shorter periods of time. We do not enter into long-term contracts with our customers, and such customers do business
with us on a non-exclusive basis. Accordingly, our business is highly vulnerable to adverse economic conditions, market evolution and
development of new or more compelling offerings by our competitors, which could either lead to reduced advertising spend generally or
motivate our current or potential customers to migrate to our competitors. Any reduction in spending by, or loss of, existing or potential
customers would negatively impact our revenue and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 27.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
the discretionary, non-exclusive nature of our relationships with customers subjects us to increased pricing pressure. Although we believe
our rates are competitive, our competitors may be able to offer more favorable pricing or other advantageous terms. As a result, we may
be compelled to reduce our rates or offer other incentives in order to maintain our current customers and attract new customers. If a
significant number of customers are able to compel us to charge lower rates or provide rate concessions or incentives, there is no assurance
that we would be able to compensate for such price reductions or conserve our profit margins.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to our Competition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Large
and established internet and technology companies, such as Google and Facebook, play a substantial role in the digital advertising market
and may significantly impair our ability to operate in this industry.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 27.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Google
is a substantial player in the digital advertising market along with other players such as Microsoft. In addition, a small number of
social network companies, such as Facebook, account for a large portion of digital advertising budgets. The high concentration of power
among Google, Facebook and some other large market participants causes us to be subject to any unilateral changes they may make with
respect to advertising on their respective platforms, which may be more lucrative than alternative methods of advertising or partnerships
with other publishers that are not subject to such changes. Furthermore, we could have limited ability to respond to, and adjust for,
changes implemented by large market participants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
companies, along with other large and established Internet and technology companies, may also leverage their power to make changes to
their web browsers, operating systems, platforms, networks or other products or services in a way that impacts the entire digital advertising
marketplace.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 27.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
advertising/marketing industry is highly competitive. If we cannot compete effectively in this market, our revenues are likely to decline.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 27.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face intense competition in the marketplace. We operate in a dynamic market that is subject to rapid development and introduction of
new technologies, products and solutions, changing branding objectives, evolving customer demands and industry guidelines, all of which
affect our ability to remain competitive. There are a large number of companies and advertising technology companies that offer products
or services similar to ours and that compete with us for finite advertising budgets. There is also a large number of niche companies
that are competitive with us, as they provide a subset of the services that we provide. Some of our existing and potential competitors
may be better established, benefit from greater name recognition, may offer solutions and technologies that we do not offer or that are
more evolved than ours, and may have significantly more financial, technical, sales and marketing resources than we do. In addition,
some competitors, particularly those with a larger and more diversified revenue base and a broader offering, may have greater flexibility
than we do to compete aggressively on the basis of price and other contract terms as well as respond to market changes. Additionally,
companies that do not currently compete with us in this space may change their services to be competitive if there is a revenue opportunity,
and new or stronger competitors may emerge through consolidations or acquisitions. If our platform is not perceived as competitively
differentiated or we fail to develop adequately to meet market evolution, we could lose customers and market share or be compelled to
reduce our prices and harm our operational results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to our Intellectual Property</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we cannot enforce and protect our intellectual property rights, our business could be adversely affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 27.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on patents, copyright, trademark, domain name and trade secret laws in the United States and similar laws in other countries, as
well as licenses and other agreements with our employees, and other parties, to establish and maintain our intellectual property rights
in the technology, products and services used in our operations. These laws and agreements may not guarantee that our intellectual property
rights will be protected and our intellectual property rights could be challenged or invalidated. Amendments to or interpretations of
U.S. patent laws or new rulings around U.S. patent laws may adversely impact our ability to protect our new technologies, content, products
and services and to defend against claims of patent infringement. In addition, such intellectual property rights may not be sufficient
to permit us to take advantage of current industry trends or otherwise to provide competitive advantages, which could result in costly
redesign efforts, discontinuance of offerings, decreased traffic and associated revenue or otherwise adversely affect our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may in the future be, subject to claims of intellectual property infringement that could adversely affect our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 27.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
companies (including patent holding companies) and individuals own patents, copyrights, trademarks, and trade secrets and frequently
enter into litigation based on allegations of infringement or other violations of intellectual property rights. As we develop and offer
our platform through various distribution channels we may experience an increase in the number of intellectual property claims against
us. These claims, whether meritorious or not, may result in litigation, may be time-consuming and costly to resolve, and may require
expensive changes in our methods of doing business. These intellectual property infringement claims may require us to enter into royalty
or licensing agreements on unfavorable terms or to incur substantial monetary liability. Additionally, these claims may result in our
being enjoined preliminarily or permanently from further use of certain intellectual property or may require us to cease or significantly
alter certain of our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of our commercial agreements may require us to indemnify third parties against intellectual property infringement claims, which may require
us to use substantial resources to defend against or settle such claims or, potentially, to pay damages. These third parties may also
discontinue the use of our platform, as a result of injunctions or otherwise, which could result in loss of revenues and adversely impact
our business. Additionally, we may be exposed to liability or substantially increased costs if a commercial partner does not honor its
contractual obligation to indemnify us for intellectual property infringement claims made by third parties or if any amounts received
are not adequate to cover our liabilities or the costs associated with defense of such claims. The occurrence of any of these events
could adversely affect our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: 34.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Patent
terms may be inadequate to protect our competitive position for an adequate amount of time.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents
have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally
20 years from its earliest U.S. non-provisional or international patent application filing date. Various extensions may be available,
but the life of a patent, and the protection it affords, is limited. Even if patents covering our products are obtained, once the patent
life has expired, we may be open to competition from competitive products, including generics. As a result, our patent portfolio may
not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Cyber and Data Collection</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not be able to protect our systems, technology and infrastructure from cyberattacks.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be under attack by perpetrators of malicious technology-related events, such as the use of botnets, malware or other destructive
or disruptive software, distributed denial of service attacks, phishing, attempts to misappropriate user information and other similar
malicious activities. The incidence of events of this nature (or any combination thereof) is on the rise worldwide. While we continuously
develop and maintain systems designed to detect and prevent events of this nature from impacting our platform, we have invested (and
continue to invest) heavily in these efforts. These efforts are costly and require ongoing monitoring and updating as technologies change
and efforts to overcome preventative security measures become more sophisticated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 27.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 27.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
event of this nature that we experience could damage our systems, technology and infrastructure, prevent us from providing our services,
compromise the integrity of our services, damage our reputation and/or be costly to remedy, as well as subject us to investigations by
regulatory authorities, fines and/or litigation that could result in liability to third parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 27.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business depends on our ability to collect and use data, and any limitation on the collection and use of this data could significantly
diminish the value of our platform and cause us to lose customers and revenue.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 27.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
platform receives, collects, stores, processes, transfers and uses certain data about how viewers engaged with videos and helps companies
to leverage that data to become a better story teller and optimize the videos. Our ability to access and utilize such data is crucial.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 27.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to either collect or use data could be restricted by new laws or regulations. We are subject to numerous federal, state, local,
and international laws, directives and regulations regarding privacy, data protection, and data security and the collection, storing,
sharing, use, processing, transfer, disclosure and protection of personal information and other data, the scope of which are changing,
subject to differing interpretations, and may be inconsistent among jurisdictions or conflict with other legal and regulatory requirements.
We are also subject to certain contractual obligations to third parties related to privacy, data protection and data security. We strive
to comply with our applicable policies and applicable laws, regulations, contractual obligations and other legal obligations relating
to privacy, data protection and data security to the extent possible. However, the regulatory framework for privacy, data protection
and data security worldwide is, and is likely to remain for the foreseeable future, uncertain and complex, and it is possible that these
or other actual or alleged obligations may be interpreted and applied in a manner that we do not anticipate or that is inconsistent from
one jurisdiction to another and may conflict with other legal obligations or our practices. Further, any significant change to applicable
laws, regulations or industry practices regarding the collection, use, retention, security or disclosure of data, or their interpretation,
or any changes regarding the manner in which the consent of users or other data subjects for the collection, use, retention or disclosure
of such data must be obtained, could increase our costs and require us to modify our services and features, possibly in a material manner,
which we may be unable to complete, and may limit our ability to store and process user data or develop new services and features.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we were found in violation of any applicable laws or regulations relating to privacy, data protection or security, our business may be
materially and adversely affected and we would likely have to change our business practices and potentially the services and features
available through our platform. In addition, these laws and regulations could impose significant costs on us and could constrain our
ability to use and process data in manners that may be commercially desirable. In addition, if a breach of data security were to occur
or to be alleged to have occurred, if any violation of laws and regulations relating to privacy, data protection or data security were
to be alleged, or if we had any actual or alleged defect in our safeguards or practices relating to privacy, data protection, or data
security, our solutions may be perceived as less desirable and our business, prospects, financial condition and results of operations
could be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also expect that there will continue to be new laws, regulations and industry standards concerning privacy, data protection and information
security proposed and enacted in various jurisdictions. For example, the European Union&#8217;s (&#8220;EU&#8221;), data protection landscape
is currently unstable, resulting in possible significant operational costs for internal compliance and risks to our business. The EU
has adopted the General Data Protection Regulation (&#8220;GDPR&#8221;), which became effective in May 2018, and contains numerous requirements
and changes from previously existing EU laws, including more robust obligations on data processors and heavier documentation requirements
for data protection compliance programs by companies. Among other requirements, the GDPR regulates the transfer of personal data subject
to the GDPR to third countries that have not been found to provide adequate protection to such personal data, including the United States.
Failure to comply with the GDPR could result in penalties for noncompliance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the GDPR, the European Commission has another draft regulation in the approval process that focuses on a person&#8217;s right
to conduct a private life. The proposed legislation, known as the Regulation of Privacy and Electronic Communications (&#8220;ePrivacy
Regulation&#8221;), would replace the current the current ePrivacy Directive. Originally planned to be adopted and implemented at the
same time as the GDPR, the ePrivacy Regulation is still being negotiated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
in June 2018, California passed the California Consumer Privacy Act (&#8220;CCPA&#8221;), which provides new data privacy rights for
consumers and new operational requirements for companies. Specifically, the CCPA provides that covered companies must provide new disclosures
to California consumers and afford such consumers new abilities to opt-out of certain sales of personal information. The CCPA became
operative January 1, 2020. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches
that is expected to increase data breach litigation. We cannot fully predict the impact of the CCPA on our business or operations, but
it may require us to modify our data practices and policies and to incur substantial costs and expenses in an effort to comply. Some
observers have noted the CCPA could mark the beginning of a trend toward more stringent privacy legislation in the United States, which
could increase our potential liability and adversely affect our business. Further in March 2017, the United Kingdom (&#8220;U.K.&#8221;)
formally notified the European Council of its intention to leave the EU pursuant to Article 50 of the Treaty on European Union (&#8220;Brexit&#8221;).
The U.K. ceased to be an EU Member State on January 31, 2020, but enacted, a Data Protection Act substantially implementing the GDPR,
effective in May 2018, which was further amended to align more substantially with the GDPR following Brexit. It is unclear how U.K. data
protection laws or regulations will develop in the medium to longer term and how data transfers to and from the U.K. will be regulated.
In addition, some countries are considering or have enacted legislation requiring local storage and processing of data that could increase
the cost and complexity of delivering our services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, failure to comply with the Israeli Privacy Protection Law 1981, and its regulations as well as the guidelines of the Israeli
Privacy Protection Authority, may expose us to administrative fines, civil claims (including class actions) and in certain cases criminal
liability. Current pending legislation may result in a change of the current enforcement measures and sanctions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 27.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
failure or perceived failure by us to comply with our posted privacy policies, our privacy-related obligations to users or other third
parties, or any other legal obligations or regulatory requirements relating to privacy, data protection or data security may result in
governmental investigations or enforcement actions, litigation, claims or public statements against us by consumer advocacy groups or
others and could result in significant liability, cause our users to lose trust in us, and otherwise materially and adversely affect
our reputation and business. Furthermore, the costs of compliance with, and other burdens imposed by, the laws, regulations, other obligations
and policies that are applicable to the businesses of our users may limit the adoption and use of, and reduce the overall demand for,
our platform. Additionally, if third parties we work with violate applicable laws, regulations or contractual obligations, such violations
may put our users&#8217; data at risk, could result in governmental investigations or enforcement actions, fines, litigation, claims,
or public statements against us by consumer advocacy groups or others and could result in significant liability, cause our users to lose
trust in us and otherwise materially and adversely affect our reputation and business. Further, public scrutiny of, or complaints about,
technology companies or their data handling or data protection practices, even if unrelated to our business, industry or operations,
may lead to increased scrutiny of technology companies, including us, and may cause government agencies to enact additional regulatory
requirements, or to modify their enforcement or investigation activities, which may increase our costs and risks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shares
of Common Stock issuable upon the conversion of warrants may substantially increase the number of shares of Common Stock available for
sale in the public market and depress the price of our Common Stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, we had outstanding: (i) Class J Warrants exercisable to purchase 3,649,318 shares of Common Stock at an exercise
price of $0.48 per share of Common Stock; and (ii) Class K Warrants exercisable to purchase 3,649,318 shares of Common Stock, at an exercise
price of $0.80 per share of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent any of these warrants are exercised and any additional warrants are issued and subsequently exercised, there will be further
dilution to our stockholders. Until the warrants expire, these warrant holders will have an opportunity to profit from any increase in
the market price of our Common Stock without assuming the risks of ownership. Holders of options and warrants may exercise these securities
at a time when we could obtain additional capital on terms more favorable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price of the warrants will dilute the voting interest of the owners of presently outstanding shares of Common Stock by adding
a substantial number of additional shares of our Common Stock. We have reserved shares of Common Stock for issuance upon the exercise
of the warrants and may increase the shares reserved for these purposes in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of our Common Stock, which are issuable upon the exercise of any outstanding warrants may be sold in the public market pursuant
to Rule 144, if applicable. The sale of our Common Stock issued or issuable upon the exercise of the warrants and options described above,
or the perception that such sales could occur, may adversely affect the market price of our Common Stock.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
Planned Reverse Split may not result in a proportional increase in the per share price of our Common Stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to effect the Planned Reverse Split with the primary intent of increasing the price of our Common Stock in order to meet the initial
listing requirements of the Nasdaq Capital Market. The effect of the Planned Reverse Split on the market price for our Common Stock cannot
be accurately predicted. In particular, we cannot assure you that the proportionate increase in the price of our common stock immediately
after the Planned Reverse Split from the price for shares of our Common Stock immediately before the Planned Reverse Split will be maintained
for us to meet the initial listing requirements of the Nasdaq Capital Market or that the such market prices will be maintained for a
substantial period of time. It is not uncommon for the market price of a company&#8217;s common stock to decline in the period following
a reverse stock split. If the market price of our Common Stock declines following the Planned Reverse Split, the percentage decline may
be greater than would occur in the absence of the Planned Reverse Split. The market price of our Common Stock may also be affected by
other factors which may be unrelated to the Planned Reverse Split or the number of shares outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
because some investors may view the Planned Reverse Split negatively, we cannot assure you that the Planned Reverse Split will not adversely
impact the market price of our Common Stock. Accordingly, our total market capitalization after the Planned Reverse Split may be lower
than the market capitalization before the Planned Reverse Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to compliance with securities law, which exposes us to potential liabilities, including potential rescission rights.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have offered and sold our Common Stock to investors pursuant to certain exemptions from the registration requirements of the Securities
Act of 1933, as amended (the &#8220;Act&#8221;) as well as those of various state securities laws. The basis for relying on such exemptions
is factual; that is, the applicability of such exemptions depends upon our conduct and that of those persons contacting prospective investors
and making the offering. We have not received a legal opinion to the effect that any of our prior offerings were exempt from registration
under any federal or state law. Instead, we have relied upon the operative facts as the basis for such exemptions, including information
provided by investors themselves.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any prior offering did not qualify for such exemption, an investor would have the right to rescind its purchase of the securities if
it so desired. It is possible that if an investor should seek rescission, such investor would succeed. A similar situation prevails under
state law in those states where the securities may be offered without registration in reliance on the partial preemption from the registration
or qualification provisions of such state statutes. If investors were successful in seeking rescission, we would face severe financial
demands that could adversely affect our business and operations. Additionally, if we did not in fact qualify for the exemptions upon
which it has relied, we may become subject to significant fines and penalties imposed by the U.S. Securities and Exchange Commission
(the &#8220;SEC&#8221;) and state securities agencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
availability of a large number of authorized but unissued shares of Common Stock may, upon their issuance, lead to dilution of existing
stockholders.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are authorized to issue 490,000,000 shares of Common Stock, of which, as of December 31, 2021, 34,753,669 shares of Common Stock were
outstanding. Additional shares of Common Stock may be issued by our board of directors without further stockholder approval. The issuance
of large numbers of shares, possibly at below market prices, is likely to result in substantial dilution to the interests of other stockholders.
In addition, issuances of large numbers of shares of Common Stock may adversely affect the market price of our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation authorizes 10,000,000 shares of preferred stock, par value $0.0001 per share of which none were issued and
outstanding as of December 31, 2021. The board of directors is authorized to provide for the issuance of these unissued shares of preferred
stock in one or more series, and to fix the number of shares and to determine the rights, preferences and privileges thereof. Accordingly,
the board of directors may issue preferred stock which may convert into large numbers of shares of common stock and consequently lead
to further dilution of other stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have never paid cash dividends and do not anticipate doing so in the foreseeable future.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid cash dividends on our Common Shares. We currently plan to retain any earnings to finance the growth of our
business rather than to pay cash dividends. Payments of any cash dividends in the future will depend on our financial condition, results
of operations and capital requirements, as well as other factors deemed relevant by our board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
Common Stock is subject to the &#8220;Penny Stock&#8221; rules of the SEC and the trading market in our stock is limited, which makes
transactions in our stock cumbersome and may reduce the value of an investment.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC has adopted Rule 15g-9 which establishes the definition of a &#8220;penny stock,&#8221; for the purposes relevant to us, as any equity
security that has a market price of less than $5.00 per share or with an exercise price of less than $5.00 per share, subject to certain
exceptions. For any transaction involving a penny stock, unless exempt, the rules require:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
    a broker or dealer approve a person&#8217;s account for transactions in penny stocks; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    broker or dealer receives from the investor a written agreement to the transaction, setting forth the identity and quantity of the
    penny stock to be purchased.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to approve a person&#8217;s account for transactions in penny stocks, the broker or dealer must:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtain
    financial information and investment experience objectives of the person; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Make
    a reasonable determination that the transactions in penny stocks are suitable for that person and the person has sufficient knowledge
    and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the SEC relating to
the penny stock market, which, in highlight form:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sets
    forth the basis on which the broker or dealer made the suitability determination; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
    the broker or dealer received a signed, written agreement from the investor prior to the transaction.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
brokers may be less willing to execute transactions in securities subject to the &#8220;penny stock&#8221; rules. This may make it more
difficult for investors to dispose of our Common Stock and cause a decline in the market value of our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading and about the commissions
payable to both the broker-dealer and the registered representative, current quotations for the securities and the rights and remedies
available to an investor in cases of fraud in penny stock transactions. Finally, monthly statements have to be sent disclosing recent
price information for the penny stock held in the account and information on the limited market in penny stocks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Since
our Common Stock is thinly traded, sale of your holding may take a considerable amount of time.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of our Common Stock are thinly-traded on the OTCQB Market, meaning that the number of persons interested in purchasing our Common
Stock at or near bid prices at any given time may be relatively small or non-existent. As a consequence, there may be periods of several
days or more when trading activity in our shares is minimal or non-existent, as compared to a seasoned issuer which has a large and steady
volume of trading activity that will generally support continuous sales without an adverse effect on share price. We cannot give you
any assurance that a broader or more active public trading market for our Common Stock will develop or be sustained, or that current
trading levels will be sustained. Due to these conditions, we can give you no assurance that you will be able to sell your shares at
or near bid prices or at all if you need money or otherwise desire to liquidate your shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shares
of Common Stock eligible for future sale may adversely affect the market.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, certain of our stockholders may be eligible to sell all or some of their shares of Common Stock by means of ordinary brokerage
transactions in the open market pursuant to Rule 144 promulgated under the Act, subject to certain limitations. In general, pursuant
to amended Rule 144, non-affiliate stockholders may sell freely after six months, subject only to the current public information requirement.
Affiliates may sell after six months, subject to the Rule 144 volume, manner of sale (for equity securities), current public information
and notice requirements. Any substantial sales of our common stock pursuant to Rule 144 may have a material adverse effect on the market
price of our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we fail to maintain effective internal controls over financial reporting, the price of our Common Stock may be adversely affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
identified a material weakness in our period and our financial reporting process. Our internal control over financial reporting may have
material weaknesses and conditions that could require correction or remediation, the disclosure of which may have an adverse impact on
the price of our Common Stock. We are required to establish and maintain appropriate internal controls over financial reporting. Failure
to establish those controls, or any failure of those controls once established, could adversely affect our public disclosures regarding
our business, prospects, financial condition or results of operations. In addition, management&#8217;s assessment of internal controls
over financial reporting may identify material weaknesses and conditions that need to be addressed in our internal controls over financial
reporting or other matters that may raise concerns for investors. Any actual or perceived weaknesses and conditions that need to be addressed
in our internal control over financial reporting or disclosure of management&#8217;s assessment of our internal controls over financial
reporting may have an adverse impact on the price of our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are required to comply with certain provisions of Section 404 of the Sarbanes-Oxley Act of 2002 and if we fail to comply in a timely
manner, our business could be harmed and our stock price could decline.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rules
adopted by the SEC pursuant to Section 404 of the Sarbanes-Oxley Act of 2002 require an annual assessment of internal controls over financial
reporting, and for certain issuers an attestation of this assessment by the issuer&#8217;s independent registered public accounting firm.
The standards that must be met for management to assess the internal controls over financial reporting as effective are complex, and
require significant documentation, testing, and possible remediation to meet the detailed standards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to incur expenses and to devote resources to Section 404 compliance on an ongoing basis. It is difficult for us to predict how
long it will take or costly it will be to complete the assessment of the effectiveness of our internal control over financial reporting
for each year and to remediate any deficiencies in our internal control over financial reporting. As a result, we may not be able to
complete the assessment and remediation process on a timely basis. In addition, although attestation requirements by our independent
registered public accounting firm are not presently applicable to us, we could become subject to these requirements in the future and
we may encounter problems or delays in completing the implementation of any resulting changes to internal controls over financial reporting.
In the event that our Chief Executive Officer and Chief Financial Officer, which currently is the same individual, determines that our
internal control over financial reporting is not effective as defined under Section 404, we cannot predict how the market prices of our
shares of Common Stock will be affected; however, we believe that there is a risk that investor confidence and share value may be negatively
affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
annual and quarterly results may fluctuate, which may cause substantial fluctuations in our Common Stock price.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
annual and quarterly operating results may in the future fluctuate significantly depending on factors including the timing of purchase
orders, new product releases by us and other companies, gain or loss of significant customers, price discounting of our product, the
timing of expenditures, product delivery requirements and economic conditions. Revenues related to our product are required to be recognized
upon satisfaction of all applicable revenue recognition criteria. The recognition of revenues from our product is dependent on a number
of factors, including, but not limited to, the terms of any license agreement and the timing of implementation of our products by our
customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
unfavorable change in these or other factors could have a material adverse effect on our operating results for a particular quarter or
year, which may cause downward pressure on our common stock price. We expect quarterly and annual fluctuations to continue for the foreseeable
future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Delaware
law contains provisions that could discourage, delay or prevent a change in control of our company, prevent attempts to replace or remove
current management and reduce the market price of our stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provisions
in our certificate of incorporation and bylaws may discourage, delay or prevent a merger or acquisition involving us that our stockholders
may consider favorable. For example, our certificate of incorporation authorizes our board of directors to issue up to ten million shares
of &#8220;blank check&#8221; preferred stock. As a result, without further stockholder approval, the board of directors has the authority
to attach special rights, including voting and dividend rights, to this preferred stock. With these rights, preferred stockholders could
make it more difficult for a third party to acquire us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also subject to the anti-takeover provisions of the Delaware General Corporation Law (the &#8220;DGCL&#8221;). Under these provisions,
if anyone becomes an &#8220;interested stockholder,&#8221; we may not enter into a &#8220;business combination&#8221; with that person
for three years without special approval, which could discourage a third party from making a takeover offer and could delay or prevent
a change in control of us. An &#8220;interested stockholder&#8221; is, generally, a stockholder who owns 15% or more of our outstanding
voting stock or an affiliate of ours who has owned 15% or more of our outstanding voting stock during the past three years, subject to
certain exceptions as described in the DGCL.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to our Operations in Israel</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Political,
economic and military instability in Israel may impede our ability to operate and harm our financial results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
offices and management team are located in the Tel-Aviv metropolitan area, Israel. Accordingly, political, economic, and military conditions
in Israel and the surrounding region may directly affect our business and operations. In recent years, Israel has been engaged in sporadic
armed conflicts with Hamas, an Islamist terrorist group that controls the Gaza Strip, with Hezbollah, an Islamist terrorist group that
controls large portions of southern Lebanon, and with Iranian-backed military forces in Syria. In addition, Iran has threatened to attack
Israel and may be developing nuclear weapons. Some of these hostilities were accompanied by missiles being fired from the Gaza Strip
against civilian targets in various parts of Israel, including areas in which our employees and some of our consultants are located,
and negatively affected business conditions in Israel. Any hostilities involving Israel or the interruption or curtailment of trade between
Israel and its trading partners could adversely affect our operations and results of operations Our commercial insurance does not cover
losses that may occur as a result of events associated with war and terrorism. Although the Israeli government currently covers the reinstatement
value of direct damages that are caused by terrorist attacks or acts of war, we cannot assure you that this government coverage will
be maintained or that it will sufficiently cover our potential damages. Any losses or damages incurred by us could have a material adverse
effect on our business. Any armed conflicts or political instability in the region would likely negatively affect business conditions
and could harm our results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
in the past, the State of Israel and Israeli companies have been subjected to economic boycotts. Several countries still restrict business
with the State of Israel and with Israeli companies. These restrictive laws and policies may have an adverse impact on our operating
results, financial condition or the expansion of our business. A campaign of boycotts, divestment and sanctions has been undertaken against
Israel, which could also adversely impact our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, many Israeli citizens are obligated to perform several days, and in some cases more, of annual military reserve duty each year
until they reach the age of 40 (or older, for reservists who are military officers or who have certain occupations) and, in the event
of a military conflict, may be called to active duty. In response to increases in terrorist activity, there have been periods of significant
call-ups of military reservists. It is possible that there will be military reserve duty call-ups in the future. Our operations could
be disrupted by such call-ups, which may include the call-up of members of our management. Such disruption could materially adversely
affect our business, prospects, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>Exchange
rate fluctuations between foreign currencies and the U.S. Dollar may negatively affect our earnings.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Our
reporting and functional currency is the U.S. dollar. Our revenues are currently primarily payable in U.S. dollars and we expect our
future revenues to be denominated primarily in U.S. dollars and Euros. However, certain amount of our expenses are in NIS and as a result,
we are exposed to the currency fluctuation risks relating to the recording of our expenses in U.S. dollars. We may, in the future, decide
to enter into currency hedging transactions. These measures, however, may not adequately protect us from material adverse effects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_004"></span>ITEM
1B. UNRESOLVED STAFF COMMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_005"></span>ITEM
2. PROPERTIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_006"></span>ITEM
3. LEGAL PROCEEDING </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results
of operations, except as set forth below. There is no action, suit, proceeding, inquiry or investigation before or by any court, public
board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of the Company,
threatened against or affecting the Company, our Common Stock, our officers or directors in their capacities as such, in which an adverse
decision could have a material adverse effect, other than as set forth below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2017, a lawsuit was filed with the Regional Labor Court in Tel Aviv (the &#8220;Tel Aviv Court&#8221;) against Emerald Israel, and
other defendants, claiming certain damages in the total amount of approximately $225,000, under the assertion of wrongful termination
by Emerald Israel. We filed our response with the Tel Aviv Court in October of 2017. The dispute was initially heard by the Tel Aviv
Court on February 13, 2020. In a supplemental hearing on February 11, 2021, the plaintiff provided a certified confirmation of payment
of approximately $14,668 by the National Insurance Institute of Israel for one month&#8217;s prior notice of termination, redemption
of 16.8 days of vacation and severance pay. On June 3, 2021, and after the plaintiff and the defendants filed their summaries, the lawsuit
against Emerald Israel was dismissed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_007"></span>ITEM
4. MINE SAFETY DISCLOSURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_008"></span>PART
II</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_009"></span>ITEM
5. MARKET FOR REGISTRANT&#8217;S COMMON STOCK, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASE OF EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Market
Information</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is currently quoted on the OTCQB market under the symbol VBIX. We plan to effect the Planned Reverse Split, and, accordingly,
share amounts, per share data, share prices, exercise prices or conversion rates in this annual report on Form 10-K are subject to change
following the effectiveness of the Planned Reverse Split. The Planned Reverse Split will not change the authorized number of shares or
the par value of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Holders
of Common Stock</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, there were approximately 2,692 stockholders of record of our Common Stock and 34,753,669 shares of our Common Stock
outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
transfer agent is Transfer Online, 512 SE Salmon Street, Portland, OR 97214-3444, Phone: (503) 227-2950.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of Common Stock are entitled to dividends if declared by our board of directors, out of funds legally available therefore. We have never
declared cash dividends on our Common Stock and our board of directors does not anticipate paying cash dividends in the foreseeable future
as it intends to retain future earnings to finance the growth of our businesses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Outstanding
Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes information of outstanding warrants as of December 31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrant Term</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Class J Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">3,649,318</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 14%; text-align: right">July 2029</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">0.48</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">3,649,318</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Class K Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,649,318</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">July 2029</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.80</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,649,318</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Share Exchange Agreement, upon the earlier of: (a) the launch of a live video product to an American consumer in
the United States by Viewbix Israel, or (b) the launch of an interactive television product to an American consumer in the United States
by Viewbix Israel, we will issue to Gix Internet an additional 1,642,193 shares of restricted Common Stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Securities
Authorized for Issuance Under Equity Compensation Plans</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes information of outstanding options as of December 31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of<br /> securities to be<br /> issued upon<br /> exercise of<br /> outstanding<br /> options, warrants<br /> and rights</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted-average exercise price of outstanding<br /> options, warrants<br /> and rights</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of<br /> securities<br /> remaining<br /> available for future<br /> issuance</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Plan Category</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left">Equity compensation plans approved by security holders 2017 Employee Incentive Plan</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">133,333</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recent
Sales of Unregistered Securities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 18, 2020, we entered into a Stock Subscription Agreement (the &#8220;Subscription&#8221;) with certain investors (the &#8220;Investors&#8221;)
in connection with the sale and issuance of an aggregate of 3,000,000 shares of Common Stock, at a purchase price of US$0.01 per share,
and for an aggregate purchase price of US$30,000. In addition, and on the same date, we entered into a Loan Agreement (the &#8220;Loan
Agreement&#8221;) with the Investors, pursuant to which the Investors lent an aggregate of $69,000 (the &#8220;Principal Amount&#8221;).
In accordance with the terms of the Loan Agreement, we repaid the interest on the Principal Amount (8% compounded annually) to the Investors
in the form of an issuance of an aggregate of 552,000 shares of Common Stock, at a price per share of $0.01. The shares of Common Stock
were issued to the Investors pursuant to Regulation S of the Securities Act of 1933, as amended. In January 2022, the Investors expressed
their intention to convert the remaining sum of the Principal Amount to shares of our Common Stock and accordingly, we agreed to extend
the repayment date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_010"></span>ITEM
6. SELECTED FINANCIAL DATA</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
required for smaller reporting companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_011"></span>ITEM
7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND PLAN OF OPERATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Overview</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following plan of operation provides information which management believes is relevant to an assessment and understanding of our results
of operations and financial condition. The discussion should be read along with our consolidated financial statements and notes thereto.
This section includes a number of forward-looking statements that reflect our current views with respect to future events and financial
performance. Forward-looking statements are often identified by words like believe, expect, estimate, anticipate, intend, project and
similar expressions, or words which refer to future events. These forward-looking statements are subject to certain risks and uncertainties
that could cause actual results to differ materially from our predictions.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Organizational
Background</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Registrant was incorporated in the State of Ohio in 1989 under a predecessor name, Zaxis International, Inc. On August 25, 1995, Zaxis
International, Inc. merged with a subsidiary of The InFerGene Company, a Delaware corporation, which entity changed its name to Zaxis
International, Inc. and the Company was reincorporated in Delaware under the name of Zaxis International, Inc. On December 30, 2014,
Zaxis entered into an agreement with Emerald Medical Applications Ltd., a private limited liability company organized under the laws
of the State of Israel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Emerald
Medical Applications Ltd.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 16, 2015, Zaxis and Emerald Israel executed a share exchange agreement, which closed on July 14, 2015, and Emerald Israel became
the Company&#8217;s wholly-owned subsidiary. Emerald Israel was engaged in the business of developing Emerald Israel&#8217;s DermaCompare
technology and the development, sale and service of imaging solutions utilizing its DermaCompare software for use in derma imaging and
analytics for the detection of skin cancer. On January 29, 2018, the Company ceased the DermaCompare operations of its former subsidiary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 29, 2018, the Company ceased the DermaCompare operations of Emerald Israel and on May 2, 2018, the District Court of Lod, Israel
issued a winding-up order for Emerald Israel and appointed an Israeli attorney to serve as special executor for Emerald Israel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Virtual
Crypto Technologies Ltd.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 17, 2018, the Company formed VCT Israel to develop and market software and hardware products facilitating, allowing and supporting
purchase and/or sale of cryptocurrencies through ATMs, tablets, personal computers (&#8220;PCs&#8221;) and/or mobile devices. On January
27, 2020, VCT Israel was sold to a third party for NIS 50,000 ($14,459).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transaction
with Gix (the &#8220;Recapitalization Transaction&#8221;)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 7, 2019, the Company entered into the Share Exchange Agreement with Gix Internet, pursuant to which on Closing Date, Gix Internet
assigned, transferred and delivered its 99.83% holdings in Viewbix Israel to the Company in exchange for Common Stock representing 65%
of the issued and outstanding share capital of the Company on a fully diluted basis as of the Closing Date, following the conversion
of certain convertible notes of the Company and excluding certain warrants to purchase shares of Common Stock expiring in 2020 and additional
warrants as further described below (the &#8220;Fully Diluted Share Capital&#8221;). In addition, upon the earlier of: (a) the launch
of a live video product to an American consumer in the United States by Viewbix Israel, or (b) the launch of an interactive television
product to an American consumer in the United States by Viewbix Israel, the Company agreed to issue to Gix Internet an additional 1,642,193
shares of restricted Common Stock representing 5% of the Fully Diluted Share Capital immediately following the Closing Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 24, 2019, and in connection with the Share Exchange Agreement, the Company filed a Certificate of Amendment to its Certificate of
Incorporation with the Secretary of State of Delaware reflecting its name change from Virtual Crypto Technologies, Inc. to Viewbix Inc.
to reflect its new operations and business focus. On August 7, 2019, FINRA approved the Registrant&#8217;s name change and its trading
symbol was changed from &#8220;VRCP&#8221; to &#8220;VBIX&#8221; on the OTCQB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the Closing Date, (i) the Company issued 20,281,085 shares of Common Stock to Gix Internet in exchange for consideration consisting of
99.83% holdings in Viewbix Israel, and (ii) convertible notes representing 3,434,889 shares of Common Stock then currently issued to
holders were converted. The shares of Common Stock were issued under Regulation S. The Company also issued a total of 7,298,636 warrants
to purchase shares of Common Stock to Gix Internet, whereby (a) 3,649,318 of such warrants to purchase shares of Common Stock were issued
with an exercise price of $0.48, and (b) 3,649,318 of such warrants to purchase shares of Common Stock were issued with an exercise price
of $0.80.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the Closing Date, Viewbix Israel became a subsidiary of the Registrant. Viewbix Israel was incorporated in February 2006 in Israel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 28.35pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 6, 2020, Algomizer Ltd. changed its name to Gix Internet Ltd.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 1, 2020, the Company announced certain cost reduction measures due the Company not achieving certain revenues goals. In connection
with these cost reduction measures, on January 1, 2020, Mr. Jonathan Stefansky, the Company&#8217;s then chief executive officer and
member of the Company&#8217;s board of directors, tendered his resignation from the Board, and on the same date the sides reached a mutual
understanding whereby Mr. Stefansky would step down as chief executive officer, effective March 1, 2020. On the same date, the Company
and Mr. Hillel Scheinfeld, the Company&#8217;s then chief operating officer, reached a similar mutual understanding and agreed he would
step down, also effective March 1, 2020. Mr. Amihay Hadad, the Company&#8217;s chief financial officer, was appointed to the Company&#8217;s
board of directors on January 1, 2020, and, effective as of March 1, 2020, he was also appointed as the Company&#8217;s chief executive
officer as well.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 27, 2020, the Company entered into an agreement with a third-party to sell Virtual Crypto Technologies Ltd. for NIS 50,000 ($14,
459), which transaction was consummated on February 12, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Results
of Operations during the year ended December 31, 2021 as compared to the year ended December 31, 2020</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
for the year ended December 31, 2021 was $41 thousand as compared to $96 thousand for the year end December 31, 2020. The reason for
the decrease during the fiscal year ended December 31, 2021 is due to the Company&#8217;s cost-reduction measures implemented beginning
on January 1, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenues for the year ended December 31, 2021 was $0 which is a slight decrease to $5 thousand for the year end December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs for the year ended December 31, 2021 was $64 thousand as compared to $108 thousand for the year end December 31,
2020. The reason for the decrease during the fiscal year ended December 31, 2021 is due to the Company&#8217;s cost-reduction measures
implemented beginning on January 1, 2020, though despite these measures, the Company hired the services of an R&amp;D team during the
fiscal year ended December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
and marketing expenses for the year ended December 31, 2021 was $2 thousand as compared to $8 thousand for the year end December 31,
2020. The reason for the decrease during the year ended December 31, 2021 is due to the Company&#8217;s cost-reduction measures implemented
beginning on January 1, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and Administration expenses for the year ended December 31, 2021 was $304 thousand as compared to $437 thousand for the year end December
31, 2020. The reason for the decrease in 2021 is due to certain cost reduction measures initiated by the Company as of the beginning
of January 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
net financial expense was $30 thousand for the year ended December 31, 2021, compared to net financial income of $13 thousand for the
year end December 31, 2020. The reason for the increase in financial expenses in 2021 is due to the loan agreement with Pure Capital
and other lenders entered into on December 18, 2020, which interest expenses were recognized in the year ended December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
taxes on income was $2 thousand for the year ended December 31, 2021 and for the year ended December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidity
and Capital Resources </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, we had current assets of $156 thousand consisting of $74 thousand in cash and cash equivalents, $8 thousand in
trade receivables, $30 thousand in other accounts receivables and, $44 thousand in prepaid expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, we had $2,436 thousand in current liabilities consisting of $9 in trade payables, $242 in other accounts payable
and accrued liabilities, $69 Short term loan, and $2,116 payable to our Parent Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, we had current assets of $225 thousand consisting of $148 thousand in cash and cash equivalents and restricted
cash, $15 thousand in trade receivables, $20 thousand in other receivables and $42 thousand in prepaid expenses. We had $2,303 thousand
in current liabilities, which consisted of $177 in accounts payable and accrued liabilities and $22 trade payable, $50 Short term loan,
and $2,054 payable to our Parent Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
had a negative working capital of $2,280 thousand and $2,078 thousand as of December 31, 2021 and December 31, 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
total liabilities as of December 31, 2021 were $2,436 thousand compared to $2,303 thousand as of December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended December 31, 2021, we had negative cash flow from operations of $74 thousand which was mainly the result of a net
loss of $386 thousand, offset by decrease in working capital of $312 thousand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended December 31, 2020, we had negative cash flow from operations of $53 thousand which was mainly the result of a net
loss of $443 thousand, depreciation expense of $5 thousand, offset by gains from the sale of a subsidiary and decrease in working capital
of $385 thousand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended December 31, 2021, we had no cash flow from investing activities as compared to a positive cash flow effect from
investing activities of $13 thousand as during the year ended December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended December 31, 2021, we had no cash flow from financing activities as compared to a positive cash flow from financing
activities of $99 thousand during the fiscal year ended December 31, 2020, which related to the Loan Agreement and issuance of shares
we have made during the fiscal year ended December 31, 2020. In January 2022, the repayment date under the Loan Agreement was extended
per the Investors&#8217; request. The Investors also expressed their intention to convert the remaining sum of the Principal Amount to
shares of our Common Stock, however, if we are required to repay the Principal Amount in cash, we will be able to receive cash flow for
the repayment from our Parent Company. The Gix Loan along with any accrued interest is due on December 31, 2022, unless extended upon
mutual consent of the Company and Gix Internet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.45pt; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no limitations in the Company&#8217;s Certificate of Incorporation on the Company&#8217;s ability to borrow funds or raise funds
through the issuance of shares of its common stock to affect a business combination. The Company&#8217;s limited resources and lack of
having cash-generating business operations may make it difficult to borrow funds or raise capital. The Company&#8217;s limitations to
borrow funds or raise funds through the issuance of restricted capital stock required to effect or facilitate a business combination
may have a material adverse effect on the Company&#8217;s financial condition and future prospects, including the ability to complete
a business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
such time as the Company can generate substantial revenues, the Company expects to finance its cash needs through a combination of the
sale of its equity and/or convertible debt securities, debt financing and strategic alliances, collaborations, and funds from its Parent
Company. To the extent that the Company raises additional capital through the sale of its equity and/or convertible debt securities,
the ownership interest of its shareholders will be diluted, and the terms of these securities may include liquidation or other preferences
that adversely affect the rights of our common shareholders. Debt financing, if available, may involve agreements that include covenants
limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring
dividends. To the extent that debt financing ultimately proves to be available, any borrowing will subject us to various risks traditionally
associated with indebtedness, including the risks of interest rate fluctuations and insufficiency of cash flow to pay principal and interest,
including debt of an acquired business. If the Company raises funds through additional collaborations or strategic alliances with third
parties, we may have to relinquish valuable rights to our future revenue streams and/or distribution arrangements. No assurance can be
given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. If
the Company is unable to raise additional funds through equity and/or debt financings when needed or on attractive terms, the Company
may be required to delay, limit, reduce or terminate the operations of some or all of its business segments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Going
Concern </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has incurred $386 thousand in net losses for the year ended December 31, 2021, has $2,280 thousand shareholders&#8217; deficit
as of December 31, 2021 and $2,078 thousand in total shareholders&#8217; deficit as of December 31, 2020 and $74 thousand negative cash
flows from operations for the year ended December 31, 2021, and $53 thousand negative cash flows from operations for the year ended December
31, 2020. Management expects the Company to continue to generate substantial operating losses and to continue to fund its operations
primarily through utilization of its current financial resources and through additional raises of capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
conditions raise substantial doubts about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plan includes
raising funds from outside potential investors. However, there is no assurance such funding will be available to the Company or that
it will be obtained on terms favorable to the Company or will provide the Company with sufficient funds to meet its objectives. These
financial statements do not include any adjustments relating to the recoverability and classification of assets, carrying amounts or
the amount and classification of liabilities that may be required should the Company be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Availability
of Additional Capital</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
potential financing transactions may include the issuance of equity and/or debt securities including convertible debt, obtaining credit
facilities, or other financing mechanisms. In the event that we seek to raise funds through additional private placements of equity or
convertible debt, the trading price of our common stock could be adversely affected. Further, any adverse conditions in the financial
markets could make it more difficult to obtain future financing through the issuance of equity or debt securities when and if needed.
Even if we are able to raise a sufficient amount of funds that may be required, it is possible that we could incur unexpected costs and
expenses or experience unexpected cash requirements that would force us to seek additional and/or alternative financing. Further, if
we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have
rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or
is not available on acceptable terms, we may have to curtail our plan of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has only limited capital. Additional financing is necessary for the Company to continue as a going concern. Our independent auditors
have issued an unqualified audit opinion for the year ended December 31, 2021 with an explanatory paragraph on going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
view of these matters, realization of a major portion of the assets in the accompanying balance sheet is dependent upon continued operations
of the Company. Management believes that actions presently being taken to obtain additional equity financing will provide the opportunity
to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contractual
Obligations and Commitments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, and 2020, we did not have any contractual obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Critical
Accounting Policies</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
consolidated financial statements are prepared in accordance with accounting principles generally accepted in the U.S. The preparation
of our consolidated financial statements and disclosures requires us to make judgments, estimates, and assumptions that affect the reported
amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as
well as the reported revenue and expenses during the reporting periods. We base our estimates on historical experience, known trends
and events and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for
making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our
estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions and conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
significant accounting policies are described in more detail in the notes to our audited consolidated financial statements appearing
elsewhere in this Annual Report on Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.9pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_012"></span>ITEM
7A. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
required for smaller reporting companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_013"></span>ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Index
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_001">Report of Independent Registered Public Accounting Firm</a> (PCAOB ID No. <b><span id="xdx_903_edei--AuditorFirmId_c20210101__20211231_zi9JRZn8I7vd"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AuditorFirmId">1197</ix:nonNumeric></span></b>)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in">F-2</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_002">Consolidated Balance Sheets</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-4</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><a href="#f_003">Consolidated Statements of Comprehensive Loss</a></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-5</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><a href="#f_004">Consolidated Statements of Changes in Stockholders&#8217; Deficit</a></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-6</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_005">Consolidated Statements of Cash Flows</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-7 - F-8</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_007">Notes to Consolidated Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-9</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="fin_001.jpg" alt="" style="height: 40pt; width: 180pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_001"></span>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>To the Stockholders and Board of Directors of Viewbix Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
                                            on the Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of Viewbix Inc. and its subsidiary (the &#8220;Company&#8221;) as of December
31, 2021 and 2020 and the related consolidated statements of comprehensive loss, stockholder&#8217;s deficit and cash flows for each
of the two years in the period ended December 31, 2021, and the related notes (collectively referred to as the &#8220;financial statements&#8221;).
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2021 and 2020, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2021,
in conformity with accounting principles generally accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note
1.E to the consolidated financial statements, the Company&#8217;s substantial net losses, shareholder&#8217;s deficit and negative cash
flows from operations raise substantial doubt about its ability to continue as a going concern. Management&#8217;s plans concerning these
matters are also described in Note 1.E to the financial statements. The financial statements do not include any adjustments that might
result from the outcome of&#8217; these uncertainties</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits,
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits
provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Audit Matter</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated
or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial
statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter
does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit
matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which it relates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="fin_002.jpg" alt="" style="height: 138pt; width: 468pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><img src="fin_001.jpg" alt="" style="height: 40pt; width: 180pt" /></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>Payable
to Parent Company - Valuation of Fair Value of Debt Recognized upon Modification &#8211; Refer to Note 4 to the consolidated financial
statements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Critical
Audit Matter Description</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement with its parent company, Gix Internet Ltd., (the &#8220;Parent Company&#8221;), effective as of December
31, 2021, for the modification of the balance payable to the Parent Company, in the amount of $2,299,956, from a current payable balance
into a loan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for the modification as an extinguishment of the balance payable to the Parent Company and the issuance of a new debt.
Accordingly, the loan was recorded at its fair value of $2,115,853 as of December 31, 2021. The difference of $184,103 between the fair
value of the loan and the carrying value of the payable to the Parent Company was recorded in the Company&#8217;s consolidated statement
of changes in stockholders&#8217; deficit as a deemed contribution to the Company by the Parent Company. The Company determined the fair
value of the loan using the discounted cash flow model. This valuation involves management judgement in determining the discount rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
identified the valuation of the loan at fair value as a critical audit matter because of the magnitude of the loan balance, the judgment
involved in determining the discount rate and due to the increased extent of audit effort in relation to our audit as a whole, <span style="background-color: white">including
the need to involve our fair value specialists.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>How
the Critical Audit Matter Was Addressed in the Audit</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit procedures related to the valuation of the fair value of the loan included the following, among others:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#9679; <span style="font-size: 10pt">With the assistance of our fair value specialists, we evaluated the Company&#8217;s valuation methodologies, assumptions and fair value results. </span></p>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#9679; <span style="font-size: 10pt">With the assistance of our fair value specialists, we developed an independent estimate of the discount rate and the resulting fair value and compared our estimate to the Company&#8217;s estimate.</span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/S/
</i><span id="xdx_907_edei--AuditorName_c20210101__20211231_zjq3AjflRD97" title="Auditor Name"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AuditorName">Brightman Almagor Zohar &amp; Co.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certified
Public Accountants</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Firm in the Deloitte Global Network</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--AuditorLocation_c20210101__20211231_zYDczQrrAQbj"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AuditorLocation">Tel
Aviv, Israel</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
17, 2022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2019</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="fin_002.jpg" alt="" style="height: 138pt; width: 468pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_002"></span>Consolidated
Balance Sheets</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_111_pn3n3_znZgjJnrJXbd" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20211231_zmwLRURV4zWg" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">December 31,</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20201231_zpmOKDk75gUk" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">December 31</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Note</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsAbstract_iB_zJrlWPrNAh5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; font-weight: bold">ASSETS</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AssetsCurrentAbstract_i01B_zE2apZuZTYcl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">CURRENT ASSETS</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maCzOqm_zK8qqt88fE06" style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 10%; text-align: center">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">74</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">148</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AccountsReceivableNetCurrent_i02I_maCzOqm_zvZnkRGaFkT" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Trade receivables</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccountsAndOtherReceivablesNetCurrent_i02I_maCzOqm_zRgz7XCIJYk7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other accounts receivable</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsAndOtherReceivablesNetCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsAndOtherReceivablesNetCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--PrepaidExpenseCurrent_i02I_maCzOqm_zZxShwpEeTph" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Prepaid expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AssetsCurrent_i01TI_mtCzOqm_maCzPHN_zQO0eb93hVAi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">156</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">225</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Assets_i01TI_mtCzPHN_zGQlBaTfOX7f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">156</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">225</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zCtc5yHOUbs9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; font-weight: bold; text-align: left">LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS&#8217; DEFICIT</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesCurrentAbstract_i01B_zRnysh3ed578" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">CURRENT LIABILITIES</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AccountsPayableTradeCurrent_i02I_maCztwB_zVzVXCAwpBOd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade payables</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_i02I_pn3n3_maCztwB_zWLBorQqgbck" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: center">3</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">242</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">177</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DueToAffiliateCurrent_i02I_maCztwB_zVr5X3co9yt8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Parent company</td><td>&#160;</td>
    <td style="text-align: center">4</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DueToAffiliateCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,116</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DueToAffiliateCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,054</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ShortTermBorrowings_i02I_maCztwB_zdgZuMEjP8Td" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Short term loan</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">5</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShortTermBorrowings" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">69</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShortTermBorrowings" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesCurrent_i01TI_mtCztwB_maLASEzIHu_zzd5VVWIlOib" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,436</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,303</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockholdersEquityAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">STOCKHOLDERS&#8217; DEFICIT</td><td>&#160;</td>
    <td style="text-align: center">6</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--ShareCapitalAbstract_i02B_zxSGFphu7yJ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Share Capital</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CommonStockValue_i03I_pn3n3_maSEzYIg_zjwzxxHAcobl" style="vertical-align: bottom; background-color: White">
    <td>Common stock, $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20211231_zwqqrPAysIe6" title="Common stock , par value"><span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20201231_zqj7USPs7UXh" title="Common stock , par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20211231_zaGOhQnlSNKb" title="Common stock, shares authorized"><span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20201231_zRE1VxyzGSMg" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">490,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20211231_zv6W8D5wIzsk" title="Common stock, shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211231_zCTGAUI4iREi" title="Common stock, shares outstanding"><span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20201231_zxevwMnnvBe1" title="Common stock, shares issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20201231_zA9v35Pnd8uj" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,753,669</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding at December 31, 2021 and at December 31, 2020</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AdditionalPaidInCapitalCommonStock_i03I_maSEzYIg_zpwCfmwK8QL8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: center">4,5</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,257</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,073</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RetainedEarningsAccumulatedDeficit_i03I_maSEzYIg_zKqBd4paUa1i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">15,540</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">15,154</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockholdersEquity_i03TI_pn3n3_mtSEzYIg_maLASEzIHu_zDiDuw6ZM6di" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total stockholders&#8217; deficit</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,280</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,078</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pn3n3_mtLASEzIHu_zAypibSh5mY" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities, temporary equity and stockholders&#8217; deficit</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">156</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">225</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_003"></span>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consolidated
Statements of Comprehensive Loss</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_113_pn3n3_zmoSmUff2Okh" summary="xdx: Statement - Consolidated Statements of Comprehensive Loss" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20210101__20211231_zYAwhqHgWNgd" style="border-bottom: Black 1.5pt solid; text-align: center">Year ended December 31,<br /> 2021</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20200101__20201231_zI6gQxCJWNhb" style="border-bottom: Black 1.5pt solid; text-align: center">Year ended December 31,<br /> 2020</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzjIl_z0Ms0edxpDgd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Revenues</td><td style="width: 2%">&#160;</td>
    <td style="width: 10%; text-align: center">7</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">96</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CostOfRevenue_msGPzjIl_zWrMxVm9BCne" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cost of revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0131">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--GrossProfit_iT_mtGPzjIl_maOILzUkX_zVrkayaA1emc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Gross profit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">91</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingExpensesAbstract_iB_zuo2vfuDq44l" style="vertical-align: bottom; background-color: White">
    <td>Expenses:</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEzszK_zBIa5ZLqcgY4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Research and development</td><td>&#160;</td>
    <td style="text-align: center">8</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">64</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">108</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--SellingAndMarketingExpense_i01_maOEzszK_zMjHkFR3nTub" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: center">9</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzszK_zhpKgLKW2CS5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">General and administrative</td><td>&#160;</td>
    <td style="text-align: center">10</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">304</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">437</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OtherGeneralExpense_i01_maOEzszK_zOTHPP9clah6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Other expenses</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0150">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--GainLossOnSaleOfBusiness_i01N_di_msOEzszK_zhw5PSmtvD6h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Gain from sale of a subsidiary</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0152">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnSaleOfBusiness" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--OperatingExpenses_i01T_mtOEzszK_msOILzUkX_zJdWUhqcuoc6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">395</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">545</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingIncomeLoss_iT_maILFCOznv4_mtOILzUkX_z2hQwlXScF5f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss from operations</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">354</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">454</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--FinanceIncome_maILFCOznv4_zms9jT5PUDq6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Finance income</td><td>&#160;</td>
    <td style="text-align: center">11</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VBIX:FinanceIncome" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VBIX:FinanceIncome" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--FinanceExpense_iN_di_msILFCOznv4_zIooIFwKErrb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Finance expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">11</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="VBIX:FinanceExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="VBIX:FinanceExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_maNILzXfw_mtILFCOznv4_zvkNyGWWtLs7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss Before taxes on income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">384</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">441</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxExpenseBenefit_msNILzXfw_zC3wF4Ds6UWk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Taxes on income</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">12</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetIncomeLoss_iT_pn3n3_mtNILzXfw_z1nmNRzTLT34" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net Loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">386</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">443</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--EarningsPerShareBasicAndDiluted_iN_pid_di_zJ0vTcMvaFm5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per share:</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.011</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.014</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_zsOqsGmCOgT" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Weighted average shares outstanding - basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">13</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,753,669</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,201,669</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_004"></span>Consolidated
Statements of Changes in Stockholders&#8217; Deficit</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_114_pn3n3_zUkPWQtcn1H1" summary="xdx: Statement - Consolidated Statements of Changes in Stockholders&apos; Deficit" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none; text-align: center">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center">&#160;</td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zIzAu8Wdu6Sj" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center">&#160;</td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zw6XVojMEpi7" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center">&#160;</td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zsEmaIVzuVe6" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center">&#160;</td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_zXDItfRCAlZj" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center">&#160;</td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Ordinary shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additional</b></span></p>
                                                                                 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>paid-in</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Total</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">shareholders&#8217;</p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">capital</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_436_c20210101__20211231_eus-gaap--StockholdersEquity_iS_zzM6oOCDjDid" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; font-weight: bold">Balance as of January 1, 2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZANWkiMQNB1" title="Balance, shares" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,753,669</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,073</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">15,154</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#160;&#160;(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,078</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--FinancingProvidedByParentCompanyAcquisition_z7i66az3Izik" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Financing provided by the Parent Company (see note 4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0189">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VBIX:FinancingProvidedByParentCompanyAcquisition" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VBIX:FinancingProvidedByParentCompanyAcquisition" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueOther_zT2J2J9YE2la" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Issuance of shares</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodSharesOther_zmoPKIPR9Tl5" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Issuance of shares, shares</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLoss_zrPtKitN6z55" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss for the period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0204">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0205">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">386</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">386</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_43F_c20210101__20211231_eus-gaap--StockholdersEquity_iE_zkN7olRW9NPh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance as of December 31, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxwV4sWoq4A1" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,753,669</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,257</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">15,540</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,280</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Ordinary shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Additional</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">paid-in</p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Total</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">shareholders&#8217;</p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">capital</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_43E_c20200101__20201231_eus-gaap--StockholdersEquity_iS_zgSsr8RB0tMj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; font-weight: bold">Balance as of January 1, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_pid_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNtmBcgsXYb4" title="Balance, shares" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,201,669</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,015</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14,711</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,693</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_434_c20200101__20201231_eus-gaap--StockholdersEquity_iS_zqag4T7YjjYa" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Balance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_pid_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhuPV8tIpV6i" title="Balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,201,669</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,015</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14,711</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,693</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueOther_z9bRSLWMUqs8" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Issuance of shares</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zI7UErEX4TN2" title="Issuance of shares, shares" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,552,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0230">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif">-</span><span><sup><span id="xdx_F26_zeRlfMWPTFe4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(*)</span></sup></span></td><td style="padding-bottom: 1.5pt; text-align: left"><sup></sup></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">58</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0232">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">58</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLoss_zLg4hwjCeH3k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss for the period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0237">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0238">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">443</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">443</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_43A_c20200101__20201231_eus-gaap--StockholdersEquity_iE_zsB2VQnH1f72" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance as of December 31, 2020</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iE_pid_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zF5ihLgaPCA2" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,753,669</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,073</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">15,154</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,078</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_435_c20200101__20201231_eus-gaap--StockholdersEquity_iE_zGmCacAuSAe2" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iE_pid_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zIWLbUAzaR0a" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,753,669</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,073</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">15,154</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,078</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
</table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: center"><span id="xdx_F08_zui6uHUE6Pue" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(*)</span></td>
    <td style="text-align: justify"><span id="xdx_F13_zi6KCooY41l5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000255" xml:lang="en-US">Represents an amount
less than $1.</ix:footnote></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_005"></span>Consolidated
Statements of Cash Flows</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_112_pn3n3_z6gmeSaCi9Xh" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20210101__20211231_zdLYj91pTdc4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_491_20200101__20201231_z52qdQ6bUmDi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
                                            the year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_iB_zBKRhX42aAY8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; font-weight: bold; text-align: justify">Cash flows from operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetIncomeLoss_i01_pn3n3_maNCPBUzUot_z7pZMHn4Xf01" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Net loss for the period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">386</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">443</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_z5yOpREiGk86" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--GainFromSaleOfSubsidiary_i02N_di_msNCPBUzUot_zPebkIu1i7Ji" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Gain from sale of a subsidiary</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0266">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="VBIX:GainFromSaleOfSubsidiary" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--Depreciation_i02_maNCPBUzUot_zjTQG9ALrKB2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Depreciation</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0269">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_z5ArV7dfFat1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidExpense_i03N_di_msNCPBUzUot_zbmQU1GpTdOi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Decrease (Increase) in trade receivables and prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInOtherReceivables_i03N_di_msNCPBUzUot_zlA3tLlDI6T9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Decrease (Increase) in other accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherReceivables" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherReceivables" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">100</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInAccountsPayableTrade_i03_maNCPBUzUot_z9LHebrA9HCi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Increase (decrease) in trade payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">55</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInDueToAffiliatesCurrent_i03_maNCPBUzUot_z1v42ajnEqDb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Increase in payable to parent company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToAffiliatesCurrent" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">246</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToAffiliatesCurrent" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">443</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUzUot_zaShpU8rAxTl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Increase (decrease) in other accounts payables and accrued liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">55</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i03T_mtNCPBUzUot_maCCERCzLfr_zEL1VDikB5Ge" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Net cash used by operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">74</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">53</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zbSMLhFXPaoi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; font-weight: bold; text-align: justify">Cash flows from investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--ProceedsFromDivestitureOfBusinesses_i01_maNCPBUz8Ny_zlwr4ObcEbU4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Cash received from the sale of a subsidiary</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0296">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_maCCERCzLfr_mtNCPBUz8Ny_z3Gq5FIRfZ94" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Net cash used in investing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0299">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zkiajo1hp7G2" style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; font-weight: bold; text-align: justify">Cash flows from financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_maNCPBUztzg_zBu3ITG9KCKk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Issuance of shares</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0305">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ProceedsFromShortTermDebt_i01_maNCPBUztzg_zrMX5jmxoL6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Short term loan received</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0308">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromShortTermDebt" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_maCCERCzLfr_mtNCPBUztzg_zt04uwi6QjD4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0311">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">99</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzLfr_zOnw6V15xF74" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Increase (decrease) in cash and cash equivalents and restricted cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">74</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zs48klijyYda" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Cash and cash equivalents and restricted cash at the beginning
    of the period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">148</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">89</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zS2dwJiClJce" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Cash and cash equivalents and restricted cash at the end
    of the period</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">74</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">148</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_006"></span>Condensed
Consolidated Statements of Cash Flows</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>SUPPLEMENTAL
DISCLOSURE OF CASH FLOW INFORMATION:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31<br /> 2021</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 78%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Modification
                                            of parent company payable into a loan (see note 4)</b></p></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ModificationOfParentCompanyPayableIntoLoan_iI_c20211231_zWsMEJgfhzXh" title="Modification of parent company payable into a loan" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="VBIX:ModificationOfParentCompanyPayableIntoLoan" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,116</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br /> February 12, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: justify">Current assets excluding cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_ecustom--CurrentAssetsExcludingCashAndCashEquivalent_iI_c20200212_zs4RTJbx4sN4" title="Current assets excluding cash and cash equivalents" style="width: 16%; text-align: right"><ix:nonFraction name="VBIX:CurrentAssetsExcludingCashAndCashEquivalent" contextRef="AsOf2020-02-12" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--LiabilitiesCurrentOne_iI_c20200212_zBQTRf1GXSw6" title="Current liabilities" style="text-align: right">(<ix:nonFraction name="VBIX:LiabilitiesCurrentOne" contextRef="AsOf2020-02-12" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Gain from sale of a subsidiary</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--SupplementalGainFromSalesOfSubsidiary_iI_c20200212_zI5AKXbTqxpd" title="Gain from sale of a subsidiary" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="VBIX:SupplementalGainFromSalesOfSubsidiary" contextRef="AsOf2020-02-12" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Cash received from the sale of a subsidiary</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_ecustom--SupplementalCashReceivedFromSaleOfSubsidiaries_iI_c20200212_zKcvE4SOBBxf" title="Cash received from the sale of a subsidiary" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="VBIX:SupplementalCashReceivedFromSaleOfSubsidiaries" contextRef="AsOf2020-02-12" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_007"></span>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock"><p id="xdx_80D_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_z1foz2h5YoQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1. <span id="xdx_82F_znp7OID2CFn7">GENEREL</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A.</i></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Organizational
                                            Background</i></b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Viewbix
Inc. (formerly known as Virtual Crypto Technologies, Inc.) (the &#8220;Company&#8221;) was incorporated in the State of Ohio in 1989
under a predecessor name, Zaxis International, Inc. (&#8220;Zaxis&#8221;). On August 25, 1995, Zaxis merged with a subsidiary of The
InFerGene Company, a Delaware corporation, which entity changed its name to Zaxis International, Inc. and the Company was reincorporated
in Delaware under the name of Zaxis International, Inc. In 2015 the Company changes its name to Emerald Medical Applications Corp.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 17, 2018, the Company formed a new wholly-owned subsidiary under the laws of the State of Israel, Virtual Crypto Technologies
Ltd. (&#8220;VCT Israel&#8221;), to develop and market software and hardware products facilitating and supporting the purchase and/or
sale of cryptocurrencies. Effective as of March 7, 2018, the Company&#8217;s name was changed from Emerald Medical Applications Corp.
to Virtual Crypto Technologies, Inc. to reflect its new operations and business focus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VCT
Israel ceased its business operation prior to consummation of the Recapitalization Transaction. On January 27, 2020, VCT Israel was sold
to a third party for NIS <span id="xdx_906_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_uNIS_c20200127__us-gaap--IncomeStatementLocationAxis__custom--VirtualCryptoIsraelMember_zzRUp93YqNNh" title="Due to relaties parties current and non current"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2020-01-27_custom_VirtualCryptoIsraelMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="NIS">50,000</ix:nonFraction></span> ($<span id="xdx_902_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20200127__us-gaap--IncomeStatementLocationAxis__custom--VirtualCryptoIsraelMember_zq7gTnXqu8sc" title="Due to related party"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2020-01-27_custom_VirtualCryptoIsraelMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,459</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 7, 2019, the Company entered into a share exchange agreement (the &#8220;Share Exchange Agreement&#8221; or the &#8220;Recapitalization
Transaction&#8221;) with Gix Internet Ltd., an company organized under the laws of the State of Israel (&#8220;Gix&#8221;), pursuant
to which, Gix assigned, transferred and delivered its <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20190207__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--ViewbixLtdMember_zeK60kGvq0Ye" title="Ownership percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2019-02-07_custom_ShareExchangeAgreementMember_custom_ViewbixLtdMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">99.83</ix:nonFraction></span>% holdings in Viewbix Ltd., a company organized under the laws of the State
of Israel (&#8220;Viewbix Israel&#8221;), to the Company in exchange for shares of restricted common stock of the Company, which resulted
in Viewbix Israel becoming a subsidiary of the Company. In connection with the Share Exchange Agreement, effective as of August 7, 2019,
the Company&#8217;s name was changed from Virtual Crypto Technologies, Inc. to Viewbix Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 1, 2020, the Company announced certain cost reduction measures due the fact the Company not achieved certain revenues goals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 5, 2021, the Company entered into a certain Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221; or the &#8220;Gix
Merger&#8221;) with Gix Media Ltd., an Israeli company and the majority-owned subsidiary of Gix (&#8220;Gix Media&#8221;) and Vmedia
Merger Sub Ltd., an Israeli company and wholly-owned subsidiary of the Company (&#8220;Merger Sub&#8221;), pursuant to which, following
the Gix Merger and upon satisfaction of the closing conditions listed in the Merger Agreement, Merger Sub will merge with and into Gix
Media, with Gix Media being the surviving entity and wholly-owned subsidiary of the Company. As of the reporting date, the closing conditions
of the Merger Agreement have not been fulfilled yet the Gix Merger has not been consummated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and its subsidiaries are collectively referred to as the &#8220;Company&#8221;. The Company has developed an interactive video
platform based on Software as a Service (&#8220;SaaS&#8221;) business model with interactive elements, and the ability to collect and
analyze information about each interactive action performed during the viewing of the video clip. The interactive elements and information
gathered, allowing the advertiser to analyze user viewing habits and optimize real-time throughout the campaign while increasing the
effectiveness of online and live video advertising.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE.
    1</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GENERAL
    (Cont.):</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>B.</i></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Emerald
                                            Medical Applications Ltd.</i></b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerald
Medical Applications Ltd., the Company&#8217;s wholly-owned subsidiary (&#8220;Emerald Israel&#8221;) was engaged in the business of
developing DermaCompare technology and the development, sale and service of imaging solutions utilizing its DermaCompare software for
use in derma imaging and analytics for the detection of skin cancer. On January 29, 2018, the Company ceased the DermaCompare operations
of its former subsidiary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 2, 2018, the District Court of Lod, Israel issued a winding-up order for Emerald Israel and appointed an Israeli attorney as special
executor for Emerald Israel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>C.</i></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock
                                            Subscription Agreement and Loan Agreement</i></b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 18, 2020, the Company entered into a Stock Subscription Agreement (the &#8220;Subscription&#8221;) with certain investors (the
&#8220;Investors&#8221;) in connection with the sale and issuance of an aggregate of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zCvcoMZSv5Vb" title="Number of share issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-172020-12-18_custom_StockSubscriptionAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,000,000</ix:nonFraction></span> shares of Common Stock, at a purchase
price of $<span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zaLFK7SuTkvf" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2020-12-18_custom_StockSubscriptionAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> per share, and for an aggregate purchase price of $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zDlT953wkg29" title="Stock issued during period value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-12-172020-12-18_custom_StockSubscriptionAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,000</ix:nonFraction></span>. In addition, and on the same date, the company entered into
a Loan Agreement (the &#8220;Loan&#8221;) with the Investors, pursuant to which the Investors lent an aggregate of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20201218__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_znpSK73yBad7" title="Debt instrument, face amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-12-18_us-gaap_InvestorMember_custom_LoanAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">69,000</ix:nonFraction></span> (the &#8220;Principal
Amount&#8221;). In accordance with the terms of the Loan, the company repaid the interest on the Principal Amount (<span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20201218__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zS95WgCjCqFc" title="Debt instrument interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-12-18_us-gaap_InvestorMember_custom_LoanAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% compounded annually)
to the Investors in the form of an issuance of an aggregate of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zkAbj8TRZkBi" title="Number of share issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-172020-12-18_custom_LoanAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">552,000</ix:nonFraction></span> shares of Common Stock, at a price per share of $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_c20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zVUTjo8M54i8" title="Shares issued, price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-18_us-gaap_InvestorMember_custom_LoanAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span>. The shares
of Common Stock were issued to the Investors pursuant to Regulation S of the Securities Act of 1933, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>D.</i></b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Merger
                                            with Gix Media Ltd.</i></b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 5, 2021, the Company entered into the Merger Agreement with Gix Media and Merger Sub, pursuant to which, following the Gix Merger,
and upon satisfaction of additional closing conditions, Merger Sub will merge with and into Gix Media, with Gix Media being the surviving
entity and wholly-owned subsidiary of the Company. As of the reporting date, the closing conditions of the Merger Agreement have not
been fulfilled yet and the Gix Merger has not been consummated (see Note 15).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE.
    1</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GENERAL
    (Cont.)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>E.</i></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Going
                                            Concern</i></b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has incurred $<span id="xdx_904_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20210101__20211231_zaJVj2fjvuhb" title="Net Income (Loss) Attributable to Parent"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">386</ix:nonFraction></span> in net loss for the year ended December 31, 2021 and <span id="xdx_907_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20200101__20201231_zA38k90eLVH5" title="Net Income (Loss) Attributable to Parent"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">443</ix:nonFraction> </span>in net loss for the year ended December 31,2020, has
$<span id="xdx_90D_eus-gaap--StockholdersEquity_iNI_pn3n3_di_c20211231_zBZ9xKunxrjj" title="Stockholders&apos; deficit"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,280</ix:nonFraction></span> stockholders&#8217; deficit as of December 31, 2021 and $<span id="xdx_903_eus-gaap--StockholdersEquity_iNI_pn3n3_di_c20201231_zBHbkgmNPIR6" title="Stockholders&apos; deficit"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,078</ix:nonFraction></span> in total stockholders&#8217; deficit as of December 31, 2020 and
$<span id="xdx_90F_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3n3_di_c20210101__20211231_zRSYEbFgMWJ" title="Cash flows from operations"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">74</ix:nonFraction> </span>in negative cash flows from operations for the year ended December 31, 2021 and <span id="xdx_906_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3n3_di_c20200101__20201231_zRQtcgfbLHb3" title="Cash flows from operations"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">53</ix:nonFraction></span> in negative cash flows from operations for the
year ended December 31, 2020. Since January 2020, the Company has significantly reduced its operations and expenses of Viewbix Israel.
Management expects the Company to continue to generate substantial operating losses and to continue to fund its operations primarily
through utilization of its current financial resources and through additional raises of capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
conditions raise substantial doubts about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plan includes
raising funds from outside potential investors. However, there is no assurance such funding will be available to the Company or that
it will be obtained on terms favorable to the Company or will provide the Company with sufficient funds to meet its objectives. These
financial statements do not include any adjustments relating to the recoverability and classification of assets, carrying amounts or
the amount and classification of liabilities that may be required should the Company be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80F_eus-gaap--SignificantAccountingPoliciesTextBlock_ziqnFdfBgBPd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE.
2 <span id="xdx_827_zuvk3xo8jZM9">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
significant accounting policies used in the preparation of the financial statements are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_843_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z8u2fRxegkM8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zABgu1YTrjAe">Functional
currency</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency of the Company and its subsidiary is the US dollar, which is the currency of the primary economic environment in
which it operates. In accordance with ASC 830, &#8220;Foreign Currency Matters&#8221; (ASC 830), balances denominated in or linked to
foreign currency are stated on the basis of the exchange rates prevailing at the applicable balance sheet date. For foreign currency
transactions included in the statement of operations, the exchange rates applicable on the relevant transaction dates are used. Gains
or losses arising from changes in the exchange rates used in the translation of such transactions are carried as financing income or
expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_843_eus-gaap--ConsolidationPolicyTextBlock_zWIVxEVqvyGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zF0sRCmT9cMf">Principles
of consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions
have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zU395BzqCbJa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zOyekG7dtEt">Cash
and cash equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments, which are highly liquid investments with original maturities of three months or less at
the date of purchase, to be cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z2144j3oOJo9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zdHyj5mquz4j">Fair
value of financial instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying values of Company&#8217;s financial assets and liabilities, including cash and cash equivalents, restricted cash, other current
assets, trade payables, other accounts payable and financing provided by the Parent Company approximate their fair value due to the short-term
maturity of these instruments.</span></p>

</ix:nonNumeric><p id="xdx_853_zqjmPPSHVyCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE.
2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zALgsAM7Kom8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zYaa53tWN7G3">Earnings
per Common Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnings
or loss per share (&#8220;EPS&#8221;) is the amount of earnings attributable to each share of common stock. For convenience, the term
is used to refer to either earnings or loss per share. EPS is computed pursuant to ASC 260-10-45. Pursuant to ASC 260-10-45-10 through
260-10-45-16 Basic EPS is computed by dividing income available to common stockholders (the numerator) by the weighted-average number
of common shares outstanding (the denominator) during the period. Income available to common stockholders shall be computed by deducting
both the dividends declared in the period on preferred stock (whether or not paid) from income from continuing operations (if that amount
appears in the income statement) and also from net income. The computation of diluted EPS is similar to the computation of basic EPS
except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive
potential common shares had been issued during the period to reflect the potential dilution that could occur from common shares issuable
through contingent shares issuance arrangement, stock options or warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_841_eus-gaap--RevenueRecognitionPolicyTextBlock_zTTIQXV8EIAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zwIXj4YsWLXd">Revenue
recognition</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company applies the provisions of Accounting Standards Codification (or &#8220;ASC&#8221;) 606, Revenue from Contracts with Customers
(&#8220;ASC 606&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generates revenues primarily by granting customers the right to access software products through the Company&#8217;s cloud-based
SaaS subscription offerings. Under a SaaS subscription agreement, the customer receives a right to access the software for a specified
period of time in an environment hosted, supported, and maintained by the Company. SaaS subscription services are a single performance
obligation satisfied over time, and associated revenue is generally recognized ratably over the contract term once the software is made
available to the customer. The SaaS subscription offerings are typically sold with one year subscription terms, generally invoiced in
advance of each annual subscription period, and are non-cancelable during the committed subscription term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_844_eus-gaap--ResearchAndDevelopmentExpensePolicy_zrXrW15X3k2b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zHlpbKqblnE8">Research
and development expenses</span>:</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses are charged to the statement of operations as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zu38Kn7CfP2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zm1DvLcbIr47">Income
Taxes</span>: </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221;, and (&#8220;ASC 740&#8221;). ASC 740 prescribes
the use of the asset and liability method whereby deferred tax asset and liability account balances are determined based on differences
between the financial reporting and tax bases of assets and liabilities and for carry forward tax losses. Deferred taxes are measured
using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation
allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more-likely-than-not that some portion
or all of the deferred tax asset will not be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, ASC 740 prescribes a recognition threshold and measurement attribute for financial statement recognition and measurement of
a tax position taken or expected to be taken in a tax return. The first step is to evaluate the tax position taken or expected to be
taken in a tax return. This is done by determining if the weight of available evidence indicates that it is more-likely-than-not that,
on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or
litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized
upon ultimate settlement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock"><p id="xdx_847_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zZ0pKrPRYT6f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_z5dK3ZP8hw4a">Contingencies</span>:</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records accruals for loss contingencies arising from claims, litigation and other sources when it is probable that a liability
has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional
information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="VBIX:AccountingForIncomeTaxesPolicyTextBlock"><p id="xdx_844_ecustom--AccountingForIncomeTaxesPolicyTextBlock_zjmjQETEN3e4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zDRXD9iLeyq8">Accounting
for Income Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the Financial Accounting Standards Board issued Accounting Standards Update No. ASU 2019-12, &#8220;Simplifying the Accounting
for Income Taxes&#8221;. This ASU amends Accounting Standards Codification (&#8220;ASC&#8221;) 740 by removing certain exceptions to
the general principles, clarifying and amending existing guidance. This guidance is effective for fiscal years, and interim periods within
those years, beginning after December 15, 2020. The Company adopted this standard in the first quarter of 2021. The adoption of this
ASU did not impact our financial statements or the related disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84D_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z8XkxIbzyaq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zWWOGKRXH013">Recently
issued accounting pronouncements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financial
Instruments &#8211; Credit Losses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU 2016-13, &#8220;Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses
on Financial Instruments&#8221; (&#8220;ASU 2016-13&#8221;). ASU 2016-13 replaces the current incurred loss model guidance with a new
method that reflects expected credit losses. Under this guidance, an entity would recognize an allowance for credit losses equal to its
estimate of expected credit losses on financial assets measured at amortized cost. In November 2019, the FASB extended the effective
date of ASU 2016-13 for smaller reporting companies. As a result, ASU 2016-13 is effective for fiscal years, and interim periods within
those years, beginning after December 15, 2022, with early adoption permitted. The standard is not expected to have a significant impact
on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Convertible
instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU 2020-06, &#8220;Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an
Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020-06&#8221;). ASU 2020-06 simplifies the accounting for convertible instruments by removing
certain separation models in Accounting Standards Codification (&#8220;ASC&#8221;) 470-20, &#8220;Debt&#8212;Debt with Conversion and
Other Options,&#8221; (&#8220;ASC 470-20&#8221;) for convertible instruments. Under ASU 2020-06, the embedded conversion features no
longer are separated from the host contract for convertible instruments with conversion features that are not required to be accounted
for as derivatives under ASC 815, &#8220;Derivatives and Hedging,&#8221; or that do not result in substantial premiums accounted for
as paid-in capital. For smaller reporting companies, ASU 2020-06 is effective for fiscal years, and interim periods within those years,
beginning after December 15, 2023, with early adoption permitted for fiscal years beginning after December 15, 2020. The Company is currently
assessing the impact of this update on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:BusinessCombinationsPolicy"><p id="xdx_842_eus-gaap--BusinessCombinationsPolicy_z6fsBtAckgu6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zSoqJjhN1eKi">Business
Combination</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 28, 2021, the FASB issued ASU 2021-08, which amends ASC 805 to &#8220;require acquiring entities to apply Topic 606 to recognize
and measure contract assets and contract liabilities in a business combination.&#8221; Under current GAAP, an acquirer generally recognizes
such items at fair value on the acquisition date. According to the FASB, this Update is intended &#8220;to improve the accounting for
acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to
the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognition
    of an acquired contract liability</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    terms and their effect on subsequent revenue recognized by the acquirer.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU
2021-08 06 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. We are
currently assessing the impact of this update on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="VBIX:WarrantsPolicyTextBlock"><p id="xdx_846_ecustom--WarrantsPolicyTextBlock_zaRYrHScf6C6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zN5Z9W9Um9we">Warrants</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2021, the Financial Accountings Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2021-04,
&#8220;Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock Compensation
(Topic 718), and Derivatives and Hedging&#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815- 40): Issuer&#8217;s Accounting
for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#8221; (&#8220;ASU 2021-04&#8221;). The
guidance is effective for the Company on January 1, 2022. The Company is currently evaluating the impact of adopting this standard</span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_80B_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zwcy6ownkL16" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
    3.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_823_zvGpz22drQg3">OTHER
    ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Composition:</b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z1M5EfCDeLU7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zV75WJRXJqXe" style="display: none">SCHEDULE
OF OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.75in">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20211231_zmk9zKpfhTSg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br /> December 30</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20201231_zMw2grzwuErb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br /> December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccountsPayableOtherCurrentAndNoncurrent_iI_pn3n3_maAPAOAzuqS_maAPAALzlaq_zekjjQrtE8Fd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Other payables and deferred revenues</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableOtherCurrentAndNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableOtherCurrentAndNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_maAPAOAzuqS_maAPAALzlaq_zfDN0dsWAzH8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Accrued liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">195</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">130</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iTI_pn3n3_mtAPAALzlaq_zypBjA2JqmF7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total other accounts payables</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">242</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">177</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zo4kdZUIDii1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zPXSAaNPhvtj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
    4.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82A_zvInVjQ9Tlh6">RELATED
    PARTY TRANSACTIONS</span>.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balances:</b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zuPoz1REKY68" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_z1V8nzkQ1l1e" style="display: none">SCHEDULE
OF RELATED PARTY TRANSACTIONS</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.75in">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_493_20211231_zOlW66snZtld" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31,</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49E_20201231_zpCMj8kd8cEd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31,</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DueToAffiliateCurrent_iI_pn3n3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gix
    &#8211; Company Payable</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DueToAffiliateCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,116</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DueToAffiliateCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,054</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A5_zOeA46apOKcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the agreement with Gix, the parties agreed to have the Company&#8217;s operations outsourced to Gix from the agreement date and
until the acquisition is consummated. The following term were included in the agreement pursuant to the above:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
    May 2018 all of the Company&#8217;s employees will become employees of Gix.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
    the periods of May 2018 to October 2018, Gix will pay the full expenses of the employees as well as other related expenses.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
    November 2018 until to the Closing Date, the employees transferred from the Company to Gix will dedicate half of their time to the
    Company&#8217;s operations and correspondingly <span id="xdx_90B_ecustom--OperationsCostsIncurredPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--GixLtdMember_zw1qt3ZatMmb" title="Operations costs incurred, percentage"><ix:nonFraction name="VBIX:OperationsCostsIncurredPercentage" contextRef="From2021-01-012021-12-31_custom_GixLtdMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span>% of the costs to be incurred by Gix in respect of these employees are to be charged
    to the Company.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
the closing date, the actual of the expenses incurred by Gix that related to the Company will be charged to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
amounts were paid by the Company to Gix during 2021 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement with Gix, its parent company, pursuant to which, effective as of December 31, 2021, the parent company
payable was modified into a loan, which may be increased from time to time, upon the written mutual consent of the Company and Gix (the
&#8220;Gix Loan&#8221;) .The Gix Loan bears interest at a rate equivalent to the minimal interest rate recognized and attributed by the
Israel Tax Authority and will be repaid, together with the accrued interest, in one payment until December 31, 2022, unless extended
upon mutual consent of the Company and Gix Internet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for the modification as an extinguishment of the parent company payable and the issuance of a new debt. The loan was
recorded at its fair value of $<span id="xdx_903_eus-gaap--DebtConversionOriginalDebtAmount1_c20220212__20220213__us-gaap--DebtInstrumentAxis__custom--GixLoanMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zf0JFDm89qV8" title="Debt modification original debt, amount"><ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2022-02-122022-02-13_custom_GixLoanMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,115,853</ix:nonFraction></span> as of the modification date, with the difference of $<span id="xdx_906_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20220212__20220213__us-gaap--DebtInstrumentAxis__custom--GixLoanMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUT2c7gA4Vwe" title="Debt conversion amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2022-02-122022-02-13_custom_GixLoanMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">184,103</ix:nonFraction></span> between the fair value of the loan
and the carrying value of the payable to the Parent Company recorded in the Company&#8217;s Consolidated Statement of Changes in Stockholders&#8217;
Deficit as a deemed contribution to the Company by the Parent Company, with a corresponding discount on the loan, to be amortized as
finance expense in the Company&#8217;s Consolidated Statements of Comprehensive Loss over the term of the loan.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ShortTermDebtTextBlock"><p id="xdx_80D_eus-gaap--ShortTermDebtTextBlock_zrXbmu5Z0Kj1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
    5.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_823_z1cxf1SvfOal">SHORT
    TERM LOAN AND ISSUES OF SHARES</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 18, 2020, the company entered into a Loan Agreement (the &#8220;Loan&#8221;) and Stock Subscription Agreement with certain Investors
as described in note 1c, pursuant to which the Investors lent an aggregate amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAndStockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_znrphiD1kOv8" title="Debt instrument, face amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-12-18_custom_LoanAndStockSubscriptionAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">69,000</ix:nonFraction></span> (the &#8220;Principal Amount&#8221;). In
accordance with the terms of the Loan, the company prepaid the interest on the Principal Amount of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAndStockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--InvestorsMember_zPxuSk5zYCd1" title="Debt instrument interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-12-18_custom_LoanAndStockSubscriptionAgreementMember_custom_InvestorsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% compounded annually to the Investors
as an issuance of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAndStockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--InvestorsMember_zceVpl9yV7jd" title="Stock issued during period, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-172020-12-18_custom_LoanAndStockSubscriptionAgreementMember_custom_InvestorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">552,000</ix:nonFraction></span> shares of Common Stock, at a price per share of $<span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_c20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAndStockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--InvestorsMember_zcj0nh0r5jC3" title="Stock issued price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2020-12-18_custom_LoanAndStockSubscriptionAgreementMember_custom_InvestorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span>. Under the Stock Subscription Agreement, the Investors
transferred an amount of $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn3n3_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--InvestorsMember_zmy0FQ1N1yDe" title="Proceeds from issuance of common stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2020-12-172020-12-18_custom_StockSubscriptionAgreementMember_custom_InvestorsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,587</ix:nonFraction></span> to the company as consideration for the issued shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company allocated the total proceeds in respect of the shares issued and the Loan extended based on theirrelative fair values. As a result
of the allocation, a discount of $<span id="xdx_90B_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn3n3_c20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAndStockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--InvestorsMember_zV6quylOw2Pi" title="Loan discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2020-12-18_custom_LoanAndStockSubscriptionAgreementMember_custom_InvestorsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19</ix:nonFraction></span> was recorded on the loan. The discount is amortized over the term of the loan as finance expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="VBIX:ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock"><p id="xdx_893_ecustom--ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock_zP20iHwNx7s6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
allocation of the proceeds to the fair value distribution of the liability and equity components on the transactions date was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zImG6ykGWEy" style="display: none">SCHEDULE
OF FAIR VALUE DISTRIBUTION OF LIABILITY AND EQUITY COMPONENTS</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.75in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Instrument</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of total fair</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Allocated</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>amount</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan</span></td><td style="width: 2%; text-align: left">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShorttermDebtFairValue_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--LoanMember_zfKX63Ycl6z4" title="Fair Value" style="width: 16%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShorttermDebtFairValue" contextRef="AsOf2020-12-18_custom_LoanMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">55,200</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_ecustom--PercentageOfFairValue_iI_pid_dp_c20201218__us-gaap--DebtInstrumentAxis__custom--LoanMember_ziI6Hx0s7e83" title="Percentage of fair value" style="width: 16%; font-weight: bold; text-align: right"><ix:nonFraction name="VBIX:PercentageOfFairValue" contextRef="AsOf2020-12-18_custom_LoanMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">49.45</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShortTermDebtAllocatedAmount_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--LoanMember_znFRCbAef7O9" title="Allocated amount" style="width: 16%; font-weight: bold; text-align: right"><ix:nonFraction name="VBIX:ShortTermDebtAllocatedAmount" contextRef="AsOf2020-12-18_custom_LoanMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49,246</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShorttermDebtFairValue_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--SharesMember_zu34jF1re4Qh" title="Fair Value" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShorttermDebtFairValue" contextRef="AsOf2020-12-18_custom_SharesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">54,000</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_ecustom--PercentageOfFairValue_iI_pid_dp_c20201218__us-gaap--DebtInstrumentAxis__custom--SharesMember_zT6kUDBqJd" title="Percentage of fair value" style="font-weight: bold; text-align: right"><ix:nonFraction name="VBIX:PercentageOfFairValue" contextRef="AsOf2020-12-18_custom_SharesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50.55</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShortTermDebtAllocatedAmount_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--SharesMember_zKuRD6y8MRH7" title="Allocated amount" style="font-weight: bold; text-align: right"><ix:nonFraction name="VBIX:ShortTermDebtAllocatedAmount" contextRef="AsOf2020-12-18_custom_SharesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50,340</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShorttermDebtFairValue_iI_pn3n3_c20201218_z1ADcZYu6lA1" title="Fair Value" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShorttermDebtFairValue" contextRef="AsOf2020-12-18" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">109,200</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_ecustom--PercentageOfFairValue_iI_pid_dp_c20201218_zuJ05joCu2xj" title="Percentage of fair value" style="font-weight: bold; text-align: right"><ix:nonFraction name="VBIX:PercentageOfFairValue" contextRef="AsOf2020-12-18" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_988_ecustom--ShortTermDebtAllocatedAmount_iI_pn3n3_c20201218_ziGh0AYVIIIg" title="Allocated amount" style="font-weight: bold; text-align: right"><ix:nonFraction name="VBIX:ShortTermDebtAllocatedAmount" contextRef="AsOf2020-12-18" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">99,586</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zmt6t7h4yKu4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfShortTermDebtTextBlock"><p id="xdx_89F_eus-gaap--ScheduleOfShortTermDebtTextBlock_za0dQ2sXMV14" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
composition of short term loan balance as of the transaction is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zhdp4aWkW9pl" style="display: none">SCHEDULE
OF COMPOSITION OF SHORT TERM LOAN</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%; margin-left: 0.75in">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20201218_zai3RvIgnCdc" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--ShortTermPrincipalAmount_iI_pn3n3_maSTBzbhn_zsKg6tmfKq9j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Principal amount</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 20%; text-align: right"><ix:nonFraction name="VBIX:ShortTermPrincipalAmount" contextRef="AsOf2020-12-18" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">69</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DiscountOnShortTermLoan_iI_pn3n3_msSTBzbhn_z0eoIF8V1V8c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Discount on Short term loan</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="VBIX:DiscountOnShortTermLoan" contextRef="AsOf2020-12-18" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">19</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--ShortTermBorrowings_iTI_pn3n3_mtSTBzbhn_zIODnTMCyY82" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Short term loan, Net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShortTermBorrowings" contextRef="AsOf2020-12-18" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<!-- Field: Split-Segment; Name: 001 -->
</ix:nonNumeric><p id="xdx_8A9_zi35FZNclEbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zXj6Si7yFhRj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
6. <span id="xdx_820_zb1YbiCLo3S9">STOCKHOLDERS&#8217; DEFICIT</span>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ordinary
Shares:</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--CommonStockVotingRights_c20210101__20211231_zUWuSQLOJFs1" title="Common stock, voting rights"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="us-gaap:CommonStockVotingRights">Ordinary
shares confer the right to: (i) participate in the general meetings, to one vote per share for any purpose, to an equal part, on share
basis, (ii) in distribution of dividends and (iii) to equally participate, on share basis, in distribution of excess of assets and funds
from the Company and they shall not confer other privileges unless stated hereunder or in the Companies Law otherwise. Some investors
have standard anti-dilutive rights, registration rights, and information and representation rights.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 18, 2020, the company entered into a Stock Subscription Agreement (the &#8220;Subscription&#8221;) with certain investors (the
&#8220;Investors&#8221;) in connection with the sale and issuance of an aggregate of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zg4pukFEKggb" title="Number of share issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-172020-12-18_custom_StockSubscriptionAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,000,000</ix:nonFraction></span> shares of Common Stock, at a purchase
price of $<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zKyqnMBcKlVc" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2020-12-18_custom_StockSubscriptionAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> per share, and for an aggregate purchase price of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zXDggJF3liJb" title="Stock issued during period value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-12-172020-12-18_custom_StockSubscriptionAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,000</ix:nonFraction></span>. In accordance with the terms of the Loan, the company repaid
the interest on the Principal Amount <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20201218__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zm0qg0lP3LUk" title="Debt instrument interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-12-18_us-gaap_InvestorMember_custom_LoanAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% compounded annually to the Investors in the form of an issuance of an aggregate of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zRbMmrGpIWG1" title="Number of share issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-172020-12-18_custom_LoanAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">552,000</ix:nonFraction></span> shares
of Common Stock, at a price per share of $<span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20201218__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zIrNxnrF1tv6" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2020-12-18_us-gaap_InvestorMember_custom_LoanAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span>. The shares of Common Stock were issued to the Investors pursuant to Regulation S of the
Securities Act of 1933, as amended. For more details, please see note 1c.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zccM6tKvs1Bj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes information of outstanding warrants as of December 31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zrVZiiruvAs1" style="display: none">SUMMARY OF OUTSTANDING WARRANTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrant Term</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 22%; text-align: left">Class J Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zrl8C6d2l38h" title="Warrants" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2021-12-31_custom_ClassJWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">3,649,318</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 16%; text-align: right"><span id="xdx_907_ecustom--WarrantTerm_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zWfllLCfmrV9" title="Warrant Term"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ClassJWarrantsMember" name="VBIX:WarrantTerm">July 2029</ix:nonNumeric></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zT6hlD65nrpe" title="Exercise Price" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-12-31_custom_ClassJWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.48</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_ecustom--WarrantExercisable_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zxVMLW21XTb5" title="Exercisable" style="width: 16%; text-align: right"><ix:nonFraction name="VBIX:WarrantExercisable" contextRef="AsOf2021-12-31_custom_ClassJWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">3,649,318</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Class K Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zxZZJ6hPxAHj" title="Warrants" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2021-12-31_custom_ClassKWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">3,649,318</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_90D_ecustom--WarrantTerm_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_z5cdcogI2Dpf" title="Warrant Term"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ClassKWarrantsMember" name="VBIX:WarrantTerm">July 2029</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zGug9JiAUcD7" title="Exercise Price" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-12-31_custom_ClassKWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.80</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--WarrantExercisable_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zziS5An11jql" title="Exercisable" style="text-align: right"><ix:nonFraction name="VBIX:WarrantExercisable" contextRef="AsOf2021-12-31_custom_ClassKWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">3,649,318</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A4_z6G7X9RSxl2i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
in connection with the Share Exchange Agreement, upon the earlier of: (a) the launch of a live video product to an American consumer
in the United States by Viewbix Israel, or (b) the launch of an interactive television product to an American consumer in the United
States by Viewbix Israel, the Company will issue to Gix an additional <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20201217__20201218__dei--LegalEntityAxis__custom--GixLtdMember_zW7kAtmAnN8i" title="Number of restricted common stock shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2020-12-172020-12-18_custom_GixLtdMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,642,193</ix:nonFraction></span> shares of restricted common stock of the Company. All
of the Company&#8217;s warrants meet the US GAAP criteria for equity classification. During 2020, <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--ClassHWarrantsMember_z3HuFfxJR8p7" title="Number of warrants expired during period"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-01-012020-12-31_custom_ClassHWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></span> class H warrants , <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--ClassIWarrantsMember_z2DpczWovEJl" title="Number of warrants expired during period"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-01-012020-12-31_custom_ClassIWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,095</ix:nonFraction></span> class
I warrants and <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--ClassGWarrantsMember_zt9opza6H1V5" title="Number of warrants expired during period"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-01-012020-12-31_custom_ClassGWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">142,857</ix:nonFraction></span> Class G warrants expired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:RevenueFromContractWithCustomerTextBlock"><p id="xdx_80D_eus-gaap--RevenueFromContractWithCustomerTextBlock_zVSFdCfTNhqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
7. <span id="xdx_822_z9kqclCBqFM3">REVENUES</span>. </b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><p id="xdx_890_eus-gaap--DisaggregationOfRevenueTableTextBlock_z9fAgJq5bob1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8BD_zTSY7UYpc1d9" style="display: none">SCHEDULE OF REVENUES</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Individual Subscriptions</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210101__20211231__srt--ProductOrServiceAxis__custom--IndividualSubscriptionsMember_zgRpownWfmO8" title="Revenues" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-12-31_custom_IndividualSubscriptionsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__custom--IndividualSubscriptionsMember_pn3n3" title="Revenues" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-12-31_custom_IndividualSubscriptionsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Enterprise Subscriptions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210101__20211231__srt--ProductOrServiceAxis__custom--EnterpriseSubscriptionsMember_zImVzQwHevPd" title="Revenues" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-12-31_custom_EnterpriseSubscriptionsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__custom--EnterpriseSubscriptionsMember_pn3n3" title="Revenues" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-12-31_custom_EnterpriseSubscriptionsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">83</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210101__20211231_zLJeKw9kpbxj" title="Revenues" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231_pn3n3" title="Revenues" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">96</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zXnxewyXKoZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"><p id="xdx_808_eus-gaap--ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_zBBYmsbj4RPa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. <span id="xdx_827_z1PTDeJ3JAJg">RESEARCH AND DEVELOPMENT EXPENSES</span>. </b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="VBIX:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock"><p id="xdx_891_ecustom--ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_znRHXTH3Nl92" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8B7_zPjyxqKeCI5" style="display: none">SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Salaries and related expense</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_zliWUf4uKjLc" title="Research and development" style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0525">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ResearchAndDevelopmentExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_pn3n3" title="Research and development" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-01-012020-12-31_custom_SalariesandRelatedExpenseMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">55</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Subcontractors</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--SubcontractorsMember_zAFjFZbpJL2a" title="Research and development" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-01-012021-12-31_custom_SubcontractorsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">64</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--SubcontractorsMember_z6hzHijwkhBf" title="Research and development" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-01-012020-12-31_custom_SubcontractorsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">53</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20210101__20211231_zOrZa5RGNRKf" title="Research and development expenses" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">64</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ResearchAndDevelopmentExpense_c20200101__20201231_pn3n3" title="Research and development expenses" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">108</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zGjA47tFMeqj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="VBIX:SalesAndMarketingExpensesDisclosureTextBlock"><p id="xdx_809_ecustom--SalesAndMarketingExpensesDisclosureTextBlock_zWwpG23gyqK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
9. <span id="xdx_822_zFidS2CnsnAb">SALES AND MARKTING EXPENSES</span>. </b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="VBIX:ScheduleOfSalesAndMarketingExpensesTableTextBlock"><p id="xdx_894_ecustom--ScheduleOfSalesAndMarketingExpensesTableTextBlock_z4i5U5icqKJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8B4_zVXGfpuncWSj" style="display: none">SCHEDULE OF SALES AND MARKETING EXPENSES</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Salaries and related expense</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SellingAndMarketingExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_ztS7H3aV0YNj" title="Sales and marketing expenses" style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0541">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SellingAndMarketingExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_pn3n3" title="Sales and marketing expenses" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2020-01-012020-12-31_custom_SalariesandRelatedExpenseMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SellingAndMarketingExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--OtherMember_zrajO4n1V7ll" title="Sales and marketing expenses" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2021-01-012021-12-31_custom_OtherMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SellingAndMarketingExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--OtherMember_pn3n3" title="Sales and marketing expenses" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2020-01-012020-12-31_custom_OtherMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SellingAndMarketingExpense_pn3n3_c20210101__20211231_zbni4G3gDIuj" title="Sales and marketing expenses" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SellingAndMarketingExpense_c20200101__20201231_pn3n3" title="Sales and marketing expenses" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_zHOfDjpvapX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="VBIX:GeneralAndAdministrativeExpensesDisclosureTextBlock"><p id="xdx_803_ecustom--GeneralAndAdministrativeExpensesDisclosureTextBlock_zbAqzzgNhD0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -68.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
10. <span id="xdx_82F_zL6gfEEaNEph">GENERAL AND ADMINISTRATIVE EXPENSES</span>. </b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="VBIX:ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock"><p id="xdx_89B_ecustom--ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock_zEaN69G9yuA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -68.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zMqHY6TgQw99" style="display: none">SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-size: 11pt; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20210101__20211231_zAZ2mliSYmT3" style="font-weight: bold; text-align: center">2021</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20200101__20201231_zmhcRID8cdU6" style="font-weight: bold; text-align: center">2020</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-size: 11pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-size: 11pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt; text-align: center">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt; text-align: center">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt; text-align: center">&#160;</td><td style="font-size: 11pt">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LaborAndRelatedExpense_maGAAEzPpY_zQOJZP2z8m7c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-left: 5.4pt">Wages, salaries and related expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">140</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">214</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ProfessionalFees_maGAAEzPpY_zc0ClPWTwc7g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">176</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--Depreciation_maGAAEzPpY_zVX3ifbAcxe5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Depreciation</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0563">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OtherGeneralAndAdministrativeExpense_maGAAEzPpY_zjDEsA4HkMah" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; padding-left: 5.4pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralAndAdministrativeExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralAndAdministrativeExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--GeneralAndAdministrativeExpense_iT_pn3n3_mtGAAEzPpY_zeqITNovxt82" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; font-size: 11pt; padding-left: 5.4pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    and administrative expenses</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">304</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">437</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zmkCbEforcHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -68.05pt"><b>&#160;</b></p>


<ix:exclude><!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="VBIX:FinancingIncomeExpensesTextBlock"><p id="xdx_802_ecustom--FinancingIncomeExpensesTextBlock_zBG0lVKmv1E3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
11. <span id="xdx_82D_zEi2bv2PU0pg">FINANCIAL EXPENSES (INCOME), NET</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></b></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="VBIX:ScheduleFinancingIncomeExpensesNetTableTextBlock"><p id="xdx_89C_ecustom--ScheduleFinancingIncomeExpensesNetTableTextBlock_zYpwyV7G9z6i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;<span id="xdx_8BA_zVFOB9kDoaW" style="display: none">SCHEDULE
OF FINANCIAL (EXPENSES) INCOME, NET</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Bank fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231__us-gaap--CreditFacilityAxis__custom--BankFeesMember_zobzR3SUeKne" title="Financing (income) expenses, net" style="width: 16%; text-align: right"><ix:nonFraction name="VBIX:FinancingIncomeExpensesNet" contextRef="From2021-01-012021-12-31_custom_BankFeesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231__us-gaap--CreditFacilityAxis__custom--BankFeesMember_zPkZh1iklpL" title="Financing (income) expenses, net" style="width: 16%; text-align: right"><ix:nonFraction name="VBIX:FinancingIncomeExpensesNet" contextRef="From2020-01-012020-12-31_custom_BankFeesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exchange rate differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231__us-gaap--CreditFacilityAxis__custom--ExchangeRateDifferencesMember_zqa4iX1UmPFe" title="Financing (income) expenses, net" style="text-align: right">(<ix:nonFraction name="VBIX:FinancingIncomeExpensesNet" contextRef="From2021-01-012021-12-31_custom_ExchangeRateDifferencesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231__us-gaap--CreditFacilityAxis__custom--ExchangeRateDifferencesMember_zPlbcOUnCZ28" title="Financing (income) expenses, net" style="text-align: right">(<ix:nonFraction name="VBIX:FinancingIncomeExpensesNet" contextRef="From2020-01-012020-12-31_custom_ExchangeRateDifferencesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Interest expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231__us-gaap--CreditFacilityAxis__custom--InterestExpensesMember_zVEpoYWkl0I4" title="Financing (income) expenses, net" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="VBIX:FinancingIncomeExpensesNet" contextRef="From2021-01-012021-12-31_custom_InterestExpensesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231__us-gaap--CreditFacilityAxis__custom--InterestExpensesMember_zswxfj2aAOAh" title="Financing (income) expenses, net" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0586">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231_zA9OXsD3KgS" title="Financing expenses (income), net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="VBIX:FinancingIncomeExpensesNet" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231_zv4LOjkgX4zk" title="Financing expenses (income), net" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="VBIX:FinancingIncomeExpensesNet" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zhGq7Kv1uEt9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_80D_eus-gaap--IncomeTaxDisclosureTextBlock_zFHs1Da3HR4g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
12. <span id="xdx_82E_zu67r7UMr1ik">INCOME TAXES</span>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to income taxes under the Israeli and U.S. tax laws</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tax
rates applicable to the income of the Company:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Viewbix
Inc. is taxed according to U.S. tax laws. <span id="xdx_908_eus-gaap--IncomeTaxExaminationDescription_c20210101__20211231_zR1cNqgHN7Mk" title="Income tax examination description"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="us-gaap:IncomeTaxExaminationDescription">On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the &#8220;Act&#8221;), which
among other provisions, reduced the U.S. corporate tax rate from 35% to 21%, effective January 1, 2018.Viewbix Israel and Israeli subsidiaries
are taxed according to Israeli tax laws.</ix:nonNumeric></span> The Israeli corporate tax rate is <span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_c20210101__20211231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zUnonec9e9hf" title="Corporate tax rate"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_c20200101__20201231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_z9kh0037ylf1" title="Corporate tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2021-01-012021-12-31_us-gaap_IsraelTaxAuthorityMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2020-01-012020-12-31_us-gaap_IsraelTaxAuthorityMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">23</ix:nonFraction></ix:nonFraction></span></span>% in the years 2021, 2020 and onwards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deferred
income taxes:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_892_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zdpdxmzeWya8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#8217;s deferred tax assets are
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zYDTPzqvw8Cd" style="display: none">SCHEDULE OF DEFERRED INCOME TAXES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.75in">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none">&#160;</td><td style="display: none; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49C_20211231_zsrOcfIccJT5" style="display: none; font-weight: bold; text-align: center">2021</td><td style="display: none; font-weight: bold">&#160;</td><td style="display: none; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49C_20201231_z2WokoXqd0Md" style="display: none; font-weight: bold; text-align: center">2020</td><td style="display: none; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br /> December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br /> December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_iI_pn3n3_maDTAOLz7uk_zKXf5q76a4J9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Deferred R&amp;D expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">167</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">114</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_maDTAOLz7uk_zSofonZhDJH4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating loss carryforward</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,055</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32,256</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DifferencesBetweenTaxBasisAndCarryingValuesOfLoans_iI_pn3n3_maDTAOLz7uk_zlZRqYGItht1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Differences between tax basis and carrying values of loans <br />(see notes 4
    and 5)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="VBIX:DifferencesBetweenTaxBasisAndCarryingValuesOfLoans" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">184</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="VBIX:DifferencesBetweenTaxBasisAndCarryingValuesOfLoans" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">18</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_mtDTAOLz7uk_zvzwlSFFD2b5" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,038</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32,352</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsGross_iI_pn3n3_maDTANzK9I_zkejzdb3WPrb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net deferred tax asset before valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,230</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,072</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzK9I_zWWrvOpzvKH8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,230</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,072</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzK9I_zOpGXZvjhlSl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0620">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0621">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_zSqfHsMUoC4l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
12. INCOME TAXES. (Cont.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, the Company has provided valuation allowances of $<span id="xdx_909_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pn3n3_c20210101__20211231_zFZBbcDnlHJc" title="Valuation allowances, deferred tax assets"><ix:nonFraction name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,909</ix:nonFraction></span> in respect of deferred tax assets resulting from tax loss
carryforward and other temporary differences. Management currently believes that because the Company has a history of losses, it is more
likely than not that the deferred tax regarding the loss carryforward and other temporary differences will not be realized in the foreseeable
future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Available
carryforward tax losses:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, Viewbix Israel incurred operating losses in Israel of approximately $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20211231__us-gaap--IncomeStatementLocationAxis__custom--ViewbixIsraelMember_zzuPrEmrnGB9" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-12-31_custom_ViewbixIsraelMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,624</ix:nonFraction></span> which may be carried forward and offset
against taxable income in the future for an indefinite period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021 the Company generated net operating losses in the U.S. of approximately $<span id="xdx_90A_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20211231__srt--StatementGeographicalAxis__country--US_z5W6h3WCd6Qc" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-12-31_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,615</ix:nonFraction></span> <span id="xdx_90F_eus-gaap--IncomeTaxExaminationDescription_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_z46VBCwh4JY4" title="Income tax examination description"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_DomesticCountryMember" name="us-gaap:IncomeTaxExaminationDescription">Net operating losses in the U.S.
are available through 2035.</ix:nonNumeric></span> Utilization of U.S. net operating losses may be subject to substantial annual limitation due to the &#8220;change
in ownership&#8221; provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in
the expiration of net operating losses before utilization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><p id="xdx_895_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zosicShTX6t5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss
from continuing operations, before taxes on income, consists of the following:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zmHjQOwPMaa2" style="display: none">SCHEDULE OF LOSS (INCOME) FROM CONTINUING OPERATIONS, BEFORE TAXES ON INCOME</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">USA</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zVnolIGZwVTc" title="Total loss before taxes on income" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-01-012021-12-31_us-gaap_DomesticCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">164</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zIVBw2hl00Ik" title="Total loss before taxes on income" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-01-012020-12-31_us-gaap_DomesticCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">65</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Israel</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zB1yXc9iqkOd" title="Total loss before taxes on income" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-01-012021-12-31_us-gaap_ForeignCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">220</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_ztMaWEjR5s1f" title="Total loss before taxes on income" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-01-012020-12-31_us-gaap_ForeignCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">376</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20210101__20211231_zxNRkT9b7U1e" title="Total loss before taxes on income" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">384</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20200101__20201231_zxRjGkRQRXR8" title="Total loss before taxes on income" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">441</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A3_zx4VNY24DFUg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:EarningsPerShareTextBlock"><p id="xdx_807_eus-gaap--EarningsPerShareTextBlock_zloGIVs67Un6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
13. <span id="xdx_822_zHuUie6lRNv5">LOSS PER SHARE-BASIC AND DILUTED</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Composition:</b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_899_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zUKTfWJQj9V2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8BD_zMZyTVCSIeb4" style="display: none">SCHEDULE OF LOSS PER SHARE-BASIC AND DILUTED</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in">
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended December 31</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-size: 11pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; width: 60%; font-weight: bold; text-align: left">Net loss attributable to ordinary stockholders</td><td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20210101__20211231_zjW4NEGZ1iP9" title="Net loss attributable to ordinary stockholders" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">386</ix:nonFraction></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20200101__20201231_zsEM81j00iQc" title="Net loss attributable to ordinary stockholders" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">443</ix:nonFraction></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Weighted-average ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20210101__20211231_zkxW0dRbDh3b" title="Weighted-average ordinary shares" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,753,669</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20200101__20201231_zhI5LPxGTgjf" title="Weighted-average ordinary shares" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,201,669</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">Loss per share-basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20210101__20211231_zPhJIGOAsdk2" title="Loss per share-basic and diluted" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.011</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200101__20201231_zb8UYTUc6Xq8" title="Loss per share-basic and diluted" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.014</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A1_zqk4oAGz3Zy8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:UnusualRisksAndUncertaintiesTextBlock"><p id="xdx_80B_eus-gaap--UnusualRisksAndUncertaintiesTextBlock_zoJaaR3xEK6h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
14. <span id="xdx_821_zUYpnaqMDd2g">COVID-19 PANDEMIC IMPLICATIONS</span>.</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
COVID-19 pandemic which originated in China in late 2019, has resulted in a widespread health crisis that has adversely affected businesses,
economies and financial markets worldwide, placed constraints on the operations of businesses, decreased consumer mobility and activity,
and caused significant economic volatility in the United States, Israel and international capital markets. The COVID-19 pandemic has
caused an economic recession, high unemployment rates and other disruptions, both in the United States, Israel and the rest of the world.
The Company is actively monitoring the pandemic and is taking any necessary measures to respond to the situation in cooperation with
the various stakeholders. Due to the uncertainty surrounding the COVID-19 pandemic, the Company will continue to assess the situation,
including government-imposed restrictions, market by market. The COVID-19 pandemic has not yet currently adversely affected our business,
however, it is not possible at this time to estimate the full impact that the COVID-19 pandemic, the continued spread of COVID-19, and
any additional measures taken by governments, health officials or by the Company in response to such spread, could have on the Company&#8217;s
business, results of operations and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zL1eT7AiJfbh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
15. <span id="xdx_828_zNSmj9f7p7r4">SUBSEQUENT EVENTS</span>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Loan
Agreement </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2022, the Investors under the Loan Agreement expressed their intention to convert the Principal Amount to the Company&#8217;s
shares of Common Stock, and accordingly, the Company agreed to extend the repayment date (see note 5).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Gix
Merger</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.5pt; text-align: justify; text-indent: 35.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 5, 2021, the Company entered into the Merger Agreement with Gix Media and Merger Sub, pursuant to which, following the Gix Merger,
and upon satisfaction of additional closing conditions, Merger Sub will merge with and into Gix Media, with Gix Media being the surviving
entity and wholly-owned subsidiary of the Company. As of the reporting date, the closing conditions of the Merger Agreement have not
been fulfilled yet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms and conditions of the Merger Agreement, at the Merger Effective Date (as defined in the Merger Agreement) all outstanding
ordinary shares of Gix Media, having no par value (the &#8220;Gix Media Shares&#8221;) will be converted into shares of Common Stock,
such that immediately following the Gix Merger, holders of Gix Media Shares will hold 90% of the Company&#8217;s capital stock on a fully
diluted basis. The Merger Agreement contains customary representations, warranties and covenants made by each of the Company, Gix Media
and Merger Sub.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 21, 2021, the shareholders of each of Gix Media and Merger Sub approved the Merger Agreement. Consummation of the Gix Merger
is subject to certain additional closing conditions, including, among other things, (i) the Company filing an amendment to its certificate
of incorporation to change the Company&#8217;s name to &#8220;Gix Media, Inc.&#8221;, (ii) obtaining approval from certain third parties,
including the approval of Bank Leumi due to certain liens registered in its favor against ordinary shares of Gix Media; (iii) conversion
of the Company&#8217;s outstanding convertible instruments into restricted shares of Common Stock and (iv) obtaining a tax pre-ruling
from the Israeli Tax Authority relating to the Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
15. SUBSEQUENT EVENTS. (Cont.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reverse
Stock Split</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Gix Merger, on February 13, 2022, the requisite majority of the Company&#8217;s stockholders approved certain amendments
to the Company&#8217;s certificate of incorporation, including, but not limited to (i) a name change from &#8220;Viewbix Inc.&#8221;
to &#8220;Gix Media, Inc.&#8221;, (ii) a reverse stock split of the Company&#8217;s common Stock at a ratio of 1-for-28 (the &#8220;Planned
Reverse Split&#8221;), (iii) a staggered board structure, and (iv) certain other provisions therein. Pursuant to the Planned Reverse
Stock Split, each twenty-eight (28) shares of the Company&#8217;s common stock will be automatically converted, without any further action
by the stockholders, into one share of the Company&#8217;s common stock. No fractional shares will be issued as the result of the reverse
stock split. Instead, each stockholder will be entitled to receive one share of common stock in lieu of the fractional share that would
have resulted from the reverse stock split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company intends to effect the foregoing amended and restated certificate of incorporation upon the closing of the Gix Merger, thus, as
of the reporting date the Planned Reverse Stock Split has not been effected.</span></p>

</ix:nonNumeric><p id="xdx_816_z9TYmRCgpR7h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_014"></span>ITEM
9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_015"></span>ITEM
9A. CONTROLS AND PROCEDURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Disclosure
Controls and Procedures</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our
reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in
the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to
ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated
to management, including our Chief Executive Officer and Chief Financial Officer, or persons performing similar functions, as appropriate,
to allow timely decisions regarding required disclosure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.4in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management, including our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure
controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of December 31, 2021, the end of the period
covered by this Annual Report on Form 10-K. Based on such evaluation, due to the material weakness discussed below, our principal executive
officer and principal financial officer concluded that our disclosure controls and procedures were not effective at a reasonable assurance
level as of December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 48; Options: NewSection; Value: 25 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Management&#8217;s
Report on Internal Control over Financial Reporting</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and
15d-15(f) of the Exchange Act. The Company&#8217;s internal control over financial reporting is designed to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance
with U.S. GAAP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.4in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of
any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions,
or that the degree of compliance with the policies or procedures may deteriorate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.4in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
evaluated the design and operating effectiveness of internal control over financial reporting based on criteria established in <i>Internal
Control - Integrated Framework (2013)</i> issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO
2013&#8221;). Based on this evaluation, management concluded that our internal control over financial reporting as of December 31, 2021
was not effective due to the material weakness described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.4in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the preparation of our consolidated financial statements as of and for the year ended December 31, 2021 and December
31, 2020, we have identified a material weakness in our internal control over financial reporting. The material weakness was identified
in the period-end financial reporting process, and is associated with our history as a private company and a material weakness is a deficiency
or combination of deficiencies in our internal control over financial reporting such that there is a reasonable possibility that a material
misstatement of our consolidated financial statements would not be prevented or detected on a timely basis. This deficiency could result
in additional misstatements to our consolidated financial statements that would be material and would not be prevented or detected on
a timely basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.4in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are evaluating and implementing additional procedures in order to remediate this material weakness, however, we cannot assure you that
these or other measures will fully remediate the material weakness in a timely manner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Attestation
Report of the Registered Public Accounting Firm</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
annual report on Form 10-K does not include an attestation report of the Company&#8217;s registered public accounting firm regarding
internal control over financial reporting. Management&#8217;s report was not subject to attestation by the Company&#8217;s registered
public accounting firm pursuant to rules of the SEC that permit the Company, as a non-accelerated filer, to provide only management&#8217;s
report in this annual report on Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Changes
in Internal Control Over Financial Reporting</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no changes in our internal control over financial reporting or in other factors identified in connection with the evaluation required
by paragraph (d) of Exchange Act Rules 13a-15 or 15d-15 that occurred during the fourth quarter ended December 31, 2021 that have materially
affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_016"></span>ITEM
9B. OTHER INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 49; Value: 25 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_017"></span>PART
III</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_018"></span>ITEM
10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors were elected to serve until the next annual meeting of shareholders and until his respective successors will have been elected
and will have qualified. The following table sets forth the name, age and position held with respect to our present executive officers
and directors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 62%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amihay
    Hadad</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director,
    Chief Executive Officer and Chief Financial Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alon
    Dayan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amihay
Hadad</i> has served as our chief executive officer since February 20, 2020, chief financial officer since July 25, 2019, and was appointed
as a member of our board of directors on January 1, 2020. From 2011 until 2018, Mr. Hadad served as the chief financial officer of Yedioth
Internet. As of January 30, 2020, Mr. Hadad serves as the chief executive officer of Gix Internet, a controlling stockholder of the Company,
in addition to his existing role as Gix Internet&#8217;s chief financial officer. Mr. Hadad holds both a B.A. and an MBA from the College
of Management Academic Studies in Rishon LeZion, Israel, and an M.A. in law from Bar-Ilan University, Israel. Mr. Hadad is also a certified
public accountant in Israel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Alon
Dayan</i> has served as a member of our board of directors since March 14, 2018, and from January 24, 2018 until July 25, 2019, he served
as our chief executive officer. From July 2014 to the present, Mr. Dayan served as the chief executive officer and founder of L1 Systems
Ltd., an Israeli based company engaged in the business of providing the public and private sectors with advanced security solutions.
Since July 2013, Mr. Dayan has served as chief executive officer and was the founder of Polaris Star, an Israeli-based company which
is engaged in providing advanced cyber security telecommunication for utilities world-wide. Mr. Dayan earned his B.Tech. degree in electronic
engineering from Ariel University in Israel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 34.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Involvement
in Certain Legal Proceedings</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
director, officers or affiliates have not, within the past five years, filed any bankruptcy petition, been convicted in or been the subject
of any pending criminal proceedings, or is any such person the subject or any order, judgment or decree involving the violation of any
state or federal securities laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Family
Relationships</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no family relationships between or among any of our directors or executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Compliance
with Section 16(a) Compliance.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(a) of the Securities and Exchange Act of 1934 requires that directors and executive officers, and persons who own beneficially more
than ten percent (10%) of the Registrant&#8217;s Common Stock, to file reports of ownership and changes of ownership with the Securities
and Exchange Commission. Copies of all filed reports are required to be furnished to the Registrant pursuant to Section 16(a). The Registrant&#8217;s
officers and directors are current in their filings are required under Section 16(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Director
Independence.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not currently have any independent directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Directors&#8217;
Term of Office.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors are elected for a term of one year and serve until such director&#8217;s successor is duly elected and qualified. Each executive
officer serves at the pleasure of the board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 50; Value: 25 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit
Committee and Financial Expert, Compensation Committee, Nominations Committee.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any of the above mentioned standing committees because our corporate financial affairs and corporate governance are simple
in nature at this stage of development and each financial transaction is approved by our officers or board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Potential
Conflicts of Interest.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
we do not have an audit or compensation committee comprised of independent directors, the functions that would have been performed by
such committees are performed by our board of directors. Thus, there is a potential conflict of interest in that our directors have the
authority to determine issues concerning management compensation, in essence their own, and audit issues that may affect management decisions.
We are not aware of any other conflicts of interest with any of our executives or directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Board&#8217;s
Role in Risk Oversight.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors assess on an ongoing basis the risks faced by the Company. These risks include financial, technological, competitive,
and operational risks. In addition, since the Company does not have an audit committee, the board of directors is also responsible for
the assessment and oversight of the Company&#8217;s financial risk exposures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Involvement
in Certain Legal Proceedings.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not aware of any material legal proceedings that have occurred within the past ten years concerning any director or control person
which involved a criminal conviction, a pending criminal proceeding, a pending or concluded administrative or civil proceeding limiting
one&#8217;s participation in the securities or banking industries, or a finding of securities or commodities law violations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_019"></span>ITEM
11. EXECUTIVE COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
compensation received by our officers, directors, and management personnel will be determined from time to time by our Board of Directors.
Our officers, directors, and management personnel will be reimbursed for any out-of-pocket expenses incurred on our behalf.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets out the compensation paid for the fiscal years ended December 31, 2021 and 2020 as applicable, to the following
Named Executive Officer:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 34.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Amihay Hadad, our current Chief Executive Officer and Chief Financial Officer.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table is in U.S. dollars <b><br />
Name and principal position</b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Salary</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Bonus</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Stock Awards</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Option Awards</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">All Other Compensation</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; font-weight: bold; text-align: left">Mr. Amihay Hadad</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">2021</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">83,326</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">83,326</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left">Current Chief Executive Officer, Chief Financial Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,072</td><td style="text-align: left">(1)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,072</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Amihay Hadad&#8217;s salary for the fiscal year-ended December 31, 2020 was paid beginning April 2020 and onwards. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Director&#8217;s
Compensation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors are not entitled to receive compensation for service rendered to us or for meeting(s) attended except for reimbursement of
out-of-pocket expenses. There is no formal or informal arrangements or agreements to compensate employee directors for service provided
as a director; however, compensation for new non-employee directors is determined on an ad hoc basis by the existing members of the board
of directors at the time a director is elected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 51; Value: 25 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Compensation
Policies and Practices as They Relate to the Company&#8217;s Risk Management</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our compensation policies and practices for all employees, including executive officers, do not create risks that are reasonably
likely to have a material adverse effect on us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Employment
Contracts</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any formal employment agreement with any of our officers. Any future compensation will be determined by the Board of Directors,
and, as appropriate, an employment agreement will be executed. We do not currently have plans to pay any compensation until such time
as the Company maintains a positive cash flow.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Outstanding
Equity Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no equity awards outstanding as of the end the year ended December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Option
Grants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2021, the board of directors did not authorize the issuance of stock options to executive officers and directors
to purchase shares of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Aggregated
Option Exercises and Fiscal Year-End Option Value</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no stock options exercised during the year ending December 31, 2021 by our executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Long-Term
Incentive Plan (&#8220;LTIP&#8221;) Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no awards made to named executive officers in the last completed fiscal year under any LTIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Indebtedness
of Management</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
officer, director or security holder known to us to own of record or beneficially more than 5% of our common stock or any member of the
immediate family or sharing the household (other than a tenant or employee) of any of the foregoing persons is indebted to us in the
years 2021 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_020"></span>ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below provides information regarding the beneficial ownership of our Common Stock as of December 31, 2021, of (i) each of our current
directors, (ii) each of the Named Executive Officers, (iii) all of our current directors and officers as a group, and (iv) each person
or entity known to us who owns more than 5% of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
percentage of Common Stock beneficially owned is based on 34,753,669 shares of Common Stock outstanding as of December 31, 2021. The
number and percentage of shares of Common Stock beneficially owned by a person or entity also include shares of Common Stock issuable
upon exercise of warrants that are currently exercisable or will become exercisable within 60 days of December 31, 2021. However, these
shares are not deemed to be outstanding for the purpose of computing the percentage of shares beneficially owned of any other person
or entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: center">Name and Address of Beneficial Owner</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center">Title of Class</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount and Nature <br /> of Beneficial <br /> Ownership<sup>(1)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Percent of Class</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left">Gix Internet Ltd.</td><td style="width: 2%">&#160;</td>
    <td style="width: 20%; text-align: left">Common Stock</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right">27,579,721</td><td style="width: 1%; text-align: left"><sup>(2)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right">79.36</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">L.I.A. Pure Capital Ltd.</td><td>&#160;</td>
    <td style="text-align: left">Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,831,427</td><td style="text-align: left"><sup>(3)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.27</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Executive Officers and Directors</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Amihay Hadad</td><td>&#160;</td>
    <td style="text-align: left">Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Alon Dayan</td><td>&#160;</td>
    <td style="text-align: left">Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Directors and officers as a group (2 individuals)</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Less than 1%</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 52; Value: 25 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
    ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to
    securities. Each of the beneficial owners named in the table have, to our knowledge, direct ownership of and sole voting and investment
    power with respect to the shares of Common Stock beneficially owned by them.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) 20,281,085 of shares of Common Stock, (ii) warrants to purchase up to 3,649,318 shares of restricted Common Stock with an exercise
    price of $0.48 per share, and (iii) warrants to purchase up to 3,649,318 shares of restricted Common Stock with an exercise price
    of $0.8 per share, which are currently exercisable or will become exercisable within 60 days of December 31, 2021.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares shown as beneficially owned by this stockholder is based on its Schedule 13G filed on February 14, 2022.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_021"></span>ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTORS INDEPENDENCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Certain
Related Party Transactions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 18, 2020, L.I.A. Pure Capital Ltd. (&#8220;Pure Capital&#8221;), together with other Investors, entered into the Stock Subscription
Agreement, pursuant to which Pure Capital was issued 1,000,000 shares of Common Stock in exchange for an investment of $10,000, at a
purchase price of US$0.01 per share. Additionally, Pure Capital, together with other Investors, entered into the Loan Agreement, pursuant
to which Pure Capital lent $23,000 and we repaid the interest on that amount in the form of an issuance of 184,000 shares of Common Stock
to Pure Capital, at a price per share of $0.01. The shares of Common Stock were issued to the Investors pursuant to Regulation S of the
Securities Act of 1933, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 13, 2022, the Company entered into a loan agreement with Gix Internet, its Parent Company. Pursuant to the loan agreement, the
Parent Company payables in the amount of $2,299,938 were modified to a loan (the &#8220;Gix Loan&#8221;). The loan agreement also
allows the Gix Loan to be increased from time to time, upon the written mutual consent of the Company and Gix Internet. The Gix Loan
bears interest, commencing on December 31, 2021, at a rate equivalent to the minimal interest rate recognized and attributed by the Israel
Tax Authority, as such may be adjusted from time to time, and shall be repaid, together with the accrued interest, in one payment until
December 31, 2022, unless extended upon mutual consent of the Company and Gix Internet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_022"></span>ITEM
14. PRINCIPAL ACCOUNTING FEES AND SERVICES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Independent
Public Accountants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Registrant&#8217;s Board of Directors has appointed Brightman Almagor Zohar &amp; Co. as independent public accountant for the fiscal
years ended December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 35.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Principal
Accounting Fees</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the fees for professional audit services rendered by (a) Brightman Almagor Zohar &amp; Co. for the audit of
the Registrant&#8217;s annual financial statements for the years ended December 31, 2021 and December 31, 2020 and (b) the aggregate
fees billed in each of the last two fiscal years as pertaining to, among others, tax compliance, tax advice and tax planning conferred
to the Registrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 34.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Year Ended</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Year Ended</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, <br />2021</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, <br />2020</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit fees <sup>(1)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">50,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">50,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax -related fees <sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,948</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    fees consist of audit and review services, consents and review of documents filed with the SEC.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    fees consist of, among other items, preparation of federal and state tax returns, review of quarterly estimated tax payments, Israeli
    tax rulings, consultation concerning tax compliance issues, and services rendered for purposes of a tax ruling filed with government
    agencies and institutions in connection with the Recapitalization Transaction.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 53; Value: 25 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_023"></span>PART
IV</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_024"></span>ITEM
15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The following documents are filed as exhibits to this report on Form 10-K or incorporated by reference herein. Any document incorporated
by reference is identified by a parenthetical reference to the SEC filing that included such document.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
No. Description</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    No.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    Description</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/797542/000079754215000006/exh3_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Incorporation (incorporated by reference to the Registrant&#8217;s registration statement on Form S-1 filed with the SEC on August 5, 2015)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/797542/000149315219011140/ex3-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment to the Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on July 25, 2019)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/797542/000079754215000006/exh3_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bylaws (incorporated by reference to the Registrant&#8217;s registration statement on Form S-1 filed with the SEC on August 5, 2015)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/797542/000149315220004372/ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description of Registrant&#8217;s Securities (incorporated by reference to the Registrant&#8217;s annual report on Form 10-K filed for the fiscal year ended December 31, 2019 with the SEC on March 20, 2020)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/797542/000149315219011140/ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant by and between the Company and Gix Media Ltd., dated July 25, 2019 (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on July 25, 2019)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/797542/000149315218005357/ex99-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2017 Employee Incentive Plan (incorporated by reference to the Registrant&#8217;s annual report on Form 10-K for the fiscal year ended December 31, 2017, filed with the SEC on April 17, 2018)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/797542/000149315220024009/ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Stock Subscription Agreement between the Company and the investors set forth therein (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed on December 21, 2020)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/797542/000149315220024009/ex10-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Loan Agreement between the Company and the investors set forth therein (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Current Report on Form 8-K filed on December 21, 2020)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/797542/000149315221030533/ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreement and Plan of Merger, dated December 5, 2021 (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on December 6, 2021)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex21-1.htm">Subsidiaries of the Registrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex31-1.htm">Section 302 Certification under the Sarbanes-Oxley Act of 2002 of the Principal Executive Officer and Principal Financial Officer</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex32-1.htm">Section 906 Certification under the Sarbanes-Oxley Act of 2002 of the Principal Executive Officer and Principal Financial Officer</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Instance Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Schema Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Calculation Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Definition Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Label Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Presentation Linkbase Document</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furnished
    herewith.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 54; Value: 25 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VIEWBIX
    INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 17, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Amihay Hadad</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amihay
    Hadad</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below on this 17<sup>th</sup> day of March
2022 by the following persons on behalf of the registrant and in the capacities indicated, including a majority of the directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Amihay Hadad</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amihay
    Hadad</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Amihay Hadad</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer and Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amihay
    Hadad</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial and Accounting Officer)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Amihay Hadad</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amihay
    Hadad</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Alon Dayan</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alon
    Dayan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 55; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>ex21-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0; margin-left: 0; background-color: white"><B>Exhibit
21.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0; background-color: white"><B>LIST
OF SUBSIDIARIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company Name</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jurisdiction of Incorporation</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Viewbix Ltd.<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerald Medical Applications Ltd.<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0">Vmedia Merger
    Sub Ltd.<SUP>(3)</SUP></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0">VB Interactive
    Video Technologies Inc. <SUP>(4)</SUP></P></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0">Israel</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0"> Delaware </P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following the consummation of that certain Share Exchange Agreement by and between Virtual Crypto Technologies Inc. and Algomizer Ltd., dated February 7, 2019, Algomizer Ltd. assigned, transferred and delivered 99.83% of Viewbix Ltd. to Virtual Crypto Technologies Inc. Virtual Crypto Technologies Inc. changed its name to Viewbix Inc. on July 24, 2019.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerald Medical Applications Ltd. is the wholly-owned subsidiary of Viewbix Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vmedia Merger Sub Ltd. is the wholly-owned subsidiary of Viewbix, Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VB Interactive Video Technologies Inc. is the wholly-owned subsidiary of Viewbix Ltd.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>ex31-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>Exhibit 31-1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>CERTIFICATION
PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>RULE 13a-14(a)
UNDER THE SECURITIES EXCHANGE ACT OF 1934,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>AS ADOPTED
PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">I, Amihay Hadad,
certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2021 of Viewbix Inc.;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the year-end covered by this report;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the year-end presented in this report;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the year-end in which this report is being prepared;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the year-end covered by this report based on such evaluation; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 17, 2022</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Amihay Hadad</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amihay Hadad</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Chief Financial Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>ex32-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>Exhibit 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>CERTIFICATION
PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>18 U.S.C.
SECTION 1350,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>AS ADOPTED
PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">In connection
with the Annual Report of Viewbix Inc. (the &ldquo;Company&rdquo;) on Form 10-K for the year ended December 31, 2021, as filed
with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), I, Amihay Hadad, Chief Executive Officer and
Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that to the best of my knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Amihay Hadad</I></FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amihay Hadad</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Chief Financial Officer</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Viewbix Inc.</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 17, 2022</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>fin_001.jpg
<TEXT>
begin 644 fin_001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" !Y B<# 2(  A$! Q$!_\0
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M&X\5>*-1UN:QAF,B6SW=U)<-$K$ L%,A4,0"0,X'2L'\*7ZTG;-9FPV>+[1
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MQR^(/Q!\>?%KQUJGQ/\ BEXQU'Q#XDURZ-SK&N:O=--<WDQ&-SN>O   & H
M    &1@XJ;FJ@NI^E6O?\'6W_!5#5;OS]+L?A9ID?_/"U\&W#K^<MXQ_7O5_
MPC_P=D_\%-M#=1XE\%?"?7(PV9/.\,WEN[#T!BO0!_WR:_,4YSBCWHNQ\L3]
MX?V6/^#OGX6^(;U="_;,_9@U+PFI8#_A(O ^I?VK;@9Y:2VE2*9 .N(S,W8
MU^KW[.7[4/[/W[7/PVM?B[^S=\6-'\7>'[H#;?:3<[C"Y&?*FC.)() #S'(J
MN.X%?Q@<GH*]@_8?_;I_:*_X)Z_&^U^.G[.7BZ2RNA)&NO:'<2-]@\06J$G[
M+=QC[Z_,VUQ\\9.Y"#D$YB90[']CE%>,_L"?MO?";_@H3^S!X=_:8^$5R([?
M5HFAUC1Y)U>XT;4(_EGLIL='1N02!O1D<#:XKV:J,PHHHH **** "BBB@ HH
MHH *_$G_ (/)O^01^SKG_G\\5?\ H&E5^VU?B3_P>3'_ (E'[.O_ %^>*O\
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M*S#S'1'95PIY"L<XXKA\U].?\$7.?^"L'P#S_P!%"@_]$RTD4]CZ:_XA,?\
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ML9X[322)(94#HP(MNZL#0D2Y)'X)Y(HXSS7[^?\ $'=^R=_T>1\4O_ +2O\
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MEUVMN[\\5]'>)O\ @YU_X*_^(=/;3[+XP>$-'9E8-=:5X"M?-&>X\\RJ"/\
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MXD>'O$+6JG5-%L=%M[Z&*;'S"&<7">8F>C,L9QU45X[^TM_P>'^#M)ANK/\
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M /1B/C+_ +^67_Q^OZSZ*7*7[21_)A_PXV_X*W9_Y,1\9?\ ?RR_^/U9TO\
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M]BG]L[XN7\>F_#+]D/XH:W-*V$^P^ =0*?BYA"*/<D"OLG]F3_@UU_X*6?M
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MP_!;XVW$@AMO@?XVD=ONQQ^#[YF/X"'-?VKD C!%(%4'(45/*5[0_CJ^&_\
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44 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>fin_002.jpg
<TEXT>
begin 644 fin_002.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" &F!9<# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!Y'^VY^SQXP_:J_9K\2? ?P)\:=
M7^'NJZZ+<6WC#0_,^U6'EW$<K%/+EC;+*AC.''#'MQ7X+?M9_LE?MD_LR_\
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M+CPYX;N)=+\T J]ZR^7;K@_>_>LG'<5^%'_!,C]I_P#;4_9%_:W_ &=/CO\
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M\*:)X$^"/[//@GPS81VVG:/X@GL[&W1<".&*VB15X]%%=_\ \'+G[-VNZ_\
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M:_IMO>:/:ZCII74;HSKOB@2W5B3*P_AS@ $E@HS7S=\%/^#E/]B/XG_$G0O
M/C_X;_$[X;6?BJ8)X7\5>._#T-OI>H9<*I\V.X<H"67YMI09^9AQGYB_X.SK
MZ+Q3^S]\ -=^'&JV\W@B36M45=0TMMVGJ_D6PMB#$",>6MQMV@\*P%)^U;_P
M37_X*C_MV_LY>'O#7QT_;X_9DOO >EO;ZGX9U#3K>6QCMD$#)&8IH[)<(8WQ
MMS@X'&0, K(_;*$DQ@FG5ROP,\)>)_ 'P4\'^!/&NMQZEK.B^%["PU;4HY&9
M;NZAMTCEE#. Q#.K-E@"<\@&NJH)"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M])FURPMH[F^T6+4(VNK>&0X21X@V]$8@[6( ..*V(G\R,/CK0 ZBBD9MHR:
M%HK.\0^*?#_A/3)-:\4:_8Z;9PKF:[U"Z2&)!ZEG( 'OFJ7@GXE>!/B9HO\
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M7EGD"JH]R>!6#X'^,'PN^)D]U;?#OXE>']>DL6Q?1Z+K$%VUNWHXB9MGXXH
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M!8YAL;*S!^0#S5+2,2[L/F)VY;]:J^"?^"IV#_P4@_87)_Z*7X@Z_P#8/@H
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M,_!\.EZ;-=P^)=#OX-.OK"<1N8Y;>>)PZ2AC\H4DDX&#TH ]8_X)=M^T0/\
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M\%_ OQ"M]/\ A?KVIZL]^MNS0.]Y807+Y,T,1\@K\QV*ZXR'!K] F95Y8XH
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MN\9+=);/I'ANRMVNM1E2=R%@<Q+_ *S/"JR_Q59\(,O_ !$%^+CG_FU^U_\
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MTMX-T3_A?%GILVG^/=#\20R/XXN/&+B51Y$<@^U22M/DQ&-2JC[WW6Q^EO\
MP2]\-?M"^#_V _A?X:_:JN;N7QY:>&D76O[08M<QIYCFWBG))S.EL88Y#WD1
MJ^4OV>_^"<?_  3I^.__  3[T']IKXE>.U\0>*M:\+6_B7Q-\??^$FD35[+6
M/LX>>Y6Z\S_1O(EW*(#@1B,(1D&O=O\ @B5\>_C/^TE_P3I\%_$WXZZS-J^L
M-<ZA8VWB&XMS')K%E;7<L-O=O_>9D0 N -Y7=CF@1XW_ ,' -Q\$M7U#]F?X
M>_M(ZOI=GX#U3XY6UWXMDUN\2&T;3[:!GG65FYV,CE3@C[V."01V7["'P/\
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M_@E5X3^!VN_M#Z!_P2(\1^,_A'I,VV\^-%]+:^9J*I,8?MD,E]>"^N$#G"S
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MQV\6>!K6Z\7>"ENE\+:]YDB3V"W$?ESJI1@&5T)5E8$$=JS?$_[(W[.GC/\
M:$T#]JSQ5\)]*OOB)X7TUK#0/%4R-]IL[=O-S&N&VD8GFY()'F-C&:](HH X
M_P"*GP'^%?QN_P"$?_X6IX.M=9_X17Q+9^(/#YN7D'V/4K5_,@N5V,N61P&
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M:Z+_ ,)/XBN==U[[-)(WVS49]OG7#;V.&;:N0,#C@5D?M'_LE?L\?M=^!/\
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MS/\ !O1_"L.J3"75;BQA+7-ZXSM::=RTDFTLQ 9B%+-@#)SZM10!\_?M+_\
M!+C]A']KWQE#\1?V@?V=-#U[7HK=;=]6W36\T\*](Y&A=?-4#CYLD#@$"O5_
MAI\%_AE\'/AS8_"/X7>!-*T+PSIMJ;:ST/3K14MHXSG<NS&#G)R3DMDDY)-=
M510!\IZW_P $2O\ @F%K_B>X\57O[)?A])+N\%U=6-K-<0V4LP8-N-LD@BZ@
M<!0..E?3WAKPWH7@_0+/PMX7T6TTW3=.M8[;3]/L+=8H;6%%"I'&B@*JJ
M   *O44 >1?M5?L)_LH_MM:9I^D?M/\ P7TKQ9'I+.VES7ID2:T+@;MCQLK
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MK CMJ($WG"03 XRNSR\'.ZO8J**!!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11N'K10 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 9OC'Q9H?@+PAJOCGQ/=-!INBZ;/?ZA
M,L;.8X(8VDD8*H);"J3@ D]JX;]E3]KGX%?MI_!VT^//[/'BB?6/#-]=SVUO
M?3:=-:LTD+[)!LF56X;C.,'M5C]KAL?LJ?$S/_1/=:_](9J_$;X-?MV?&7]B
M#_@W2^'O_"A-5FTGQ3X_^+&H^'[?Q!;V9EFTNU,TTLTUNO1YSY:QIG)Q(Q'S
M*" #]^3.@&32?:(^AS7XN_L2?M,_M;_"?]OWX5>$?AO\0?VF/B9\,O&RC2_B
M4OQG^'-U:1:7=R1D17=M.4VQ1B4JQW'A%927)!6C^P1%_P %-/\ @IG\?_C%
M\.S_ ,%%/$?@WP/\+?BI)-,8[5KV_O1+-,L5@&\V+9:K':O\N[ :3.UL\ 6/
MVR\Y!US33<Q X.?^^:_-O_@FE^TW^T!\4O\ @LA^UA\%/B-\6]>UCPGX/NV7
MPOX>OKQGM=,7[6JXB3HORG'TS7SS^R5^U-_P4]^/?_!,/]J#Q#\#OBAXL\9?
M$SP_\6'T[PS(MP;O4K+2U6,S162X+&0(6**H+$YV\XH&C]JA<Q$XR:<9XP,\
M_E7Y _\ !$K]IWP!XJ^+M[JOQ(_X*3?%Z[\1>&? -U<_$#X0?&"W6"*WO81&
M;J]AE+<PP!9?W3*)%#!R<*PKYL_:P_;+^(7A+X;^)OVP/V,O^"AW[4/CVZT'
MQPODZ_?> YX/ \-H]WL2TDN&4H&"R1H/,*^8?E\M=X  Y3]C?VB/^"C'P6_9
MM_:S^&/['OC70]=N/$GQ8DV>';K3[:-K6$^;Y7[YF<,OS>@-?027,9&#GC]:
M_'O]O?QMJ'Q/_P""O/\ P3W^(^J0QPW7B#0;#4[F.$Y57GD25E'MEC7D'Q?_
M &_OV@OVPOVR/CG8:M^T'^T%X)\/_#_6[K1/AQX=^!7@J?4($F@DDB6XU$QC
M=EVA\QE)#?.P4JJ 4#Y3]X_M<.-Q;BE$\;' S^5?A?\ M2?\%*?^"D'AK_@D
MO\%?B]XK\4^+_A_\4[/XM7/A_P 17FH:5-ILVN6\$7FP37%O(JEXWC>(/P%=
MHW/ ) V_CI\/?^"H/[+G_!2/X2_L7^%_^"HGC;5YOCUX=D_X2#7M4L8I/[%D
M5I6O)+.%FV*RI$QB9=C*3C(P#0'*?ML)D(S3@0PW"ORL_P""7?Q"_:N^ W_!
M8'XN?\$[/B]^U)XD^*'A/2/!<>L:7J'BQ]US!-NMF5E.3LRMPZLH.UL*< J*
M_5->% H)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R_%WC/PO
MX#TF+7?%^LPV%I-J5EI\4\V=K75W=16EM%P#S)/-%&.V7&<#FM2O/OVF=0\.
MZ;\-]/N/%/@2;Q%:MX^\)Q1Z?#(RM#<2>(=/2WO,KSBVF:.Z(Z$6Y!X)H []
M)%?[M.J*$Y?'H*EH **** "BBB@#C?$W[0_P.\&?%[0?@%XK^*FAZ?XU\4VT
MMQX=\+W5^BWNHQ1J[.\41.YU41R$D# V&H?'_P"TM\ ?A5\0_#?PF^)'Q<T'
M1/$WC&8Q>%=#U+4$BN=5D#!2L"$YD.YE'&>2*_,3_@L3\5_'_P #_P#@N=^R
M_P#%'X7_  2U7XBZ]I7@75SI_@W0Y@EYJ+21ZA$P1B"!L1VD)(/RQO7D_P"U
M!^U/\>OVH?\ @L+^QSJ?QX_8O\5?!NXTCQ9)%IMCXHNDF?5%>Y@+R1[54@(4
M .1CY@?6@I(_<=;F-QD9_*O-_P!JS]K[]G[]B;X1S?'/]I/QR?#_ (9AU""R
M>^73Y[IC/*2$41P([G.">%X -?G/_P %8OVY_BG\&_V@_%>B?#O_ (++>"?A
MNFA:"LNB?#*Q\!_VOJ#Z@(0SP7D\4$BP%WVA1(V55ON#DMYY\?O^"JO[2WQE
M_P"#>OP_^U_J7_"-GQPWQ&M] UF[OO"=CJ%GJ"PO*//-I<PR0([[8V.U!A@=
MH4': .4_33]K7_@I%^QM^P]X+\/^._VDOC!#HEGXJ;'AN&WTZXO+C4!L5RZ1
M01N^Q59278!0649W,H/:?LV_M-_![]K7X.:3\>O@5KUWJGA?7/.&FWUUI-Q9
MM*8I6AD_=W"(^%D1USC!*G!-?CU_P6/\"?M+?%O_ (*+?LAVEA\9_#]B?%T-
MA'X'^T>$8)XM#NV^S&:>XB?='=AI2&$978JKC;WKZ(_X*$?'?XP?LJZ+\,/@
MQXG_ ."Q'@'X/:MI_A,?\)@MG\-HKV^UK4,D"[BLK6!OLMO(?,^7")NZ;CT
MY3].A*C-M4YIU?GG_P &^?\ P43^.G[>'PG^(FA?'_Q?I_BK5?A[XJCL=/\
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MG1CA3FGUR/P6\/?$[PM\+M!\/?&?Q[#XG\56FFQQZ]XAM]-2SCU"Y ^>584
M6,$_PJ !774 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\&^,KFZ^(7@/38[_ ,3:0VDW$<=K X@*L)V01.<7,/"L3\W3@X_*GX'^#/\
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MK_:,/[0?V%OV>=#LM-.C_P#"(^9_PD'D! 9/-^UK]DW;<XVS8SU..>5^+_\
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M ,$(/^"G/Q6_8CTC]B7XB?M/?"72_"W@35(KKP;INBZ+<I_:<PD;?/?W BW
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MG6NLZ3>+<6MU DUM-&V5DC9=RL/8C!_&@"Y11N!Z&DWI_>'YT +10"",@T4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM'O-:8J!J2P&6-2;81#S6WNDH!K]4(&+1 D4$L=1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% #9N4Z5YS^RW?Z9J'PZU2?2?ANWA6)?B%XN
MC;2VW_OY$\1ZBLE]\_.+MPUX,?+BZ^7C%>C3$B/Y:XG]GVW\?6O@B^B^)'C&
MTU[4&\9>(WM[ZRE5TBL&UN^:QM25 &^WM#;V[C&0\# EB"2 =Q1110 4444
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MQ4 @GS'_ ()Z>"_"?P]_X*!_M9>!_ OAVRTG1]+N/!-MINFZ?;+#!;1+I=R
MB*H 4#V%;7_!,.RM-?3]H35=?L8[B\U/]H3Q+;:I)<1[FN((72"%'!ZJ(%10
M.FWMS0![-\8/VS_V=/@=\%M-_:!\=_$FV;PQKK6R>'+S1K>34)-:DN%W01V<
M5NKR7+NOS 1J?E!8X )$/[,W[9_P2_:RL]6_X55J>JP:IX?FBB\1>&_$OA^Z
MTO5-,:1-Z>=;72(X5EY5U#(V#AC@U^:/_!/B3^U_C%^QC\.-9F-UX9\.^(?B
MW_PBL,[;H7:UD>.V9.JRF*)I-C+D*"=M?:ER8]$_X+9Z;;:1MC77/V9]0N-<
M6(#][+:Z]8QVI?'<)<W 7=V+8QS0!]:#..:*!THH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** ,;XB^"=*^)GP^U[X<:]<7$
M-CX@T:ZTV\EM&594AGB:)V0LK ,%8X)4C/4'I61\!_A%X<_9]^"G@[X">#K^
M_NM(\$^%=/T#2;K5)$>YEMK.VCMXWE9$1&D*1@L515+$D*HXK4^)_CBS^&/P
MU\1?$G4;*2YM_#VAW>IW%O"P#RI!"\K(I/ )"8&>,FL/]G?XRZ5^T%\ O OQ
M]T72;BPL_'/@_3?$%G873*9;>*\M8[A8WV\%E$@!QD9!H \1N_\ @DY\"X?V
M8O!/[-7A7XC^.M%?X<^+K[Q-X&\<6&I6HUK2M2NKZZO)'#_9O(>,O=RQF-H2
M#'M!RPWUM?![_@G/X#^%OQKL_P!I7Q'\9OB'XX^($/A>[T"\\2>+M8MI6N[*
M>2.01F&*WCCB$31GRUB5%_>R%Q(S;A]$&< XV-0+E#T_G0!Y]^S%^SEX._92
M^#&D_ SX?:AJEYI.CR7#6UQK$\<EPYFG>9MS1QQKPTA PHP,=^:9\??V:_!G
M[1+^#Y/&>IZM:'P3XTL_$VE?V3/$GG7=MOV1R^9&^Z([SN"[6/&&%>B&X4<E
M3Z4/<*@R5- 'GO[3?[-G@S]J_P"#6H?!#XC:IJUEI>I75K//<Z+-%'<*T%PD
MZA3+'(H!:-0<J3@G!!YKD_VEOV'_  1^T)XQT3XM:/\ $GQA\/?'WAS39K#2
M?'/@34(H+P6,S*TMG,L\4L-Q SJK;70E67*E#G/MWVE<XVFO+?VU_P!H>]_9
M4_9/^('[26E^&(=:N/!/ABYU6+2;BZ,*731+GRS(%8H#ZX./2@#)_9]_8=^&
M/P%T'Q9!/XC\2>-->\?K_P 5QXP\9ZDMSJ6L#RC$L;-&D<<421L52.)$51V)
M))\MA_X)%^%&_9AU[]CS4/VOOC1+\/\ 5+>TLM*T>/6M-631=.MY-Z6$$IL"
M6@("QLLH?=&BITSGZN\/ZU_:WAZQUB2#R_M5G',R!LA=RAL9]LU;^U(6V[6H
M \;_ &?/V2/$?P"UQ=4F_:V^*_C2PATW[%:^'/&5YH[6%NN$"NB66G6SJRA<
M#Y]H!/RFLSX ?\$\/@;^S=^TCX\_:A\ WOB"?7_'R[+JQU2^BEL='C:XDN9H
M[&-8D:%)9Y#+(&=\L!C;SGWAKA%."/K09UQG% '@7BW_ ()S_!?QC\(?C9\%
MM3\4>*H]+^/'B6XUSQA<6]];"XM+B:VM+9ELV-N5C0)91$"193N9\D@@#K_C
M/^RK\/\ XY^#_!?@CQ;K6L6]KX'\5:7KVE2:;<0I)+<V&?)28O$P,9S\P4*Q
MXPR]_3S-C^!ORKY7\5?\%+=3&K^--6^$'[(_CKQWX-^'>MW6E>+/&.BW-E'&
MES:DB\6U@EE62[\@AE?:!\RLJ[B,4 >N>./V6? /Q!_:7\ ?M4:]JVLP^(/A
MSINJV6AV=K<1+9SQZA$D<QG1HFD9@$&S;(@!SD-TKOO%.@6GBWP[?>&+Z61;
M?4+*:UN&A8!U21"A*Y!&<$XX(SV->3?$O]OK]FWX<_L[^'?VDYO%LVK:+XTM
M;:3P/8Z):M<7_B&6>+S8;>UMQ\\DA7D@@! "7*@&M;]C#]J'P_\ MD?LT>%_
MVE_#/A2_T.Q\46]Q+;Z3JDB-<6PBNI;<ARA*Y)B+8!X#8H E^$W[*_PO^$7[
M+VE?LA6L%UKG@_3/#+:"]OXB:.:6^L6C:-TG,:(K;E8AMJ*#D\"O%M'_ ."2
M'PR$^C>$OB)^T9\5/&?PY\-ZC;WOA_X5>)]?MIM&@>W<26T<ICMDN+J&%P-D
M4TSKA4#[]M=E\??^"B/PL^"'[5OP[_9%/AO4M<\1^/-4AM+J336C\G0EF65H
M)+K<<_O/(F*J 25B9N!@U@_&[_@H;X^\ ?M,ZU^S%\&/V,_&'Q0U3P[X=T_5
M];OO#NM6%O#:1W;RK%&XN9%.\^2S8&>"#0!VGQL_8-^"7QZ_:<^&O[5_CBXU
MF/Q)\+S<'1;;3[R*.SOO-*L@O$:)GE$,BF2(*Z!7=B=V0!5O/^"??P1OOVZ8
M?^"@AO=>3QE;^&UTG^S5O(1I4V$DC6[>'R?,-R(I&B#>:%"8&W/-;]S^U5X=
M^'7[-R_M%_M.>%KSX9P10YU#0]:N([JZMI6D*1VX^S%Q--(=H2./<S%@ ,UG
M?L3_ +97A[]M?X;ZY\2?#7PW\0>%H=%\77F@RZ9XF@2*[,EOL)D:-2?+SO&4
M;YE((8 @B@#D_B1_P3>T77?BKKWQ>^!O[3_Q0^$NH>+[Q;GQE8^ ]5LA9:O.
M$5/M307=K.(K@HJKYL97('S*QP1US_L0_#_4OB5\&?B_X@^(GC35M=^"-OK,
M7AZ]U;5HKB35&U.T%K<R:@S0[YGV#<IC:+#=0PPH\DUG_@K3I]OI.N?&CP[^
MR]XRUCX,^&]9GT[6/BI8WEH8 (9_)FO8;3?YT]HC;]TJC)"Y56'-?7NDZA9Z
MMIEOJFFW<=Q;W,*RV]Q"P9)$895E(Z@@Y![T 6!THHHH **** "BBB@ HHHH
M *\X_:H_X5[_ ,*OT[_A9L>H-IO_  L3PA]E&ELHD&H_\))IOV G<"/*%[]F
M,G&3'OQSBO1ZXWX[?\)W_P (/9_\*[\,V6K:A_PE_A[[1:ZA"LD:6']LV?VZ
M<!B!YD-I]HF1NJR1(0"0 0#KH.O3M4E1P8Z9Y[BI* "BBB@ HHHH \WU?]FW
MP1J?[4>G_M97&J:M_P )%I?@R;PS;V*W$0L3:RW N&<KY?F&7> ,B0+C^'/-
M6/VDO@F/VC?@AX@^";_$7Q%X37Q!:I WB+PG>K;ZC98D5]T,C*P0G;M)*GY6
M85S>N?M.:KI?[=>C_LA1>$+=[75/AO<>*&UUKP^9&\=X+80>5MP5(.[>6'/&
M#BD^-_[3FJ?";]I3X0? BU\(6]]#\3;[5H+C4I+PQOIXLK59PRQA2)-VXJ<E
M<<=: *7QP_8.^%7Q^\&>#M$\8>)?%5CXB\ 6\:^#_B)H.L"VU_391"L4DJW&
MQE<RJB^8DB-&Y&2G3',?#?\ X)L^%M$^)VA_&#X^?M#_ !*^,&N^%[EKGPK'
M\0=8MFL-'N""OVF"TM+>"(SA6*^9('(!.W;FO6?''[5_[,'PQ\76_P /_B3^
MT9X#\/Z]=L@M=$USQ?96EY,7("A8995=BQ( P.2:I_%3XN>-_!OQP^'W@71K
M+PF?#WB"'69O$]UK7B9+34;9+2WBDB>RMCS=KN=O.(P(EV,2 U &='^ROIC_
M !>^(?Q4U'XK^,+N#XB>%[?1;KPS<:HC:=I4<4<B--:1E/W<KB7YB2PRH.#S
M7B7A3_@C;X/\+?#6Q^!Q_;I_:,O? =CIZ:=_PA<WC33(;&>Q4;?LC&VTV*81
M%>#LD1B.,U!\!OVVOC+^U?\ M@>,?#7PD^/7P;TWX<^ _&$FBMX;EA?4O$'B
M*&WB1[N]AEBO4C@C$C[$812* A9B3E:^D?!?[5G[,?Q&\=2_"WX>_M$^!=>\
M36ZNT_AW1O%UE=7T83[Y:WCE:0!>^5X[T <_I_['W@SPU\4OAGX[\!>,_$GA
MO1?A?X>N]%T?P+HNH"/1KRVF@6!/M,)4M(T*J#&=PP>3FNF_:$^#<OQU\!KX
M+LOBWXP\$W45_'=VGB#P1J4=K?0R(& 7,L4L;QL&(:-T(8?3-=Q*,QD8KPGX
MV_%;]N:P^(5UX._9O_99\*ZQH]C:QRGQ9XR\?&PAOI&3<8(+:WMIY,CE2\C(
M W(4C!(!G_!+_@G[X<^&?Q6L?CK\6/C_ /$'XK>,-'L[BT\/ZMX^U.V:+1HI
ML"7[);6L$,4;NH4-(RNY P"H)%<U\1?^"5/P_P#&7B#Q,O@_]I#XK>"?!_CB
M\GO/&WP[\)>(;>#2=4N)S_I#KYEN\UKYV6\X0R)OW9&T@D[OP7_X*"^'/B!^
MRIKG[2/C[X6:_H.H>$]?O/#_ (J\':5 ^KW=OJUO.L#6UOY$8-R'=X]CA5!#
MC.WG%_\ X)__ +8/C']LKPEXV\1^./@G-X!O_"/CZZ\/-X?O-46ZN46.WMY@
MT[(H1)<3@-&I95*X#-C- 'L7P^\">$_A=X(TCX<> =!ATO0]!TV#3]'TVUXC
MM;6&,1QQKWP%4#\*\JTG]@7X#6OPU^*GPCUI=8USP_\ &#Q5J?B#Q99:I>)\
MES?.&D2W:*.,QHK*&3)9U(!WFO(-<_X**_M0^)M/\;_'3X ?LH:-XD^$'P]U
MK4+'4]7NO&C6^L:ZE@Y2]NM/MA;-%Y<;)(%$DF9=G!7-;/[0?_!0GXJP>(_@
MAX4_8A^#WA_XC7?QJ\-ZCX@TN3Q%XFDTF&VTVWM;:YCE+"&3)=;C&T@%2H!Z
MG !HZ%_P2_T&X\0^')/C=^U=\6?B=X;\'ZM#J7AGP5XRU>R;3X;F YMY;DVU
MI%+>-"<,GFR$ J"P8\U]2PNBH%9N?]JO!?"/Q[_:I\(?L[^/?C#^UC\"/"_A
M34O"NEW6H:7I?AOQ8^IPWL$-LTI,DA@0QG<NW 5O6N%_9A_:8_X*;_&FX\&^
M+_B'^QG\._#O@GQ+:VU]?ZM9_$V6YO;.SFC$@<6YM5WN 1\NX<GK0!];"1#T
M:@RQCJU?)_CG]MG]J#Q[\=?'/PA_8F_9IT'Q?9_"VXAM/&GB+Q=XO?2H;O4I
M+=;@Z98B*WF+RI%)'OE?"HS;2I^]71>'/VSOBO\ '3]F7PK\;OV3?V<?^$FU
MKQ)?3V-_H?B#Q-'ID/AVY@>6*Z%W,(Y&?RIXFCVQ(Q<X^Z.0 ?2 93T-%?-_
M[,_[9GQ2\7?M+>(/V,_VGO@MIG@[X@:3X/@\5:;+X;\1-J>F:QH[W)M6FCD>
M&&2*2.?]VT;J<Y!#'D#Z/5MPR* %HHHH **** "BBB@ HHHH **** "BBB@
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MRJ 2 % % '6T444 %%%% !7DW[3?[,"_M&>)/AGX@?QF=)_X5U\0;/Q0D/\
M9WGB_:!)%^SD^8ABSYF=XW8Q]TUZS10!\N_\%/O^"9/@C_@I?\'K7X?ZSXXN
M?!OB'2[B1M%\9:?IXN9K:"90ES;-%YD7FPRH &0MC*JW44WXU_L*?'?4?VIM
M4_:R_91_:GM_AWKWBKPS9Z%XQL=:\$PZY:WL-J[M;SPAIHFAE02,N,E'SR!C
MGZDHH ^)=>_X)%^,A^S-\0/V=? W[86L6LOQ(^(Z>*O%'B;Q!X9CU"YU%71#
M=V<Z1W$"LD\Z>8QC\I0C&()M.:Z_7?V"OVA/B_\  #QC^S3^TO\ M;Z7XB\*
M^(O#,6F:/;^%?A?#H<NB3PR1207",+R=951H4_<E0IQC.WBOJNB@#XPF_P""
M:'[2OQ1\9_"_QU^T[^W+_P )/-\)?'6GZ_X;TK0_A]#IEE.EL'5TN%6Y=WFD
M4Q@2[ML05L1N7)'L_P"S=^R2O[//Q>^,/Q7B\;MJS?%GQM#XA>R;31#_ &88
M[.&U\@.)&$P(BW;]J$;L8.,GVBB@#Y0\7_L#_M$> OC%XP^+'[#_ .U['\.+
M7X@ZFNJ>+_"7B#P1!KFG2:IL6.2_M0TL,EO)(B)YB;F1BN>. NY^T#^Q+\7_
M (X?!KX<Z2W[3]Q;?$WX9^*H?$>C?$2Y\)V[PW=^D-Q _GV".L?E/#<RQ[%8
M;<J0<C-?2=% 'SW\./V,O'>B?M=:'^V=\4OC;!XB\3:?\%9/ 6K6ECX7%C;W
MLCZK'J!OD_TA_*_U8B\G:V?O;Q]VN5_:(_9<^/?@%?C]^T#^RUXJNKSX@_%;
MPWHNE>&]/@MXX#HEQ:"2 7?G22XD 6Y:4C:I BP-Q(KZNHH Q/ OA_5O#/@O
M1_#FM:U<ZG>:?I=O;7>I7C!IKN1(U1IG/=V(W$]R37GGQ8_9:C^*/[47PK_:
M5D\9/9M\,5UD1Z,NGB1=1^WV1M>92X\K9G=]UMV,<=:]>HH \#_:G_9 \>_%
M[XA^&_C]^S]\<YOAO\1_"]A<:9;ZW)H,6J66HZ;.RO)9W=K(Z>8F]%='5U9&
MR1G<14G[(7[&FI?LZ:]XT^+_ ,3OBQ=>/OB7\1[ZUG\8>+;C2XK&)H[6'R;6
MTM;:,L(+>)"VU2SL6=BS'@+[Q10!X[\%OV44^#O[2?Q=_:&A\;-J#?%:XT:5
M]);3O*&F?8+:6# D\QO.\SS-WW4V[<<YR/,/BM^P!^T/%\3_ !EXU_9%_;.F
M^&&D_$RY6[\<:'/X)M]6V7PA6![ZPE>6-K69XD0,&$BEE#C!&#]8T4 ?+?BO
M_@E[\/M,_9R^&'P;_9Y\?:EX$\1?!>Z6\^''CB.UBO;BVNFC>.Z:ZB<*ERET
M))3.GR!F?*[=JBNA_97_ &-?B%\)OBKXE_:-_:+^/'_"R/B-XDTNVTC^V+?P
M['I-EI>EP,72TMK9))-H:0M([LY9F*C@*!7T'10 #..:*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#SW]K;/_#*GQ-Q_
MT3W6O_2&:OS.^*WBCXJ^+OV8?^"??[*7AGX47'CKPIXZ^$6GWOB;P(GC!-!C
M\5&Q\,VLD-E-=."IA4L9G@/^M\M5.:^[?^"@WQ%_:#TWX4:I\(/V?_V6M:^(
M6H^.?#>I:3'J%CK%I:6>CS2Q>2CW;3NK",B5FW1JY_=X(Y%5=*_X)[?##QE^
MQ9\(_P!E[XUM>3ZE\*_#&A6NA^*O#FI2Z?J&F:GI]A':_;+.YB(>%B%<<<%6
MP1TP ?+?PM_9_P#VE_@+H'[0>JI^R3;? _X1ZW\$]0DM?!>G?$BWUBV@\01P
M7'F75LD('V7S(&7<%4 M$#U-=#\'?V//@U\,?^"46O?M12Z//JWQ2US]F?5&
MU?X@:M?2RZA(DNCO+]G1F8B"!,(J1H J!%[Y)^G_ (=_L1^&/!?A7Q;X5\6_
M';XH>.(/&>BS:1J+>-/&L]Z+>UD5U9;="%C@8ASEU7<<#)P *] \'_!+X?>"
MO@E8_L]66D?;/"]AX=30UL=0/G>?9"'R?+D) WY3Y3QSDT ?!?\ P4%\0R:5
M_P &V-S?MK$EO=3?"KPQ'%<><5=W-S8?*&SG)7=^&:V/VU_V/M:3]K?Q5^TS
M^T!^QG;_ +2'PRUO0[&#3=-T_5&.O>!Q;(PN%M+"5DBN89F82GRG2;<#D' W
M>B:[_P $3OV6/&?PIF^ /C_XE_%?Q!X"CA2+1/!NK?$*XDL-%"-F-K>/L8Q\
MJ;]VU3@#N/3OC-^PEI'Q?\::CXO/[3/QD\,PZRNS5-!\)_$.XLM/E'EB,[(@
M#Y!8#YC$5))+?>YH ^>_B7\6OV"OVF?!OP:_9A^$'[+FJ?&V&^\!KXL\&^#1
MJ@LK'2]"C:.S%UJ$EW,HR'(C5'65RX/ ^]7SXB:WX)_X)_?\% O@0?A?#X!T
M7PE:LVB_#^Q\4?VO:>'_ +3I$,TT,$P"JJ-(3+Y:J K2,*^[_%__  2\_9QU
M";P3JWPNU3Q9\-]4^'_A7_A&/#NL?#WQ%)87(T<N)#8RMAA-&9%$GS G?\^<
M\U-HG_!,']EGP]\(_B;\';*R\13:;\8+-8?'U]?>(9KF^U.3R?*>Y:YFW2&>
M0'<\C$EF.>.!0.Y\I_M?1_$K]H#]OK0?V>M1_9"'QL\'^$O@KINO6?@34?B!
M#H>G->W-RT3W\T<RE;UXEC2-5((C\TGJ17G_ .T%\(?VM?@'_P $G_VBO!_Q
M5\ 7WPV\)W'Q%\(7/PD\,V_CR/6KCPY8S>(-*6YM8KJ)MR1),"T:<;%D*C@5
M^AOQ\_86^#7[0&M>'/'-YK'BCPKXM\)Z?)I^@>-/!/B"73=4@LWV[[9Y4XEA
M8HK&-PRY&<9K*U?_ ()Y?"?QI^SKK_[-/Q3^)/Q$\9:/XFU33[_5M3\5>-)[
MV_,MG>07<*1229$$8EMXSY<:JI!;C+$T#N?+?[7W_!/']FWX,?M"_LZ:+\)-
M!U3PS-\1/'EUX<^)&I:!KMU;77BO36T^:YG@OI0Y:<2R0C>Q(8AV (S7>?!G
MX$_"3]B__@K?9?"+]F3PA#X1\)>._@I<:KX@\+Z5,ZV,NI6>H+%%>"$DJLQB
M?RRPQD*,^_U7\5?V>_AY\9O&G@7Q[XV@O6U#X=>(7UKPV;:Z,:"Z:WDMR9!C
MYU\N1AM..<&L3XM_LXVOB#XD77[2_P .BJ?%#2_A[J7A[P?-JVH/'IL;3_O8
MS.JQR,J^>L9:149@F?E;H0D]86)&7)%?#.D_#C]N3]@KPA\3? WPS\.?#74_
MAG?>(M<\5Z7\0O$GBNXM;OPO:7DDMY=)<:>+1UOFB9G\O;/$'&P.>IKZ4_8?
M_9R_X9+_ &4? _[/EQK7]IWGAO0XH-5U3S7?[9>$;YY0S@,0TK/@L <8R :Y
M'XP?\$]/AQ^T#XZU+6OC-\7/B5K_ (9U:^AN+[X;W/C*:/P_+Y8&(GM8P/,A
M)4,T+,49N2#0!YW_ ,$B/ASK'A3_ ()"_"/1?B%IGF:E:^![C4K1KVV DMTN
MFNIH&4')1OLUPJY!W;6(.,D5Q_\ P3H^,^I?LY?\$)/"/QLT/P#K'BB^T'PW
MJLNG^']!T^2YNKZX;6+N.*-8XE9B#(ZEB =J;FZ U]U7.AZ:=#;0+>U2&U:U
M^S+#"-BI'MV[5 X4 <#'2N/_ &:OV>_AW^RS\%=#_9^^%D%XGA_P[%,FFIJ%
MUYTP66>2=MSX&[YY&[<# [4 ?E!XN^.?P4^'/C+]G?QKXLTKXD:Q\0M4^.D?
MBKXL>)M0^$NLV\NI79TZXC$%HLMNK20P*5AAMXPQ6*/=C[Q/W?XR_86^)?CO
MX^^*OVMO@3^V=XJ^'UY\0-!TB*ZTF'PG97*1BS@=8-PND\Q5/F%GB^5MQ8;A
MQM]L^-'[-WPV^.7BSP+XR\=6UY)>?#OQ.NO^'?LUUL5;P1/$#(,'>NUVXXYP
M<\5Y[\5?V!]!^*'C_6/'NF_M-_&;PF/$$R2:MH_A'XC7-G8NRQ)$6BBPWV=B
MB*"8BN<9X-!7,5_^"=OQV^('[3W[/MY>_'VRT?4/$O@_QYJGAK5M2TNSVV6I
M7.FW>V._BC;/E%L(VW/R2*=O05PO_!-2#5+CX;_M"1:+O%]+\>O%BVC*VW,N
M(@F&^N/3&*^D/@5\#?AA^S=\+-+^#WP@\.KI>@Z.DGV:W\QI':21S)++)(V6
MDD>1F=W8EF9F).357X(_L^_#S]G^V\26WP[@NXU\6>++SQ'JPO+GS";ZYV^:
M5./E4[!A><?R"3XI_8^U/PMI'_!N/''K:PVMMI_P2UZSU".==GD72K>1M&X_
MA?SC@@\Y/?-?6G_!/&S\0:=^P%\#=.\6Q3)JUO\ !_PU%JB7(Q(MPNEVPD#?
M[6\'/O7GGB__ ().?LU^+_$VL2WOB3QU:^$?$7B!M<\2?#.Q\7SQ>'-5OGE\
MZ626R&5VRR#?)&"$D;)(Y.?J*W4)"J*H4*,*J]A0-CZ***!!1110 4444 %%
M%% !7G_[2UGH%_\ #C3X/$OCZX\-VZ^/?"DD>H6J,S37">(-/>"R^4@[;J81
MVK'. MPQ((!!] K@?VD[B"V^'-A)<_#?_A*E;QYX53^R_F_<LWB#3U%]\H_Y
M="1=\\?Z-S@9- '<VY.<'TZ5+4<'4BI* "BBB@ HHHH ^$?VJ_A'XO\ C'_P
M6#\&^'/!GQ[\6?#RYA^ =],VL>$5LFN)%_M4+Y9%W;S*%)/4*"2HYK'^)7[/
MOQ#^"O\ P4:_9CN_''[67CSXCPW^J>)UM[7QE'IH2S9=-4EXA:6D&2<X)8M@
M#@#)K[>NO@Q\,;WXP6OQ\NO"<+^+[/07T6UUHS2;X[%Y?-:$+NV8,GS9V[O?
M'%'B[X,?#'QUXZ\,_$WQ;X3AO-<\&37,OAF_>:138O<1>5,RJK!6+(-OS!L=
ML4 ?G/\ M0^*[G]K+]G_ /:&^-WPP_8\^ FF>!]+C\0Z+KOC[XD-+)KVL76F
MI);3SI#!9_N2DB%8#)<%BRH=HW<5O@Q?2>/OBI_P3'E\9A=4_M#X'^,HM0&H
M+YHNE/AO2D(D#YW[EX;=G=DYZU]AZQ_P2R_8/\2?%/4OBWKOP"L[K4M:OWO]
M6LY-1NO[.N[QA\UU)9"7[.TQP#O,>=RAOO &N\\/?L?_ +-_A34?AOJWA_X7
MVUO<?"'1[O2_AS*MY<,=%L[F"*WGB3=(?,#Q0QKF3>0%R"#DD*3/CW]FR\_9
ML_9 ^''[6G[3.N_!/0?L?@'XI^)-R:+X=MEN5T^.V@S9Q,J I&W38,(-QX/-
M>*_M9^%OBK\/;O\ 9?\ BCXA_9@^ /PEM+WX^>&G\,:=\/;J:XU^&.<N\D#S
M):6T#QM$V)PNY68J<G-?IY:_LW? ^P\/>,/"<7PZL9-,\?ZE=7WC"QNF>:/5
M+BY0).\@D9N&55&U<*,< 5Y3\/\ _@D[^P'\-)K6Z\._ *"6?3KZSNM)N-4U
MJ^NY--:UF2:W2V::9C;Q(\<?[M,(PC0,&"@4!S'O-AXT\*Z[K.H>&-&\3:;=
M:AI)1=4L;>]CDFLV=0\8EC5MT>Y"&&X#<""..:\X_:2^!GC?]H;0X](^''[5
MOC+X:SV)GAO+KP3]@D:9W086;[5;RD;,[@$*'YNO((J_LM_LFVW[//CWXK?$
MW5/%W]O^(/BOX^E\0:GJ'V#[.+:U6%(+*P WN66"%-N\D;BS':N=M8/QE_X)
M<_L1?';XFZE\7_B!\'YO^$BUMHSKVI:/XDU#3SJ7EQB*/SUM9T60JBA02,X'
M6@DXO_@CM?BR_9Y\:?!PV^FW#?#'XN:YX7D\4:7'(L?BB2/R+J35'WNY,TCW
M3)*=[ RPOC'W1:_X)<#'B;]I0#_HX_6/_2&PKZ&^#'P3^$O[/7PXT_X1?!+X
M?Z;X9\-Z2A2PT?2;<1Q1Y.YF]69F)9F8EF)))).:?\-O@S\,_A#<^(;OX<>%
M8]+D\5>()M;\0-'-(_VS4)41'G.]FVDK&@PN%^7@=: /BK_@G?XI\._"3_@D
M%XTT+XG7UO8W7P]D\::7XPANI0OV:ZAN[PR1MN[MO7&>&#+C.:/V+O\ @GSX
M:^,7[$7[-WBSXA_$'QQX0\9>#_A+%;VC>$_$#Z?<PV>H)%,T<@*ED.$C4CY2
M"A7H*]Y^*O\ P2^_85^-OQ:N?C/\3/@#8:EK6I7$$^M WUU'::M-#CRI+NUC
MD6&Y9-HP9$;H,YK=_:3_ &!?V5OVK-<TOQ;\9OAJ]YK.CV366FZSINM7FGW4
M%JS%F@$EK+&3&222K9'- TSP;]GO3?$OBSXI_M%?\$[OBW\>=>\?> ]%\.Z=
M#;^*=:NHAJFF#5;687&FRW42JLCQKM=&90ZK*N[=]X\I^T]\-/B%_P $RM(^
M%OQ$_9Y_:B^(&M_;OB;X>\(S?#OQIK2ZC9:W87DZ6TD4,>P/!+%%^\5HN!LY
M4U]6>!OV%_V2?AQ\!M:_9H\%? O1;'P5XD24>(M%C1W_ +4:48DDN)F8RS2$
M ?O&<OP,$8&.9^"O_!,/]B;X!?$2Q^+'P_\ @RLGB+2%E70]6U_6KW59=)$B
M[7-K]LFD%LS+\I:,!BN1G!(H$>;_ /!,.]T[P5\9?VNOAKXEN8[76K/]I+4O
M$5U:S,%9--U#2M-DM)SG^%UBDP3Q\I[5Q_[!7[3GPV_9C_8#UGXY^-A>W6F^
M*_B]XLO/ .A:);_:+_Q!]IU>X-M!90+_ *UYL-(N#M"MO8@9(^B/VCO^"='[
M'/[6?C2W^(7QT^#<.J:U#IO]ES:E9ZK=V,MY8;F;[)<-:RQF>'+N0DF0-S8P
M&.;?QK_X)W?L8?M#>#/"/P\^+'P(TZ^T7P&K+X/TZQO;K3X])5HUC(A^R2Q%
M1L15ZGI[G(5<Y#]B+]GWXIQ>-/$W[:W[4NFV]C\3_B)8V]DOAVUNO.@\*:'
M[O;:6CX&Z7<[2SN.&D.!P@KZ6A)*9*XKPOX!?\$TOV)_V7_B!'\4?@9\%VT/
M7(;62WCO?^$EU.Z"QR##KY=Q<R1\CC.W([8KW8  8%!(4444 %%%% !1110
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MNA^[YY^3F@#N**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!W[1'Q=\-?$?PW\5I-1LM-U33_"O]DZEI%]:VS7666.1XYK=D4KT#JV,E@>
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M$=,NXW,Q>$R1G]^61T5N%., 'W;!]W.?XC3\#TID)RF0.]/H ,#THP/2BB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M67CS1?'G[07[4GQ;^,A\+Z@E]X7T7XC>(;:33=/NT'[NZ-M:6T"SSKDX>;>
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M?_$']OS]H;Q%X!NH_(OO FK>-+4V][;'[UI-<QVB74D#+\A7S0Q7(W\UZO\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 R?_ %?2N.^
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !7#?M#W-W:?#^QEL_AJOBMSXW\,H=+>-F\A6UVQ5K_"@\VBDW@., VH)(&2
M.YKB/V@H-:N? -C'H'Q"M_#$_P#PFGAII-2NIC&LT URQ,UD" <M=1![15_B
M:Y5>,YH [.W&./:I*BML9.W'/I4M !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% #9?N8_I7 _LUW5[>> -2FOOA>OA!AX\\4HNDQHRBX1=?OU34,, <WB@
M7I.,$W1(R"">^EY7\:X+]F^WUVV\!:DGB+XD6OBJX;QUXH:/4[.;S%@@.OWY
M@L22!A[2$QV;+_"]LR]J ._HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!L
M_P#J'^3=\I^7UXKC?V>I[FY^!7@FZO/ "^$YI?"6FM-X6565='8VL9-F P!
MB/[O! (V5V-QN\B3:V#L.#Z<5R'[/T&J6WP-\%P:YXV@\37T?A/35O/$EK+Y
MD>K3"UC#W:-_$LK9D![AJ .RHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O.?VI+KP/
M9_#+39OB%X;OM5T__A8GA!+>UT^3;)'?-XDTU;*<G_GG#=&"9QWCB<=Z]&KD
M?C<_Q)C\%6K?"I+-M4_X2O0?M7VXH$_LW^U[3^T2-Y \P67VG9W+[=N6P* .
MIMR3U/:I:BMRK'<H_P#U5+0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX-_MN?L@_M#>);CP9\#OVE/!?BK5[6(RR:9HNOPSSM&,9D1%;=(@R 70%02
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M[9>1!P#C.3P": .TSGI1573M1L[^QCU*VDS%-"LD;8/*L,C]#5CSHO[WMTH
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M>%_C)_P5)_:B\7>-M(L-8F\'6?@[P[X7N+RW686VF7.B1ZC-&FX$*))[AV;
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M_#KX9QZ;I<,,=_<QR;M:U([$&_,WEVB-DC%O*" 0:H_\%-OAS\"M<^$.@?\
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M0_:T^(6F+X\_:$735UFX\"V\D>G^'5TN II?V03GS)9878RO(^WS#M7"A<L
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M#GPC=:)IZ_$;QC#<6=[,9))+^/Q-J<=[<@DGY)[M;B=!T"3*!TQ0!Z91110
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MVE/^":'P?^+'CK5I+_7+GPFEEJ]]/)NDN;BTD>U,TA[O((1(3W+YKY5_8?\
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M7P^O_ 'ANXT70IO ^DR:+H]Y(7FL;1K.(Q0.QY+(FU2>Y6@#O:*** "BBB@
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M*/<I&Q_Y][O=$R]0&0G[PSZ#^R'^RQX\^$'Q-^*_[0/QT\4:7K7CCXG>+OM
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M"M'[5'PJU;]F;XPZ_P# GPOX:\36G]G^*O&'A./5KF^EL6P)1:6ESB.*5UR
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M ((P7_CW5M#^/_B7QKHFDZ.M]^T5X@E;2M$NFFL[.[_="\CCE*J)ML^Y6E
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M6GP+CU:/PQI_A>&QL(=>C5;V)H"8I4G"DKY@E5P=I(ST)% 'O5%%% !1110
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M:?!;]H;_ (-S)+KP%X[L=:N/AW\*=%O)KC1[L22Z1K>EV]I>)&2IS'*KQH"
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M#2_\2?M&77C?P]X9MG\2>!O@'XFO[>WT.:YB\Y/M5Q:RV\33,A^022<IM;8
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MP_X\T-_A=:VEQXPLO$?@:\MKJU^U#= BP!6D=W4J0H7.&!Z5J> O^"COP/\
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MK;79B\F75&"CYKEX (AVC4OM WL3[]]H.,A:^?/V4_VS/BS^U?XDO/%WA?\
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M?\)CKWPG\1>#;C^U+NT.B^)[=8KK;#.\0FP"1Y<@7>A[JP/<5UXG<_\ +/\
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MO!OA_7?#OA+3M \5^+)O$&H6MFD5[K-U:Q0O>R 8:5HX@$4L>=J@ 9X%>8_
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M5/ TC/="7[<UG!:RFY' V!OM.-O.-G7G ]@H **** "BBB@ KB?V@+KQ#:>
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MS4[:'XH#Q?N\?^+)6U99FD\@R>(=0<Z?EF)'V,L;+;G"FUPH50  #T2BBB@
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MWP7J_BTV7VC^R=+N+S[/YFWS/+C9]N<<9VXS0!X3\*?V#?%^B_&*']H+X_\
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M1WUK1O$GBKPA-:JDFI?9G2X_LJ[#9*Q><J[PO),0YQR?=#-O7:0*:LGEMP*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2]1TZUUSQ9\4M&=+BUO(XT:%X(;6-$2+8S1^7L):60R&3*[>3\5?LP?\% O
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M!!:VKV^GZ#XR^*6A-8QJR@;Y%MK.)IY .CNQQR<9.:"N8^=/AOXJ\7)^P/\
M#GX&^&_&6J^';'XK?M9ZWX5\2ZWHMTUO<P::^IZI<S1),H)A,WV80;QAAYV
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MIVLP4XR..O\ ^"J'B?Q%X?U_]EM- UZ\L5U+]K'PS9:BMG<O']JMGL=49H9
MI&]"40E3D$J..!6+^SM^S9\;/@5XZUCXT>*?@SXZ^(OQ"UK1QI%QXX\;?$S2
MI+NTTX2>8+2U2WABBMXM^'.U-S, 69L*!A^%_P!BWXL:;\(_A?\ "GQI\+?B
M3XH;X4_%.'Q[H>O:Y\5-)FO;W4(OM0C@NG: [[8+=N"B!'^1<.!D$ [G]B^*
M-O\ @H[^V8I7_F<O!?\ ZB=A7UG7@/[-?PJ\6^#?VA_BA\:-<^#&M^'[OXJ7
M.FZCKT^H>++&^MH;BPL+?3X(K>*"-9(U:&+>Q=I,N#@J"%'OP)QR* "BBB@
MHHHH ;-C9R*\W_93U#PGJ?PTU2Y\%^ 9O#=FOQ&\813:?/.\AFNX_$NI)=7@
M+DD+=7"S707HJW 50%4 >DODCBN/^!^F?%32?"%];?&/5XK[6&\6Z_-9SP;=
MJZ5)K%Y)ID7RJOS1V#VD;<9W(<ECEB =C1110 4444 ,D56;D=J_(SQ/XO\
MBQXL_P""=VI6>D_%_P 1Z1JM]^W)>:-#KUCJDJW5K:-K\L7EH^?E14.%4_*/
MEP,X!_6S6)KZVL+BZTS3_M5Q';NT-J) GG. 2$W'A<D 9/3-?#\'[$7B.V^$
M?_"F%_9J\:G2Q\8G^)2W7_"RM&-PNKM>M>&'=]FV_9O,8KLV>9M_Y:9^:@#+
M^+?[.WP[_8M_;P_9IF_9YN_$6D0_$3Q%KOAWQ[97?C'4;R'7+0:/<3HTPN9Y
M/WR3(LJRH5?<!DD<5RO[,7P7^$_[.WQP_;3^/_P_\&:G)X@^%_B&:[\+QW7B
M;4K@$_\ "*6]RR2)+<,MR7D=_FE#L-V%(V@#Z#^,OPX^+WQQ^*OPU^+OBO\
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M$U[;-KMY]K%G"US<Q2BXN$MTCW%6D^:256?=R&D^.O[*WQ^^*/QBNOC[\*_
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MA%K6@V'BGQ7J'BJ[O-8\566H'[?=O'YEO$MM&A2(!<KNW$8(+'(KWE,[!D4
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M?L,FI+&E@8&-N+9K=6$>-P$FXU^@'[./@WXQ_LQ_L^>'/V:O!/[)VLZCX?\
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M48G.ZN)D^''_  6(O=6OO$6L?L$_LMZAXHU2S;3M4\?W3R?:KZS*;#YMIO\
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M+P#\,OB#H=OXNOX]0\:^ K/XC:))HFMWBVRV_G2QRVS2H3&B!A'(H8IGC)R
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M^']]XBU'P=8WGBOPJ^B:@T9%QI<E]'<M!AB%!DC^5LJ W'3..H-;% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%%  >E0^2Y[5-10!'#$8VSMP-O0=O\_TJ
M2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
3 HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>vbix-20211231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWamE+bP9z5Z8+ekhvWB6bdn6/yQmgXitRyOieozGIVoK -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:VBIX="http://corp.viewbix.com/20211231" elementFormDefault="qualified" targetNamespace="http://corp.viewbix.com/20211231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://corp.viewbix.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/StatementsOfComprehensiveLoss" id="StatementsOfComprehensiveLoss">
	  <link:definition>00000004 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit" id="StatementsOfChangesInStockholdersDeficit">
	  <link:definition>00000005 - Statement - Consolidated Statements of Changes in Stockholders' Deficit</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000006 - Statement - Consolidated Statements of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/Generel" id="Generel">
	  <link:definition>00000007 - Disclosure - GENEREL</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilities" id="OtherAccountsPayableAndAccruedLiabilities">
	  <link:definition>00000009 - Disclosure - OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
	  <link:definition>00000010 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfShares" id="ShortTermLoanAndIssuesOfShares">
	  <link:definition>00000011 - Disclosure - SHORT TERM LOAN AND ISSUES OF SHARES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/StockholdersDeficit" id="StockholdersDeficit">
	  <link:definition>00000012 - Disclosure - STOCKHOLDERS&#8217; DEFICIT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/Revenues" id="Revenues">
	  <link:definition>00000013 - Disclosure - REVENUES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/ResearchAndDevelopmentExpenses" id="ResearchAndDevelopmentExpenses">
	  <link:definition>00000014 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/SalesAndMarktingExpenses" id="SalesAndMarktingExpenses">
	  <link:definition>00000015 - Disclosure - SALES AND MARKTING EXPENSES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/GeneralAndAdministrativeExpenses" id="GeneralAndAdministrativeExpenses">
	  <link:definition>00000016 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/FinancialExpensesIncomeNet" id="FinancialExpensesIncomeNet">
	  <link:definition>00000017 - Disclosure - FINANCIAL EXPENSES (INCOME), NET</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000018 - Disclosure - INCOME TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/LossPerShare-basicAndDiluted" id="LossPerShare-basicAndDiluted">
	  <link:definition>00000019 - Disclosure - LOSS PER SHARE-BASIC AND DILUTED</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/Covid-19PandemicImplications" id="Covid-19PandemicImplications">
	  <link:definition>00000020 - Disclosure - COVID-19 PANDEMIC IMPLICATIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000021 - Disclosure - SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilitiesTables" id="OtherAccountsPayableAndAccruedLiabilitiesTables">
	  <link:definition>00000023 - Disclosure - OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/RelatedPartyTransactionsTables" id="RelatedPartyTransactionsTables">
	  <link:definition>00000024 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesTables" id="ShortTermLoanAndIssuesOfSharesTables">
	  <link:definition>00000025 - Disclosure - SHORT TERM LOAN AND ISSUES OF SHARES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/StockholdersDeficitTables" id="StockholdersDeficitTables">
	  <link:definition>00000026 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/RevenuesTables" id="RevenuesTables">
	  <link:definition>00000027 - Disclosure - REVENUES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/ResearchAndDevelopmentExpensesTables" id="ResearchAndDevelopmentExpensesTables">
	  <link:definition>00000028 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/SalesAndMarktingExpensesTables" id="SalesAndMarktingExpensesTables">
	  <link:definition>00000029 - Disclosure - SALES AND MARKTING EXPENSES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/GeneralAndAdministrativeExpensesTables" id="GeneralAndAdministrativeExpensesTables">
	  <link:definition>00000030 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/FinancialExpensesIncomeNetTables" id="FinancialExpensesIncomeNetTables">
	  <link:definition>00000031 - Disclosure - FINANCIAL EXPENSES (INCOME), NET (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000032 - Disclosure - INCOME TAXES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/LossPerShare-basicAndDilutedTables" id="LossPerShare-basicAndDilutedTables">
	  <link:definition>00000033 - Disclosure - LOSS PER SHARE-BASIC AND DILUTED (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/GenerelDetailsNarrative" id="GenerelDetailsNarrative">
	  <link:definition>00000034 - Disclosure - GENEREL (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/ScheduleOfOtherAccountsPayableAndAccruedLiabilitiesDetails" id="ScheduleOfOtherAccountsPayableAndAccruedLiabilitiesDetails">
	  <link:definition>00000035 - Disclosure - SCHEDULE OF OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/ScheduleOfRelatedPartyTransactionsDetails" id="ScheduleOfRelatedPartyTransactionsDetails">
	  <link:definition>00000036 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTIONS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
	  <link:definition>00000037 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails" id="ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails">
	  <link:definition>00000038 - Disclosure - SCHEDULE OF FAIR VALUE DISTRIBUTION OF LIABILITY AND EQUITY COMPONENTS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/ScheduleOfCompositionOfShortTermLoanDetails" id="ScheduleOfCompositionOfShortTermLoanDetails">
	  <link:definition>00000039 - Disclosure - SCHEDULE OF COMPOSITION OF SHORT TERM LOAN (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative" id="ShortTermLoanAndIssuesOfSharesDetailsNarrative">
	  <link:definition>00000040 - Disclosure - SHORT TERM LOAN AND ISSUES OF SHARES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/SummaryOfOutstandingWarrantsDetails" id="SummaryOfOutstandingWarrantsDetails">
	  <link:definition>00000041 - Disclosure - SUMMARY OF OUTSTANDING WARRANTS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative" id="StockholdersDeficitDetailsNarrative">
	  <link:definition>00000042 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/ScheduleOfRevenuesDetails" id="ScheduleOfRevenuesDetails">
	  <link:definition>00000043 - Disclosure - SCHEDULE OF REVENUES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails" id="ScheduleOfResearchAndDevelopmentExpensesDetails">
	  <link:definition>00000044 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/ScheduleOfSalesAndMarketingExpensesDetails" id="ScheduleOfSalesAndMarketingExpensesDetails">
	  <link:definition>00000045 - Disclosure - SCHEDULE OF SALES AND MARKETING EXPENSES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" id="ScheduleOfGeneralAndAdministrativeExpensesDetails">
	  <link:definition>00000046 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/ScheduleOfFinancialExpensesIncomeNetDetails" id="ScheduleOfFinancialExpensesIncomeNetDetails">
	  <link:definition>00000047 - Disclosure - SCHEDULE OF FINANCIAL (EXPENSES) INCOME, NET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails" id="ScheduleOfDeferredIncomeTaxesDetails">
	  <link:definition>00000048 - Disclosure - SCHEDULE OF DEFERRED INCOME TAXES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails" id="ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails">
	  <link:definition>00000049 - Disclosure - SCHEDULE OF LOSS (INCOME) FROM CONTINUING OPERATIONS, BEFORE TAXES ON INCOME (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000050 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://corp.viewbix.com/role/ScheduleOfLossPerShare-basicAndDilutedDetails" id="ScheduleOfLossPerShare-basicAndDilutedDetails">
	  <link:definition>00000051 - Disclosure - SCHEDULE OF LOSS PER SHARE-BASIC AND DILUTED (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="vbix-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="vbix-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="vbix-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="vbix-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="VBIX_VirtualCryptoIsraelMember" name="VirtualCryptoIsraelMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_ShareExchangeAgreementMember" name="ShareExchangeAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_ViewbixLtdMember" name="ViewbixLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_StockSubscriptionAgreementMember" name="StockSubscriptionAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_LoanAgreementMember" name="LoanAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_GixLtdMember" name="GixLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_GixLoanMember" name="GixLoanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_LoanAndStockSubscriptionAgreementMember" name="LoanAndStockSubscriptionAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_InvestorsMember" name="InvestorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_LoanMember" name="LoanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_SharesMember" name="SharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_ClassHWarrantsMember" name="ClassHWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_ClassIWarrantsMember" name="ClassIWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_ClassGWarrantsMember" name="ClassGWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_ClassJWarrantsMember" name="ClassJWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_ClassKWarrantsMember" name="ClassKWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_IndividualSubscriptionsMember" name="IndividualSubscriptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_EnterpriseSubscriptionsMember" name="EnterpriseSubscriptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_SalariesandRelatedExpenseMember" name="SalariesandRelatedExpenseMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_SubcontractorsMember" name="SubcontractorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_OtherMember" name="OtherMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_BankFeesMember" name="BankFeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_ExchangeRateDifferencesMember" name="ExchangeRateDifferencesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_InterestExpensesMember" name="InterestExpensesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_ViewbixIsraelMember" name="ViewbixIsraelMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_ShareCapitalAbstract" name="ShareCapitalAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_FinanceIncome" name="FinanceIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_FinanceExpense" name="FinanceExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_FinancingProvidedByParentCompanyAcquisition" name="FinancingProvidedByParentCompanyAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_GainFromSaleOfSubsidiary" name="GainFromSaleOfSubsidiary" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_ModificationOfParentCompanyPayableIntoLoan" name="ModificationOfParentCompanyPayableIntoLoan" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_CurrentAssetsExcludingCashAndCashEquivalent" name="CurrentAssetsExcludingCashAndCashEquivalent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_LiabilitiesCurrentOne" name="LiabilitiesCurrentOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_SupplementalGainFromSalesOfSubsidiary" name="SupplementalGainFromSalesOfSubsidiary" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_SupplementalCashReceivedFromSaleOfSubsidiaries" name="SupplementalCashReceivedFromSaleOfSubsidiaries" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_DisclosureSalesAndMarktingExpensesAbstract" name="DisclosureSalesAndMarktingExpensesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_SalesAndMarketingExpensesDisclosureTextBlock" name="SalesAndMarketingExpensesDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract" name="DisclosureGeneralAndAdministrativeExpensesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_GeneralAndAdministrativeExpensesDisclosureTextBlock" name="GeneralAndAdministrativeExpensesDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_DisclosureFinancialExpensesIncomeNetAbstract" name="DisclosureFinancialExpensesIncomeNetAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_FinancingIncomeExpensesTextBlock" name="FinancingIncomeExpensesTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_AccountingForIncomeTaxesPolicyTextBlock" name="AccountingForIncomeTaxesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_WarrantsPolicyTextBlock" name="WarrantsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock" name="ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" name="ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_ScheduleOfSalesAndMarketingExpensesTableTextBlock" name="ScheduleOfSalesAndMarketingExpensesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock" name="ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_ScheduleFinancingIncomeExpensesNetTableTextBlock" name="ScheduleFinancingIncomeExpensesNetTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_OperationsCostsIncurredPercentage" name="OperationsCostsIncurredPercentage" nillable="true" xbrli:periodType="duration" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_PercentageOfFairValue" name="PercentageOfFairValue" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_ShortTermDebtAllocatedAmount" name="ShortTermDebtAllocatedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_ShortTermPrincipalAmount" name="ShortTermPrincipalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_DiscountOnShortTermLoan" name="DiscountOnShortTermLoan" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_WarrantTerm" name="WarrantTerm" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_WarrantExercisable" name="WarrantExercisable" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_FinancingIncomeExpensesNet" name="FinancingIncomeExpensesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_DifferencesBetweenTaxBasisAndCarryingValuesOfLoans" name="DifferencesBetweenTaxBasisAndCarryingValuesOfLoans" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_FinancingProvidedByParentCompanyAcquisitions" name="FinancingProvidedByParentCompanyAcquisitions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VBIX_PayableToParentCompanyTextBlock" name="PayableToParentCompanyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>vbix-20211231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://corp.viewbix.com/role/Cover" xlink:href="vbix-20211231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/BalanceSheets" xlink:href="vbix-20211231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/BalanceSheetsParenthetical" xlink:href="vbix-20211231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/StatementsOfComprehensiveLoss" xlink:href="vbix-20211231.xsd#StatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit" xlink:href="vbix-20211231.xsd#StatementsOfChangesInStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/StatementsOfCashFlows" xlink:href="vbix-20211231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/Generel" xlink:href="vbix-20211231.xsd#Generel" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="vbix-20211231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilities" xlink:href="vbix-20211231.xsd#OtherAccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/RelatedPartyTransactions" xlink:href="vbix-20211231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfShares" xlink:href="vbix-20211231.xsd#ShortTermLoanAndIssuesOfShares" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/StockholdersDeficit" xlink:href="vbix-20211231.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/Revenues" xlink:href="vbix-20211231.xsd#Revenues" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ResearchAndDevelopmentExpenses" xlink:href="vbix-20211231.xsd#ResearchAndDevelopmentExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/SalesAndMarktingExpenses" xlink:href="vbix-20211231.xsd#SalesAndMarktingExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/GeneralAndAdministrativeExpenses" xlink:href="vbix-20211231.xsd#GeneralAndAdministrativeExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/FinancialExpensesIncomeNet" xlink:href="vbix-20211231.xsd#FinancialExpensesIncomeNet" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/IncomeTaxes" xlink:href="vbix-20211231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/LossPerShare-basicAndDiluted" xlink:href="vbix-20211231.xsd#LossPerShare-basicAndDiluted" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/Covid-19PandemicImplications" xlink:href="vbix-20211231.xsd#Covid-19PandemicImplications" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/SubsequentEvents" xlink:href="vbix-20211231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="vbix-20211231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilitiesTables" xlink:href="vbix-20211231.xsd#OtherAccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/RelatedPartyTransactionsTables" xlink:href="vbix-20211231.xsd#RelatedPartyTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesTables" xlink:href="vbix-20211231.xsd#ShortTermLoanAndIssuesOfSharesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/StockholdersDeficitTables" xlink:href="vbix-20211231.xsd#StockholdersDeficitTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/RevenuesTables" xlink:href="vbix-20211231.xsd#RevenuesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ResearchAndDevelopmentExpensesTables" xlink:href="vbix-20211231.xsd#ResearchAndDevelopmentExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/SalesAndMarktingExpensesTables" xlink:href="vbix-20211231.xsd#SalesAndMarktingExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/GeneralAndAdministrativeExpensesTables" xlink:href="vbix-20211231.xsd#GeneralAndAdministrativeExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/FinancialExpensesIncomeNetTables" xlink:href="vbix-20211231.xsd#FinancialExpensesIncomeNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/IncomeTaxesTables" xlink:href="vbix-20211231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/LossPerShare-basicAndDilutedTables" xlink:href="vbix-20211231.xsd#LossPerShare-basicAndDilutedTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/GenerelDetailsNarrative" xlink:href="vbix-20211231.xsd#GenerelDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfOtherAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="vbix-20211231.xsd#ScheduleOfOtherAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfRelatedPartyTransactionsDetails" xlink:href="vbix-20211231.xsd#ScheduleOfRelatedPartyTransactionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="vbix-20211231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails" xlink:href="vbix-20211231.xsd#ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfCompositionOfShortTermLoanDetails" xlink:href="vbix-20211231.xsd#ScheduleOfCompositionOfShortTermLoanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative" xlink:href="vbix-20211231.xsd#ShortTermLoanAndIssuesOfSharesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/SummaryOfOutstandingWarrantsDetails" xlink:href="vbix-20211231.xsd#SummaryOfOutstandingWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative" xlink:href="vbix-20211231.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfRevenuesDetails" xlink:href="vbix-20211231.xsd#ScheduleOfRevenuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails" xlink:href="vbix-20211231.xsd#ScheduleOfResearchAndDevelopmentExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfSalesAndMarketingExpensesDetails" xlink:href="vbix-20211231.xsd#ScheduleOfSalesAndMarketingExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" xlink:href="vbix-20211231.xsd#ScheduleOfGeneralAndAdministrativeExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfFinancialExpensesIncomeNetDetails" xlink:href="vbix-20211231.xsd#ScheduleOfFinancialExpensesIncomeNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails" xlink:href="vbix-20211231.xsd#ScheduleOfDeferredIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails" xlink:href="vbix-20211231.xsd#ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative" xlink:href="vbix-20211231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfLossPerShare-basicAndDilutedDetails" xlink:href="vbix-20211231.xsd#ScheduleOfLossPerShare-basicAndDilutedDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_us-gaapAccountsAndOtherReceivablesNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsAndOtherReceivablesNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableTradeCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent" xlink:label="loc_us-gaapDueToAffiliateCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDueToAffiliateCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/StatementsOfComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOtherGeneralExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="loc_us-gaapGainLossOnSaleOfBusiness" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGainLossOnSaleOfBusiness" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_FinanceIncome" xlink:label="loc_VBIXFinanceIncome" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_VBIXFinanceIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_FinanceExpense" xlink:label="loc_VBIXFinanceExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_VBIXFinanceExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; Deficit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_GainFromSaleOfSubsidiary" xlink:label="loc_VBIXGainFromSaleOfSubsidiary" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_VBIXGainFromSaleOfSubsidiary" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInOtherReceivables" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherReceivables" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueToAffiliatesCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueToAffiliatesCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDueToAffiliatesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaapProceedsFromDivestitureOfBusinesses" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromDivestitureOfBusinesses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_us-gaapProceedsFromShortTermDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromShortTermDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/Generel" xlink:title="00000007 - Disclosure - GENEREL" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilities" xlink:title="00000009 - Disclosure - OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/RelatedPartyTransactions" xlink:title="00000010 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfShares" xlink:title="00000011 - Disclosure - SHORT TERM LOAN AND ISSUES OF SHARES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/StockholdersDeficit" xlink:title="00000012 - Disclosure - STOCKHOLDERS&#8217; DEFICIT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/Revenues" xlink:title="00000013 - Disclosure - REVENUES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ResearchAndDevelopmentExpenses" xlink:title="00000014 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/SalesAndMarktingExpenses" xlink:title="00000015 - Disclosure - SALES AND MARKTING EXPENSES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/GeneralAndAdministrativeExpenses" xlink:title="00000016 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/FinancialExpensesIncomeNet" xlink:title="00000017 - Disclosure - FINANCIAL EXPENSES (INCOME), NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/IncomeTaxes" xlink:title="00000018 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/LossPerShare-basicAndDiluted" xlink:title="00000019 - Disclosure - LOSS PER SHARE-BASIC AND DILUTED" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/Covid-19PandemicImplications" xlink:title="00000020 - Disclosure - COVID-19 PANDEMIC IMPLICATIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/SubsequentEvents" xlink:title="00000021 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000023 - Disclosure - OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/RelatedPartyTransactionsTables" xlink:title="00000024 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesTables" xlink:title="00000025 - Disclosure - SHORT TERM LOAN AND ISSUES OF SHARES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/StockholdersDeficitTables" xlink:title="00000026 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/RevenuesTables" xlink:title="00000027 - Disclosure - REVENUES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ResearchAndDevelopmentExpensesTables" xlink:title="00000028 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/SalesAndMarktingExpensesTables" xlink:title="00000029 - Disclosure - SALES AND MARKTING EXPENSES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/GeneralAndAdministrativeExpensesTables" xlink:title="00000030 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/FinancialExpensesIncomeNetTables" xlink:title="00000031 - Disclosure - FINANCIAL EXPENSES (INCOME), NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/IncomeTaxesTables" xlink:title="00000032 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/LossPerShare-basicAndDilutedTables" xlink:title="00000033 - Disclosure - LOSS PER SHARE-BASIC AND DILUTED (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/GenerelDetailsNarrative" xlink:title="00000034 - Disclosure - GENEREL (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfOtherAccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000035 - Disclosure - SCHEDULE OF OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableOtherCurrentAndNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_us-gaapAccountsPayableOtherCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfRelatedPartyTransactionsDetails" xlink:title="00000036 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTIONS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000037 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails" xlink:title="00000038 - Disclosure - SCHEDULE OF FAIR VALUE DISTRIBUTION OF LIABILITY AND EQUITY COMPONENTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfCompositionOfShortTermLoanDetails" xlink:title="00000039 - Disclosure - SCHEDULE OF COMPOSITION OF SHORT TERM LOAN (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ShortTermPrincipalAmount" xlink:label="loc_VBIXShortTermPrincipalAmount" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapShortTermBorrowings" xlink:to="loc_VBIXShortTermPrincipalAmount" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_DiscountOnShortTermLoan" xlink:label="loc_VBIXDiscountOnShortTermLoan" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapShortTermBorrowings" xlink:to="loc_VBIXDiscountOnShortTermLoan" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative" xlink:title="00000040 - Disclosure - SHORT TERM LOAN AND ISSUES OF SHARES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/SummaryOfOutstandingWarrantsDetails" xlink:title="00000041 - Disclosure - SUMMARY OF OUTSTANDING WARRANTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000042 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfRevenuesDetails" xlink:title="00000043 - Disclosure - SCHEDULE OF REVENUES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails" xlink:title="00000044 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfSalesAndMarketingExpensesDetails" xlink:title="00000045 - Disclosure - SCHEDULE OF SALES AND MARKETING EXPENSES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" xlink:title="00000046 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGeneralAndAdministrativeExpense" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGeneralAndAdministrativeExpense" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGeneralAndAdministrativeExpense" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherGeneralAndAdministrativeExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGeneralAndAdministrativeExpense" xlink:to="loc_us-gaapOtherGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfFinancialExpensesIncomeNetDetails" xlink:title="00000047 - Disclosure - SCHEDULE OF FINANCIAL (EXPENSES) INCOME, NET (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails" xlink:title="00000048 - Disclosure - SCHEDULE OF DEFERRED INCOME TAXES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:to="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_DifferencesBetweenTaxBasisAndCarryingValuesOfLoans" xlink:label="loc_VBIXDifferencesBetweenTaxBasisAndCarryingValuesOfLoans" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:to="loc_VBIXDifferencesBetweenTaxBasisAndCarryingValuesOfLoans" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails" xlink:title="00000049 - Disclosure - SCHEDULE OF LOSS (INCOME) FROM CONTINUING OPERATIONS, BEFORE TAXES ON INCOME (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000050 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfLossPerShare-basicAndDilutedDetails" xlink:title="00000051 - Disclosure - SCHEDULE OF LOSS PER SHARE-BASIC AND DILUTED (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>vbix-20211231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://corp.viewbix.com/role/Cover" xlink:href="vbix-20211231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/BalanceSheets" xlink:href="vbix-20211231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/BalanceSheetsParenthetical" xlink:href="vbix-20211231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/StatementsOfComprehensiveLoss" xlink:href="vbix-20211231.xsd#StatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit" xlink:href="vbix-20211231.xsd#StatementsOfChangesInStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/StatementsOfCashFlows" xlink:href="vbix-20211231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/Generel" xlink:href="vbix-20211231.xsd#Generel" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="vbix-20211231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilities" xlink:href="vbix-20211231.xsd#OtherAccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/RelatedPartyTransactions" xlink:href="vbix-20211231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfShares" xlink:href="vbix-20211231.xsd#ShortTermLoanAndIssuesOfShares" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/StockholdersDeficit" xlink:href="vbix-20211231.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/Revenues" xlink:href="vbix-20211231.xsd#Revenues" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ResearchAndDevelopmentExpenses" xlink:href="vbix-20211231.xsd#ResearchAndDevelopmentExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/SalesAndMarktingExpenses" xlink:href="vbix-20211231.xsd#SalesAndMarktingExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/GeneralAndAdministrativeExpenses" xlink:href="vbix-20211231.xsd#GeneralAndAdministrativeExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/FinancialExpensesIncomeNet" xlink:href="vbix-20211231.xsd#FinancialExpensesIncomeNet" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/IncomeTaxes" xlink:href="vbix-20211231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/LossPerShare-basicAndDiluted" xlink:href="vbix-20211231.xsd#LossPerShare-basicAndDiluted" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/Covid-19PandemicImplications" xlink:href="vbix-20211231.xsd#Covid-19PandemicImplications" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/SubsequentEvents" xlink:href="vbix-20211231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="vbix-20211231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilitiesTables" xlink:href="vbix-20211231.xsd#OtherAccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/RelatedPartyTransactionsTables" xlink:href="vbix-20211231.xsd#RelatedPartyTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesTables" xlink:href="vbix-20211231.xsd#ShortTermLoanAndIssuesOfSharesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/StockholdersDeficitTables" xlink:href="vbix-20211231.xsd#StockholdersDeficitTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/RevenuesTables" xlink:href="vbix-20211231.xsd#RevenuesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ResearchAndDevelopmentExpensesTables" xlink:href="vbix-20211231.xsd#ResearchAndDevelopmentExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/SalesAndMarktingExpensesTables" xlink:href="vbix-20211231.xsd#SalesAndMarktingExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/GeneralAndAdministrativeExpensesTables" xlink:href="vbix-20211231.xsd#GeneralAndAdministrativeExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/FinancialExpensesIncomeNetTables" xlink:href="vbix-20211231.xsd#FinancialExpensesIncomeNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/IncomeTaxesTables" xlink:href="vbix-20211231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/LossPerShare-basicAndDilutedTables" xlink:href="vbix-20211231.xsd#LossPerShare-basicAndDilutedTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/GenerelDetailsNarrative" xlink:href="vbix-20211231.xsd#GenerelDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfOtherAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="vbix-20211231.xsd#ScheduleOfOtherAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfRelatedPartyTransactionsDetails" xlink:href="vbix-20211231.xsd#ScheduleOfRelatedPartyTransactionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="vbix-20211231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails" xlink:href="vbix-20211231.xsd#ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfCompositionOfShortTermLoanDetails" xlink:href="vbix-20211231.xsd#ScheduleOfCompositionOfShortTermLoanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative" xlink:href="vbix-20211231.xsd#ShortTermLoanAndIssuesOfSharesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/SummaryOfOutstandingWarrantsDetails" xlink:href="vbix-20211231.xsd#SummaryOfOutstandingWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative" xlink:href="vbix-20211231.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfRevenuesDetails" xlink:href="vbix-20211231.xsd#ScheduleOfRevenuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails" xlink:href="vbix-20211231.xsd#ScheduleOfResearchAndDevelopmentExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfSalesAndMarketingExpensesDetails" xlink:href="vbix-20211231.xsd#ScheduleOfSalesAndMarketingExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" xlink:href="vbix-20211231.xsd#ScheduleOfGeneralAndAdministrativeExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfFinancialExpensesIncomeNetDetails" xlink:href="vbix-20211231.xsd#ScheduleOfFinancialExpensesIncomeNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails" xlink:href="vbix-20211231.xsd#ScheduleOfDeferredIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails" xlink:href="vbix-20211231.xsd#ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative" xlink:href="vbix-20211231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfLossPerShare-basicAndDilutedDetails" xlink:href="vbix-20211231.xsd#ScheduleOfLossPerShare-basicAndDilutedDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/StatementsOfComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Comprehensive Loss" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_FinancingProvidedByParentCompanyAcquisition" xlink:label="loc_VBIXFinancingProvidedByParentCompanyAcquisition_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VBIXFinancingProvidedByParentCompanyAcquisition_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_50" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/Generel" xlink:title="00000007 - Disclosure - GENEREL" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilities" xlink:title="00000009 - Disclosure - OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/RelatedPartyTransactions" xlink:title="00000010 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfShares" xlink:title="00000011 - Disclosure - SHORT TERM LOAN AND ISSUES OF SHARES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/StockholdersDeficit" xlink:title="00000012 - Disclosure - STOCKHOLDERS&#8217; DEFICIT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/Revenues" xlink:title="00000013 - Disclosure - REVENUES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ResearchAndDevelopmentExpenses" xlink:title="00000014 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/SalesAndMarktingExpenses" xlink:title="00000015 - Disclosure - SALES AND MARKTING EXPENSES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/GeneralAndAdministrativeExpenses" xlink:title="00000016 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/FinancialExpensesIncomeNet" xlink:title="00000017 - Disclosure - FINANCIAL EXPENSES (INCOME), NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/IncomeTaxes" xlink:title="00000018 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/LossPerShare-basicAndDiluted" xlink:title="00000019 - Disclosure - LOSS PER SHARE-BASIC AND DILUTED" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/Covid-19PandemicImplications" xlink:title="00000020 - Disclosure - COVID-19 PANDEMIC IMPLICATIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/SubsequentEvents" xlink:title="00000021 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000023 - Disclosure - OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/RelatedPartyTransactionsTables" xlink:title="00000024 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesTables" xlink:title="00000025 - Disclosure - SHORT TERM LOAN AND ISSUES OF SHARES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/StockholdersDeficitTables" xlink:title="00000026 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/RevenuesTables" xlink:title="00000027 - Disclosure - REVENUES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ResearchAndDevelopmentExpensesTables" xlink:title="00000028 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/SalesAndMarktingExpensesTables" xlink:title="00000029 - Disclosure - SALES AND MARKTING EXPENSES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/GeneralAndAdministrativeExpensesTables" xlink:title="00000030 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/FinancialExpensesIncomeNetTables" xlink:title="00000031 - Disclosure - FINANCIAL EXPENSES (INCOME), NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/IncomeTaxesTables" xlink:title="00000032 - Disclosure - INCOME TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/LossPerShare-basicAndDilutedTables" xlink:title="00000033 - Disclosure - LOSS PER SHARE-BASIC AND DILUTED (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/GenerelDetailsNarrative" xlink:title="00000034 - Disclosure - GENEREL (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_VirtualCryptoIsraelMember" xlink:label="loc_VBIXVirtualCryptoIsraelMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_VBIXVirtualCryptoIsraelMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ShareExchangeAgreementMember" xlink:label="loc_VBIXShareExchangeAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_VBIXShareExchangeAgreementMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_StockSubscriptionAgreementMember" xlink:label="loc_VBIXStockSubscriptionAgreementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_VBIXStockSubscriptionAgreementMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_LoanAgreementMember" xlink:label="loc_VBIXLoanAgreementMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_VBIXLoanAgreementMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ViewbixLtdMember" xlink:label="loc_VBIXViewbixLtdMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_VBIXViewbixLtdMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_110" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_110" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_110" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfOtherAccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000035 - Disclosure - SCHEDULE OF OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfRelatedPartyTransactionsDetails" xlink:title="00000036 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTIONS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000037 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_GixLtdMember" xlink:label="loc_VBIXGixLtdMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_VBIXGixLtdMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_GixLoanMember" xlink:label="loc_VBIXGixLoanMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_VBIXGixLoanMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_OperationsCostsIncurredPercentage" xlink:label="loc_VBIXOperationsCostsIncurredPercentage_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VBIXOperationsCostsIncurredPercentage_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="loc_us-gaapDebtConversionOriginalDebtAmount1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionOriginalDebtAmount1_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails" xlink:title="00000038 - Disclosure - SCHEDULE OF FAIR VALUE DISTRIBUTION OF LIABILITY AND EQUITY COMPONENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_LoanMember" xlink:label="loc_VBIXLoanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_VBIXLoanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_SharesMember" xlink:label="loc_VBIXSharesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_VBIXSharesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShorttermDebtFairValue" xlink:label="loc_us-gaapShorttermDebtFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapShorttermDebtFairValue_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_PercentageOfFairValue" xlink:label="loc_VBIXPercentageOfFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_VBIXPercentageOfFairValue_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ShortTermDebtAllocatedAmount" xlink:label="loc_VBIXShortTermDebtAllocatedAmount_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_VBIXShortTermDebtAllocatedAmount_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfCompositionOfShortTermLoanDetails" xlink:title="00000039 - Disclosure - SCHEDULE OF COMPOSITION OF SHORT TERM LOAN (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative" xlink:title="00000040 - Disclosure - SHORT TERM LOAN AND ISSUES OF SHARES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_LoanAndStockSubscriptionAgreementMember" xlink:label="loc_VBIXLoanAndStockSubscriptionAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_VBIXLoanAndStockSubscriptionAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_StockSubscriptionAgreementMember" xlink:label="loc_VBIXStockSubscriptionAgreementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_VBIXStockSubscriptionAgreementMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_InvestorsMember" xlink:label="loc_VBIXInvestorsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_VBIXInvestorsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount_50" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/SummaryOfOutstandingWarrantsDetails" xlink:title="00000041 - Disclosure - SUMMARY OF OUTSTANDING WARRANTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ClassJWarrantsMember" xlink:label="loc_VBIXClassJWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VBIXClassJWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ClassKWarrantsMember" xlink:label="loc_VBIXClassKWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VBIXClassKWarrantsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_WarrantTerm" xlink:label="loc_VBIXWarrantTerm_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_VBIXWarrantTerm_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_WarrantExercisable" xlink:label="loc_VBIXWarrantExercisable_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_VBIXWarrantExercisable_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000042 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_StockSubscriptionAgreementMember" xlink:label="loc_VBIXStockSubscriptionAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_VBIXStockSubscriptionAgreementMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_LoanAgreementMember" xlink:label="loc_VBIXLoanAgreementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_VBIXLoanAgreementMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_GixLtdMember" xlink:label="loc_VBIXGixLtdMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_VBIXGixLtdMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ClassHWarrantsMember" xlink:label="loc_VBIXClassHWarrantsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VBIXClassHWarrantsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ClassIWarrantsMember" xlink:label="loc_VBIXClassIWarrantsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VBIXClassIWarrantsMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ClassGWarrantsMember" xlink:label="loc_VBIXClassGWarrantsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VBIXClassGWarrantsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockVotingRights_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_100" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfRevenuesDetails" xlink:title="00000043 - Disclosure - SCHEDULE OF REVENUES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_IndividualSubscriptionsMember" xlink:label="loc_VBIXIndividualSubscriptionsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_VBIXIndividualSubscriptionsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_EnterpriseSubscriptionsMember" xlink:label="loc_VBIXEnterpriseSubscriptionsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_VBIXEnterpriseSubscriptionsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails" xlink:title="00000044 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_SalariesandRelatedExpenseMember" xlink:label="loc_VBIXSalariesandRelatedExpenseMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_VBIXSalariesandRelatedExpenseMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_SubcontractorsMember" xlink:label="loc_VBIXSubcontractorsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_VBIXSubcontractorsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfSalesAndMarketingExpensesDetails" xlink:title="00000045 - Disclosure - SCHEDULE OF SALES AND MARKETING EXPENSES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_SalariesandRelatedExpenseMember" xlink:label="loc_VBIXSalariesandRelatedExpenseMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_VBIXSalariesandRelatedExpenseMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_OtherMember" xlink:label="loc_VBIXOtherMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_VBIXOtherMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSellingAndMarketingExpense_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" xlink:title="00000046 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfFinancialExpensesIncomeNetDetails" xlink:title="00000047 - Disclosure - SCHEDULE OF FINANCIAL (EXPENSES) INCOME, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaapCreditFacilityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapCreditFacilityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_BankFeesMember" xlink:label="loc_VBIXBankFeesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_VBIXBankFeesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ExchangeRateDifferencesMember" xlink:label="loc_VBIXExchangeRateDifferencesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_VBIXExchangeRateDifferencesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_InterestExpensesMember" xlink:label="loc_VBIXInterestExpensesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_VBIXInterestExpensesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_FinancingIncomeExpensesNet" xlink:label="loc_VBIXFinancingIncomeExpensesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_VBIXFinancingIncomeExpensesNet_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails" xlink:title="00000048 - Disclosure - SCHEDULE OF DEFERRED INCOME TAXES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails" xlink:title="00000049 - Disclosure - SCHEDULE OF LOSS (INCOME) FROM CONTINUING OPERATIONS, BEFORE TAXES ON INCOME (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000050 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="loc_us-gaapIsraelTaxAuthorityMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:to="loc_us-gaapIsraelTaxAuthorityMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ViewbixIsraelMember" xlink:label="loc_VBIXViewbixIsraelMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_VBIXViewbixIsraelMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="loc_countryUS_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="loc_us-gaapIncomeTaxExaminationDescription_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationDescription_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_70" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfLossPerShare-basicAndDilutedDetails" xlink:title="00000051 - Disclosure - SCHEDULE OF LOSS PER SHARE-BASIC AND DILUTED (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>vbix-20211231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_VirtualCryptoIsraelMember" xlink:label="VBIX_VirtualCryptoIsraelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_VirtualCryptoIsraelMember" xlink:to="VBIX_VirtualCryptoIsraelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_VirtualCryptoIsraelMember_lbl" xml:lang="en-US">Virtual Crypto Israel [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ShareExchangeAgreementMember" xlink:label="VBIX_ShareExchangeAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ShareExchangeAgreementMember" xlink:to="VBIX_ShareExchangeAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_ShareExchangeAgreementMember_lbl" xml:lang="en-US">Share Exchange Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ViewbixLtdMember" xlink:label="VBIX_ViewbixLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ViewbixLtdMember" xlink:to="VBIX_ViewbixLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_ViewbixLtdMember_lbl" xml:lang="en-US">Viewbix Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_StockSubscriptionAgreementMember" xlink:label="VBIX_StockSubscriptionAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_StockSubscriptionAgreementMember" xlink:to="VBIX_StockSubscriptionAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_StockSubscriptionAgreementMember_lbl" xml:lang="en-US">Stock Subscription Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember" xlink:label="us-gaap_InvestorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestorMember_lbl" xml:lang="en-US">Investor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_LoanAgreementMember" xlink:label="VBIX_LoanAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_LoanAgreementMember" xlink:to="VBIX_LoanAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_LoanAgreementMember_lbl" xml:lang="en-US">Loan Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_GixLtdMember" xlink:label="VBIX_GixLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_GixLtdMember" xlink:to="VBIX_GixLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_GixLtdMember_lbl" xml:lang="en-US">Gix Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_GixLoanMember" xlink:label="VBIX_GixLoanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_GixLoanMember" xlink:to="VBIX_GixLoanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_GixLoanMember_lbl" xml:lang="en-US">Gix Loan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_LoanAndStockSubscriptionAgreementMember" xlink:label="VBIX_LoanAndStockSubscriptionAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_LoanAndStockSubscriptionAgreementMember" xlink:to="VBIX_LoanAndStockSubscriptionAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_LoanAndStockSubscriptionAgreementMember_lbl" xml:lang="en-US">Loan And Stock Subscription Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_InvestorsMember" xlink:label="VBIX_InvestorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_InvestorsMember" xlink:to="VBIX_InvestorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_InvestorsMember_lbl" xml:lang="en-US">Investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_LoanMember" xlink:label="VBIX_LoanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_LoanMember" xlink:to="VBIX_LoanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_LoanMember_lbl" xml:lang="en-US">Loan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_SharesMember" xlink:label="VBIX_SharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_SharesMember" xlink:to="VBIX_SharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_SharesMember_lbl" xml:lang="en-US">Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ClassHWarrantsMember" xlink:label="VBIX_ClassHWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ClassHWarrantsMember" xlink:to="VBIX_ClassHWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_ClassHWarrantsMember_lbl" xml:lang="en-US">Class H Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ClassIWarrantsMember" xlink:label="VBIX_ClassIWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ClassIWarrantsMember" xlink:to="VBIX_ClassIWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_ClassIWarrantsMember_lbl" xml:lang="en-US">Class I Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ClassGWarrantsMember" xlink:label="VBIX_ClassGWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ClassGWarrantsMember" xlink:to="VBIX_ClassGWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_ClassGWarrantsMember_lbl" xml:lang="en-US">Class G Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ClassJWarrantsMember" xlink:label="VBIX_ClassJWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ClassJWarrantsMember" xlink:to="VBIX_ClassJWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_ClassJWarrantsMember_lbl" xml:lang="en-US">Class J Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ClassKWarrantsMember" xlink:label="VBIX_ClassKWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ClassKWarrantsMember" xlink:to="VBIX_ClassKWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_ClassKWarrantsMember_lbl" xml:lang="en-US">Class K Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_IndividualSubscriptionsMember" xlink:label="VBIX_IndividualSubscriptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_IndividualSubscriptionsMember" xlink:to="VBIX_IndividualSubscriptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_IndividualSubscriptionsMember_lbl" xml:lang="en-US">Individual Subscriptions [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_EnterpriseSubscriptionsMember" xlink:label="VBIX_EnterpriseSubscriptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_EnterpriseSubscriptionsMember" xlink:to="VBIX_EnterpriseSubscriptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_EnterpriseSubscriptionsMember_lbl" xml:lang="en-US">Enterprise Subscriptions [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_SalariesandRelatedExpenseMember" xlink:label="VBIX_SalariesandRelatedExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_SalariesandRelatedExpenseMember" xlink:to="VBIX_SalariesandRelatedExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_SalariesandRelatedExpenseMember_lbl" xml:lang="en-US">Salaries and Related Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_SubcontractorsMember" xlink:label="VBIX_SubcontractorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_SubcontractorsMember" xlink:to="VBIX_SubcontractorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_SubcontractorsMember_lbl" xml:lang="en-US">Subcontractors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_OtherMember" xlink:label="VBIX_OtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_OtherMember" xlink:to="VBIX_OtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_OtherMember_lbl" xml:lang="en-US">Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CreditFacilityAxis_lbl" xml:lang="en-US">Credit Facility [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_BankFeesMember" xlink:label="VBIX_BankFeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_BankFeesMember" xlink:to="VBIX_BankFeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_BankFeesMember_lbl" xml:lang="en-US">Bank Fees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ExchangeRateDifferencesMember" xlink:label="VBIX_ExchangeRateDifferencesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ExchangeRateDifferencesMember" xlink:to="VBIX_ExchangeRateDifferencesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_ExchangeRateDifferencesMember_lbl" xml:lang="en-US">Exchange Rate Differences [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_InterestExpensesMember" xlink:label="VBIX_InterestExpensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_InterestExpensesMember" xlink:to="VBIX_InterestExpensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_InterestExpensesMember_lbl" xml:lang="en-US">Interest Expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="us-gaap_IsraelTaxAuthorityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IsraelTaxAuthorityMember" xlink:to="us-gaap_IsraelTaxAuthorityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IsraelTaxAuthorityMember_lbl" xml:lang="en-US">Israel Tax Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ViewbixIsraelMember" xlink:label="VBIX_ViewbixIsraelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ViewbixIsraelMember" xlink:to="VBIX_ViewbixIsraelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_ViewbixIsraelMember_lbl" xml:lang="en-US">Viewbix Israel [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="country_US" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl" xml:lang="en-US">UNITED STATES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCountryMember_lbl" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">CURRENT ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xml:lang="en-US">Other accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS&#8217; DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="us-gaap_AccountsPayableTradeCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US">Trade payables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent" xlink:label="us-gaap_DueToAffiliateCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToAffiliateCurrent" xlink:to="us-gaap_DueToAffiliateCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToAffiliateCurrent_lbl" xml:lang="en-US">Parent company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="us-gaap_ShortTermBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBorrowings_lbl" xml:lang="en-US">Short term loan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">STOCKHOLDERS&#8217; DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ShareCapitalAbstract" xlink:label="VBIX_ShareCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ShareCapitalAbstract" xlink:to="VBIX_ShareCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_ShareCapitalAbstract_lbl" xml:lang="en-US">Share Capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.0001 par value; 490,000,000 shares authorized; 34,753,669 shares issued and outstanding at December 31, 2021 and at December 31, 2020</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&#8217; deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities, temporary equity and stockholders&#8217; deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock , par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Expenses:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherGeneralExpense" xlink:label="us-gaap_OtherGeneralExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralExpense" xlink:to="us-gaap_OtherGeneralExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherGeneralExpense_lbl" xml:lang="en-US">Other expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="us-gaap_GainLossOnSaleOfBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfBusiness" xlink:to="us-gaap_GainLossOnSaleOfBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfBusiness_lbl" xml:lang="en-US">Gain from sale of a subsidiary</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_FinanceIncome" xlink:label="VBIX_FinanceIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_FinanceIncome" xlink:to="VBIX_FinanceIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_FinanceIncome_lbl" xml:lang="en-US">Finance income</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_FinanceExpense" xlink:label="VBIX_FinanceExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_FinanceExpense" xlink:to="VBIX_FinanceExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="VBIX_FinanceExpense_lbl" xml:lang="en-US">Finance expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss Before taxes on income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Taxes on income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted net loss per share:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average shares outstanding - basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_FinancingProvidedByParentCompanyAcquisition" xlink:label="VBIX_FinancingProvidedByParentCompanyAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_FinancingProvidedByParentCompanyAcquisition" xlink:to="VBIX_FinancingProvidedByParentCompanyAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_FinancingProvidedByParentCompanyAcquisition_lbl" xml:lang="en-US">Financing provided by the Parent Company (see note 4)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Issuance of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Issuance of shares, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss for the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US">Cash flows from operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_GainFromSaleOfSubsidiary" xlink:label="VBIX_GainFromSaleOfSubsidiary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_GainFromSaleOfSubsidiary" xlink:to="VBIX_GainFromSaleOfSubsidiary_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="VBIX_GainFromSaleOfSubsidiary_lbl" xml:lang="en-US">Gain from sale of a subsidiary</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Decrease (Increase) in trade receivables and prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xml:lang="en-US">Decrease (Increase) in other accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl" xml:lang="en-US">Increase (decrease) in trade payables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueToAffiliatesCurrent" xlink:label="us-gaap_IncreaseDecreaseInDueToAffiliatesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToAffiliatesCurrent" xlink:to="us-gaap_IncreaseDecreaseInDueToAffiliatesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDueToAffiliatesCurrent_lbl" xml:lang="en-US">Increase in payable to parent company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Increase (decrease) in other accounts payables and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used by operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinesses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xml:lang="en-US">Cash received from the sale of a subsidiary</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Issuance of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="us-gaap_ProceedsFromShortTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromShortTermDebt" xlink:to="us-gaap_ProceedsFromShortTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromShortTermDebt_lbl" xml:lang="en-US">Short term loan received</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Increase (decrease) in cash and cash equivalents and restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash and cash equivalents and restricted cash at the beginning of the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash and cash equivalents and restricted cash at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ModificationOfParentCompanyPayableIntoLoan" xlink:label="VBIX_ModificationOfParentCompanyPayableIntoLoan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ModificationOfParentCompanyPayableIntoLoan" xlink:to="VBIX_ModificationOfParentCompanyPayableIntoLoan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_ModificationOfParentCompanyPayableIntoLoan_lbl" xml:lang="en-US">Modification of parent company payable into a loan</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_CurrentAssetsExcludingCashAndCashEquivalent" xlink:label="VBIX_CurrentAssetsExcludingCashAndCashEquivalent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_CurrentAssetsExcludingCashAndCashEquivalent" xlink:to="VBIX_CurrentAssetsExcludingCashAndCashEquivalent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_CurrentAssetsExcludingCashAndCashEquivalent_lbl" xml:lang="en-US">Current assets excluding cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_LiabilitiesCurrentOne" xlink:label="VBIX_LiabilitiesCurrentOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_LiabilitiesCurrentOne" xlink:to="VBIX_LiabilitiesCurrentOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_LiabilitiesCurrentOne_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_SupplementalGainFromSalesOfSubsidiary" xlink:label="VBIX_SupplementalGainFromSalesOfSubsidiary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_SupplementalGainFromSalesOfSubsidiary" xlink:to="VBIX_SupplementalGainFromSalesOfSubsidiary_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_SupplementalGainFromSalesOfSubsidiary_lbl" xml:lang="en-US">Gain from sale of a subsidiary</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_SupplementalCashReceivedFromSaleOfSubsidiaries" xlink:label="VBIX_SupplementalCashReceivedFromSaleOfSubsidiaries" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_SupplementalCashReceivedFromSaleOfSubsidiaries" xlink:to="VBIX_SupplementalCashReceivedFromSaleOfSubsidiaries_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="VBIX_SupplementalCashReceivedFromSaleOfSubsidiaries_lbl" xml:lang="en-US">Cash received from the sale of a subsidiary</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">GENEREL</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="us-gaap_ShortTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTextBlock" xlink:to="us-gaap_ShortTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTextBlock_lbl" xml:lang="en-US">SHORT TERM LOAN AND ISSUES OF SHARES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">STOCKHOLDERS&#8217; DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xml:lang="en-US">REVENUES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="us-gaap_ResearchAndDevelopmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentAbstract" xlink:to="us-gaap_ResearchAndDevelopmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentAbstract_lbl" xml:lang="en-US">Research and Development [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl" xml:lang="en-US">RESEARCH AND DEVELOPMENT EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_DisclosureSalesAndMarktingExpensesAbstract" xlink:label="VBIX_DisclosureSalesAndMarktingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_DisclosureSalesAndMarktingExpensesAbstract" xlink:to="VBIX_DisclosureSalesAndMarktingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_DisclosureSalesAndMarktingExpensesAbstract_lbl" xml:lang="en-US">Sales And Markting Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_SalesAndMarketingExpensesDisclosureTextBlock" xlink:label="VBIX_SalesAndMarketingExpensesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_SalesAndMarketingExpensesDisclosureTextBlock" xlink:to="VBIX_SalesAndMarketingExpensesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_SalesAndMarketingExpensesDisclosureTextBlock_lbl" xml:lang="en-US">SALES AND MARKTING EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract" xlink:label="VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract" xlink:to="VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract_lbl" xml:lang="en-US">General And Administrative Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_GeneralAndAdministrativeExpensesDisclosureTextBlock" xlink:label="VBIX_GeneralAndAdministrativeExpensesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_GeneralAndAdministrativeExpensesDisclosureTextBlock" xlink:to="VBIX_GeneralAndAdministrativeExpensesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_GeneralAndAdministrativeExpensesDisclosureTextBlock_lbl" xml:lang="en-US">GENERAL AND ADMINISTRATIVE EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_DisclosureFinancialExpensesIncomeNetAbstract" xlink:label="VBIX_DisclosureFinancialExpensesIncomeNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_DisclosureFinancialExpensesIncomeNetAbstract" xlink:to="VBIX_DisclosureFinancialExpensesIncomeNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_DisclosureFinancialExpensesIncomeNetAbstract_lbl" xml:lang="en-US">Financial Expenses Income Net</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_FinancingIncomeExpensesTextBlock" xlink:label="VBIX_FinancingIncomeExpensesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_FinancingIncomeExpensesTextBlock" xlink:to="VBIX_FinancingIncomeExpensesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_FinancingIncomeExpensesTextBlock_lbl" xml:lang="en-US">FINANCIAL EXPENSES (INCOME), NET</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">LOSS PER SHARE-BASIC AND DILUTED</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRisksAndUncertaintiesTextBlock" xlink:label="us-gaap_UnusualRisksAndUncertaintiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnusualRisksAndUncertaintiesTextBlock" xlink:to="us-gaap_UnusualRisksAndUncertaintiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnusualRisksAndUncertaintiesTextBlock_lbl" xml:lang="en-US">COVID-19 PANDEMIC IMPLICATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Functional currency</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair value of financial instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and development expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US">Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_AccountingForIncomeTaxesPolicyTextBlock" xlink:label="VBIX_AccountingForIncomeTaxesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_AccountingForIncomeTaxesPolicyTextBlock" xlink:to="VBIX_AccountingForIncomeTaxesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_AccountingForIncomeTaxesPolicyTextBlock_lbl" xml:lang="en-US">Accounting for Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently issued accounting pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="us-gaap_BusinessCombinationsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsPolicy" xlink:to="us-gaap_BusinessCombinationsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsPolicy_lbl" xml:lang="en-US">Business Combination</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_WarrantsPolicyTextBlock" xlink:label="VBIX_WarrantsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_WarrantsPolicyTextBlock" xlink:to="VBIX_WarrantsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_WarrantsPolicyTextBlock_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF RELATED PARTY TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock" xlink:label="VBIX_ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock" xlink:to="VBIX_ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF FAIR VALUE DISTRIBUTION OF LIABILITY AND EQUITY COMPONENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:label="us-gaap_ScheduleOfShortTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="us-gaap_ScheduleOfShortTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTextBlock_lbl" xml:lang="en-US">SCHEDULE OF COMPOSITION OF SHORT TERM LOAN</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">SUMMARY OF OUTSTANDING WARRANTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF REVENUES</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" xlink:label="VBIX_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" xlink:to="VBIX_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ScheduleOfSalesAndMarketingExpensesTableTextBlock" xlink:label="VBIX_ScheduleOfSalesAndMarketingExpensesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ScheduleOfSalesAndMarketingExpensesTableTextBlock" xlink:to="VBIX_ScheduleOfSalesAndMarketingExpensesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_ScheduleOfSalesAndMarketingExpensesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF SALES AND MARKETING EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock" xlink:label="VBIX_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock" xlink:to="VBIX_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ScheduleFinancingIncomeExpensesNetTableTextBlock" xlink:label="VBIX_ScheduleFinancingIncomeExpensesNetTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ScheduleFinancingIncomeExpensesNetTableTextBlock" xlink:to="VBIX_ScheduleFinancingIncomeExpensesNetTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_ScheduleFinancingIncomeExpensesNetTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF FINANCIAL (EXPENSES) INCOME, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF DEFERRED INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF LOSS (INCOME) FROM CONTINUING OPERATIONS, BEFORE TAXES ON INCOME</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF LOSS PER SHARE-BASIC AND DILUTED</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Due to related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Ownership percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Number of share issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Sale of stock, price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Stock issued during period value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt instrument, face amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Debt instrument interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Shares issued, price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Cash flows from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableOtherCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableOtherCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableOtherCurrentAndNoncurrent_lbl" xml:lang="en-US">Other payables and deferred revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Total other accounts payables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToAffiliateCurrent" xlink:to="us-gaap_DueToAffiliateCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DueToAffiliateCurrent_2_lbl" xml:lang="en-US">Gix &#8211; Company Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_OperationsCostsIncurredPercentage" xlink:label="VBIX_OperationsCostsIncurredPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_OperationsCostsIncurredPercentage" xlink:to="VBIX_OperationsCostsIncurredPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_OperationsCostsIncurredPercentage_lbl" xml:lang="en-US">Operations costs incurred, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionOriginalDebtAmount1" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1_lbl" xml:lang="en-US">Debt modification original debt, amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US">Debt conversion amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShorttermDebtFairValue" xlink:label="us-gaap_ShorttermDebtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShorttermDebtFairValue" xlink:to="us-gaap_ShorttermDebtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShorttermDebtFairValue_lbl" xml:lang="en-US">Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_PercentageOfFairValue" xlink:label="VBIX_PercentageOfFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_PercentageOfFairValue" xlink:to="VBIX_PercentageOfFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_PercentageOfFairValue_lbl" xml:lang="en-US">Percentage of fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ShortTermDebtAllocatedAmount" xlink:label="VBIX_ShortTermDebtAllocatedAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ShortTermDebtAllocatedAmount" xlink:to="VBIX_ShortTermDebtAllocatedAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_ShortTermDebtAllocatedAmount_lbl" xml:lang="en-US">Allocated amount</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ShortTermPrincipalAmount" xlink:label="VBIX_ShortTermPrincipalAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ShortTermPrincipalAmount" xlink:to="VBIX_ShortTermPrincipalAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_ShortTermPrincipalAmount_lbl" xml:lang="en-US">Principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_DiscountOnShortTermLoan" xlink:label="VBIX_DiscountOnShortTermLoan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_DiscountOnShortTermLoan" xlink:to="VBIX_DiscountOnShortTermLoan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_DiscountOnShortTermLoan_lbl" xml:lang="en-US">Discount on Short term loan</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ShortTermBorrowings_2_lbl" xml:lang="en-US">Short term loan, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Stock issued during period, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_2_lbl" xml:lang="en-US">Stock issued price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Loan discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_WarrantTerm" xlink:label="VBIX_WarrantTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_WarrantTerm" xlink:to="VBIX_WarrantTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_WarrantTerm_lbl" xml:lang="en-US">Warrant Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_WarrantExercisable" xlink:label="VBIX_WarrantExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_WarrantExercisable" xlink:to="VBIX_WarrantExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_WarrantExercisable_lbl" xml:lang="en-US">Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockVotingRights_lbl" xml:lang="en-US">Common stock, voting rights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US">Number of restricted common stock shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_lbl" xml:lang="en-US">Number of warrants expired during period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xml:lang="en-US">Research and development expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SellingAndMarketingExpense_2_lbl" xml:lang="en-US">Sales and marketing expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract" xlink:to="VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract_2_lbl" xml:lang="en-US">Schedule Of General And Administrative Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="us-gaap_LaborAndRelatedExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LaborAndRelatedExpense_lbl" xml:lang="en-US">Wages, salaries and related expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">General and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="us-gaap_LineOfCreditFacilityTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_LineOfCreditFacilityTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityTable_lbl" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="us-gaap_LineOfCreditFacilityLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityLineItems_lbl" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_FinancingIncomeExpensesNet" xlink:label="VBIX_FinancingIncomeExpensesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_FinancingIncomeExpensesNet" xlink:to="VBIX_FinancingIncomeExpensesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_FinancingIncomeExpensesNet_lbl" xml:lang="en-US">Financing expenses (income), net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xml:lang="en-US">Deferred R&amp;D expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating loss carryforward</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_DifferencesBetweenTaxBasisAndCarryingValuesOfLoans" xlink:label="VBIX_DifferencesBetweenTaxBasisAndCarryingValuesOfLoans" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_DifferencesBetweenTaxBasisAndCarryingValuesOfLoans" xlink:to="VBIX_DifferencesBetweenTaxBasisAndCarryingValuesOfLoans_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_DifferencesBetweenTaxBasisAndCarryingValuesOfLoans_lbl" xml:lang="en-US">Differences between tax basis and carrying values of loans (see notes 4 and 5)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Net deferred tax asset before valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Total loss before taxes on income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="us-gaap_IncomeTaxExaminationDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationDescription" xlink:to="us-gaap_IncomeTaxExaminationDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationDescription_lbl" xml:lang="en-US">Income tax examination description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Corporate tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xml:lang="en-US">Valuation allowances, deferred tax assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLossCarryforwards_2_lbl" xml:lang="en-US">Operating loss carryforwards</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_NetIncomeLoss_4_lbl" xml:lang="en-US">Net loss attributable to ordinary stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_lbl" xml:lang="en-US">Weighted-average ordinary shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_2_lbl" xml:lang="en-US">Loss per share-basic and diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ShareCapitalAbstract" xlink:to="VBIX_ShareCapitalAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_ShareCapitalAbstract_doc" xml:lang="en-US">Share Capital Abstract.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_FinancingProvidedByParentCompanyAcquisition" xlink:to="VBIX_FinancingProvidedByParentCompanyAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_FinancingProvidedByParentCompanyAcquisition_doc" xml:lang="en-US">Financing provided by parent company acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ClassJWarrantsMember" xlink:to="VBIX_ClassJWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_ClassJWarrantsMember_doc" xml:lang="en-US">Class J Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ClassKWarrantsMember" xlink:to="VBIX_ClassKWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_ClassKWarrantsMember_doc" xml:lang="en-US">Class K Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_WarrantTerm" xlink:to="VBIX_WarrantTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_WarrantTerm_doc" xml:lang="en-US">Warrant term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_WarrantExercisable" xlink:to="VBIX_WarrantExercisable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_WarrantExercisable_doc" xml:lang="en-US">Warrant Exercisable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_FinanceIncome" xlink:to="VBIX_FinanceIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_FinanceIncome_doc" xml:lang="en-US">Finance income.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_StockSubscriptionAgreementMember" xlink:to="VBIX_StockSubscriptionAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_StockSubscriptionAgreementMember_doc" xml:lang="en-US">Stock Subscription Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_FinanceExpense" xlink:to="VBIX_FinanceExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_FinanceExpense_doc" xml:lang="en-US">Finance expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_LoanAgreementMember" xlink:to="VBIX_LoanAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_LoanAgreementMember_doc" xml:lang="en-US">Loan Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_GixLtdMember" xlink:to="VBIX_GixLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_GixLtdMember_doc" xml:lang="en-US">Gix Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ClassHWarrantsMember" xlink:to="VBIX_ClassHWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_ClassHWarrantsMember_doc" xml:lang="en-US">Class H Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ClassIWarrantsMember" xlink:to="VBIX_ClassIWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_ClassIWarrantsMember_doc" xml:lang="en-US">Class I Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ClassGWarrantsMember" xlink:to="VBIX_ClassGWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_ClassGWarrantsMember_doc" xml:lang="en-US">Class G Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_GainFromSaleOfSubsidiary" xlink:to="VBIX_GainFromSaleOfSubsidiary_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_GainFromSaleOfSubsidiary_doc" xml:lang="en-US">Gain from sale of subsidiary.</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_FinancingProvidedByParentCompanyAcquisitions" xlink:label="VBIX_FinancingProvidedByParentCompanyAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_FinancingProvidedByParentCompanyAcquisitions" xlink:to="VBIX_FinancingProvidedByParentCompanyAcquisitions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_FinancingProvidedByParentCompanyAcquisitions_doc" xml:lang="en-US">Financing provided by parent company acquisitions.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_CurrentAssetsExcludingCashAndCashEquivalent" xlink:to="VBIX_CurrentAssetsExcludingCashAndCashEquivalent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_CurrentAssetsExcludingCashAndCashEquivalent_doc" xml:lang="en-US">Current assets excluding cash and cash equivalent.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_LiabilitiesCurrentOne" xlink:to="VBIX_LiabilitiesCurrentOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_LiabilitiesCurrentOne_doc" xml:lang="en-US">Liabilities current one.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_SupplementalGainFromSalesOfSubsidiary" xlink:to="VBIX_SupplementalGainFromSalesOfSubsidiary_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_SupplementalGainFromSalesOfSubsidiary_doc" xml:lang="en-US">Supplemental gain from sales of subsidiary.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_IndividualSubscriptionsMember" xlink:to="VBIX_IndividualSubscriptionsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_IndividualSubscriptionsMember_doc" xml:lang="en-US">Individual Subscriptions [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_EnterpriseSubscriptionsMember" xlink:to="VBIX_EnterpriseSubscriptionsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_EnterpriseSubscriptionsMember_doc" xml:lang="en-US">Enterprise Subscriptions [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_VirtualCryptoIsraelMember" xlink:to="VBIX_VirtualCryptoIsraelMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_VirtualCryptoIsraelMember_doc" xml:lang="en-US">Virtual Crypto Israel [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" xlink:to="VBIX_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_doc" xml:lang="en-US">Schedule of Research And Development Expenses [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_SalariesandRelatedExpenseMember" xlink:to="VBIX_SalariesandRelatedExpenseMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_SalariesandRelatedExpenseMember_doc" xml:lang="en-US">Salaries and Related Expense [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_OtherMember" xlink:to="VBIX_OtherMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_OtherMember_doc" xml:lang="en-US">Other [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_SupplementalCashReceivedFromSaleOfSubsidiaries" xlink:to="VBIX_SupplementalCashReceivedFromSaleOfSubsidiaries_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_SupplementalCashReceivedFromSaleOfSubsidiaries_doc" xml:lang="en-US">Supplemental cash received from sale of subsidiaries.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_SubcontractorsMember" xlink:to="VBIX_SubcontractorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_SubcontractorsMember_doc" xml:lang="en-US">Subcontractors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_SalesAndMarketingExpensesDisclosureTextBlock" xlink:to="VBIX_SalesAndMarketingExpensesDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_SalesAndMarketingExpensesDisclosureTextBlock_doc" xml:lang="en-US">Sales and Marketing Expenses Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ScheduleOfSalesAndMarketingExpensesTableTextBlock" xlink:to="VBIX_ScheduleOfSalesAndMarketingExpensesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_ScheduleOfSalesAndMarketingExpensesTableTextBlock_doc" xml:lang="en-US">Schedule of Sales and Marketing Expenses [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_GeneralAndAdministrativeExpensesDisclosureTextBlock" xlink:to="VBIX_GeneralAndAdministrativeExpensesDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_GeneralAndAdministrativeExpensesDisclosureTextBlock_doc" xml:lang="en-US">General and Administrative Expenses Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock" xlink:to="VBIX_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock_doc" xml:lang="en-US">Schedule of General and Administrative Expenses [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_FinancingIncomeExpensesTextBlock" xlink:to="VBIX_FinancingIncomeExpensesTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_FinancingIncomeExpensesTextBlock_doc" xml:lang="en-US">Financing Income Expenses [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_AccountingForIncomeTaxesPolicyTextBlock" xlink:to="VBIX_AccountingForIncomeTaxesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_AccountingForIncomeTaxesPolicyTextBlock_doc" xml:lang="en-US">Accounting for Income Taxes [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_FinancingIncomeExpensesNet" xlink:to="VBIX_FinancingIncomeExpensesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_FinancingIncomeExpensesNet_doc" xml:lang="en-US">Financing (Income) Expenses, Net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_BankFeesMember" xlink:to="VBIX_BankFeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_BankFeesMember_doc" xml:lang="en-US">Bank Fees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ExchangeRateDifferencesMember" xlink:to="VBIX_ExchangeRateDifferencesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_ExchangeRateDifferencesMember_doc" xml:lang="en-US">Exchange Rate Differences [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_WarrantsPolicyTextBlock" xlink:to="VBIX_WarrantsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_WarrantsPolicyTextBlock_doc" xml:lang="en-US">Warrants [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_InterestExpensesMember" xlink:to="VBIX_InterestExpensesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_InterestExpensesMember_doc" xml:lang="en-US">Interest Expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_PayableToParentCompanyTextBlock" xlink:label="VBIX_PayableToParentCompanyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_PayableToParentCompanyTextBlock" xlink:to="VBIX_PayableToParentCompanyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_PayableToParentCompanyTextBlock_doc" xml:lang="en-US">Payable to Parent Company [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_OperationsCostsIncurredPercentage" xlink:to="VBIX_OperationsCostsIncurredPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_OperationsCostsIncurredPercentage_doc" xml:lang="en-US">Operations costs incurred, percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ViewbixIsraelMember" xlink:to="VBIX_ViewbixIsraelMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_ViewbixIsraelMember_doc" xml:lang="en-US">Viewbix Israel [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_DifferencesBetweenTaxBasisAndCarryingValuesOfLoans" xlink:to="VBIX_DifferencesBetweenTaxBasisAndCarryingValuesOfLoans_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_DifferencesBetweenTaxBasisAndCarryingValuesOfLoans_doc" xml:lang="en-US">Differences between tax basis and carrying values of loans.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_LoanAndStockSubscriptionAgreementMember" xlink:to="VBIX_LoanAndStockSubscriptionAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_LoanAndStockSubscriptionAgreementMember_doc" xml:lang="en-US">Loan And Stock Subscription Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_InvestorsMember" xlink:to="VBIX_InvestorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_InvestorsMember_doc" xml:lang="en-US">Investors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_PercentageOfFairValue" xlink:to="VBIX_PercentageOfFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_PercentageOfFairValue_doc" xml:lang="en-US">Percentage of fair value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ShortTermDebtAllocatedAmount" xlink:to="VBIX_ShortTermDebtAllocatedAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_ShortTermDebtAllocatedAmount_doc" xml:lang="en-US">Allocated amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_DiscountOnShortTermLoan" xlink:to="VBIX_DiscountOnShortTermLoan_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_DiscountOnShortTermLoan_doc" xml:lang="en-US">Discount on Short term loan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ShortTermPrincipalAmount" xlink:to="VBIX_ShortTermPrincipalAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_ShortTermPrincipalAmount_doc" xml:lang="en-US">Short Term Principal Amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_GixLoanMember" xlink:to="VBIX_GixLoanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_GixLoanMember_doc" xml:lang="en-US">Gix Loan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ShareExchangeAgreementMember" xlink:to="VBIX_ShareExchangeAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_ShareExchangeAgreementMember_doc" xml:lang="en-US">Share Exchange Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ViewbixLtdMember" xlink:to="VBIX_ViewbixLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_ViewbixLtdMember_doc" xml:lang="en-US">Viewbix Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_LoanMember" xlink:to="VBIX_LoanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_LoanMember_doc" xml:lang="en-US">Loan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_SharesMember" xlink:to="VBIX_SharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_SharesMember_doc" xml:lang="en-US">Shares [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ScheduleFinancingIncomeExpensesNetTableTextBlock" xlink:to="VBIX_ScheduleFinancingIncomeExpensesNetTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_ScheduleFinancingIncomeExpensesNetTableTextBlock_doc" xml:lang="en-US">Schedule of Financing Income (Expenses) [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock" xlink:to="VBIX_ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock_doc" xml:lang="en-US">Schedule of fair value distribution of liability and equity components on transactions date [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_ModificationOfParentCompanyPayableIntoLoan" xlink:to="VBIX_ModificationOfParentCompanyPayableIntoLoan_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VBIX_ModificationOfParentCompanyPayableIntoLoan_doc" xml:lang="en-US">Modification of parent company payable into a loan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_5_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_5_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfBusiness" xlink:to="us-gaap_GainLossOnSaleOfBusiness_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfBusiness_2_lbl" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_FinanceExpense" xlink:to="VBIX_FinanceExpense_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_FinanceExpense_3_lbl" xml:lang="en-US">Finance expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_GainFromSaleOfSubsidiary" xlink:to="VBIX_GainFromSaleOfSubsidiary_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_GainFromSaleOfSubsidiary_3_lbl" xml:lang="en-US">Gain from sale of subsidiary</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_3_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VBIX_SupplementalCashReceivedFromSaleOfSubsidiaries" xlink:to="VBIX_SupplementalCashReceivedFromSaleOfSubsidiaries_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VBIX_SupplementalCashReceivedFromSaleOfSubsidiaries_3_lbl" xml:lang="en-US">Supplemental cash received from sale of subsidiaries</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_2_lbl" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>vbix-20211231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://corp.viewbix.com/role/Cover" xlink:href="vbix-20211231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/BalanceSheets" xlink:href="vbix-20211231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/BalanceSheetsParenthetical" xlink:href="vbix-20211231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/StatementsOfComprehensiveLoss" xlink:href="vbix-20211231.xsd#StatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit" xlink:href="vbix-20211231.xsd#StatementsOfChangesInStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/StatementsOfCashFlows" xlink:href="vbix-20211231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/Generel" xlink:href="vbix-20211231.xsd#Generel" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="vbix-20211231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilities" xlink:href="vbix-20211231.xsd#OtherAccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/RelatedPartyTransactions" xlink:href="vbix-20211231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfShares" xlink:href="vbix-20211231.xsd#ShortTermLoanAndIssuesOfShares" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/StockholdersDeficit" xlink:href="vbix-20211231.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/Revenues" xlink:href="vbix-20211231.xsd#Revenues" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ResearchAndDevelopmentExpenses" xlink:href="vbix-20211231.xsd#ResearchAndDevelopmentExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/SalesAndMarktingExpenses" xlink:href="vbix-20211231.xsd#SalesAndMarktingExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/GeneralAndAdministrativeExpenses" xlink:href="vbix-20211231.xsd#GeneralAndAdministrativeExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/FinancialExpensesIncomeNet" xlink:href="vbix-20211231.xsd#FinancialExpensesIncomeNet" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/IncomeTaxes" xlink:href="vbix-20211231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/LossPerShare-basicAndDiluted" xlink:href="vbix-20211231.xsd#LossPerShare-basicAndDiluted" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/Covid-19PandemicImplications" xlink:href="vbix-20211231.xsd#Covid-19PandemicImplications" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/SubsequentEvents" xlink:href="vbix-20211231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="vbix-20211231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilitiesTables" xlink:href="vbix-20211231.xsd#OtherAccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/RelatedPartyTransactionsTables" xlink:href="vbix-20211231.xsd#RelatedPartyTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesTables" xlink:href="vbix-20211231.xsd#ShortTermLoanAndIssuesOfSharesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/StockholdersDeficitTables" xlink:href="vbix-20211231.xsd#StockholdersDeficitTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/RevenuesTables" xlink:href="vbix-20211231.xsd#RevenuesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ResearchAndDevelopmentExpensesTables" xlink:href="vbix-20211231.xsd#ResearchAndDevelopmentExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/SalesAndMarktingExpensesTables" xlink:href="vbix-20211231.xsd#SalesAndMarktingExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/GeneralAndAdministrativeExpensesTables" xlink:href="vbix-20211231.xsd#GeneralAndAdministrativeExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/FinancialExpensesIncomeNetTables" xlink:href="vbix-20211231.xsd#FinancialExpensesIncomeNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/IncomeTaxesTables" xlink:href="vbix-20211231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/LossPerShare-basicAndDilutedTables" xlink:href="vbix-20211231.xsd#LossPerShare-basicAndDilutedTables" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/GenerelDetailsNarrative" xlink:href="vbix-20211231.xsd#GenerelDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfOtherAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="vbix-20211231.xsd#ScheduleOfOtherAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfRelatedPartyTransactionsDetails" xlink:href="vbix-20211231.xsd#ScheduleOfRelatedPartyTransactionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="vbix-20211231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails" xlink:href="vbix-20211231.xsd#ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfCompositionOfShortTermLoanDetails" xlink:href="vbix-20211231.xsd#ScheduleOfCompositionOfShortTermLoanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative" xlink:href="vbix-20211231.xsd#ShortTermLoanAndIssuesOfSharesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/SummaryOfOutstandingWarrantsDetails" xlink:href="vbix-20211231.xsd#SummaryOfOutstandingWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative" xlink:href="vbix-20211231.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfRevenuesDetails" xlink:href="vbix-20211231.xsd#ScheduleOfRevenuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails" xlink:href="vbix-20211231.xsd#ScheduleOfResearchAndDevelopmentExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfSalesAndMarketingExpensesDetails" xlink:href="vbix-20211231.xsd#ScheduleOfSalesAndMarketingExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" xlink:href="vbix-20211231.xsd#ScheduleOfGeneralAndAdministrativeExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfFinancialExpensesIncomeNetDetails" xlink:href="vbix-20211231.xsd#ScheduleOfFinancialExpensesIncomeNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails" xlink:href="vbix-20211231.xsd#ScheduleOfDeferredIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails" xlink:href="vbix-20211231.xsd#ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative" xlink:href="vbix-20211231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://corp.viewbix.com/role/ScheduleOfLossPerShare-basicAndDilutedDetails" xlink:href="vbix-20211231.xsd#ScheduleOfLossPerShare-basicAndDilutedDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_us-gaapAccountsAndOtherReceivablesNetCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsAndOtherReceivablesNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableTradeCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent" xlink:label="loc_us-gaapDueToAffiliateCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDueToAffiliateCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ShareCapitalAbstract" xlink:label="loc_VBIXShareCapitalAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_VBIXShareCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VBIXShareCapitalAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VBIXShareCapitalAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VBIXShareCapitalAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VBIXShareCapitalAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/StatementsOfComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaapRevenueFromContractWithCustomerAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOtherGeneralExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="loc_us-gaapGainLossOnSaleOfBusiness" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfBusiness" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_FinanceIncome" xlink:label="loc_VBIXFinanceIncome" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_VBIXFinanceIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_FinanceExpense" xlink:label="loc_VBIXFinanceExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_VBIXFinanceExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_FinancingProvidedByParentCompanyAcquisition" xlink:label="loc_VBIXFinancingProvidedByParentCompanyAcquisition" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VBIXFinancingProvidedByParentCompanyAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_GainFromSaleOfSubsidiary" xlink:label="loc_VBIXGainFromSaleOfSubsidiary" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_VBIXGainFromSaleOfSubsidiary" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInOtherReceivables" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueToAffiliatesCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueToAffiliatesCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDueToAffiliatesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaapProceedsFromDivestitureOfBusinesses" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromDivestitureOfBusinesses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_us-gaapProceedsFromShortTermDebt" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromShortTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ModificationOfParentCompanyPayableIntoLoan" xlink:label="loc_VBIXModificationOfParentCompanyPayableIntoLoan" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_VBIXModificationOfParentCompanyPayableIntoLoan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_CurrentAssetsExcludingCashAndCashEquivalent" xlink:label="loc_VBIXCurrentAssetsExcludingCashAndCashEquivalent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_VBIXCurrentAssetsExcludingCashAndCashEquivalent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_LiabilitiesCurrentOne" xlink:label="loc_VBIXLiabilitiesCurrentOne" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_VBIXLiabilitiesCurrentOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_SupplementalGainFromSalesOfSubsidiary" xlink:label="loc_VBIXSupplementalGainFromSalesOfSubsidiary" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_VBIXSupplementalGainFromSalesOfSubsidiary" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_SupplementalCashReceivedFromSaleOfSubsidiaries" xlink:label="loc_VBIXSupplementalCashReceivedFromSaleOfSubsidiaries" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_VBIXSupplementalCashReceivedFromSaleOfSubsidiaries" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/Generel" xlink:title="00000007 - Disclosure - GENEREL">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilities" xlink:title="00000009 - Disclosure - OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/RelatedPartyTransactions" xlink:title="00000010 - Disclosure - RELATED PARTY TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfShares" xlink:title="00000011 - Disclosure - SHORT TERM LOAN AND ISSUES OF SHARES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="loc_us-gaapShortTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShortTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/StockholdersDeficit" xlink:title="00000012 - Disclosure - STOCKHOLDERS&#8217; DEFICIT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/Revenues" xlink:title="00000013 - Disclosure - REVENUES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaapRevenueFromContractWithCustomerAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ResearchAndDevelopmentExpenses" xlink:title="00000014 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaapResearchAndDevelopmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="loc_us-gaapResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapResearchAndDevelopmentAbstract" xlink:to="loc_us-gaapResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/SalesAndMarktingExpenses" xlink:title="00000015 - Disclosure - SALES AND MARKTING EXPENSES">
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_DisclosureSalesAndMarktingExpensesAbstract" xlink:label="loc_VBIXDisclosureSalesAndMarktingExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_SalesAndMarketingExpensesDisclosureTextBlock" xlink:label="loc_VBIXSalesAndMarketingExpensesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VBIXDisclosureSalesAndMarktingExpensesAbstract" xlink:to="loc_VBIXSalesAndMarketingExpensesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/GeneralAndAdministrativeExpenses" xlink:title="00000016 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES">
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract" xlink:label="loc_VBIXDisclosureGeneralAndAdministrativeExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_GeneralAndAdministrativeExpensesDisclosureTextBlock" xlink:label="loc_VBIXGeneralAndAdministrativeExpensesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VBIXDisclosureGeneralAndAdministrativeExpensesAbstract" xlink:to="loc_VBIXGeneralAndAdministrativeExpensesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/FinancialExpensesIncomeNet" xlink:title="00000017 - Disclosure - FINANCIAL EXPENSES (INCOME), NET">
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_DisclosureFinancialExpensesIncomeNetAbstract" xlink:label="loc_VBIXDisclosureFinancialExpensesIncomeNetAbstract" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_FinancingIncomeExpensesTextBlock" xlink:label="loc_VBIXFinancingIncomeExpensesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VBIXDisclosureFinancialExpensesIncomeNetAbstract" xlink:to="loc_VBIXFinancingIncomeExpensesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/IncomeTaxes" xlink:title="00000018 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/LossPerShare-basicAndDiluted" xlink:title="00000019 - Disclosure - LOSS PER SHARE-BASIC AND DILUTED">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/Covid-19PandemicImplications" xlink:title="00000020 - Disclosure - COVID-19 PANDEMIC IMPLICATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualRisksAndUncertaintiesTextBlock" xlink:label="loc_us-gaapUnusualRisksAndUncertaintiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapUnusualRisksAndUncertaintiesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/SubsequentEvents" xlink:title="00000021 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_AccountingForIncomeTaxesPolicyTextBlock" xlink:label="loc_VBIXAccountingForIncomeTaxesPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_VBIXAccountingForIncomeTaxesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_us-gaapBusinessCombinationsPolicy" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessCombinationsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_WarrantsPolicyTextBlock" xlink:label="loc_VBIXWarrantsPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_VBIXWarrantsPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000023 - Disclosure - OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/RelatedPartyTransactionsTables" xlink:title="00000024 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesTables" xlink:title="00000025 - Disclosure - SHORT TERM LOAN AND ISSUES OF SHARES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock" xlink:label="loc_VBIXScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_VBIXScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:label="loc_us-gaapScheduleOfShortTermDebtTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/StockholdersDeficitTables" xlink:title="00000026 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/RevenuesTables" xlink:title="00000027 - Disclosure - REVENUES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaapRevenueFromContractWithCustomerAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ResearchAndDevelopmentExpensesTables" xlink:title="00000028 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaapResearchAndDevelopmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" xlink:label="loc_VBIXScheduleOfResearchAndDevelopmentExpensesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapResearchAndDevelopmentAbstract" xlink:to="loc_VBIXScheduleOfResearchAndDevelopmentExpensesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/SalesAndMarktingExpensesTables" xlink:title="00000029 - Disclosure - SALES AND MARKTING EXPENSES (Tables)">
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_DisclosureSalesAndMarktingExpensesAbstract" xlink:label="loc_VBIXDisclosureSalesAndMarktingExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ScheduleOfSalesAndMarketingExpensesTableTextBlock" xlink:label="loc_VBIXScheduleOfSalesAndMarketingExpensesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VBIXDisclosureSalesAndMarktingExpensesAbstract" xlink:to="loc_VBIXScheduleOfSalesAndMarketingExpensesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/GeneralAndAdministrativeExpensesTables" xlink:title="00000030 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables)">
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract" xlink:label="loc_VBIXDisclosureGeneralAndAdministrativeExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock" xlink:label="loc_VBIXScheduleOfGeneralAndAdministrativeExpensesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VBIXDisclosureGeneralAndAdministrativeExpensesAbstract" xlink:to="loc_VBIXScheduleOfGeneralAndAdministrativeExpensesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/FinancialExpensesIncomeNetTables" xlink:title="00000031 - Disclosure - FINANCIAL EXPENSES (INCOME), NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_DisclosureFinancialExpensesIncomeNetAbstract" xlink:label="loc_VBIXDisclosureFinancialExpensesIncomeNetAbstract" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ScheduleFinancingIncomeExpensesNetTableTextBlock" xlink:label="loc_VBIXScheduleFinancingIncomeExpensesNetTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VBIXDisclosureFinancialExpensesIncomeNetAbstract" xlink:to="loc_VBIXScheduleFinancingIncomeExpensesNetTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/IncomeTaxesTables" xlink:title="00000032 - Disclosure - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/LossPerShare-basicAndDilutedTables" xlink:title="00000033 - Disclosure - LOSS PER SHARE-BASIC AND DILUTED (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/GenerelDetailsNarrative" xlink:title="00000034 - Disclosure - GENEREL (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_VirtualCryptoIsraelMember" xlink:label="loc_VBIXVirtualCryptoIsraelMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_VBIXVirtualCryptoIsraelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ShareExchangeAgreementMember" xlink:label="loc_VBIXShareExchangeAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_VBIXShareExchangeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_StockSubscriptionAgreementMember" xlink:label="loc_VBIXStockSubscriptionAgreementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_VBIXStockSubscriptionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_LoanAgreementMember" xlink:label="loc_VBIXLoanAgreementMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_VBIXLoanAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ViewbixLtdMember" xlink:label="loc_VBIXViewbixLtdMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_VBIXViewbixLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfOtherAccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000035 - Disclosure - SCHEDULE OF OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableOtherCurrentAndNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableOtherCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfRelatedPartyTransactionsDetails" xlink:title="00000036 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTIONS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent" xlink:label="loc_us-gaapDueToAffiliateCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapDueToAffiliateCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000037 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_GixLtdMember" xlink:label="loc_VBIXGixLtdMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_VBIXGixLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_GixLoanMember" xlink:label="loc_VBIXGixLoanMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_VBIXGixLoanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_OperationsCostsIncurredPercentage" xlink:label="loc_VBIXOperationsCostsIncurredPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VBIXOperationsCostsIncurredPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="loc_us-gaapDebtConversionOriginalDebtAmount1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionOriginalDebtAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails" xlink:title="00000038 - Disclosure - SCHEDULE OF FAIR VALUE DISTRIBUTION OF LIABILITY AND EQUITY COMPONENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_LoanMember" xlink:label="loc_VBIXLoanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_VBIXLoanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_SharesMember" xlink:label="loc_VBIXSharesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_VBIXSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShorttermDebtFairValue" xlink:label="loc_us-gaapShorttermDebtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapShorttermDebtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_PercentageOfFairValue" xlink:label="loc_VBIXPercentageOfFairValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_VBIXPercentageOfFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ShortTermDebtAllocatedAmount" xlink:label="loc_VBIXShortTermDebtAllocatedAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_VBIXShortTermDebtAllocatedAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfCompositionOfShortTermLoanDetails" xlink:title="00000039 - Disclosure - SCHEDULE OF COMPOSITION OF SHORT TERM LOAN (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ShortTermPrincipalAmount" xlink:label="loc_VBIXShortTermPrincipalAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_VBIXShortTermPrincipalAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_DiscountOnShortTermLoan" xlink:label="loc_VBIXDiscountOnShortTermLoan" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_VBIXDiscountOnShortTermLoan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative" xlink:title="00000040 - Disclosure - SHORT TERM LOAN AND ISSUES OF SHARES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_LoanAndStockSubscriptionAgreementMember" xlink:label="loc_VBIXLoanAndStockSubscriptionAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_VBIXLoanAndStockSubscriptionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_StockSubscriptionAgreementMember" xlink:label="loc_VBIXStockSubscriptionAgreementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_VBIXStockSubscriptionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_InvestorsMember" xlink:label="loc_VBIXInvestorsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_VBIXInvestorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/SummaryOfOutstandingWarrantsDetails" xlink:title="00000041 - Disclosure - SUMMARY OF OUTSTANDING WARRANTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ClassJWarrantsMember" xlink:label="loc_VBIXClassJWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VBIXClassJWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ClassKWarrantsMember" xlink:label="loc_VBIXClassKWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VBIXClassKWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_WarrantTerm" xlink:label="loc_VBIXWarrantTerm" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_VBIXWarrantTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_WarrantExercisable" xlink:label="loc_VBIXWarrantExercisable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_VBIXWarrantExercisable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000042 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_StockSubscriptionAgreementMember" xlink:label="loc_VBIXStockSubscriptionAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_VBIXStockSubscriptionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_LoanAgreementMember" xlink:label="loc_VBIXLoanAgreementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_VBIXLoanAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_GixLtdMember" xlink:label="loc_VBIXGixLtdMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_VBIXGixLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ClassHWarrantsMember" xlink:label="loc_VBIXClassHWarrantsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VBIXClassHWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ClassIWarrantsMember" xlink:label="loc_VBIXClassIWarrantsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VBIXClassIWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ClassGWarrantsMember" xlink:label="loc_VBIXClassGWarrantsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VBIXClassGWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockVotingRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfRevenuesDetails" xlink:title="00000043 - Disclosure - SCHEDULE OF REVENUES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaapRevenueFromContractWithCustomerAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapDisaggregationOfRevenueLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_IndividualSubscriptionsMember" xlink:label="loc_VBIXIndividualSubscriptionsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_VBIXIndividualSubscriptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_EnterpriseSubscriptionsMember" xlink:label="loc_VBIXEnterpriseSubscriptionsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_VBIXEnterpriseSubscriptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails" xlink:title="00000044 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaapResearchAndDevelopmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapResearchAndDevelopmentAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_SalariesandRelatedExpenseMember" xlink:label="loc_VBIXSalariesandRelatedExpenseMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_VBIXSalariesandRelatedExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_SubcontractorsMember" xlink:label="loc_VBIXSubcontractorsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_VBIXSubcontractorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfSalesAndMarketingExpensesDetails" xlink:title="00000045 - Disclosure - SCHEDULE OF SALES AND MARKETING EXPENSES (Details)">
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_DisclosureSalesAndMarktingExpensesAbstract" xlink:label="loc_VBIXDisclosureSalesAndMarktingExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VBIXDisclosureSalesAndMarktingExpensesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_SalariesandRelatedExpenseMember" xlink:label="loc_VBIXSalariesandRelatedExpenseMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_VBIXSalariesandRelatedExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_OtherMember" xlink:label="loc_VBIXOtherMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_VBIXOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" xlink:title="00000046 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)">
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract" xlink:label="loc_VBIXDisclosureGeneralAndAdministrativeExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VBIXDisclosureGeneralAndAdministrativeExpensesAbstract" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VBIXDisclosureGeneralAndAdministrativeExpensesAbstract" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VBIXDisclosureGeneralAndAdministrativeExpensesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherGeneralAndAdministrativeExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VBIXDisclosureGeneralAndAdministrativeExpensesAbstract" xlink:to="loc_us-gaapOtherGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VBIXDisclosureGeneralAndAdministrativeExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfFinancialExpensesIncomeNetDetails" xlink:title="00000047 - Disclosure - SCHEDULE OF FINANCIAL (EXPENSES) INCOME, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_DisclosureFinancialExpensesIncomeNetAbstract" xlink:label="loc_VBIXDisclosureFinancialExpensesIncomeNetAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VBIXDisclosureFinancialExpensesIncomeNetAbstract" xlink:to="loc_us-gaapLineOfCreditFacilityTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaapCreditFacilityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapCreditFacilityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_BankFeesMember" xlink:label="loc_VBIXBankFeesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_VBIXBankFeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ExchangeRateDifferencesMember" xlink:label="loc_VBIXExchangeRateDifferencesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_VBIXExchangeRateDifferencesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_InterestExpensesMember" xlink:label="loc_VBIXInterestExpensesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_VBIXInterestExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_FinancingIncomeExpensesNet" xlink:label="loc_VBIXFinancingIncomeExpensesNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_VBIXFinancingIncomeExpensesNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails" xlink:title="00000048 - Disclosure - SCHEDULE OF DEFERRED INCOME TAXES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_DifferencesBetweenTaxBasisAndCarryingValuesOfLoans" xlink:label="loc_VBIXDifferencesBetweenTaxBasisAndCarryingValuesOfLoans" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_VBIXDifferencesBetweenTaxBasisAndCarryingValuesOfLoans" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails" xlink:title="00000049 - Disclosure - SCHEDULE OF LOSS (INCOME) FROM CONTINUING OPERATIONS, BEFORE TAXES ON INCOME (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapOperatingLossCarryforwardsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000050 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapOperatingLossCarryforwardsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="loc_us-gaapIsraelTaxAuthorityMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:to="loc_us-gaapIsraelTaxAuthorityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vbix-20211231.xsd#VBIX_ViewbixIsraelMember" xlink:label="loc_VBIXViewbixIsraelMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_VBIXViewbixIsraelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_srtStatementGeographicalAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="loc_us-gaapIncomeTaxExaminationDescription" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://corp.viewbix.com/role/ScheduleOfLossPerShare-basicAndDilutedDetails" xlink:title="00000051 - Disclosure - SCHEDULE OF LOSS PER SHARE-BASIC AND DILUTED (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992385420760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 17, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-15746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VIEWBIX
INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000797542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">68-0080601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">11
    Derech Menachem Begin Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Ramat Gan<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">5268104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">+972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">9-774-1505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, Par Value $0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VBIX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 815,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,753,669<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Brightman Almagor Zohar & Co.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Tel
Aviv, Israel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992385226760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade receivables</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Other accounts receivable</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">225<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Trade payables</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Other accounts payable and accrued liabilities</a></td>
<td class="nump">242<span></span>
</td>
<td class="nump">177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Parent company</a></td>
<td class="nump">2,116<span></span>
</td>
<td class="nump">2,054<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short term loan</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,436<span></span>
</td>
<td class="nump">2,303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_ShareCapitalAbstract', window );"><strong>Share Capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 490,000,000 shares authorized; 34,753,669 shares issued and outstanding at December 31, 2021 and at December 31, 2020</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">13,257<span></span>
</td>
<td class="nump">13,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(15,540)<span></span>
</td>
<td class="num">(15,154)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; deficit</a></td>
<td class="num">(2,280)<span></span>
</td>
<td class="num">(2,078)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, temporary equity and stockholders&#8217; deficit</a></td>
<td class="nump">$ 156<span></span>
</td>
<td class="nump">$ 225<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_ShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Capital Abstract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_ShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391702296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock , par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">490,000,000<span></span>
</td>
<td class="nump">490,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">34,753,669<span></span>
</td>
<td class="nump">34,753,669<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">34,753,669<span></span>
</td>
<td class="nump">34,753,669<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992385258040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">304<span></span>
</td>
<td class="nump">437<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherGeneralExpense', window );">Other expenses</a></td>
<td class="nump">25<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from sale of a subsidiary</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">395<span></span>
</td>
<td class="nump">545<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(354)<span></span>
</td>
<td class="num">(454)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_FinanceIncome', window );">Finance income</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_FinanceExpense', window );">Finance expense</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss Before taxes on income</a></td>
<td class="num">(384)<span></span>
</td>
<td class="num">(441)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Taxes on income</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">$ (386)<span></span>
</td>
<td class="num">$ (443)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per share:</a></td>
<td class="num">$ (0.011)<span></span>
</td>
<td class="num">$ (0.014)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average shares outstanding - basic and diluted</a></td>
<td class="nump">34,753,669<span></span>
</td>
<td class="nump">31,201,669<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_FinanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_FinanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of general expenses not normally included in Other Operating Costs and Expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.6)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992385291544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Stockholders' Deficit - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 13,015<span></span>
</td>
<td class="num">$ (14,711)<span></span>
</td>
<td class="num">$ (1,693)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2019</a></td>
<td class="nump">31,201,669<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Issuance of shares</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">58<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issuance of shares, shares</a></td>
<td class="nump">3,552,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(443)<span></span>
</td>
<td class="num">(443)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,073<span></span>
</td>
<td class="num">(15,154)<span></span>
</td>
<td class="num">(2,078)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="nump">34,753,669<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_FinancingProvidedByParentCompanyAcquisition', window );">Financing provided by the Parent Company (see note 4)</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(386)<span></span>
</td>
<td class="num">(386)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 13,257<span></span>
</td>
<td class="num">$ (15,540)<span></span>
</td>
<td class="num">$ (2,280)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2021</a></td>
<td class="nump">34,753,669<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents an amount
less than $1.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_FinancingProvidedByParentCompanyAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing provided by parent company acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_FinancingProvidedByParentCompanyAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992386750984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 12, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period</a></td>
<td class="num">$ (386)<span></span>
</td>
<td class="num">$ (443)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_GainFromSaleOfSubsidiary', window );">Gain from sale of a subsidiary</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Decrease (Increase) in trade receivables and prepaid expenses</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Decrease (Increase) in other accounts receivable</a></td>
<td class="num">(10)<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Increase (decrease) in trade payables</a></td>
<td class="nump">52<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToAffiliatesCurrent', window );">Increase in payable to parent company</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Increase (decrease) in other accounts payables and accrued liabilities</a></td>
<td class="nump">19<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used by operating activities</a></td>
<td class="num">(74)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Cash received from the sale of a subsidiary</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Issuance of shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Short term loan received</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease) in cash and cash equivalents and restricted cash</a></td>
<td class="num">(74)<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents and restricted cash at the beginning of the period</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents and restricted cash at the end of the period</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_ModificationOfParentCompanyPayableIntoLoan', window );">Modification of parent company payable into a loan</a></td>
<td class="nump">$ 2,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_CurrentAssetsExcludingCashAndCashEquivalent', window );">Current assets excluding cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_LiabilitiesCurrentOne', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_SupplementalGainFromSalesOfSubsidiary', window );">Gain from sale of a subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_SupplementalCashReceivedFromSaleOfSubsidiaries', window );">Cash received from the sale of a subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_CurrentAssetsExcludingCashAndCashEquivalent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Current assets excluding cash and cash equivalent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_CurrentAssetsExcludingCashAndCashEquivalent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_GainFromSaleOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain from sale of subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_GainFromSaleOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_LiabilitiesCurrentOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liabilities current one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_LiabilitiesCurrentOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_ModificationOfParentCompanyPayableIntoLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Modification of parent company payable into a loan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_ModificationOfParentCompanyPayableIntoLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_SupplementalCashReceivedFromSaleOfSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental cash received from sale of subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_SupplementalCashReceivedFromSaleOfSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_SupplementalGainFromSalesOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental gain from sales of subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_SupplementalGainFromSalesOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToAffiliatesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in current obligations (due within one year or one operating cycle) owed to an entity that is controlling, under the control of, or within the same control group as the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToAffiliatesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391543080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENEREL<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">GENEREL</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_z1foz2h5YoQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1. <span id="xdx_82F_znp7OID2CFn7">GENEREL</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A.</i></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Organizational
                                            Background</i></b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Viewbix
Inc. (formerly known as Virtual Crypto Technologies, Inc.) (the &#8220;Company&#8221;) was incorporated in the State of Ohio in 1989
under a predecessor name, Zaxis International, Inc. (&#8220;Zaxis&#8221;). On August 25, 1995, Zaxis merged with a subsidiary of The
InFerGene Company, a Delaware corporation, which entity changed its name to Zaxis International, Inc. and the Company was reincorporated
in Delaware under the name of Zaxis International, Inc. In 2015 the Company changes its name to Emerald Medical Applications Corp.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 17, 2018, the Company formed a new wholly-owned subsidiary under the laws of the State of Israel, Virtual Crypto Technologies
Ltd. (&#8220;VCT Israel&#8221;), to develop and market software and hardware products facilitating and supporting the purchase and/or
sale of cryptocurrencies. Effective as of March 7, 2018, the Company&#8217;s name was changed from Emerald Medical Applications Corp.
to Virtual Crypto Technologies, Inc. to reflect its new operations and business focus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VCT
Israel ceased its business operation prior to consummation of the Recapitalization Transaction. On January 27, 2020, VCT Israel was sold
to a third party for NIS <span id="xdx_906_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_uNIS_c20200127__us-gaap--IncomeStatementLocationAxis__custom--VirtualCryptoIsraelMember_zzRUp93YqNNh" title="Due to relaties parties current and non current">50,000</span> ($<span id="xdx_902_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20200127__us-gaap--IncomeStatementLocationAxis__custom--VirtualCryptoIsraelMember_zq7gTnXqu8sc" title="Due to related party">14,459</span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 7, 2019, the Company entered into a share exchange agreement (the &#8220;Share Exchange Agreement&#8221; or the &#8220;Recapitalization
Transaction&#8221;) with Gix Internet Ltd., an company organized under the laws of the State of Israel (&#8220;Gix&#8221;), pursuant
to which, Gix assigned, transferred and delivered its <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20190207__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--ViewbixLtdMember_zeK60kGvq0Ye" title="Ownership percentage">99.83</span>% holdings in Viewbix Ltd., a company organized under the laws of the State
of Israel (&#8220;Viewbix Israel&#8221;), to the Company in exchange for shares of restricted common stock of the Company, which resulted
in Viewbix Israel becoming a subsidiary of the Company. In connection with the Share Exchange Agreement, effective as of August 7, 2019,
the Company&#8217;s name was changed from Virtual Crypto Technologies, Inc. to Viewbix Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 1, 2020, the Company announced certain cost reduction measures due the fact the Company not achieved certain revenues goals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 5, 2021, the Company entered into a certain Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221; or the &#8220;Gix
Merger&#8221;) with Gix Media Ltd., an Israeli company and the majority-owned subsidiary of Gix (&#8220;Gix Media&#8221;) and Vmedia
Merger Sub Ltd., an Israeli company and wholly-owned subsidiary of the Company (&#8220;Merger Sub&#8221;), pursuant to which, following
the Gix Merger and upon satisfaction of the closing conditions listed in the Merger Agreement, Merger Sub will merge with and into Gix
Media, with Gix Media being the surviving entity and wholly-owned subsidiary of the Company. As of the reporting date, the closing conditions
of the Merger Agreement have not been fulfilled yet the Gix Merger has not been consummated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and its subsidiaries are collectively referred to as the &#8220;Company&#8221;. The Company has developed an interactive video
platform based on Software as a Service (&#8220;SaaS&#8221;) business model with interactive elements, and the ability to collect and
analyze information about each interactive action performed during the viewing of the video clip. The interactive elements and information
gathered, allowing the advertiser to analyze user viewing habits and optimize real-time throughout the campaign while increasing the
effectiveness of online and live video advertising.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE.
    1</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GENERAL
    (Cont.):</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>B.</i></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Emerald
                                            Medical Applications Ltd.</i></b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerald
Medical Applications Ltd., the Company&#8217;s wholly-owned subsidiary (&#8220;Emerald Israel&#8221;) was engaged in the business of
developing DermaCompare technology and the development, sale and service of imaging solutions utilizing its DermaCompare software for
use in derma imaging and analytics for the detection of skin cancer. On January 29, 2018, the Company ceased the DermaCompare operations
of its former subsidiary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 2, 2018, the District Court of Lod, Israel issued a winding-up order for Emerald Israel and appointed an Israeli attorney as special
executor for Emerald Israel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>C.</i></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock
                                            Subscription Agreement and Loan Agreement</i></b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 18, 2020, the Company entered into a Stock Subscription Agreement (the &#8220;Subscription&#8221;) with certain investors (the
&#8220;Investors&#8221;) in connection with the sale and issuance of an aggregate of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zCvcoMZSv5Vb" title="Number of share issued">3,000,000</span> shares of Common Stock, at a purchase
price of $<span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zaLFK7SuTkvf" title="Sale of stock, price per share">0.01</span> per share, and for an aggregate purchase price of $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zDlT953wkg29" title="Stock issued during period value">30,000</span>. In addition, and on the same date, the company entered into
a Loan Agreement (the &#8220;Loan&#8221;) with the Investors, pursuant to which the Investors lent an aggregate of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20201218__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_znpSK73yBad7" title="Debt instrument, face amount">69,000</span> (the &#8220;Principal
Amount&#8221;). In accordance with the terms of the Loan, the company repaid the interest on the Principal Amount (<span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20201218__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zS95WgCjCqFc" title="Debt instrument interest rate">8</span>% compounded annually)
to the Investors in the form of an issuance of an aggregate of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zkAbj8TRZkBi" title="Number of share issued">552,000</span> shares of Common Stock, at a price per share of $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_c20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zVUTjo8M54i8" title="Shares issued, price per share">0.01</span>. The shares
of Common Stock were issued to the Investors pursuant to Regulation S of the Securities Act of 1933, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>D.</i></b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Merger
                                            with Gix Media Ltd.</i></b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 5, 2021, the Company entered into the Merger Agreement with Gix Media and Merger Sub, pursuant to which, following the Gix Merger,
and upon satisfaction of additional closing conditions, Merger Sub will merge with and into Gix Media, with Gix Media being the surviving
entity and wholly-owned subsidiary of the Company. As of the reporting date, the closing conditions of the Merger Agreement have not
been fulfilled yet and the Gix Merger has not been consummated (see Note 15).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE.
    1</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GENERAL
    (Cont.)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>E.</i></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Going
                                            Concern</i></b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has incurred $<span id="xdx_904_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20210101__20211231_zaJVj2fjvuhb" title="Net Income (Loss) Attributable to Parent">386</span> in net loss for the year ended December 31, 2021 and <span id="xdx_907_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20200101__20201231_zA38k90eLVH5" title="Net Income (Loss) Attributable to Parent">443 </span>in net loss for the year ended December 31,2020, has
$<span id="xdx_90D_eus-gaap--StockholdersEquity_iNI_pn3n3_di_c20211231_zBZ9xKunxrjj" title="Stockholders' deficit">2,280</span> stockholders&#8217; deficit as of December 31, 2021 and $<span id="xdx_903_eus-gaap--StockholdersEquity_iNI_pn3n3_di_c20201231_zBHbkgmNPIR6" title="Stockholders' deficit">2,078</span> in total stockholders&#8217; deficit as of December 31, 2020 and
$<span id="xdx_90F_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3n3_di_c20210101__20211231_zRSYEbFgMWJ" title="Cash flows from operations">74 </span>in negative cash flows from operations for the year ended December 31, 2021 and <span id="xdx_906_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3n3_di_c20200101__20201231_zRQtcgfbLHb3" title="Cash flows from operations">53</span> in negative cash flows from operations for the
year ended December 31, 2020. Since January 2020, the Company has significantly reduced its operations and expenses of Viewbix Israel.
Management expects the Company to continue to generate substantial operating losses and to continue to fund its operations primarily
through utilization of its current financial resources and through additional raises of capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
conditions raise substantial doubts about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plan includes
raising funds from outside potential investors. However, there is no assurance such funding will be available to the Company or that
it will be obtained on terms favorable to the Company or will provide the Company with sufficient funds to meet its objectives. These
financial statements do not include any adjustments relating to the recoverability and classification of assets, carrying amounts or
the amount and classification of liabilities that may be required should the Company be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391436584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--SignificantAccountingPoliciesTextBlock_ziqnFdfBgBPd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE.
2 <span id="xdx_827_zuvk3xo8jZM9">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
significant accounting policies used in the preparation of the financial statements are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_843_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z8u2fRxegkM8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zABgu1YTrjAe">Functional
currency</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency of the Company and its subsidiary is the US dollar, which is the currency of the primary economic environment in
which it operates. In accordance with ASC 830, &#8220;Foreign Currency Matters&#8221; (ASC 830), balances denominated in or linked to
foreign currency are stated on the basis of the exchange rates prevailing at the applicable balance sheet date. For foreign currency
transactions included in the statement of operations, the exchange rates applicable on the relevant transaction dates are used. Gains
or losses arising from changes in the exchange rates used in the translation of such transactions are carried as financing income or
expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_843_eus-gaap--ConsolidationPolicyTextBlock_zWIVxEVqvyGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zF0sRCmT9cMf">Principles
of consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions
have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zU395BzqCbJa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zOyekG7dtEt">Cash
and cash equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments, which are highly liquid investments with original maturities of three months or less at
the date of purchase, to be cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z2144j3oOJo9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zdHyj5mquz4j">Fair
value of financial instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying values of Company&#8217;s financial assets and liabilities, including cash and cash equivalents, restricted cash, other current
assets, trade payables, other accounts payable and financing provided by the Parent Company approximate their fair value due to the short-term
maturity of these instruments.</span></p>

<p id="xdx_853_zqjmPPSHVyCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE.
2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zALgsAM7Kom8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zYaa53tWN7G3">Earnings
per Common Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnings
or loss per share (&#8220;EPS&#8221;) is the amount of earnings attributable to each share of common stock. For convenience, the term
is used to refer to either earnings or loss per share. EPS is computed pursuant to ASC 260-10-45. Pursuant to ASC 260-10-45-10 through
260-10-45-16 Basic EPS is computed by dividing income available to common stockholders (the numerator) by the weighted-average number
of common shares outstanding (the denominator) during the period. Income available to common stockholders shall be computed by deducting
both the dividends declared in the period on preferred stock (whether or not paid) from income from continuing operations (if that amount
appears in the income statement) and also from net income. The computation of diluted EPS is similar to the computation of basic EPS
except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive
potential common shares had been issued during the period to reflect the potential dilution that could occur from common shares issuable
through contingent shares issuance arrangement, stock options or warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_841_eus-gaap--RevenueRecognitionPolicyTextBlock_zTTIQXV8EIAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zwIXj4YsWLXd">Revenue
recognition</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company applies the provisions of Accounting Standards Codification (or &#8220;ASC&#8221;) 606, Revenue from Contracts with Customers
(&#8220;ASC 606&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generates revenues primarily by granting customers the right to access software products through the Company&#8217;s cloud-based
SaaS subscription offerings. Under a SaaS subscription agreement, the customer receives a right to access the software for a specified
period of time in an environment hosted, supported, and maintained by the Company. SaaS subscription services are a single performance
obligation satisfied over time, and associated revenue is generally recognized ratably over the contract term once the software is made
available to the customer. The SaaS subscription offerings are typically sold with one year subscription terms, generally invoiced in
advance of each annual subscription period, and are non-cancelable during the committed subscription term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_844_eus-gaap--ResearchAndDevelopmentExpensePolicy_zrXrW15X3k2b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zHlpbKqblnE8">Research
and development expenses</span>:</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses are charged to the statement of operations as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zu38Kn7CfP2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zm1DvLcbIr47">Income
Taxes</span>: </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221;, and (&#8220;ASC 740&#8221;). ASC 740 prescribes
the use of the asset and liability method whereby deferred tax asset and liability account balances are determined based on differences
between the financial reporting and tax bases of assets and liabilities and for carry forward tax losses. Deferred taxes are measured
using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation
allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more-likely-than-not that some portion
or all of the deferred tax asset will not be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, ASC 740 prescribes a recognition threshold and measurement attribute for financial statement recognition and measurement of
a tax position taken or expected to be taken in a tax return. The first step is to evaluate the tax position taken or expected to be
taken in a tax return. This is done by determining if the weight of available evidence indicates that it is more-likely-than-not that,
on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or
litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized
upon ultimate settlement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_847_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zZ0pKrPRYT6f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_z5dK3ZP8hw4a">Contingencies</span>:</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records accruals for loss contingencies arising from claims, litigation and other sources when it is probable that a liability
has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional
information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_844_ecustom--AccountingForIncomeTaxesPolicyTextBlock_zjmjQETEN3e4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zDRXD9iLeyq8">Accounting
for Income Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the Financial Accounting Standards Board issued Accounting Standards Update No. ASU 2019-12, &#8220;Simplifying the Accounting
for Income Taxes&#8221;. This ASU amends Accounting Standards Codification (&#8220;ASC&#8221;) 740 by removing certain exceptions to
the general principles, clarifying and amending existing guidance. This guidance is effective for fiscal years, and interim periods within
those years, beginning after December 15, 2020. The Company adopted this standard in the first quarter of 2021. The adoption of this
ASU did not impact our financial statements or the related disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_84D_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z8XkxIbzyaq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zWWOGKRXH013">Recently
issued accounting pronouncements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financial
Instruments &#8211; Credit Losses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU 2016-13, &#8220;Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses
on Financial Instruments&#8221; (&#8220;ASU 2016-13&#8221;). ASU 2016-13 replaces the current incurred loss model guidance with a new
method that reflects expected credit losses. Under this guidance, an entity would recognize an allowance for credit losses equal to its
estimate of expected credit losses on financial assets measured at amortized cost. In November 2019, the FASB extended the effective
date of ASU 2016-13 for smaller reporting companies. As a result, ASU 2016-13 is effective for fiscal years, and interim periods within
those years, beginning after December 15, 2022, with early adoption permitted. The standard is not expected to have a significant impact
on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Convertible
instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU 2020-06, &#8220;Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an
Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020-06&#8221;). ASU 2020-06 simplifies the accounting for convertible instruments by removing
certain separation models in Accounting Standards Codification (&#8220;ASC&#8221;) 470-20, &#8220;Debt&#8212;Debt with Conversion and
Other Options,&#8221; (&#8220;ASC 470-20&#8221;) for convertible instruments. Under ASU 2020-06, the embedded conversion features no
longer are separated from the host contract for convertible instruments with conversion features that are not required to be accounted
for as derivatives under ASC 815, &#8220;Derivatives and Hedging,&#8221; or that do not result in substantial premiums accounted for
as paid-in capital. For smaller reporting companies, ASU 2020-06 is effective for fiscal years, and interim periods within those years,
beginning after December 15, 2023, with early adoption permitted for fiscal years beginning after December 15, 2020. The Company is currently
assessing the impact of this update on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--BusinessCombinationsPolicy_z6fsBtAckgu6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zSoqJjhN1eKi">Business
Combination</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 28, 2021, the FASB issued ASU 2021-08, which amends ASC 805 to &#8220;require acquiring entities to apply Topic 606 to recognize
and measure contract assets and contract liabilities in a business combination.&#8221; Under current GAAP, an acquirer generally recognizes
such items at fair value on the acquisition date. According to the FASB, this Update is intended &#8220;to improve the accounting for
acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to
the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognition
    of an acquired contract liability</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    terms and their effect on subsequent revenue recognized by the acquirer.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU
2021-08 06 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. We are
currently assessing the impact of this update on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_ecustom--WarrantsPolicyTextBlock_zaRYrHScf6C6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zN5Z9W9Um9we">Warrants</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2021, the Financial Accountings Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2021-04,
&#8220;Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock Compensation
(Topic 718), and Derivatives and Hedging&#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815- 40): Issuer&#8217;s Accounting
for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#8221; (&#8220;ASU 2021-04&#8221;). The
guidance is effective for the Company on January 1, 2022. The Company is currently evaluating the impact of adopting this standard</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391497272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zwcy6ownkL16" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
    3.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_823_zvGpz22drQg3">OTHER
    ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Composition:</b></span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z1M5EfCDeLU7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zV75WJRXJqXe" style="display: none">SCHEDULE
OF OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.75in">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20211231_zmk9zKpfhTSg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December 30</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20201231_zMw2grzwuErb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccountsPayableOtherCurrentAndNoncurrent_iI_pn3n3_maAPAOAzuqS_maAPAALzlaq_zekjjQrtE8Fd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Other payables and deferred revenues</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">47</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">47</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_maAPAOAzuqS_maAPAALzlaq_zfDN0dsWAzH8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Accrued liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">195</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">130</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iTI_pn3n3_mtAPAALzlaq_zypBjA2JqmF7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total other accounts payables</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">242</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">177</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A0_zo4kdZUIDii1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391450616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zPXSAaNPhvtj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
    4.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82A_zvInVjQ9Tlh6">RELATED
    PARTY TRANSACTIONS</span>.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balances:</b></span></p>

<p id="xdx_890_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zuPoz1REKY68" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_z1V8nzkQ1l1e" style="display: none">SCHEDULE
OF RELATED PARTY TRANSACTIONS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.75in">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_493_20211231_zOlW66snZtld" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31,</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49E_20201231_zpCMj8kd8cEd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31,</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DueToAffiliateCurrent_iI_pn3n3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gix
    &#8211; Company Payable</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,116</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,054</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8A5_zOeA46apOKcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the agreement with Gix, the parties agreed to have the Company&#8217;s operations outsourced to Gix from the agreement date and
until the acquisition is consummated. The following term were included in the agreement pursuant to the above:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
    May 2018 all of the Company&#8217;s employees will become employees of Gix.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
    the periods of May 2018 to October 2018, Gix will pay the full expenses of the employees as well as other related expenses.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
    November 2018 until to the Closing Date, the employees transferred from the Company to Gix will dedicate half of their time to the
    Company&#8217;s operations and correspondingly <span id="xdx_90B_ecustom--OperationsCostsIncurredPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--GixLtdMember_zw1qt3ZatMmb" title="Operations costs incurred, percentage">50</span>% of the costs to be incurred by Gix in respect of these employees are to be charged
    to the Company.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
the closing date, the actual of the expenses incurred by Gix that related to the Company will be charged to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
amounts were paid by the Company to Gix during 2021 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement with Gix, its parent company, pursuant to which, effective as of December 31, 2021, the parent company
payable was modified into a loan, which may be increased from time to time, upon the written mutual consent of the Company and Gix (the
&#8220;Gix Loan&#8221;) .The Gix Loan bears interest at a rate equivalent to the minimal interest rate recognized and attributed by the
Israel Tax Authority and will be repaid, together with the accrued interest, in one payment until December 31, 2022, unless extended
upon mutual consent of the Company and Gix Internet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for the modification as an extinguishment of the parent company payable and the issuance of a new debt. The loan was
recorded at its fair value of $<span id="xdx_903_eus-gaap--DebtConversionOriginalDebtAmount1_c20220212__20220213__us-gaap--DebtInstrumentAxis__custom--GixLoanMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zf0JFDm89qV8" title="Debt modification original debt, amount">2,115,853</span> as of the modification date, with the difference of $<span id="xdx_906_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20220212__20220213__us-gaap--DebtInstrumentAxis__custom--GixLoanMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUT2c7gA4Vwe" title="Debt conversion amount">184,103</span> between the fair value of the loan
and the carrying value of the payable to the Parent Company recorded in the Company&#8217;s Consolidated Statement of Changes in Stockholders&#8217;
Deficit as a deemed contribution to the Company by the Parent Company, with a corresponding discount on the loan, to be amortized as
finance expense in the Company&#8217;s Consolidated Statements of Comprehensive Loss over the term of the loan.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391562536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHORT TERM LOAN AND ISSUES OF SHARES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTextBlock', window );">SHORT TERM LOAN AND ISSUES OF SHARES</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--ShortTermDebtTextBlock_zrXbmu5Z0Kj1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
    5.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_823_z1cxf1SvfOal">SHORT
    TERM LOAN AND ISSUES OF SHARES</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 18, 2020, the company entered into a Loan Agreement (the &#8220;Loan&#8221;) and Stock Subscription Agreement with certain Investors
as described in note 1c, pursuant to which the Investors lent an aggregate amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAndStockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_znrphiD1kOv8" title="Debt instrument, face amount">69,000</span> (the &#8220;Principal Amount&#8221;). In
accordance with the terms of the Loan, the company prepaid the interest on the Principal Amount of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAndStockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--InvestorsMember_zPxuSk5zYCd1" title="Debt instrument interest rate">8</span>% compounded annually to the Investors
as an issuance of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAndStockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--InvestorsMember_zceVpl9yV7jd" title="Stock issued during period, shares">552,000</span> shares of Common Stock, at a price per share of $<span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_c20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAndStockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--InvestorsMember_zcj0nh0r5jC3" title="Stock issued price per share">0.01</span>. Under the Stock Subscription Agreement, the Investors
transferred an amount of $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn3n3_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--InvestorsMember_zmy0FQ1N1yDe" title="Proceeds from issuance of common stock">30,587</span> to the company as consideration for the issued shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company allocated the total proceeds in respect of the shares issued and the Loan extended based on theirrelative fair values. As a result
of the allocation, a discount of $<span id="xdx_90B_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn3n3_c20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAndStockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--InvestorsMember_zV6quylOw2Pi" title="Loan discount">19</span> was recorded on the loan. The discount is amortized over the term of the loan as finance expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_893_ecustom--ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock_zP20iHwNx7s6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
allocation of the proceeds to the fair value distribution of the liability and equity components on the transactions date was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zImG6ykGWEy" style="display: none">SCHEDULE
OF FAIR VALUE DISTRIBUTION OF LIABILITY AND EQUITY COMPONENTS</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.75in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Instrument</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of total fair</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Allocated</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>amount</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan</span></td><td style="width: 2%; text-align: left">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShorttermDebtFairValue_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--LoanMember_zfKX63Ycl6z4" style="width: 16%; font-weight: bold; text-align: right" title="Fair Value">55,200</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_ecustom--PercentageOfFairValue_iI_pid_dp_c20201218__us-gaap--DebtInstrumentAxis__custom--LoanMember_ziI6Hx0s7e83" style="width: 16%; font-weight: bold; text-align: right" title="Percentage of fair value">49.45</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShortTermDebtAllocatedAmount_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--LoanMember_znFRCbAef7O9" style="width: 16%; font-weight: bold; text-align: right" title="Allocated amount">49,246</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShorttermDebtFairValue_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--SharesMember_zu34jF1re4Qh" style="font-weight: bold; text-align: right" title="Fair Value">54,000</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_ecustom--PercentageOfFairValue_iI_pid_dp_c20201218__us-gaap--DebtInstrumentAxis__custom--SharesMember_zT6kUDBqJd" style="font-weight: bold; text-align: right" title="Percentage of fair value">50.55</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShortTermDebtAllocatedAmount_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--SharesMember_zKuRD6y8MRH7" style="font-weight: bold; text-align: right" title="Allocated amount">50,340</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShorttermDebtFairValue_iI_pn3n3_c20201218_z1ADcZYu6lA1" style="font-weight: bold; text-align: right" title="Fair Value">109,200</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_ecustom--PercentageOfFairValue_iI_pid_dp_c20201218_zuJ05joCu2xj" style="font-weight: bold; text-align: right" title="Percentage of fair value">100</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_988_ecustom--ShortTermDebtAllocatedAmount_iI_pn3n3_c20201218_ziGh0AYVIIIg" style="font-weight: bold; text-align: right" title="Allocated amount">99,586</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AD_zmt6t7h4yKu4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89F_eus-gaap--ScheduleOfShortTermDebtTextBlock_za0dQ2sXMV14" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
composition of short term loan balance as of the transaction is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zhdp4aWkW9pl" style="display: none">SCHEDULE
OF COMPOSITION OF SHORT TERM LOAN</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%; margin-left: 0.75in">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20201218_zai3RvIgnCdc" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--ShortTermPrincipalAmount_iI_pn3n3_maSTBzbhn_zsKg6tmfKq9j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Principal amount</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 20%; text-align: right">69</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DiscountOnShortTermLoan_iI_pn3n3_msSTBzbhn_z0eoIF8V1V8c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Discount on Short term loan</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(19</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--ShortTermBorrowings_iTI_pn3n3_mtSTBzbhn_zIODnTMCyY82" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Short term loan, Net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">50</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A9_zi35FZNclEbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for short-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391436024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; DEFICIT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS&#8217; DEFICIT</a></td>
<td class="text"><p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zXj6Si7yFhRj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
6. <span id="xdx_820_zb1YbiCLo3S9">STOCKHOLDERS&#8217; DEFICIT</span>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ordinary
Shares:</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--CommonStockVotingRights_c20210101__20211231_zUWuSQLOJFs1" title="Common stock, voting rights">Ordinary
shares confer the right to: (i) participate in the general meetings, to one vote per share for any purpose, to an equal part, on share
basis, (ii) in distribution of dividends and (iii) to equally participate, on share basis, in distribution of excess of assets and funds
from the Company and they shall not confer other privileges unless stated hereunder or in the Companies Law otherwise. Some investors
have standard anti-dilutive rights, registration rights, and information and representation rights.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 18, 2020, the company entered into a Stock Subscription Agreement (the &#8220;Subscription&#8221;) with certain investors (the
&#8220;Investors&#8221;) in connection with the sale and issuance of an aggregate of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zg4pukFEKggb" title="Number of share issued">3,000,000</span> shares of Common Stock, at a purchase
price of $<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zKyqnMBcKlVc" title="Sale of stock, price per share">0.01</span> per share, and for an aggregate purchase price of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zXDggJF3liJb" title="Stock issued during period value">30,000</span>. In accordance with the terms of the Loan, the company repaid
the interest on the Principal Amount <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20201218__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zm0qg0lP3LUk" title="Debt instrument interest rate">8</span>% compounded annually to the Investors in the form of an issuance of an aggregate of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zRbMmrGpIWG1" title="Number of share issued">552,000</span> shares
of Common Stock, at a price per share of $<span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20201218__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zIrNxnrF1tv6" title="Sale of stock, price per share">0.01</span>. The shares of Common Stock were issued to the Investors pursuant to Regulation S of the
Securities Act of 1933, as amended. For more details, please see note 1c.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zccM6tKvs1Bj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes information of outstanding warrants as of December 31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zrVZiiruvAs1" style="display: none">SUMMARY OF OUTSTANDING WARRANTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrant Term</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 22%; text-align: left">Class J Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zrl8C6d2l38h" style="width: 16%; text-align: right" title="Warrants">3,649,318</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 16%; text-align: right"><span id="xdx_907_ecustom--WarrantTerm_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zWfllLCfmrV9" title="Warrant Term">July 2029</span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zT6hlD65nrpe" style="width: 16%; text-align: right" title="Exercise Price">0.48</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_ecustom--WarrantExercisable_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zxVMLW21XTb5" style="width: 16%; text-align: right" title="Exercisable">3,649,318</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Class K Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zxZZJ6hPxAHj" style="text-align: right" title="Warrants">3,649,318</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_90D_ecustom--WarrantTerm_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_z5cdcogI2Dpf" title="Warrant Term">July 2029</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zGug9JiAUcD7" style="text-align: right" title="Exercise Price">0.80</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--WarrantExercisable_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zziS5An11jql" style="text-align: right" title="Exercisable">3,649,318</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A4_z6G7X9RSxl2i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
in connection with the Share Exchange Agreement, upon the earlier of: (a) the launch of a live video product to an American consumer
in the United States by Viewbix Israel, or (b) the launch of an interactive television product to an American consumer in the United
States by Viewbix Israel, the Company will issue to Gix an additional <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20201217__20201218__dei--LegalEntityAxis__custom--GixLtdMember_zW7kAtmAnN8i" title="Number of restricted common stock shares issued">1,642,193</span> shares of restricted common stock of the Company. All
of the Company&#8217;s warrants meet the US GAAP criteria for equity classification. During 2020, <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--ClassHWarrantsMember_z3HuFfxJR8p7" title="Number of warrants expired during period">50,000</span> class H warrants , <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--ClassIWarrantsMember_z2DpczWovEJl" title="Number of warrants expired during period">38,095</span> class
I warrants and <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--ClassGWarrantsMember_zt9opza6H1V5" title="Number of warrants expired during period">142,857</span> Class G warrants expired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391546200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUES</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--RevenueFromContractWithCustomerTextBlock_zVSFdCfTNhqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
7. <span id="xdx_822_z9kqclCBqFM3">REVENUES</span>. </b></span></p>

<p id="xdx_890_eus-gaap--DisaggregationOfRevenueTableTextBlock_z9fAgJq5bob1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8BD_zTSY7UYpc1d9" style="display: none">SCHEDULE OF REVENUES</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Individual Subscriptions</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210101__20211231__srt--ProductOrServiceAxis__custom--IndividualSubscriptionsMember_zgRpownWfmO8" style="width: 16%; text-align: right" title="Revenues">10</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__custom--IndividualSubscriptionsMember_pn3n3" style="width: 16%; text-align: right" title="Revenues">13</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Enterprise Subscriptions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210101__20211231__srt--ProductOrServiceAxis__custom--EnterpriseSubscriptionsMember_zImVzQwHevPd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">31</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__custom--EnterpriseSubscriptionsMember_pn3n3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">83</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210101__20211231_zLJeKw9kpbxj" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">41</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">96</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A7_zXnxewyXKoZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391437704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESEARCH AND DEVELOPMENT EXPENSES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">RESEARCH AND DEVELOPMENT EXPENSES</a></td>
<td class="text"><p id="xdx_808_eus-gaap--ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_zBBYmsbj4RPa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. <span id="xdx_827_z1PTDeJ3JAJg">RESEARCH AND DEVELOPMENT EXPENSES</span>. </b></span></p>

<p id="xdx_891_ecustom--ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_znRHXTH3Nl92" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8B7_zPjyxqKeCI5" style="display: none">SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Salaries and related expense</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_zliWUf4uKjLc" style="width: 16%; text-align: right" title="Research and development"><span style="-sec-ix-hidden: xdx2ixbrl0525">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ResearchAndDevelopmentExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_pn3n3" style="width: 16%; text-align: right" title="Research and development">55</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Subcontractors</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--SubcontractorsMember_zAFjFZbpJL2a" style="border-bottom: Black 1.5pt solid; text-align: right" title="Research and development">64</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--SubcontractorsMember_z6hzHijwkhBf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Research and development">53</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20210101__20211231_zOrZa5RGNRKf" style="border-bottom: Black 2.5pt double; text-align: right" title="Research and development expenses">64</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ResearchAndDevelopmentExpense_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Research and development expenses">108</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A2_zGjA47tFMeqj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 730<br> -URI http://asc.fasb.org/subtopic&amp;trid=2197926<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992388269032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SALES AND MARKTING EXPENSES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_DisclosureSalesAndMarktingExpensesAbstract', window );"><strong>Sales And Markting Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_SalesAndMarketingExpensesDisclosureTextBlock', window );">SALES AND MARKTING EXPENSES</a></td>
<td class="text"><p id="xdx_809_ecustom--SalesAndMarketingExpensesDisclosureTextBlock_zWwpG23gyqK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
9. <span id="xdx_822_zFidS2CnsnAb">SALES AND MARKTING EXPENSES</span>. </b></span></p>

<p id="xdx_894_ecustom--ScheduleOfSalesAndMarketingExpensesTableTextBlock_z4i5U5icqKJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8B4_zVXGfpuncWSj" style="display: none">SCHEDULE OF SALES AND MARKETING EXPENSES</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Salaries and related expense</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SellingAndMarketingExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_ztS7H3aV0YNj" style="width: 16%; text-align: right" title="Sales and marketing expenses"><span style="-sec-ix-hidden: xdx2ixbrl0541">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SellingAndMarketingExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_pn3n3" style="width: 16%; text-align: right" title="Sales and marketing expenses">7</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SellingAndMarketingExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--OtherMember_zrajO4n1V7ll" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sales and marketing expenses">2</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SellingAndMarketingExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--OtherMember_pn3n3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sales and marketing expenses">1</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SellingAndMarketingExpense_pn3n3_c20210101__20211231_zbni4G3gDIuj" style="border-bottom: Black 2.5pt double; text-align: right" title="Sales and marketing expenses">2</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SellingAndMarketingExpense_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Sales and marketing expenses">8</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AF_zHOfDjpvapX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_DisclosureSalesAndMarktingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_DisclosureSalesAndMarktingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_SalesAndMarketingExpensesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales and Marketing Expenses Disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_SalesAndMarketingExpensesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391437704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL AND ADMINISTRATIVE EXPENSES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract', window );"><strong>General And Administrative Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_GeneralAndAdministrativeExpensesDisclosureTextBlock', window );">GENERAL AND ADMINISTRATIVE EXPENSES</a></td>
<td class="text"><p id="xdx_803_ecustom--GeneralAndAdministrativeExpensesDisclosureTextBlock_zbAqzzgNhD0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -68.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
10. <span id="xdx_82F_zL6gfEEaNEph">GENERAL AND ADMINISTRATIVE EXPENSES</span>. </b></span></p>

<p id="xdx_89B_ecustom--ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock_zEaN69G9yuA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -68.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zMqHY6TgQw99" style="display: none">SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-size: 11pt; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20210101__20211231_zAZ2mliSYmT3" style="font-weight: bold; text-align: center">2021</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20200101__20201231_zmhcRID8cdU6" style="font-weight: bold; text-align: center">2020</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-size: 11pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-size: 11pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt; text-align: center">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt; text-align: center">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt; text-align: center">&#160;</td><td style="font-size: 11pt">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LaborAndRelatedExpense_maGAAEzPpY_zQOJZP2z8m7c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-left: 5.4pt">Wages, salaries and related expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">140</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">214</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ProfessionalFees_maGAAEzPpY_zc0ClPWTwc7g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">176</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--Depreciation_maGAAEzPpY_zVX3ifbAcxe5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Depreciation</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0563">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OtherGeneralAndAdministrativeExpense_maGAAEzPpY_zjDEsA4HkMah" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; padding-left: 5.4pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">42</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--GeneralAndAdministrativeExpense_iT_pn3n3_mtGAAEzPpY_zeqITNovxt82" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; font-size: 11pt; padding-left: 5.4pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    and administrative expenses</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">304</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">437</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A7_zmkCbEforcHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -68.05pt"><b>&#160;</b></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_GeneralAndAdministrativeExpensesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>General and Administrative Expenses Disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_GeneralAndAdministrativeExpensesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391529736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL EXPENSES (INCOME), NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_DisclosureFinancialExpensesIncomeNetAbstract', window );"><strong>Financial Expenses Income Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_FinancingIncomeExpensesTextBlock', window );">FINANCIAL EXPENSES (INCOME), NET</a></td>
<td class="text"><p id="xdx_802_ecustom--FinancingIncomeExpensesTextBlock_zBG0lVKmv1E3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
11. <span id="xdx_82D_zEi2bv2PU0pg">FINANCIAL EXPENSES (INCOME), NET</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></b></p>

<p id="xdx_89C_ecustom--ScheduleFinancingIncomeExpensesNetTableTextBlock_zYpwyV7G9z6i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;<span id="xdx_8BA_zVFOB9kDoaW" style="display: none">SCHEDULE
OF FINANCIAL (EXPENSES) INCOME, NET</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Bank fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231__us-gaap--CreditFacilityAxis__custom--BankFeesMember_zobzR3SUeKne" style="width: 16%; text-align: right" title="Financing (income) expenses, net">3</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231__us-gaap--CreditFacilityAxis__custom--BankFeesMember_zPkZh1iklpL" style="width: 16%; text-align: right" title="Financing (income) expenses, net">1</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exchange rate differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231__us-gaap--CreditFacilityAxis__custom--ExchangeRateDifferencesMember_zqa4iX1UmPFe" style="text-align: right" title="Financing (income) expenses, net">(1</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231__us-gaap--CreditFacilityAxis__custom--ExchangeRateDifferencesMember_zPlbcOUnCZ28" style="text-align: right" title="Financing (income) expenses, net">(14</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Interest expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231__us-gaap--CreditFacilityAxis__custom--InterestExpensesMember_zVEpoYWkl0I4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Financing (income) expenses, net">28</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231__us-gaap--CreditFacilityAxis__custom--InterestExpensesMember_zswxfj2aAOAh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Financing (income) expenses, net"><span style="-sec-ix-hidden: xdx2ixbrl0586">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231_zA9OXsD3KgS" style="border-bottom: Black 2.5pt double; text-align: right" title="Financing expenses (income), net">30</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231_zv4LOjkgX4zk" style="border-bottom: Black 2.5pt double; text-align: right" title="Financing expenses (income), net">(13</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A7_zhGq7Kv1uEt9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_DisclosureFinancialExpensesIncomeNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_DisclosureFinancialExpensesIncomeNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_FinancingIncomeExpensesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Income Expenses [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_FinancingIncomeExpensesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391437704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--IncomeTaxDisclosureTextBlock_zFHs1Da3HR4g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
12. <span id="xdx_82E_zu67r7UMr1ik">INCOME TAXES</span>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to income taxes under the Israeli and U.S. tax laws</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tax
rates applicable to the income of the Company:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Viewbix
Inc. is taxed according to U.S. tax laws. <span id="xdx_908_eus-gaap--IncomeTaxExaminationDescription_c20210101__20211231_zR1cNqgHN7Mk" title="Income tax examination description">On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the &#8220;Act&#8221;), which
among other provisions, reduced the U.S. corporate tax rate from 35% to 21%, effective January 1, 2018.Viewbix Israel and Israeli subsidiaries
are taxed according to Israeli tax laws.</span> The Israeli corporate tax rate is <span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_c20210101__20211231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zUnonec9e9hf" title="Corporate tax rate"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_c20200101__20201231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_z9kh0037ylf1" title="Corporate tax rate">23</span></span>% in the years 2021, 2020 and onwards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deferred
income taxes:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_892_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zdpdxmzeWya8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#8217;s deferred tax assets are
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zYDTPzqvw8Cd" style="display: none">SCHEDULE OF DEFERRED INCOME TAXES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.75in">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none">&#160;</td><td style="display: none; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49C_20211231_zsrOcfIccJT5" style="display: none; font-weight: bold; text-align: center">2021</td><td style="display: none; font-weight: bold">&#160;</td><td style="display: none; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49C_20201231_z2WokoXqd0Md" style="display: none; font-weight: bold; text-align: center">2020</td><td style="display: none; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_iI_pn3n3_maDTAOLz7uk_zKXf5q76a4J9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Deferred R&amp;D expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">167</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">114</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_maDTAOLz7uk_zSofonZhDJH4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating loss carryforward</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,055</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,256</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DifferencesBetweenTaxBasisAndCarryingValuesOfLoans_iI_pn3n3_maDTAOLz7uk_zlZRqYGItht1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Differences between tax basis and carrying values of loans <br/>(see notes 4
    and 5)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(184</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(18</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_mtDTAOLz7uk_zvzwlSFFD2b5" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">33,038</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">32,352</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsGross_iI_pn3n3_maDTANzK9I_zkejzdb3WPrb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net deferred tax asset before valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,230</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,072</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzK9I_zWWrvOpzvKH8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,230</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,072</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzK9I_zOpGXZvjhlSl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0620">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0621">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AE_zSqfHsMUoC4l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
12. INCOME TAXES. (Cont.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, the Company has provided valuation allowances of $<span id="xdx_909_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pn3n3_c20210101__20211231_zFZBbcDnlHJc" title="Valuation allowances, deferred tax assets">3,909</span> in respect of deferred tax assets resulting from tax loss
carryforward and other temporary differences. Management currently believes that because the Company has a history of losses, it is more
likely than not that the deferred tax regarding the loss carryforward and other temporary differences will not be realized in the foreseeable
future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Available
carryforward tax losses:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, Viewbix Israel incurred operating losses in Israel of approximately $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20211231__us-gaap--IncomeStatementLocationAxis__custom--ViewbixIsraelMember_zzuPrEmrnGB9" title="Operating loss carryforwards">14,624</span> which may be carried forward and offset
against taxable income in the future for an indefinite period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021 the Company generated net operating losses in the U.S. of approximately $<span id="xdx_90A_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20211231__srt--StatementGeographicalAxis__country--US_z5W6h3WCd6Qc" title="Operating loss carryforwards">18,615</span> <span id="xdx_90F_eus-gaap--IncomeTaxExaminationDescription_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_z46VBCwh4JY4" title="Income tax examination description">Net operating losses in the U.S.
are available through 2035.</span> Utilization of U.S. net operating losses may be subject to substantial annual limitation due to the &#8220;change
in ownership&#8221; provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in
the expiration of net operating losses before utilization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_895_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zosicShTX6t5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss
from continuing operations, before taxes on income, consists of the following:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zmHjQOwPMaa2" style="display: none">SCHEDULE OF LOSS (INCOME) FROM CONTINUING OPERATIONS, BEFORE TAXES ON INCOME</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">USA</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zVnolIGZwVTc" style="width: 16%; text-align: right" title="Total loss before taxes on income">164</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zIVBw2hl00Ik" style="width: 16%; text-align: right" title="Total loss before taxes on income">65</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Israel</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zB1yXc9iqkOd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total loss before taxes on income">220</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_ztMaWEjR5s1f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total loss before taxes on income">376</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20210101__20211231_zxNRkT9b7U1e" style="border-bottom: Black 2.5pt double; text-align: right" title="Total loss before taxes on income">384</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20200101__20201231_zxRjGkRQRXR8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total loss before taxes on income">441</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A3_zx4VNY24DFUg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992388269032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOSS PER SHARE-BASIC AND DILUTED<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">LOSS PER SHARE-BASIC AND DILUTED</a></td>
<td class="text"><p id="xdx_807_eus-gaap--EarningsPerShareTextBlock_zloGIVs67Un6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
13. <span id="xdx_822_zHuUie6lRNv5">LOSS PER SHARE-BASIC AND DILUTED</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Composition:</b></span></p>

<p id="xdx_899_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zUKTfWJQj9V2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8BD_zMZyTVCSIeb4" style="display: none">SCHEDULE OF LOSS PER SHARE-BASIC AND DILUTED</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in">
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended December 31</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-size: 11pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; width: 60%; font-weight: bold; text-align: left">Net loss attributable to ordinary stockholders</td><td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20210101__20211231_zjW4NEGZ1iP9" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Net loss attributable to ordinary stockholders">386</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20200101__20201231_zsEM81j00iQc" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Net loss attributable to ordinary stockholders">443</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Weighted-average ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20210101__20211231_zkxW0dRbDh3b" style="text-align: right" title="Weighted-average ordinary shares">34,753,669</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20200101__20201231_zhI5LPxGTgjf" style="text-align: right" title="Weighted-average ordinary shares">31,201,669</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">Loss per share-basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20210101__20211231_zPhJIGOAsdk2" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss per share-basic and diluted">0.011</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200101__20201231_zb8UYTUc6Xq8" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss per share-basic and diluted">0.014</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A1_zqk4oAGz3Zy8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391437704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COVID-19 PANDEMIC IMPLICATIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualRisksAndUncertaintiesTextBlock', window );">COVID-19 PANDEMIC IMPLICATIONS</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--UnusualRisksAndUncertaintiesTextBlock_zoJaaR3xEK6h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
14. <span id="xdx_821_zUYpnaqMDd2g">COVID-19 PANDEMIC IMPLICATIONS</span>.</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
COVID-19 pandemic which originated in China in late 2019, has resulted in a widespread health crisis that has adversely affected businesses,
economies and financial markets worldwide, placed constraints on the operations of businesses, decreased consumer mobility and activity,
and caused significant economic volatility in the United States, Israel and international capital markets. The COVID-19 pandemic has
caused an economic recession, high unemployment rates and other disruptions, both in the United States, Israel and the rest of the world.
The Company is actively monitoring the pandemic and is taking any necessary measures to respond to the situation in cooperation with
the various stakeholders. Due to the uncertainty surrounding the COVID-19 pandemic, the Company will continue to assess the situation,
including government-imposed restrictions, market by market. The COVID-19 pandemic has not yet currently adversely affected our business,
however, it is not possible at this time to estimate the full impact that the COVID-19 pandemic, the continued spread of COVID-19, and
any additional measures taken by governments, health officials or by the Company in response to such spread, could have on the Company&#8217;s
business, results of operations and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualRisksAndUncertaintiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of the unusual risk or uncertainty, if estimable, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualRisksAndUncertaintiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391529736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zL1eT7AiJfbh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
15. <span id="xdx_828_zNSmj9f7p7r4">SUBSEQUENT EVENTS</span>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Loan
Agreement </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2022, the Investors under the Loan Agreement expressed their intention to convert the Principal Amount to the Company&#8217;s
shares of Common Stock, and accordingly, the Company agreed to extend the repayment date (see note 5).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Gix
Merger</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.5pt; text-align: justify; text-indent: 35.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 5, 2021, the Company entered into the Merger Agreement with Gix Media and Merger Sub, pursuant to which, following the Gix Merger,
and upon satisfaction of additional closing conditions, Merger Sub will merge with and into Gix Media, with Gix Media being the surviving
entity and wholly-owned subsidiary of the Company. As of the reporting date, the closing conditions of the Merger Agreement have not
been fulfilled yet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms and conditions of the Merger Agreement, at the Merger Effective Date (as defined in the Merger Agreement) all outstanding
ordinary shares of Gix Media, having no par value (the &#8220;Gix Media Shares&#8221;) will be converted into shares of Common Stock,
such that immediately following the Gix Merger, holders of Gix Media Shares will hold 90% of the Company&#8217;s capital stock on a fully
diluted basis. The Merger Agreement contains customary representations, warranties and covenants made by each of the Company, Gix Media
and Merger Sub.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 21, 2021, the shareholders of each of Gix Media and Merger Sub approved the Merger Agreement. Consummation of the Gix Merger
is subject to certain additional closing conditions, including, among other things, (i) the Company filing an amendment to its certificate
of incorporation to change the Company&#8217;s name to &#8220;Gix Media, Inc.&#8221;, (ii) obtaining approval from certain third parties,
including the approval of Bank Leumi due to certain liens registered in its favor against ordinary shares of Gix Media; (iii) conversion
of the Company&#8217;s outstanding convertible instruments into restricted shares of Common Stock and (iv) obtaining a tax pre-ruling
from the Israeli Tax Authority relating to the Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
15. SUBSEQUENT EVENTS. (Cont.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reverse
Stock Split</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Gix Merger, on February 13, 2022, the requisite majority of the Company&#8217;s stockholders approved certain amendments
to the Company&#8217;s certificate of incorporation, including, but not limited to (i) a name change from &#8220;Viewbix Inc.&#8221;
to &#8220;Gix Media, Inc.&#8221;, (ii) a reverse stock split of the Company&#8217;s common Stock at a ratio of 1-for-28 (the &#8220;Planned
Reverse Split&#8221;), (iii) a staggered board structure, and (iv) certain other provisions therein. Pursuant to the Planned Reverse
Stock Split, each twenty-eight (28) shares of the Company&#8217;s common stock will be automatically converted, without any further action
by the stockholders, into one share of the Company&#8217;s common stock. No fractional shares will be issued as the result of the reverse
stock split. Instead, each stockholder will be entitled to receive one share of common stock in lieu of the fractional share that would
have resulted from the reverse stock split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company intends to effect the foregoing amended and restated certificate of incorporation upon the closing of the Gix Merger, thus, as
of the reporting date the Planned Reverse Stock Split has not been effected.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992385226216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Functional currency</a></td>
<td class="text"><p id="xdx_843_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z8u2fRxegkM8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zABgu1YTrjAe">Functional
currency</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency of the Company and its subsidiary is the US dollar, which is the currency of the primary economic environment in
which it operates. In accordance with ASC 830, &#8220;Foreign Currency Matters&#8221; (ASC 830), balances denominated in or linked to
foreign currency are stated on the basis of the exchange rates prevailing at the applicable balance sheet date. For foreign currency
transactions included in the statement of operations, the exchange rates applicable on the relevant transaction dates are used. Gains
or losses arising from changes in the exchange rates used in the translation of such transactions are carried as financing income or
expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation</a></td>
<td class="text"><p id="xdx_843_eus-gaap--ConsolidationPolicyTextBlock_zWIVxEVqvyGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zF0sRCmT9cMf">Principles
of consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions
have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zU395BzqCbJa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zOyekG7dtEt">Cash
and cash equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments, which are highly liquid investments with original maturities of three months or less at
the date of purchase, to be cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair value of financial instruments</a></td>
<td class="text"><p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z2144j3oOJo9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zdHyj5mquz4j">Fair
value of financial instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying values of Company&#8217;s financial assets and liabilities, including cash and cash equivalents, restricted cash, other current
assets, trade payables, other accounts payable and financing provided by the Parent Company approximate their fair value due to the short-term
maturity of these instruments.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings per Common Share</a></td>
<td class="text"><p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zALgsAM7Kom8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zYaa53tWN7G3">Earnings
per Common Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnings
or loss per share (&#8220;EPS&#8221;) is the amount of earnings attributable to each share of common stock. For convenience, the term
is used to refer to either earnings or loss per share. EPS is computed pursuant to ASC 260-10-45. Pursuant to ASC 260-10-45-10 through
260-10-45-16 Basic EPS is computed by dividing income available to common stockholders (the numerator) by the weighted-average number
of common shares outstanding (the denominator) during the period. Income available to common stockholders shall be computed by deducting
both the dividends declared in the period on preferred stock (whether or not paid) from income from continuing operations (if that amount
appears in the income statement) and also from net income. The computation of diluted EPS is similar to the computation of basic EPS
except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive
potential common shares had been issued during the period to reflect the potential dilution that could occur from common shares issuable
through contingent shares issuance arrangement, stock options or warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><p id="xdx_841_eus-gaap--RevenueRecognitionPolicyTextBlock_zTTIQXV8EIAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zwIXj4YsWLXd">Revenue
recognition</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company applies the provisions of Accounting Standards Codification (or &#8220;ASC&#8221;) 606, Revenue from Contracts with Customers
(&#8220;ASC 606&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generates revenues primarily by granting customers the right to access software products through the Company&#8217;s cloud-based
SaaS subscription offerings. Under a SaaS subscription agreement, the customer receives a right to access the software for a specified
period of time in an environment hosted, supported, and maintained by the Company. SaaS subscription services are a single performance
obligation satisfied over time, and associated revenue is generally recognized ratably over the contract term once the software is made
available to the customer. The SaaS subscription offerings are typically sold with one year subscription terms, generally invoiced in
advance of each annual subscription period, and are non-cancelable during the committed subscription term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and development expenses</a></td>
<td class="text"><p id="xdx_844_eus-gaap--ResearchAndDevelopmentExpensePolicy_zrXrW15X3k2b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zHlpbKqblnE8">Research
and development expenses</span>:</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses are charged to the statement of operations as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zu38Kn7CfP2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zm1DvLcbIr47">Income
Taxes</span>: </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221;, and (&#8220;ASC 740&#8221;). ASC 740 prescribes
the use of the asset and liability method whereby deferred tax asset and liability account balances are determined based on differences
between the financial reporting and tax bases of assets and liabilities and for carry forward tax losses. Deferred taxes are measured
using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation
allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more-likely-than-not that some portion
or all of the deferred tax asset will not be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, ASC 740 prescribes a recognition threshold and measurement attribute for financial statement recognition and measurement of
a tax position taken or expected to be taken in a tax return. The first step is to evaluate the tax position taken or expected to be
taken in a tax return. This is done by determining if the weight of available evidence indicates that it is more-likely-than-not that,
on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or
litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized
upon ultimate settlement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingencies</a></td>
<td class="text"><p id="xdx_847_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zZ0pKrPRYT6f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_z5dK3ZP8hw4a">Contingencies</span>:</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records accruals for loss contingencies arising from claims, litigation and other sources when it is probable that a liability
has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional
information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_AccountingForIncomeTaxesPolicyTextBlock', window );">Accounting for Income Taxes</a></td>
<td class="text"><p id="xdx_844_ecustom--AccountingForIncomeTaxesPolicyTextBlock_zjmjQETEN3e4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zDRXD9iLeyq8">Accounting
for Income Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the Financial Accounting Standards Board issued Accounting Standards Update No. ASU 2019-12, &#8220;Simplifying the Accounting
for Income Taxes&#8221;. This ASU amends Accounting Standards Codification (&#8220;ASC&#8221;) 740 by removing certain exceptions to
the general principles, clarifying and amending existing guidance. This guidance is effective for fiscal years, and interim periods within
those years, beginning after December 15, 2020. The Company adopted this standard in the first quarter of 2021. The adoption of this
ASU did not impact our financial statements or the related disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently issued accounting pronouncements</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z8XkxIbzyaq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zWWOGKRXH013">Recently
issued accounting pronouncements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financial
Instruments &#8211; Credit Losses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU 2016-13, &#8220;Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses
on Financial Instruments&#8221; (&#8220;ASU 2016-13&#8221;). ASU 2016-13 replaces the current incurred loss model guidance with a new
method that reflects expected credit losses. Under this guidance, an entity would recognize an allowance for credit losses equal to its
estimate of expected credit losses on financial assets measured at amortized cost. In November 2019, the FASB extended the effective
date of ASU 2016-13 for smaller reporting companies. As a result, ASU 2016-13 is effective for fiscal years, and interim periods within
those years, beginning after December 15, 2022, with early adoption permitted. The standard is not expected to have a significant impact
on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Convertible
instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU 2020-06, &#8220;Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an
Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020-06&#8221;). ASU 2020-06 simplifies the accounting for convertible instruments by removing
certain separation models in Accounting Standards Codification (&#8220;ASC&#8221;) 470-20, &#8220;Debt&#8212;Debt with Conversion and
Other Options,&#8221; (&#8220;ASC 470-20&#8221;) for convertible instruments. Under ASU 2020-06, the embedded conversion features no
longer are separated from the host contract for convertible instruments with conversion features that are not required to be accounted
for as derivatives under ASC 815, &#8220;Derivatives and Hedging,&#8221; or that do not result in substantial premiums accounted for
as paid-in capital. For smaller reporting companies, ASU 2020-06 is effective for fiscal years, and interim periods within those years,
beginning after December 15, 2023, with early adoption permitted for fiscal years beginning after December 15, 2020. The Company is currently
assessing the impact of this update on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
Inc. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combination</a></td>
<td class="text"><p id="xdx_842_eus-gaap--BusinessCombinationsPolicy_z6fsBtAckgu6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zSoqJjhN1eKi">Business
Combination</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 28, 2021, the FASB issued ASU 2021-08, which amends ASC 805 to &#8220;require acquiring entities to apply Topic 606 to recognize
and measure contract assets and contract liabilities in a business combination.&#8221; Under current GAAP, an acquirer generally recognizes
such items at fair value on the acquisition date. According to the FASB, this Update is intended &#8220;to improve the accounting for
acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to
the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognition
    of an acquired contract liability</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    terms and their effect on subsequent revenue recognized by the acquirer.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU
2021-08 06 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. We are
currently assessing the impact of this update on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_WarrantsPolicyTextBlock', window );">Warrants</a></td>
<td class="text"><p id="xdx_846_ecustom--WarrantsPolicyTextBlock_zaRYrHScf6C6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zN5Z9W9Um9we">Warrants</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2021, the Financial Accountings Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2021-04,
&#8220;Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock Compensation
(Topic 718), and Derivatives and Hedging&#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815- 40): Issuer&#8217;s Accounting
for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#8221; (&#8220;ASU 2021-04&#8221;). The
guidance is effective for the Company on January 1, 2022. The Company is currently evaluating the impact of adopting this standard</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_AccountingForIncomeTaxesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounting for Income Taxes [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_AccountingForIncomeTaxesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_WarrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_WarrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391457960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">SCHEDULE OF OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z1M5EfCDeLU7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zV75WJRXJqXe" style="display: none">SCHEDULE
OF OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.75in">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20211231_zmk9zKpfhTSg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December 30</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20201231_zMw2grzwuErb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccountsPayableOtherCurrentAndNoncurrent_iI_pn3n3_maAPAOAzuqS_maAPAALzlaq_zekjjQrtE8Fd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Other payables and deferred revenues</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">47</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">47</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_maAPAOAzuqS_maAPAALzlaq_zfDN0dsWAzH8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Accrued liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">195</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">130</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iTI_pn3n3_mtAPAALzlaq_zypBjA2JqmF7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total other accounts payables</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">242</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">177</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992388265400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">SCHEDULE OF RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zuPoz1REKY68" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_z1V8nzkQ1l1e" style="display: none">SCHEDULE
OF RELATED PARTY TRANSACTIONS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.75in">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_493_20211231_zOlW66snZtld" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31,</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49E_20201231_zpCMj8kd8cEd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31,</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DueToAffiliateCurrent_iI_pn3n3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gix
    &#8211; Company Payable</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,116</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,054</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992385446008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHORT TERM LOAN AND ISSUES OF SHARES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock', window );">SCHEDULE OF FAIR VALUE DISTRIBUTION OF LIABILITY AND EQUITY COMPONENTS</a></td>
<td class="text"><p id="xdx_893_ecustom--ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock_zP20iHwNx7s6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
allocation of the proceeds to the fair value distribution of the liability and equity components on the transactions date was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zImG6ykGWEy" style="display: none">SCHEDULE
OF FAIR VALUE DISTRIBUTION OF LIABILITY AND EQUITY COMPONENTS</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.75in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Instrument</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of total fair</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Allocated</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>amount</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan</span></td><td style="width: 2%; text-align: left">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShorttermDebtFairValue_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--LoanMember_zfKX63Ycl6z4" style="width: 16%; font-weight: bold; text-align: right" title="Fair Value">55,200</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_ecustom--PercentageOfFairValue_iI_pid_dp_c20201218__us-gaap--DebtInstrumentAxis__custom--LoanMember_ziI6Hx0s7e83" style="width: 16%; font-weight: bold; text-align: right" title="Percentage of fair value">49.45</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShortTermDebtAllocatedAmount_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--LoanMember_znFRCbAef7O9" style="width: 16%; font-weight: bold; text-align: right" title="Allocated amount">49,246</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShorttermDebtFairValue_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--SharesMember_zu34jF1re4Qh" style="font-weight: bold; text-align: right" title="Fair Value">54,000</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_ecustom--PercentageOfFairValue_iI_pid_dp_c20201218__us-gaap--DebtInstrumentAxis__custom--SharesMember_zT6kUDBqJd" style="font-weight: bold; text-align: right" title="Percentage of fair value">50.55</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShortTermDebtAllocatedAmount_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--SharesMember_zKuRD6y8MRH7" style="font-weight: bold; text-align: right" title="Allocated amount">50,340</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShorttermDebtFairValue_iI_pn3n3_c20201218_z1ADcZYu6lA1" style="font-weight: bold; text-align: right" title="Fair Value">109,200</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_ecustom--PercentageOfFairValue_iI_pid_dp_c20201218_zuJ05joCu2xj" style="font-weight: bold; text-align: right" title="Percentage of fair value">100</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_988_ecustom--ShortTermDebtAllocatedAmount_iI_pn3n3_c20201218_ziGh0AYVIIIg" style="font-weight: bold; text-align: right" title="Allocated amount">99,586</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">SCHEDULE OF COMPOSITION OF SHORT TERM LOAN</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--ScheduleOfShortTermDebtTextBlock_za0dQ2sXMV14" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
composition of short term loan balance as of the transaction is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zhdp4aWkW9pl" style="display: none">SCHEDULE
OF COMPOSITION OF SHORT TERM LOAN</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%; margin-left: 0.75in">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20201218_zai3RvIgnCdc" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--ShortTermPrincipalAmount_iI_pn3n3_maSTBzbhn_zsKg6tmfKq9j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Principal amount</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 20%; text-align: right">69</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DiscountOnShortTermLoan_iI_pn3n3_msSTBzbhn_z0eoIF8V1V8c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Discount on Short term loan</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(19</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--ShortTermBorrowings_iTI_pn3n3_mtSTBzbhn_zIODnTMCyY82" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Short term loan, Net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">50</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of fair value distribution of liability and equity components on transactions date [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391504040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; DEFICIT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">SUMMARY OF OUTSTANDING WARRANTS</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zccM6tKvs1Bj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes information of outstanding warrants as of December 31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zrVZiiruvAs1" style="display: none">SUMMARY OF OUTSTANDING WARRANTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrant Term</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 22%; text-align: left">Class J Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zrl8C6d2l38h" style="width: 16%; text-align: right" title="Warrants">3,649,318</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 16%; text-align: right"><span id="xdx_907_ecustom--WarrantTerm_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zWfllLCfmrV9" title="Warrant Term">July 2029</span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zT6hlD65nrpe" style="width: 16%; text-align: right" title="Exercise Price">0.48</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_ecustom--WarrantExercisable_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zxVMLW21XTb5" style="width: 16%; text-align: right" title="Exercisable">3,649,318</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Class K Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zxZZJ6hPxAHj" style="text-align: right" title="Warrants">3,649,318</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_90D_ecustom--WarrantTerm_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_z5cdcogI2Dpf" title="Warrant Term">July 2029</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zGug9JiAUcD7" style="text-align: right" title="Exercise Price">0.80</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--WarrantExercisable_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zziS5An11jql" style="text-align: right" title="Exercisable">3,649,318</td><td style="text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391564312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">SCHEDULE OF REVENUES</a></td>
<td class="text"><p id="xdx_890_eus-gaap--DisaggregationOfRevenueTableTextBlock_z9fAgJq5bob1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8BD_zTSY7UYpc1d9" style="display: none">SCHEDULE OF REVENUES</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Individual Subscriptions</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210101__20211231__srt--ProductOrServiceAxis__custom--IndividualSubscriptionsMember_zgRpownWfmO8" style="width: 16%; text-align: right" title="Revenues">10</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__custom--IndividualSubscriptionsMember_pn3n3" style="width: 16%; text-align: right" title="Revenues">13</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Enterprise Subscriptions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210101__20211231__srt--ProductOrServiceAxis__custom--EnterpriseSubscriptionsMember_zImVzQwHevPd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">31</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__custom--EnterpriseSubscriptionsMember_pn3n3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">83</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210101__20211231_zLJeKw9kpbxj" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">41</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">96</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992392935864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESEARCH AND DEVELOPMENT EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock', window );">SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES</a></td>
<td class="text"><p id="xdx_891_ecustom--ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_znRHXTH3Nl92" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8B7_zPjyxqKeCI5" style="display: none">SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Salaries and related expense</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_zliWUf4uKjLc" style="width: 16%; text-align: right" title="Research and development"><span style="-sec-ix-hidden: xdx2ixbrl0525">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ResearchAndDevelopmentExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_pn3n3" style="width: 16%; text-align: right" title="Research and development">55</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Subcontractors</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--SubcontractorsMember_zAFjFZbpJL2a" style="border-bottom: Black 1.5pt solid; text-align: right" title="Research and development">64</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--SubcontractorsMember_z6hzHijwkhBf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Research and development">53</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20210101__20211231_zOrZa5RGNRKf" style="border-bottom: Black 2.5pt double; text-align: right" title="Research and development expenses">64</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ResearchAndDevelopmentExpense_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Research and development expenses">108</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Research And Development Expenses [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391497272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SALES AND MARKTING EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_DisclosureSalesAndMarktingExpensesAbstract', window );"><strong>Sales And Markting Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_ScheduleOfSalesAndMarketingExpensesTableTextBlock', window );">SCHEDULE OF SALES AND MARKETING EXPENSES</a></td>
<td class="text"><p id="xdx_894_ecustom--ScheduleOfSalesAndMarketingExpensesTableTextBlock_z4i5U5icqKJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8B4_zVXGfpuncWSj" style="display: none">SCHEDULE OF SALES AND MARKETING EXPENSES</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Salaries and related expense</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SellingAndMarketingExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_ztS7H3aV0YNj" style="width: 16%; text-align: right" title="Sales and marketing expenses"><span style="-sec-ix-hidden: xdx2ixbrl0541">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SellingAndMarketingExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_pn3n3" style="width: 16%; text-align: right" title="Sales and marketing expenses">7</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SellingAndMarketingExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--OtherMember_zrajO4n1V7ll" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sales and marketing expenses">2</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SellingAndMarketingExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--OtherMember_pn3n3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sales and marketing expenses">1</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SellingAndMarketingExpense_pn3n3_c20210101__20211231_zbni4G3gDIuj" style="border-bottom: Black 2.5pt double; text-align: right" title="Sales and marketing expenses">2</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SellingAndMarketingExpense_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Sales and marketing expenses">8</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_DisclosureSalesAndMarktingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_DisclosureSalesAndMarktingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_ScheduleOfSalesAndMarketingExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Sales and Marketing Expenses [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_ScheduleOfSalesAndMarketingExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391543912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL AND ADMINISTRATIVE EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract', window );"><strong>General And Administrative Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock', window );">SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES</a></td>
<td class="text"><p id="xdx_89B_ecustom--ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock_zEaN69G9yuA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -68.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zMqHY6TgQw99" style="display: none">SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-size: 11pt; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20210101__20211231_zAZ2mliSYmT3" style="font-weight: bold; text-align: center">2021</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20200101__20201231_zmhcRID8cdU6" style="font-weight: bold; text-align: center">2020</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-size: 11pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-size: 11pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt; text-align: center">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt; text-align: center">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt; text-align: center">&#160;</td><td style="font-size: 11pt">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LaborAndRelatedExpense_maGAAEzPpY_zQOJZP2z8m7c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-left: 5.4pt">Wages, salaries and related expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">140</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">214</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ProfessionalFees_maGAAEzPpY_zc0ClPWTwc7g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">176</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--Depreciation_maGAAEzPpY_zVX3ifbAcxe5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Depreciation</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0563">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OtherGeneralAndAdministrativeExpense_maGAAEzPpY_zjDEsA4HkMah" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; padding-left: 5.4pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">42</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--GeneralAndAdministrativeExpense_iT_pn3n3_mtGAAEzPpY_zeqITNovxt82" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; font-size: 11pt; padding-left: 5.4pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    and administrative expenses</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">304</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">437</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of General and Administrative Expenses [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391528072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL EXPENSES (INCOME), NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_DisclosureFinancialExpensesIncomeNetAbstract', window );"><strong>Financial Expenses Income Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_ScheduleFinancingIncomeExpensesNetTableTextBlock', window );">SCHEDULE OF FINANCIAL (EXPENSES) INCOME, NET</a></td>
<td class="text"><p id="xdx_89C_ecustom--ScheduleFinancingIncomeExpensesNetTableTextBlock_zYpwyV7G9z6i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;<span id="xdx_8BA_zVFOB9kDoaW" style="display: none">SCHEDULE
OF FINANCIAL (EXPENSES) INCOME, NET</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Bank fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231__us-gaap--CreditFacilityAxis__custom--BankFeesMember_zobzR3SUeKne" style="width: 16%; text-align: right" title="Financing (income) expenses, net">3</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231__us-gaap--CreditFacilityAxis__custom--BankFeesMember_zPkZh1iklpL" style="width: 16%; text-align: right" title="Financing (income) expenses, net">1</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exchange rate differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231__us-gaap--CreditFacilityAxis__custom--ExchangeRateDifferencesMember_zqa4iX1UmPFe" style="text-align: right" title="Financing (income) expenses, net">(1</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231__us-gaap--CreditFacilityAxis__custom--ExchangeRateDifferencesMember_zPlbcOUnCZ28" style="text-align: right" title="Financing (income) expenses, net">(14</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Interest expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231__us-gaap--CreditFacilityAxis__custom--InterestExpensesMember_zVEpoYWkl0I4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Financing (income) expenses, net">28</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231__us-gaap--CreditFacilityAxis__custom--InterestExpensesMember_zswxfj2aAOAh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Financing (income) expenses, net"><span style="-sec-ix-hidden: xdx2ixbrl0586">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231_zA9OXsD3KgS" style="border-bottom: Black 2.5pt double; text-align: right" title="Financing expenses (income), net">30</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231_zv4LOjkgX4zk" style="border-bottom: Black 2.5pt double; text-align: right" title="Financing expenses (income), net">(13</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_DisclosureFinancialExpensesIncomeNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_DisclosureFinancialExpensesIncomeNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_ScheduleFinancingIncomeExpensesNetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Financing Income (Expenses) [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_ScheduleFinancingIncomeExpensesNetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992478198568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">SCHEDULE OF DEFERRED INCOME TAXES</a></td>
<td class="text"><p id="xdx_892_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zdpdxmzeWya8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#8217;s deferred tax assets are
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zYDTPzqvw8Cd" style="display: none">SCHEDULE OF DEFERRED INCOME TAXES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.75in">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none">&#160;</td><td style="display: none; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49C_20211231_zsrOcfIccJT5" style="display: none; font-weight: bold; text-align: center">2021</td><td style="display: none; font-weight: bold">&#160;</td><td style="display: none; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49C_20201231_z2WokoXqd0Md" style="display: none; font-weight: bold; text-align: center">2020</td><td style="display: none; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_iI_pn3n3_maDTAOLz7uk_zKXf5q76a4J9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Deferred R&amp;D expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">167</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">114</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_maDTAOLz7uk_zSofonZhDJH4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating loss carryforward</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,055</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,256</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DifferencesBetweenTaxBasisAndCarryingValuesOfLoans_iI_pn3n3_maDTAOLz7uk_zlZRqYGItht1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Differences between tax basis and carrying values of loans <br/>(see notes 4
    and 5)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(184</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(18</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_mtDTAOLz7uk_zvzwlSFFD2b5" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">33,038</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">32,352</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsGross_iI_pn3n3_maDTANzK9I_zkejzdb3WPrb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net deferred tax asset before valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,230</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,072</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzK9I_zWWrvOpzvKH8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,230</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,072</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzK9I_zOpGXZvjhlSl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0620">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0621">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">SCHEDULE OF LOSS (INCOME) FROM CONTINUING OPERATIONS, BEFORE TAXES ON INCOME</a></td>
<td class="text"><p id="xdx_895_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zosicShTX6t5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss
from continuing operations, before taxes on income, consists of the following:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zmHjQOwPMaa2" style="display: none">SCHEDULE OF LOSS (INCOME) FROM CONTINUING OPERATIONS, BEFORE TAXES ON INCOME</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">USA</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zVnolIGZwVTc" style="width: 16%; text-align: right" title="Total loss before taxes on income">164</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zIVBw2hl00Ik" style="width: 16%; text-align: right" title="Total loss before taxes on income">65</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Israel</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zB1yXc9iqkOd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total loss before taxes on income">220</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_ztMaWEjR5s1f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total loss before taxes on income">376</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20210101__20211231_zxNRkT9b7U1e" style="border-bottom: Black 2.5pt double; text-align: right" title="Total loss before taxes on income">384</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20200101__20201231_zxRjGkRQRXR8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total loss before taxes on income">441</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992388242120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOSS PER SHARE-BASIC AND DILUTED (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">SCHEDULE OF LOSS PER SHARE-BASIC AND DILUTED</a></td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zUKTfWJQj9V2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8BD_zMZyTVCSIeb4" style="display: none">SCHEDULE OF LOSS PER SHARE-BASIC AND DILUTED</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in">
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended December 31</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-size: 11pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; width: 60%; font-weight: bold; text-align: left">Net loss attributable to ordinary stockholders</td><td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20210101__20211231_zjW4NEGZ1iP9" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Net loss attributable to ordinary stockholders">386</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20200101__20201231_zsEM81j00iQc" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Net loss attributable to ordinary stockholders">443</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Weighted-average ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20210101__20211231_zkxW0dRbDh3b" style="text-align: right" title="Weighted-average ordinary shares">34,753,669</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20200101__20201231_zhI5LPxGTgjf" style="text-align: right" title="Weighted-average ordinary shares">31,201,669</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">Loss per share-basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20210101__20211231_zPhJIGOAsdk2" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss per share-basic and diluted">0.011</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200101__20201231_zb8UYTUc6Xq8" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss per share-basic and diluted">0.014</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992383155976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENEREL (Details Narrative)<br> $ / shares in Units, &#8362; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 18, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 27, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 27, 2020 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Feb. 07, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 386<span></span>
</td>
<td class="nump">$ 443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,280<span></span>
</td>
<td class="nump">2,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash flows from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=VBIX_ShareExchangeAgreementMember', window );">Share Exchange Agreement [Member] | Viewbix Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.83%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=VBIX_StockSubscriptionAgreementMember', window );">Stock Subscription Agreement [Member] | Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of share issued | shares</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock issued during period value</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=VBIX_LoanAgreementMember', window );">Loan Agreement [Member] | Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of share issued | shares</a></td>
<td class="nump">552,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 69,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued, price per share | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=VBIX_VirtualCryptoIsraelMember', window );">Virtual Crypto Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,459<span></span>
</td>
<td class="nump">&#8362; 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=VBIX_ShareExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=VBIX_ShareExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=VBIX_ViewbixLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=VBIX_ViewbixLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=VBIX_StockSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=VBIX_StockSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=VBIX_LoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=VBIX_LoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=VBIX_VirtualCryptoIsraelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=VBIX_VirtualCryptoIsraelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992392072440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrentAndNoncurrent', window );">Other payables and deferred revenues</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Accrued liabilities</a></td>
<td class="nump">195<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Total other accounts payables</a></td>
<td class="nump">$ 242<span></span>
</td>
<td class="nump">$ 177<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred and payable classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391522520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF RELATED PARTY TRANSACTIONS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Gix &#8211; Company Payable</a></td>
<td class="nump">$ 2,116<span></span>
</td>
<td class="nump">$ 2,054<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992385229912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 13, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=VBIX_GixLoanMember', window );">Gix Loan [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt modification original debt, amount</a></td>
<td class="nump">$ 2,115,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion amount</a></td>
<td class="nump">$ 184,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=VBIX_GixLtdMember', window );">Gix Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_OperationsCostsIncurredPercentage', window );">Operations costs incurred, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_OperationsCostsIncurredPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operations costs incurred, percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_OperationsCostsIncurredPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=VBIX_GixLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=VBIX_GixLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=VBIX_GixLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=VBIX_GixLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992389450664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF FAIR VALUE DISTRIBUTION OF LIABILITY AND EQUITY COMPONENTS (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 18, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShorttermDebtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 109,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_PercentageOfFairValue', window );">Percentage of fair value</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_ShortTermDebtAllocatedAmount', window );">Allocated amount</a></td>
<td class="nump">$ 99,586<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=VBIX_LoanMember', window );">Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShorttermDebtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 55,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_PercentageOfFairValue', window );">Percentage of fair value</a></td>
<td class="nump">49.45%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_ShortTermDebtAllocatedAmount', window );">Allocated amount</a></td>
<td class="nump">$ 49,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=VBIX_SharesMember', window );">Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShorttermDebtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 54,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_PercentageOfFairValue', window );">Percentage of fair value</a></td>
<td class="nump">50.55%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_ShortTermDebtAllocatedAmount', window );">Allocated amount</a></td>
<td class="nump">$ 50,340<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_PercentageOfFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_PercentageOfFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_ShortTermDebtAllocatedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allocated amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_ShortTermDebtAllocatedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShorttermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShorttermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=VBIX_LoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=VBIX_LoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=VBIX_SharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=VBIX_SharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992383048552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF COMPOSITION OF SHORT TERM LOAN (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 18, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_ShortTermPrincipalAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_DiscountOnShortTermLoan', window );">Discount on Short term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short term loan, Net</a></td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_DiscountOnShortTermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount on Short term loan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_DiscountOnShortTermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_ShortTermPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short Term Principal Amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_ShortTermPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992389369800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHORT TERM LOAN AND ISSUES OF SHARES (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 18, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=VBIX_LoanAndStockSubscriptionAgreementMember', window );">Loan And Stock Subscription Agreement [Member] | Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 69,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=VBIX_LoanAndStockSubscriptionAgreementMember', window );">Loan And Stock Subscription Agreement [Member] | Investors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period, shares</a></td>
<td class="nump">552,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock issued price per share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Loan discount</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=VBIX_StockSubscriptionAgreementMember', window );">Stock Subscription Agreement [Member] | Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period, shares</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock issued price per share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=VBIX_StockSubscriptionAgreementMember', window );">Stock Subscription Agreement [Member] | Investors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">$ 30,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=VBIX_LoanAndStockSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=VBIX_LoanAndStockSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=VBIX_InvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=VBIX_InvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=VBIX_StockSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=VBIX_StockSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992388198584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF OUTSTANDING WARRANTS (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=VBIX_ClassJWarrantsMember', window );">Class J Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants</a></td>
<td class="nump">3,649,318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_WarrantTerm', window );">Warrant Term</a></td>
<td class="text">July 2029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise Price | $ / shares</a></td>
<td class="nump">$ 0.48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_WarrantExercisable', window );">Exercisable</a></td>
<td class="nump">3,649,318<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=VBIX_ClassKWarrantsMember', window );">Class K Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants</a></td>
<td class="nump">3,649,318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_WarrantTerm', window );">Warrant Term</a></td>
<td class="text">July 2029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise Price | $ / shares</a></td>
<td class="nump">$ 0.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_WarrantExercisable', window );">Exercisable</a></td>
<td class="nump">3,649,318<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_WarrantExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant Exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_WarrantExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_WarrantTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_WarrantTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=VBIX_ClassJWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=VBIX_ClassJWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=VBIX_ClassKWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=VBIX_ClassKWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992386212776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; DEFICIT (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 18, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common stock, voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Ordinary
shares confer the right to: (i) participate in the general meetings, to one vote per share for any purpose, to an equal part, on share
basis, (ii) in distribution of dividends and (iii) to equally participate, on share basis, in distribution of excess of assets and funds
from the Company and they shall not confer other privileges unless stated hereunder or in the Companies Law otherwise. Some investors
have standard anti-dilutive rights, registration rights, and information and representation rights.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=VBIX_ClassHWarrantsMember', window );">Class H Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations', window );">Number of warrants expired during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=VBIX_ClassIWarrantsMember', window );">Class I Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations', window );">Number of warrants expired during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,095<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=VBIX_ClassGWarrantsMember', window );">Class G Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations', window );">Number of warrants expired during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,857<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=VBIX_GixLtdMember', window );">Gix Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Number of restricted common stock shares issued</a></td>
<td class="nump">1,642,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=VBIX_StockSubscriptionAgreementMember', window );">Stock Subscription Agreement [Member] | Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of share issued</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock issued during period value</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=VBIX_LoanAgreementMember', window );">Loan Agreement [Member] | Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of share issued</a></td>
<td class="nump">552,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=VBIX_ClassHWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=VBIX_ClassHWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=VBIX_ClassIWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=VBIX_ClassIWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=VBIX_ClassGWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=VBIX_ClassGWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=VBIX_GixLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=VBIX_GixLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=VBIX_StockSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=VBIX_StockSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=VBIX_LoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=VBIX_LoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992383315176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF REVENUES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=VBIX_IndividualSubscriptionsMember', window );">Individual Subscriptions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=VBIX_EnterpriseSubscriptionsMember', window );">Enterprise Subscriptions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=VBIX_IndividualSubscriptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=VBIX_IndividualSubscriptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=VBIX_EnterpriseSubscriptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=VBIX_EnterpriseSubscriptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992383149512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 108<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=VBIX_SalariesandRelatedExpenseMember', window );">Salaries and Related Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=VBIX_SubcontractorsMember', window );">Subcontractors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=VBIX_SalariesandRelatedExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=VBIX_SalariesandRelatedExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=VBIX_SubcontractorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=VBIX_SubcontractorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992383064872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF SALES AND MARKETING EXPENSES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing expenses</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=VBIX_SalariesandRelatedExpenseMember', window );">Salaries and Related Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=VBIX_OtherMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing expenses</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=VBIX_SalariesandRelatedExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=VBIX_SalariesandRelatedExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=VBIX_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=VBIX_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992383158424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract', window );"><strong>General And Administrative Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Wages, salaries and related expenses</a></td>
<td class="nump">$ 140<span></span>
</td>
<td class="nump">$ 214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">Other</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">$ 304<span></span>
</td>
<td class="nump">$ 437<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992386748696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF FINANCIAL (EXPENSES) INCOME, NET (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_FinancingIncomeExpensesNet', window );">Financing expenses (income), net</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=VBIX_BankFeesMember', window );">Bank Fees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_FinancingIncomeExpensesNet', window );">Financing expenses (income), net</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=VBIX_ExchangeRateDifferencesMember', window );">Exchange Rate Differences [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_FinancingIncomeExpensesNet', window );">Financing expenses (income), net</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=VBIX_InterestExpensesMember', window );">Interest Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_FinancingIncomeExpensesNet', window );">Financing expenses (income), net</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_FinancingIncomeExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing (Income) Expenses, Net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_FinancingIncomeExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=VBIX_BankFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=VBIX_BankFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=VBIX_ExchangeRateDifferencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=VBIX_ExchangeRateDifferencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=VBIX_InterestExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=VBIX_InterestExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992383129752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF DEFERRED INCOME TAXES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Deferred R&amp;D expenses</a></td>
<td class="nump">$ 167<span></span>
</td>
<td class="nump">$ 114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforward</a></td>
<td class="nump">33,055<span></span>
</td>
<td class="nump">32,256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VBIX_DifferencesBetweenTaxBasisAndCarryingValuesOfLoans', window );">Differences between tax basis and carrying values of loans (see notes 4 and 5)</a></td>
<td class="num">(184)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Total</a></td>
<td class="nump">33,038<span></span>
</td>
<td class="nump">32,352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Net deferred tax asset before valuation allowance</a></td>
<td class="nump">7,230<span></span>
</td>
<td class="nump">7,072<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(7,230)<span></span>
</td>
<td class="num">(7,072)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax asset</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VBIX_DifferencesBetweenTaxBasisAndCarryingValuesOfLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Differences between tax basis and carrying values of loans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VBIX_DifferencesBetweenTaxBasisAndCarryingValuesOfLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VBIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992383304520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF LOSS (INCOME) FROM CONTINUING OPERATIONS, BEFORE TAXES ON INCOME (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total loss before taxes on income</a></td>
<td class="nump">$ 384<span></span>
</td>
<td class="nump">$ 441<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total loss before taxes on income</a></td>
<td class="nump">164<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total loss before taxes on income</a></td>
<td class="nump">$ 220<span></span>
</td>
<td class="nump">$ 376<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992389413992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationDescription', window );">Income tax examination description</a></td>
<td class="text">On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the &#8220;Act&#8221;), which
among other provisions, reduced the U.S. corporate tax rate from 35% to 21%, effective January 1, 2018.Viewbix Israel and Israeli subsidiaries
are taxed according to Israeli tax laws.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation allowances, deferred tax assets</a></td>
<td class="nump">$ 3,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 33,055<span></span>
</td>
<td class="nump">$ 32,256<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationDescription', window );">Income tax examination description</a></td>
<td class="text">Net operating losses in the U.S.
are available through 2035.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 18,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=VBIX_ViewbixIsraelMember', window );">Viewbix Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 14,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember', window );">Israel Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Corporate tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=VBIX_ViewbixIsraelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=VBIX_ViewbixIsraelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139992391619320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF LOSS PER SHARE-BASIC AND DILUTED (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to ordinary stockholders</a></td>
<td class="nump">$ 386<span></span>
</td>
<td class="nump">$ 443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average ordinary shares</a></td>
<td class="nump">34,753,669<span></span>
</td>
<td class="nump">31,201,669<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Loss per share-basic and diluted</a></td>
<td class="nump">$ 0.011<span></span>
</td>
<td class="nump">$ 0.014<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>form10-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:VBIX="http://corp.viewbix.com/20211231"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="vbix-20211231.xsd" xlink:type="simple"/>
    <context id="From2021-01-01to2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-03-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
        </entity>
        <period>
            <instant>2022-03-17</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-02-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
        </entity>
        <period>
            <instant>2020-02-12</instant>
        </period>
    </context>
    <context id="AsOf2020-01-27_custom_VirtualCryptoIsraelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">VBIX:VirtualCryptoIsraelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-27</instant>
        </period>
    </context>
    <context id="AsOf2019-02-07_custom_ShareExchangeAgreementMember_custom_ViewbixLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">VBIX:ShareExchangeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VBIX:ViewbixLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-07</instant>
        </period>
    </context>
    <context id="From2020-12-172020-12-18_custom_StockSubscriptionAgreementMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">VBIX:StockSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-17</startDate>
            <endDate>2020-12-18</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-18_custom_StockSubscriptionAgreementMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">VBIX:StockSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-18</instant>
        </period>
    </context>
    <context id="AsOf2020-12-18_us-gaap_InvestorMember_custom_LoanAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">VBIX:LoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-18</instant>
        </period>
    </context>
    <context id="From2020-12-172020-12-18_custom_LoanAgreementMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">VBIX:LoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-17</startDate>
            <endDate>2020-12-18</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_GixLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VBIX:GixLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-02-122022-02-13_custom_GixLoanMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">VBIX:GixLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-12</startDate>
            <endDate>2022-02-13</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-18_custom_LoanAndStockSubscriptionAgreementMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">VBIX:LoanAndStockSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-18</instant>
        </period>
    </context>
    <context id="AsOf2020-12-18_custom_LoanAndStockSubscriptionAgreementMember_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">VBIX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">VBIX:LoanAndStockSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-18</instant>
        </period>
    </context>
    <context id="From2020-12-172020-12-18_custom_LoanAndStockSubscriptionAgreementMember_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">VBIX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">VBIX:LoanAndStockSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-17</startDate>
            <endDate>2020-12-18</endDate>
        </period>
    </context>
    <context id="From2020-12-172020-12-18_custom_StockSubscriptionAgreementMember_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">VBIX:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">VBIX:StockSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-17</startDate>
            <endDate>2020-12-18</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-18_custom_LoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">VBIX:LoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-18</instant>
        </period>
    </context>
    <context id="AsOf2020-12-18_custom_SharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">VBIX:SharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-18</instant>
        </period>
    </context>
    <context id="AsOf2020-12-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
        </entity>
        <period>
            <instant>2020-12-18</instant>
        </period>
    </context>
    <context id="From2020-12-172020-12-18_custom_GixLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VBIX:GixLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-17</startDate>
            <endDate>2020-12-18</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ClassHWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VBIX:ClassHWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ClassIWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VBIX:ClassIWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ClassGWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VBIX:ClassGWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ClassJWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VBIX:ClassJWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ClassJWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VBIX:ClassJWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ClassKWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VBIX:ClassKWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ClassKWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VBIX:ClassKWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_IndividualSubscriptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">VBIX:IndividualSubscriptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_IndividualSubscriptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">VBIX:IndividualSubscriptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EnterpriseSubscriptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">VBIX:EnterpriseSubscriptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EnterpriseSubscriptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">VBIX:EnterpriseSubscriptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SalariesandRelatedExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">VBIX:SalariesandRelatedExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SalariesandRelatedExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">VBIX:SalariesandRelatedExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SubcontractorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">VBIX:SubcontractorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SubcontractorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">VBIX:SubcontractorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">VBIX:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">VBIX:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_BankFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">VBIX:BankFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_BankFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">VBIX:BankFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ExchangeRateDifferencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">VBIX:ExchangeRateDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ExchangeRateDifferencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">VBIX:ExchangeRateDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_InterestExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">VBIX:InterestExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_InterestExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">VBIX:InterestExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_IsraelTaxAuthorityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_IsraelTaxAuthorityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ViewbixIsraelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">VBIX:ViewbixIsraelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="NIS">
        <measure>iso4217:ILS</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-01-01to2021-12-31">0000797542</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-01-01to2021-12-31">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2021-01-01to2021-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:CostOfRevenue
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0131"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherGeneralExpense
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0150"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0152"
      unitRef="USD"
      xsi:nil="true"/>
    <VBIX:FinancingProvidedByParentCompanyAcquisition
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0189"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0204"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0205"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0230"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0232"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0237"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0238"
      unitRef="USD"
      xsi:nil="true"/>
    <VBIX:GainFromSaleOfSubsidiary
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0266"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Depreciation
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0269"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0296"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0299"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0305"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0308"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0311"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-01-012021-12-31_custom_SalariesandRelatedExpenseMember"
      id="xdx2ixbrl0525"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2021-01-012021-12-31_custom_SalariesandRelatedExpenseMember"
      id="xdx2ixbrl0541"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Depreciation
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0563"
      unitRef="USD"
      xsi:nil="true"/>
    <VBIX:FinancingIncomeExpensesNet
      contextRef="From2020-01-012020-12-31_custom_InterestExpensesMember"
      id="xdx2ixbrl0586"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0620"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0621"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2021-01-01to2021-12-31">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2021-01-01to2021-12-31">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2021-01-01to2021-12-31">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2021-01-01to2021-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2021-01-01to2021-12-31">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="From2021-01-01to2021-12-31">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2021-01-01to2021-12-31">000-15746</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2021-01-01to2021-12-31">VIEWBIX INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-01-01to2021-12-31">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-01-01to2021-12-31">68-0080601</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-01-01to2021-12-31">11     Derech Menachem Begin Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2021-01-01to2021-12-31">Ramat Gan</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="From2021-01-01to2021-12-31">IL</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="From2021-01-01to2021-12-31">5268104</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-01-01to2021-12-31">+972</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-01-01to2021-12-31">9-774-1505</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2021-01-01to2021-12-31">Common     Stock, Par Value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-01-01to2021-12-31">VBIX</dei:TradingSymbol>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2021-01-01to2021-12-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2021-01-01to2021-12-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2021-01-01to2021-12-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2021-01-01to2021-12-31">No</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2021-01-01to2021-12-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2021-01-01to2021-12-31">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-01-01to2021-12-31">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="From2021-01-01to2021-12-31">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany contextRef="From2021-01-01to2021-12-31">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">815277</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2022-03-17" decimals="INF" unitRef="Shares">34753669</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorFirmId contextRef="From2021-01-01to2021-12-31">1197</dei:AuditorFirmId>
    <dei:AuditorName contextRef="From2021-01-01to2021-12-31">Brightman Almagor Zohar &amp; Co.</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2021-01-01to2021-12-31">Tel Aviv, Israel</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">74000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">148000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">8000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">15000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">30000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">20000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">44000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">42000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">156000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">225000</us-gaap:AssetsCurrent>
    <us-gaap:Assets contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">156000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">225000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">9000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">22000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">242000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">177000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:DueToAffiliateCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">2116000</us-gaap:DueToAffiliateCurrent>
    <us-gaap:DueToAffiliateCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">2054000</us-gaap:DueToAffiliateCurrent>
    <us-gaap:ShortTermBorrowings contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">69000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">50000</us-gaap:ShortTermBorrowings>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">2436000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">2303000</us-gaap:LiabilitiesCurrent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">490000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">490000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">34753669</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">34753669</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">34753669</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">34753669</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">3000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">3000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">13257000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">13073000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">-15540000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">-15154000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">-2280000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">-2078000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">156000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">225000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">41000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">96000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">5000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">41000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">91000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">64000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">108000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">2000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">8000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">304000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">437000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">25000</us-gaap:OtherGeneralExpense>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">8000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:OperatingExpenses
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">395000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">545000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-354000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-454000</us-gaap:OperatingIncomeLoss>
    <VBIX:FinanceIncome
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">1000</VBIX:FinanceIncome>
    <VBIX:FinanceIncome
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">20000</VBIX:FinanceIncome>
    <VBIX:FinanceExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">31000</VBIX:FinanceExpense>
    <VBIX:FinanceExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">7000</VBIX:FinanceExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-384000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-441000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">2000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">2000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-386000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-443000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.011</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.014</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">34753669</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">31201669</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">34753669</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">13073000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-15154000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">-2078000</us-gaap:StockholdersEquity>
    <VBIX:FinancingProvidedByParentCompanyAcquisition
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">184000</VBIX:FinancingProvidedByParentCompanyAcquisition>
    <VBIX:FinancingProvidedByParentCompanyAcquisition
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">184000</VBIX:FinancingProvidedByParentCompanyAcquisition>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-386000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-386000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">34753669</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">13257000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-15540000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">-2280000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">31201669</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">13015000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-14711000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">-1693000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">31201669</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">13015000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-14711000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">-1693000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">3552000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">58000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">58000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-443000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-443000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">34753669</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">13073000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-15154000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">-2078000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">34753669</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">13073000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-15154000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">-2078000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-386000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-443000</us-gaap:NetIncomeLoss>
    <VBIX:GainFromSaleOfSubsidiary
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">8000</VBIX:GainFromSaleOfSubsidiary>
    <us-gaap:Depreciation
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">5000</us-gaap:Depreciation>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-5000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">40000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">10000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-100000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">52000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-55000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInDueToAffiliatesCurrent
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">246000</us-gaap:IncreaseDecreaseInDueToAffiliatesCurrent>
    <us-gaap:IncreaseDecreaseInDueToAffiliatesCurrent
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">443000</us-gaap:IncreaseDecreaseInDueToAffiliatesCurrent>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">19000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-55000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-74000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-53000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">13000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">13000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">49000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">50000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">99000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-74000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">59000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">148000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">89000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">74000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">148000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <VBIX:ModificationOfParentCompanyPayableIntoLoan contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">2116000</VBIX:ModificationOfParentCompanyPayableIntoLoan>
    <VBIX:CurrentAssetsExcludingCashAndCashEquivalent contextRef="AsOf2020-02-12" decimals="-3" unitRef="USD">6000</VBIX:CurrentAssetsExcludingCashAndCashEquivalent>
    <VBIX:LiabilitiesCurrentOne contextRef="AsOf2020-02-12" decimals="-3" unitRef="USD">-1000</VBIX:LiabilitiesCurrentOne>
    <VBIX:SupplementalGainFromSalesOfSubsidiary contextRef="AsOf2020-02-12" decimals="-3" unitRef="USD">8000</VBIX:SupplementalGainFromSalesOfSubsidiary>
    <VBIX:SupplementalCashReceivedFromSaleOfSubsidiaries contextRef="AsOf2020-02-12" decimals="-3" unitRef="USD">13000</VBIX:SupplementalCashReceivedFromSaleOfSubsidiaries>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80D_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_z1foz2h5YoQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1. &lt;span id="xdx_82F_znp7OID2CFn7"&gt;GENEREL&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;A.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Organizational
                                            Background&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Viewbix
Inc. (formerly known as Virtual Crypto Technologies, Inc.) (the &#x201c;Company&#x201d;) was incorporated in the State of Ohio in 1989
under a predecessor name, Zaxis International, Inc. (&#x201c;Zaxis&#x201d;). On August 25, 1995, Zaxis merged with a subsidiary of The
InFerGene Company, a Delaware corporation, which entity changed its name to Zaxis International, Inc. and the Company was reincorporated
in Delaware under the name of Zaxis International, Inc. In 2015 the Company changes its name to Emerald Medical Applications Corp.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 17, 2018, the Company formed a new wholly-owned subsidiary under the laws of the State of Israel, Virtual Crypto Technologies
Ltd. (&#x201c;VCT Israel&#x201d;), to develop and market software and hardware products facilitating and supporting the purchase and/or
sale of cryptocurrencies. Effective as of March 7, 2018, the Company&#x2019;s name was changed from Emerald Medical Applications Corp.
to Virtual Crypto Technologies, Inc. to reflect its new operations and business focus.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;VCT
Israel ceased its business operation prior to consummation of the Recapitalization Transaction. On January 27, 2020, VCT Israel was sold
to a third party for NIS &lt;span id="xdx_906_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_uNIS_c20200127__us-gaap--IncomeStatementLocationAxis__custom--VirtualCryptoIsraelMember_zzRUp93YqNNh" title="Due to relaties parties current and non current"&gt;50,000&lt;/span&gt; ($&lt;span id="xdx_902_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20200127__us-gaap--IncomeStatementLocationAxis__custom--VirtualCryptoIsraelMember_zq7gTnXqu8sc" title="Due to related party"&gt;14,459&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 7, 2019, the Company entered into a share exchange agreement (the &#x201c;Share Exchange Agreement&#x201d; or the &#x201c;Recapitalization
Transaction&#x201d;) with Gix Internet Ltd., an company organized under the laws of the State of Israel (&#x201c;Gix&#x201d;), pursuant
to which, Gix assigned, transferred and delivered its &lt;span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20190207__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--ViewbixLtdMember_zeK60kGvq0Ye" title="Ownership percentage"&gt;99.83&lt;/span&gt;% holdings in Viewbix Ltd., a company organized under the laws of the State
of Israel (&#x201c;Viewbix Israel&#x201d;), to the Company in exchange for shares of restricted common stock of the Company, which resulted
in Viewbix Israel becoming a subsidiary of the Company. In connection with the Share Exchange Agreement, effective as of August 7, 2019,
the Company&#x2019;s name was changed from Virtual Crypto Technologies, Inc. to Viewbix Inc.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 1, 2020, the Company announced certain cost reduction measures due the fact the Company not achieved certain revenues goals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 5, 2021, the Company entered into a certain Agreement and Plan of Merger (the &#x201c;Merger Agreement&#x201d; or the &#x201c;Gix
Merger&#x201d;) with Gix Media Ltd., an Israeli company and the majority-owned subsidiary of Gix (&#x201c;Gix Media&#x201d;) and Vmedia
Merger Sub Ltd., an Israeli company and wholly-owned subsidiary of the Company (&#x201c;Merger Sub&#x201d;), pursuant to which, following
the Gix Merger and upon satisfaction of the closing conditions listed in the Merger Agreement, Merger Sub will merge with and into Gix
Media, with Gix Media being the surviving entity and wholly-owned subsidiary of the Company. As of the reporting date, the closing conditions
of the Merger Agreement have not been fulfilled yet the Gix Merger has not been consummated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company and its subsidiaries are collectively referred to as the &#x201c;Company&#x201d;. The Company has developed an interactive video
platform based on Software as a Service (&#x201c;SaaS&#x201d;) business model with interactive elements, and the ability to collect and
analyze information about each interactive action performed during the viewing of the video clip. The interactive elements and information
gathered, allowing the advertiser to analyze user viewing habits and optimize real-time throughout the campaign while increasing the
effectiveness of online and live video advertising.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Viewbix
Inc. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.S.
dollars in thousands (except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE.
    1&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GENERAL
    (Cont.):&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;B.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Emerald
                                            Medical Applications Ltd.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Emerald
Medical Applications Ltd., the Company&#x2019;s wholly-owned subsidiary (&#x201c;Emerald Israel&#x201d;) was engaged in the business of
developing DermaCompare technology and the development, sale and service of imaging solutions utilizing its DermaCompare software for
use in derma imaging and analytics for the detection of skin cancer. On January 29, 2018, the Company ceased the DermaCompare operations
of its former subsidiary.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 2, 2018, the District Court of Lod, Israel issued a winding-up order for Emerald Israel and appointed an Israeli attorney as special
executor for Emerald Israel.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;C.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Stock
                                            Subscription Agreement and Loan Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 18, 2020, the Company entered into a Stock Subscription Agreement (the &#x201c;Subscription&#x201d;) with certain investors (the
&#x201c;Investors&#x201d;) in connection with the sale and issuance of an aggregate of &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zCvcoMZSv5Vb" title="Number of share issued"&gt;3,000,000&lt;/span&gt; shares of Common Stock, at a purchase
price of $&lt;span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zaLFK7SuTkvf" title="Sale of stock, price per share"&gt;0.01&lt;/span&gt; per share, and for an aggregate purchase price of $&lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zDlT953wkg29" title="Stock issued during period value"&gt;30,000&lt;/span&gt;. In addition, and on the same date, the company entered into
a Loan Agreement (the &#x201c;Loan&#x201d;) with the Investors, pursuant to which the Investors lent an aggregate of $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20201218__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_znpSK73yBad7" title="Debt instrument, face amount"&gt;69,000&lt;/span&gt; (the &#x201c;Principal
Amount&#x201d;). In accordance with the terms of the Loan, the company repaid the interest on the Principal Amount (&lt;span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20201218__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zS95WgCjCqFc" title="Debt instrument interest rate"&gt;8&lt;/span&gt;% compounded annually)
to the Investors in the form of an issuance of an aggregate of &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zkAbj8TRZkBi" title="Number of share issued"&gt;552,000&lt;/span&gt; shares of Common Stock, at a price per share of $&lt;span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_c20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zVUTjo8M54i8" title="Shares issued, price per share"&gt;0.01&lt;/span&gt;. The shares
of Common Stock were issued to the Investors pursuant to Regulation S of the Securities Act of 1933, as amended.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;D.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Merger
                                            with Gix Media Ltd.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 5, 2021, the Company entered into the Merger Agreement with Gix Media and Merger Sub, pursuant to which, following the Gix Merger,
and upon satisfaction of additional closing conditions, Merger Sub will merge with and into Gix Media, with Gix Media being the surviving
entity and wholly-owned subsidiary of the Company. As of the reporting date, the closing conditions of the Merger Agreement have not
been fulfilled yet and the Gix Merger has not been consummated (see Note 15).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Viewbix
Inc. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.S.
dollars in thousands (except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 72px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE.
    1&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GENERAL
    (Cont.)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;E.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Going
                                            Concern&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has incurred $&lt;span id="xdx_904_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20210101__20211231_zaJVj2fjvuhb" title="Net Income (Loss) Attributable to Parent"&gt;386&lt;/span&gt; in net loss for the year ended December 31, 2021 and &lt;span id="xdx_907_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20200101__20201231_zA38k90eLVH5" title="Net Income (Loss) Attributable to Parent"&gt;443 &lt;/span&gt;in net loss for the year ended December 31,2020, has
$&lt;span id="xdx_90D_eus-gaap--StockholdersEquity_iNI_pn3n3_di_c20211231_zBZ9xKunxrjj" title="Stockholders' deficit"&gt;2,280&lt;/span&gt; stockholders&#x2019; deficit as of December 31, 2021 and $&lt;span id="xdx_903_eus-gaap--StockholdersEquity_iNI_pn3n3_di_c20201231_zBHbkgmNPIR6" title="Stockholders' deficit"&gt;2,078&lt;/span&gt; in total stockholders&#x2019; deficit as of December 31, 2020 and
$&lt;span id="xdx_90F_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3n3_di_c20210101__20211231_zRSYEbFgMWJ" title="Cash flows from operations"&gt;74 &lt;/span&gt;in negative cash flows from operations for the year ended December 31, 2021 and &lt;span id="xdx_906_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3n3_di_c20200101__20201231_zRQtcgfbLHb3" title="Cash flows from operations"&gt;53&lt;/span&gt; in negative cash flows from operations for the
year ended December 31, 2020. Since January 2020, the Company has significantly reduced its operations and expenses of Viewbix Israel.
Management expects the Company to continue to generate substantial operating losses and to continue to fund its operations primarily
through utilization of its current financial resources and through additional raises of capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Such
conditions raise substantial doubts about the Company&#x2019;s ability to continue as a going concern. Management&#x2019;s plan includes
raising funds from outside potential investors. However, there is no assurance such funding will be available to the Company or that
it will be obtained on terms favorable to the Company or will provide the Company with sufficient funds to meet its objectives. These
financial statements do not include any adjustments relating to the recoverability and classification of assets, carrying amounts or
the amount and classification of liabilities that may be required should the Company be unable to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Viewbix
Inc. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.S.
dollars in thousands (except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="AsOf2020-01-27_custom_VirtualCryptoIsraelMember"
      decimals="-3"
      unitRef="NIS">50000000</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="AsOf2020-01-27_custom_VirtualCryptoIsraelMember"
      decimals="-3"
      unitRef="USD">14459000</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2019-02-07_custom_ShareExchangeAgreementMember_custom_ViewbixLtdMember"
      decimals="INF"
      unitRef="Pure">0.9983</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-172020-12-18_custom_StockSubscriptionAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="Shares">3000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2020-12-18_custom_StockSubscriptionAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-12-172020-12-18_custom_StockSubscriptionAgreementMember_us-gaap_InvestorMember"
      decimals="-3"
      unitRef="USD">30000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-12-18_us-gaap_InvestorMember_custom_LoanAgreementMember"
      decimals="-3"
      unitRef="USD">69000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-12-18_us-gaap_InvestorMember_custom_LoanAgreementMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-172020-12-18_custom_LoanAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="Shares">552000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-18_us-gaap_InvestorMember_custom_LoanAgreementMember"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-386000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-443000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">-2280000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">-2078000</us-gaap:StockholdersEquity>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-74000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-53000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80F_eus-gaap--SignificantAccountingPoliciesTextBlock_ziqnFdfBgBPd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE.
2 &lt;span id="xdx_827_zuvk3xo8jZM9"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
significant accounting policies used in the preparation of the financial statements are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z8u2fRxegkM8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zABgu1YTrjAe"&gt;Functional
currency&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
functional currency of the Company and its subsidiary is the US dollar, which is the currency of the primary economic environment in
which it operates. In accordance with ASC 830, &#x201c;Foreign Currency Matters&#x201d; (ASC 830), balances denominated in or linked to
foreign currency are stated on the basis of the exchange rates prevailing at the applicable balance sheet date. For foreign currency
transactions included in the statement of operations, the exchange rates applicable on the relevant transaction dates are used. Gains
or losses arising from changes in the exchange rates used in the translation of such transactions are carried as financing income or
expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--ConsolidationPolicyTextBlock_zWIVxEVqvyGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zF0sRCmT9cMf"&gt;Principles
of consolidation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions
have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zU395BzqCbJa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_869_zOyekG7dtEt"&gt;Cash
and cash equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments, which are highly liquid investments with original maturities of three months or less at
the date of purchase, to be cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z2144j3oOJo9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zdHyj5mquz4j"&gt;Fair
value of financial instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying values of Company&#x2019;s financial assets and liabilities, including cash and cash equivalents, restricted cash, other current
assets, trade payables, other accounts payable and financing provided by the Parent Company approximate their fair value due to the short-term
maturity of these instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_853_zqjmPPSHVyCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Viewbix
Inc. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.S.
dollars in thousands (except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE.
2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zALgsAM7Kom8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zYaa53tWN7G3"&gt;Earnings
per Common Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnings
or loss per share (&#x201c;EPS&#x201d;) is the amount of earnings attributable to each share of common stock. For convenience, the term
is used to refer to either earnings or loss per share. EPS is computed pursuant to ASC 260-10-45. Pursuant to ASC 260-10-45-10 through
260-10-45-16 Basic EPS is computed by dividing income available to common stockholders (the numerator) by the weighted-average number
of common shares outstanding (the denominator) during the period. Income available to common stockholders shall be computed by deducting
both the dividends declared in the period on preferred stock (whether or not paid) from income from continuing operations (if that amount
appears in the income statement) and also from net income. The computation of diluted EPS is similar to the computation of basic EPS
except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive
potential common shares had been issued during the period to reflect the potential dilution that could occur from common shares issuable
through contingent shares issuance arrangement, stock options or warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--RevenueRecognitionPolicyTextBlock_zTTIQXV8EIAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zwIXj4YsWLXd"&gt;Revenue
recognition&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company applies the provisions of Accounting Standards Codification (or &#x201c;ASC&#x201d;) 606, Revenue from Contracts with Customers
(&#x201c;ASC 606&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company generates revenues primarily by granting customers the right to access software products through the Company&#x2019;s cloud-based
SaaS subscription offerings. Under a SaaS subscription agreement, the customer receives a right to access the software for a specified
period of time in an environment hosted, supported, and maintained by the Company. SaaS subscription services are a single performance
obligation satisfied over time, and associated revenue is generally recognized ratably over the contract term once the software is made
available to the customer. The SaaS subscription offerings are typically sold with one year subscription terms, generally invoiced in
advance of each annual subscription period, and are non-cancelable during the committed subscription term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--ResearchAndDevelopmentExpensePolicy_zrXrW15X3k2b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zHlpbKqblnE8"&gt;Research
and development expenses&lt;/span&gt;:&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
and development expenses are charged to the statement of operations as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zu38Kn7CfP2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zm1DvLcbIr47"&gt;Income
Taxes&lt;/span&gt;: &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes in accordance with ASC 740, &#x201c;Income Taxes&#x201d;, and (&#x201c;ASC 740&#x201d;). ASC 740 prescribes
the use of the asset and liability method whereby deferred tax asset and liability account balances are determined based on differences
between the financial reporting and tax bases of assets and liabilities and for carry forward tax losses. Deferred taxes are measured
using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation
allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more-likely-than-not that some portion
or all of the deferred tax asset will not be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, ASC 740 prescribes a recognition threshold and measurement attribute for financial statement recognition and measurement of
a tax position taken or expected to be taken in a tax return. The first step is to evaluate the tax position taken or expected to be
taken in a tax return. This is done by determining if the weight of available evidence indicates that it is more-likely-than-not that,
on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or
litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized
upon ultimate settlement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Viewbix
Inc. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.S.
dollars in thousands (except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zZ0pKrPRYT6f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_z5dK3ZP8hw4a"&gt;Contingencies&lt;/span&gt;:&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company records accruals for loss contingencies arising from claims, litigation and other sources when it is probable that a liability
has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional
information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_ecustom--AccountingForIncomeTaxesPolicyTextBlock_zjmjQETEN3e4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_869_zDRXD9iLeyq8"&gt;Accounting
for Income Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2019, the Financial Accounting Standards Board issued Accounting Standards Update No. ASU 2019-12, &#x201c;Simplifying the Accounting
for Income Taxes&#x201d;. This ASU amends Accounting Standards Codification (&#x201c;ASC&#x201d;) 740 by removing certain exceptions to
the general principles, clarifying and amending existing guidance. This guidance is effective for fiscal years, and interim periods within
those years, beginning after December 15, 2020. The Company adopted this standard in the first quarter of 2021. The adoption of this
ASU did not impact our financial statements or the related disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z8XkxIbzyaq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zWWOGKRXH013"&gt;Recently
issued accounting pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Financial
Instruments &#x2013; Credit Losses&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2016, the FASB issued ASU 2016-13, &#x201c;Financial Instruments &#x2013; Credit Losses (Topic 326): Measurement of Credit Losses
on Financial Instruments&#x201d; (&#x201c;ASU 2016-13&#x201d;). ASU 2016-13 replaces the current incurred loss model guidance with a new
method that reflects expected credit losses. Under this guidance, an entity would recognize an allowance for credit losses equal to its
estimate of expected credit losses on financial assets measured at amortized cost. In November 2019, the FASB extended the effective
date of ASU 2016-13 for smaller reporting companies. As a result, ASU 2016-13 is effective for fiscal years, and interim periods within
those years, beginning after December 15, 2022, with early adoption permitted. The standard is not expected to have a significant impact
on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Convertible
instruments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
August 2020, the FASB issued ASU 2020-06, &#x201c;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an
Entity&#x2019;s Own Equity&#x201d; (&#x201c;ASU 2020-06&#x201d;). ASU 2020-06 simplifies the accounting for convertible instruments by removing
certain separation models in Accounting Standards Codification (&#x201c;ASC&#x201d;) 470-20, &#x201c;Debt&#x2014;Debt with Conversion and
Other Options,&#x201d; (&#x201c;ASC 470-20&#x201d;) for convertible instruments. Under ASU 2020-06, the embedded conversion features no
longer are separated from the host contract for convertible instruments with conversion features that are not required to be accounted
for as derivatives under ASC 815, &#x201c;Derivatives and Hedging,&#x201d; or that do not result in substantial premiums accounted for
as paid-in capital. For smaller reporting companies, ASU 2020-06 is effective for fiscal years, and interim periods within those years,
beginning after December 15, 2023, with early adoption permitted for fiscal years beginning after December 15, 2020. The Company is currently
assessing the impact of this update on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Viewbix
Inc. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.S.
dollars in thousands (except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--BusinessCombinationsPolicy_z6fsBtAckgu6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_zSoqJjhN1eKi"&gt;Business
Combination&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 28, 2021, the FASB issued ASU 2021-08, which amends ASC 805 to &#x201c;require acquiring entities to apply Topic 606 to recognize
and measure contract assets and contract liabilities in a business combination.&#x201d; Under current GAAP, an acquirer generally recognizes
such items at fair value on the acquisition date. According to the FASB, this Update is intended &#x201c;to improve the accounting for
acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to
the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.5in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Recognition
    of an acquired contract liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payment
    terms and their effect on subsequent revenue recognized by the acquirer.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASU
2021-08 06 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. We are
currently assessing the impact of this update on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_ecustom--WarrantsPolicyTextBlock_zaRYrHScf6C6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zN5Z9W9Um9we"&gt;Warrants&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
May 2021, the Financial Accountings Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2021-04,
&#x201c;Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50), Compensation&#x2014;Stock Compensation
(Topic 718), and Derivatives and Hedging&#x2014; Contracts in Entity&#x2019;s Own Equity (Subtopic 815- 40): Issuer&#x2019;s Accounting
for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#x201d; (&#x201c;ASU 2021-04&#x201d;). The
guidance is effective for the Company on January 1, 2022. The Company is currently evaluating the impact of adopting this standard&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_843_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z8u2fRxegkM8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zABgu1YTrjAe"&gt;Functional
currency&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
functional currency of the Company and its subsidiary is the US dollar, which is the currency of the primary economic environment in
which it operates. In accordance with ASC 830, &#x201c;Foreign Currency Matters&#x201d; (ASC 830), balances denominated in or linked to
foreign currency are stated on the basis of the exchange rates prevailing at the applicable balance sheet date. For foreign currency
transactions included in the statement of operations, the exchange rates applicable on the relevant transaction dates are used. Gains
or losses arising from changes in the exchange rates used in the translation of such transactions are carried as financing income or
expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_843_eus-gaap--ConsolidationPolicyTextBlock_zWIVxEVqvyGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zF0sRCmT9cMf"&gt;Principles
of consolidation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions
have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zU395BzqCbJa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_869_zOyekG7dtEt"&gt;Cash
and cash equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments, which are highly liquid investments with original maturities of three months or less at
the date of purchase, to be cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z2144j3oOJo9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zdHyj5mquz4j"&gt;Fair
value of financial instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying values of Company&#x2019;s financial assets and liabilities, including cash and cash equivalents, restricted cash, other current
assets, trade payables, other accounts payable and financing provided by the Parent Company approximate their fair value due to the short-term
maturity of these instruments.&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zALgsAM7Kom8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zYaa53tWN7G3"&gt;Earnings
per Common Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnings
or loss per share (&#x201c;EPS&#x201d;) is the amount of earnings attributable to each share of common stock. For convenience, the term
is used to refer to either earnings or loss per share. EPS is computed pursuant to ASC 260-10-45. Pursuant to ASC 260-10-45-10 through
260-10-45-16 Basic EPS is computed by dividing income available to common stockholders (the numerator) by the weighted-average number
of common shares outstanding (the denominator) during the period. Income available to common stockholders shall be computed by deducting
both the dividends declared in the period on preferred stock (whether or not paid) from income from continuing operations (if that amount
appears in the income statement) and also from net income. The computation of diluted EPS is similar to the computation of basic EPS
except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive
potential common shares had been issued during the period to reflect the potential dilution that could occur from common shares issuable
through contingent shares issuance arrangement, stock options or warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_841_eus-gaap--RevenueRecognitionPolicyTextBlock_zTTIQXV8EIAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zwIXj4YsWLXd"&gt;Revenue
recognition&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company applies the provisions of Accounting Standards Codification (or &#x201c;ASC&#x201d;) 606, Revenue from Contracts with Customers
(&#x201c;ASC 606&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company generates revenues primarily by granting customers the right to access software products through the Company&#x2019;s cloud-based
SaaS subscription offerings. Under a SaaS subscription agreement, the customer receives a right to access the software for a specified
period of time in an environment hosted, supported, and maintained by the Company. SaaS subscription services are a single performance
obligation satisfied over time, and associated revenue is generally recognized ratably over the contract term once the software is made
available to the customer. The SaaS subscription offerings are typically sold with one year subscription terms, generally invoiced in
advance of each annual subscription period, and are non-cancelable during the committed subscription term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_844_eus-gaap--ResearchAndDevelopmentExpensePolicy_zrXrW15X3k2b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zHlpbKqblnE8"&gt;Research
and development expenses&lt;/span&gt;:&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
and development expenses are charged to the statement of operations as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zu38Kn7CfP2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zm1DvLcbIr47"&gt;Income
Taxes&lt;/span&gt;: &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes in accordance with ASC 740, &#x201c;Income Taxes&#x201d;, and (&#x201c;ASC 740&#x201d;). ASC 740 prescribes
the use of the asset and liability method whereby deferred tax asset and liability account balances are determined based on differences
between the financial reporting and tax bases of assets and liabilities and for carry forward tax losses. Deferred taxes are measured
using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation
allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more-likely-than-not that some portion
or all of the deferred tax asset will not be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, ASC 740 prescribes a recognition threshold and measurement attribute for financial statement recognition and measurement of
a tax position taken or expected to be taken in a tax return. The first step is to evaluate the tax position taken or expected to be
taken in a tax return. This is done by determining if the weight of available evidence indicates that it is more-likely-than-not that,
on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or
litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized
upon ultimate settlement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Viewbix
Inc. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.S.
dollars in thousands (except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_847_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zZ0pKrPRYT6f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_z5dK3ZP8hw4a"&gt;Contingencies&lt;/span&gt;:&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company records accruals for loss contingencies arising from claims, litigation and other sources when it is probable that a liability
has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional
information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <VBIX:AccountingForIncomeTaxesPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_844_ecustom--AccountingForIncomeTaxesPolicyTextBlock_zjmjQETEN3e4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_869_zDRXD9iLeyq8"&gt;Accounting
for Income Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2019, the Financial Accounting Standards Board issued Accounting Standards Update No. ASU 2019-12, &#x201c;Simplifying the Accounting
for Income Taxes&#x201d;. This ASU amends Accounting Standards Codification (&#x201c;ASC&#x201d;) 740 by removing certain exceptions to
the general principles, clarifying and amending existing guidance. This guidance is effective for fiscal years, and interim periods within
those years, beginning after December 15, 2020. The Company adopted this standard in the first quarter of 2021. The adoption of this
ASU did not impact our financial statements or the related disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</VBIX:AccountingForIncomeTaxesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84D_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z8XkxIbzyaq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zWWOGKRXH013"&gt;Recently
issued accounting pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Financial
Instruments &#x2013; Credit Losses&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2016, the FASB issued ASU 2016-13, &#x201c;Financial Instruments &#x2013; Credit Losses (Topic 326): Measurement of Credit Losses
on Financial Instruments&#x201d; (&#x201c;ASU 2016-13&#x201d;). ASU 2016-13 replaces the current incurred loss model guidance with a new
method that reflects expected credit losses. Under this guidance, an entity would recognize an allowance for credit losses equal to its
estimate of expected credit losses on financial assets measured at amortized cost. In November 2019, the FASB extended the effective
date of ASU 2016-13 for smaller reporting companies. As a result, ASU 2016-13 is effective for fiscal years, and interim periods within
those years, beginning after December 15, 2022, with early adoption permitted. The standard is not expected to have a significant impact
on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Convertible
instruments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
August 2020, the FASB issued ASU 2020-06, &#x201c;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an
Entity&#x2019;s Own Equity&#x201d; (&#x201c;ASU 2020-06&#x201d;). ASU 2020-06 simplifies the accounting for convertible instruments by removing
certain separation models in Accounting Standards Codification (&#x201c;ASC&#x201d;) 470-20, &#x201c;Debt&#x2014;Debt with Conversion and
Other Options,&#x201d; (&#x201c;ASC 470-20&#x201d;) for convertible instruments. Under ASU 2020-06, the embedded conversion features no
longer are separated from the host contract for convertible instruments with conversion features that are not required to be accounted
for as derivatives under ASC 815, &#x201c;Derivatives and Hedging,&#x201d; or that do not result in substantial premiums accounted for
as paid-in capital. For smaller reporting companies, ASU 2020-06 is effective for fiscal years, and interim periods within those years,
beginning after December 15, 2023, with early adoption permitted for fiscal years beginning after December 15, 2020. The Company is currently
assessing the impact of this update on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Viewbix
Inc. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.S.
dollars in thousands (except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationsPolicy contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_842_eus-gaap--BusinessCombinationsPolicy_z6fsBtAckgu6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_zSoqJjhN1eKi"&gt;Business
Combination&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 28, 2021, the FASB issued ASU 2021-08, which amends ASC 805 to &#x201c;require acquiring entities to apply Topic 606 to recognize
and measure contract assets and contract liabilities in a business combination.&#x201d; Under current GAAP, an acquirer generally recognizes
such items at fair value on the acquisition date. According to the FASB, this Update is intended &#x201c;to improve the accounting for
acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to
the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.5in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Recognition
    of an acquired contract liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payment
    terms and their effect on subsequent revenue recognized by the acquirer.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASU
2021-08 06 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. We are
currently assessing the impact of this update on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessCombinationsPolicy>
    <VBIX:WarrantsPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_846_ecustom--WarrantsPolicyTextBlock_zaRYrHScf6C6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zN5Z9W9Um9we"&gt;Warrants&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
May 2021, the Financial Accountings Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2021-04,
&#x201c;Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50), Compensation&#x2014;Stock Compensation
(Topic 718), and Derivatives and Hedging&#x2014; Contracts in Entity&#x2019;s Own Equity (Subtopic 815- 40): Issuer&#x2019;s Accounting
for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#x201d; (&#x201c;ASU 2021-04&#x201d;). The
guidance is effective for the Company on January 1, 2022. The Company is currently evaluating the impact of adopting this standard&lt;/span&gt;&lt;/p&gt;

</VBIX:WarrantsPolicyTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80B_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zwcy6ownkL16" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
    3.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_823_zvGpz22drQg3"&gt;OTHER
    ACCOUNTS PAYABLE AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Composition:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z1M5EfCDeLU7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zV75WJRXJqXe" style="display: none"&gt;SCHEDULE
OF OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.75in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20211231_zmk9zKpfhTSg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December 30&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20201231_zMw2grzwuErb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December 31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AccountsPayableOtherCurrentAndNoncurrent_iI_pn3n3_maAPAOAzuqS_maAPAALzlaq_zekjjQrtE8Fd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;Other payables and deferred revenues&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;47&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;47&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_maAPAOAzuqS_maAPAALzlaq_zfDN0dsWAzH8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Accrued liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;195&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;130&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iTI_pn3n3_mtAPAALzlaq_zypBjA2JqmF7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total other accounts payables&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;242&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;177&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zo4kdZUIDii1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Viewbix
Inc. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.S.
dollars in thousands (except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89A_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z1M5EfCDeLU7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zV75WJRXJqXe" style="display: none"&gt;SCHEDULE
OF OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.75in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20211231_zmk9zKpfhTSg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December 30&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20201231_zMw2grzwuErb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December 31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AccountsPayableOtherCurrentAndNoncurrent_iI_pn3n3_maAPAOAzuqS_maAPAALzlaq_zekjjQrtE8Fd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;Other payables and deferred revenues&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;47&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;47&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_maAPAOAzuqS_maAPAALzlaq_zfDN0dsWAzH8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Accrued liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;195&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;130&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iTI_pn3n3_mtAPAALzlaq_zypBjA2JqmF7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total other accounts payables&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;242&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;177&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableOtherCurrentAndNoncurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">47000</us-gaap:AccountsPayableOtherCurrentAndNoncurrent>
    <us-gaap:AccountsPayableOtherCurrentAndNoncurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">47000</us-gaap:AccountsPayableOtherCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">195000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">130000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">242000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">177000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zPXSAaNPhvtj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
    4.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_82A_zvInVjQ9Tlh6"&gt;RELATED
    PARTY TRANSACTIONS&lt;/span&gt;.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Balances:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zuPoz1REKY68" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_z1V8nzkQ1l1e" style="display: none"&gt;SCHEDULE
OF RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.75in"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20211231_zOlW66snZtld" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
    31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20201231_zpCMj8kd8cEd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
    31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DueToAffiliateCurrent_iI_pn3n3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Gix
    &#x2013; Company Payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,116&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,054&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A5_zOeA46apOKcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the agreement with Gix, the parties agreed to have the Company&#x2019;s operations outsourced to Gix from the agreement date and
until the acquisition is consummated. The following term were included in the agreement pursuant to the above:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
    May 2018 all of the Company&#x2019;s employees will become employees of Gix.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Between
    the periods of May 2018 to October 2018, Gix will pay the full expenses of the employees as well as other related expenses.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
    November 2018 until to the Closing Date, the employees transferred from the Company to Gix will dedicate half of their time to the
    Company&#x2019;s operations and correspondingly &lt;span id="xdx_90B_ecustom--OperationsCostsIncurredPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--GixLtdMember_zw1qt3ZatMmb" title="Operations costs incurred, percentage"&gt;50&lt;/span&gt;% of the costs to be incurred by Gix in respect of these employees are to be charged
    to the Company.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
the closing date, the actual of the expenses incurred by Gix that related to the Company will be charged to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;No
amounts were paid by the Company to Gix during 2021 and 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company entered into an agreement with Gix, its parent company, pursuant to which, effective as of December 31, 2021, the parent company
payable was modified into a loan, which may be increased from time to time, upon the written mutual consent of the Company and Gix (the
&#x201c;Gix Loan&#x201d;) .The Gix Loan bears interest at a rate equivalent to the minimal interest rate recognized and attributed by the
Israel Tax Authority and will be repaid, together with the accrued interest, in one payment until December 31, 2022, unless extended
upon mutual consent of the Company and Gix Internet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounted for the modification as an extinguishment of the parent company payable and the issuance of a new debt. The loan was
recorded at its fair value of $&lt;span id="xdx_903_eus-gaap--DebtConversionOriginalDebtAmount1_c20220212__20220213__us-gaap--DebtInstrumentAxis__custom--GixLoanMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zf0JFDm89qV8" title="Debt modification original debt, amount"&gt;2,115,853&lt;/span&gt; as of the modification date, with the difference of $&lt;span id="xdx_906_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20220212__20220213__us-gaap--DebtInstrumentAxis__custom--GixLoanMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUT2c7gA4Vwe" title="Debt conversion amount"&gt;184,103&lt;/span&gt; between the fair value of the loan
and the carrying value of the payable to the Parent Company recorded in the Company&#x2019;s Consolidated Statement of Changes in Stockholders&#x2019;
Deficit as a deemed contribution to the Company by the Parent Company, with a corresponding discount on the loan, to be amortized as
finance expense in the Company&#x2019;s Consolidated Statements of Comprehensive Loss over the term of the loan.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Viewbix
Inc. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.S.
dollars in thousands (except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_890_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zuPoz1REKY68" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_z1V8nzkQ1l1e" style="display: none"&gt;SCHEDULE
OF RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.75in"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20211231_zOlW66snZtld" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
    31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20201231_zpCMj8kd8cEd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
    31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DueToAffiliateCurrent_iI_pn3n3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Gix
    &#x2013; Company Payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,116&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,054&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:DueToAffiliateCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">2116000</us-gaap:DueToAffiliateCurrent>
    <us-gaap:DueToAffiliateCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">2054000</us-gaap:DueToAffiliateCurrent>
    <VBIX:OperationsCostsIncurredPercentage
      contextRef="From2021-01-012021-12-31_custom_GixLtdMember"
      decimals="INF"
      unitRef="Pure">0.50</VBIX:OperationsCostsIncurredPercentage>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="From2022-02-122022-02-13_custom_GixLoanMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">2115853</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2022-02-122022-02-13_custom_GixLoanMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">184103</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:ShortTermDebtTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80D_eus-gaap--ShortTermDebtTextBlock_zrXbmu5Z0Kj1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
    5.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_823_z1cxf1SvfOal"&gt;SHORT
    TERM LOAN AND ISSUES OF SHARES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 18, 2020, the company entered into a Loan Agreement (the &#x201c;Loan&#x201d;) and Stock Subscription Agreement with certain Investors
as described in note 1c, pursuant to which the Investors lent an aggregate amount of $&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAndStockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_znrphiD1kOv8" title="Debt instrument, face amount"&gt;69,000&lt;/span&gt; (the &#x201c;Principal Amount&#x201d;). In
accordance with the terms of the Loan, the company prepaid the interest on the Principal Amount of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAndStockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--InvestorsMember_zPxuSk5zYCd1" title="Debt instrument interest rate"&gt;8&lt;/span&gt;% compounded annually to the Investors
as an issuance of &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAndStockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--InvestorsMember_zceVpl9yV7jd" title="Stock issued during period, shares"&gt;552,000&lt;/span&gt; shares of Common Stock, at a price per share of $&lt;span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_c20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAndStockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--InvestorsMember_zcj0nh0r5jC3" title="Stock issued price per share"&gt;0.01&lt;/span&gt;. Under the Stock Subscription Agreement, the Investors
transferred an amount of $&lt;span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn3n3_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--InvestorsMember_zmy0FQ1N1yDe" title="Proceeds from issuance of common stock"&gt;30,587&lt;/span&gt; to the company as consideration for the issued shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company allocated the total proceeds in respect of the shares issued and the Loan extended based on theirrelative fair values. As a result
of the allocation, a discount of $&lt;span id="xdx_90B_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn3n3_c20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAndStockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--InvestorsMember_zV6quylOw2Pi" title="Loan discount"&gt;19&lt;/span&gt; was recorded on the loan. The discount is amortized over the term of the loan as finance expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_ecustom--ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock_zP20iHwNx7s6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
allocation of the proceeds to the fair value distribution of the liability and equity components on the transactions date was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BE_zImG6ykGWEy" style="display: none"&gt;SCHEDULE
OF FAIR VALUE DISTRIBUTION OF LIABILITY AND EQUITY COMPONENTS&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.75in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Instrument&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;% of total fair&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Allocated&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;amount&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShorttermDebtFairValue_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--LoanMember_zfKX63Ycl6z4" style="width: 16%; font-weight: bold; text-align: right" title="Fair Value"&gt;55,200&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PercentageOfFairValue_iI_pid_dp_c20201218__us-gaap--DebtInstrumentAxis__custom--LoanMember_ziI6Hx0s7e83" style="width: 16%; font-weight: bold; text-align: right" title="Percentage of fair value"&gt;49.45&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShortTermDebtAllocatedAmount_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--LoanMember_znFRCbAef7O9" style="width: 16%; font-weight: bold; text-align: right" title="Allocated amount"&gt;49,246&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShorttermDebtFairValue_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--SharesMember_zu34jF1re4Qh" style="font-weight: bold; text-align: right" title="Fair Value"&gt;54,000&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--PercentageOfFairValue_iI_pid_dp_c20201218__us-gaap--DebtInstrumentAxis__custom--SharesMember_zT6kUDBqJd" style="font-weight: bold; text-align: right" title="Percentage of fair value"&gt;50.55&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShortTermDebtAllocatedAmount_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--SharesMember_zKuRD6y8MRH7" style="font-weight: bold; text-align: right" title="Allocated amount"&gt;50,340&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShorttermDebtFairValue_iI_pn3n3_c20201218_z1ADcZYu6lA1" style="font-weight: bold; text-align: right" title="Fair Value"&gt;109,200&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--PercentageOfFairValue_iI_pid_dp_c20201218_zuJ05joCu2xj" style="font-weight: bold; text-align: right" title="Percentage of fair value"&gt;100&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ShortTermDebtAllocatedAmount_iI_pn3n3_c20201218_ziGh0AYVIIIg" style="font-weight: bold; text-align: right" title="Allocated amount"&gt;99,586&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zmt6t7h4yKu4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfShortTermDebtTextBlock_za0dQ2sXMV14" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
composition of short term loan balance as of the transaction is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zhdp4aWkW9pl" style="display: none"&gt;SCHEDULE
OF COMPOSITION OF SHORT TERM LOAN&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%; margin-left: 0.75in"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20201218_zai3RvIgnCdc" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ShortTermPrincipalAmount_iI_pn3n3_maSTBzbhn_zsKg6tmfKq9j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Principal amount&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 20%; text-align: right"&gt;69&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DiscountOnShortTermLoan_iI_pn3n3_msSTBzbhn_z0eoIF8V1V8c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Discount on Short term loan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(19&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ShortTermBorrowings_iTI_pn3n3_mtSTBzbhn_zIODnTMCyY82" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Short term loan, Net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zi35FZNclEbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Viewbix
Inc. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.S.
dollars in thousands (except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShortTermDebtTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-12-18_custom_LoanAndStockSubscriptionAgreementMember_us-gaap_InvestorMember"
      decimals="-3"
      unitRef="USD">69000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-12-18_custom_LoanAndStockSubscriptionAgreementMember_custom_InvestorsMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-172020-12-18_custom_LoanAndStockSubscriptionAgreementMember_custom_InvestorsMember"
      decimals="INF"
      unitRef="Shares">552000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2020-12-18_custom_LoanAndStockSubscriptionAgreementMember_custom_InvestorsMember"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2020-12-172020-12-18_custom_StockSubscriptionAgreementMember_custom_InvestorsMember"
      decimals="-3"
      unitRef="USD">30587000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2020-12-18_custom_LoanAndStockSubscriptionAgreementMember_custom_InvestorsMember"
      decimals="-3"
      unitRef="USD">19000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <VBIX:ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_893_ecustom--ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock_zP20iHwNx7s6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
allocation of the proceeds to the fair value distribution of the liability and equity components on the transactions date was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BE_zImG6ykGWEy" style="display: none"&gt;SCHEDULE
OF FAIR VALUE DISTRIBUTION OF LIABILITY AND EQUITY COMPONENTS&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.75in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Instrument&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;% of total fair&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Allocated&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;amount&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShorttermDebtFairValue_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--LoanMember_zfKX63Ycl6z4" style="width: 16%; font-weight: bold; text-align: right" title="Fair Value"&gt;55,200&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PercentageOfFairValue_iI_pid_dp_c20201218__us-gaap--DebtInstrumentAxis__custom--LoanMember_ziI6Hx0s7e83" style="width: 16%; font-weight: bold; text-align: right" title="Percentage of fair value"&gt;49.45&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShortTermDebtAllocatedAmount_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--LoanMember_znFRCbAef7O9" style="width: 16%; font-weight: bold; text-align: right" title="Allocated amount"&gt;49,246&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShorttermDebtFairValue_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--SharesMember_zu34jF1re4Qh" style="font-weight: bold; text-align: right" title="Fair Value"&gt;54,000&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--PercentageOfFairValue_iI_pid_dp_c20201218__us-gaap--DebtInstrumentAxis__custom--SharesMember_zT6kUDBqJd" style="font-weight: bold; text-align: right" title="Percentage of fair value"&gt;50.55&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShortTermDebtAllocatedAmount_iI_pn3n3_c20201218__us-gaap--DebtInstrumentAxis__custom--SharesMember_zKuRD6y8MRH7" style="font-weight: bold; text-align: right" title="Allocated amount"&gt;50,340&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShorttermDebtFairValue_iI_pn3n3_c20201218_z1ADcZYu6lA1" style="font-weight: bold; text-align: right" title="Fair Value"&gt;109,200&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--PercentageOfFairValue_iI_pid_dp_c20201218_zuJ05joCu2xj" style="font-weight: bold; text-align: right" title="Percentage of fair value"&gt;100&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ShortTermDebtAllocatedAmount_iI_pn3n3_c20201218_ziGh0AYVIIIg" style="font-weight: bold; text-align: right" title="Allocated amount"&gt;99,586&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</VBIX:ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock>
    <us-gaap:ShorttermDebtFairValue
      contextRef="AsOf2020-12-18_custom_LoanMember"
      decimals="-3"
      unitRef="USD">55200000</us-gaap:ShorttermDebtFairValue>
    <VBIX:PercentageOfFairValue
      contextRef="AsOf2020-12-18_custom_LoanMember"
      decimals="INF"
      unitRef="Pure">0.4945</VBIX:PercentageOfFairValue>
    <VBIX:ShortTermDebtAllocatedAmount
      contextRef="AsOf2020-12-18_custom_LoanMember"
      decimals="-3"
      unitRef="USD">49246000</VBIX:ShortTermDebtAllocatedAmount>
    <us-gaap:ShorttermDebtFairValue
      contextRef="AsOf2020-12-18_custom_SharesMember"
      decimals="-3"
      unitRef="USD">54000000</us-gaap:ShorttermDebtFairValue>
    <VBIX:PercentageOfFairValue
      contextRef="AsOf2020-12-18_custom_SharesMember"
      decimals="INF"
      unitRef="Pure">0.5055</VBIX:PercentageOfFairValue>
    <VBIX:ShortTermDebtAllocatedAmount
      contextRef="AsOf2020-12-18_custom_SharesMember"
      decimals="-3"
      unitRef="USD">50340000</VBIX:ShortTermDebtAllocatedAmount>
    <us-gaap:ShorttermDebtFairValue contextRef="AsOf2020-12-18" decimals="-3" unitRef="USD">109200000</us-gaap:ShorttermDebtFairValue>
    <VBIX:PercentageOfFairValue contextRef="AsOf2020-12-18" decimals="INF" unitRef="Pure">1</VBIX:PercentageOfFairValue>
    <VBIX:ShortTermDebtAllocatedAmount contextRef="AsOf2020-12-18" decimals="-3" unitRef="USD">99586000</VBIX:ShortTermDebtAllocatedAmount>
    <us-gaap:ScheduleOfShortTermDebtTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89F_eus-gaap--ScheduleOfShortTermDebtTextBlock_za0dQ2sXMV14" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
composition of short term loan balance as of the transaction is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zhdp4aWkW9pl" style="display: none"&gt;SCHEDULE
OF COMPOSITION OF SHORT TERM LOAN&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%; margin-left: 0.75in"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20201218_zai3RvIgnCdc" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ShortTermPrincipalAmount_iI_pn3n3_maSTBzbhn_zsKg6tmfKq9j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Principal amount&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 20%; text-align: right"&gt;69&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DiscountOnShortTermLoan_iI_pn3n3_msSTBzbhn_z0eoIF8V1V8c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Discount on Short term loan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(19&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ShortTermBorrowings_iTI_pn3n3_mtSTBzbhn_zIODnTMCyY82" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Short term loan, Net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <VBIX:ShortTermPrincipalAmount contextRef="AsOf2020-12-18" decimals="-3" unitRef="USD">69000</VBIX:ShortTermPrincipalAmount>
    <VBIX:DiscountOnShortTermLoan contextRef="AsOf2020-12-18" decimals="-3" unitRef="USD">-19000</VBIX:DiscountOnShortTermLoan>
    <us-gaap:ShortTermBorrowings contextRef="AsOf2020-12-18" decimals="-3" unitRef="USD">50000</us-gaap:ShortTermBorrowings>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zXj6Si7yFhRj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
6. &lt;span id="xdx_820_zb1YbiCLo3S9"&gt;STOCKHOLDERS&#x2019; DEFICIT&lt;/span&gt;.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Ordinary
Shares:&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--CommonStockVotingRights_c20210101__20211231_zUWuSQLOJFs1" title="Common stock, voting rights"&gt;Ordinary
shares confer the right to: (i) participate in the general meetings, to one vote per share for any purpose, to an equal part, on share
basis, (ii) in distribution of dividends and (iii) to equally participate, on share basis, in distribution of excess of assets and funds
from the Company and they shall not confer other privileges unless stated hereunder or in the Companies Law otherwise. Some investors
have standard anti-dilutive rights, registration rights, and information and representation rights.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 18, 2020, the company entered into a Stock Subscription Agreement (the &#x201c;Subscription&#x201d;) with certain investors (the
&#x201c;Investors&#x201d;) in connection with the sale and issuance of an aggregate of &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zg4pukFEKggb" title="Number of share issued"&gt;3,000,000&lt;/span&gt; shares of Common Stock, at a purchase
price of $&lt;span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zKyqnMBcKlVc" title="Sale of stock, price per share"&gt;0.01&lt;/span&gt; per share, and for an aggregate purchase price of $&lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--StockSubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zXDggJF3liJb" title="Stock issued during period value"&gt;30,000&lt;/span&gt;. In accordance with the terms of the Loan, the company repaid
the interest on the Principal Amount &lt;span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20201218__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zm0qg0lP3LUk" title="Debt instrument interest rate"&gt;8&lt;/span&gt;% compounded annually to the Investors in the form of an issuance of an aggregate of &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20201217__20201218__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zRbMmrGpIWG1" title="Number of share issued"&gt;552,000&lt;/span&gt; shares
of Common Stock, at a price per share of $&lt;span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20201218__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zIrNxnrF1tv6" title="Sale of stock, price per share"&gt;0.01&lt;/span&gt;. The shares of Common Stock were issued to the Investors pursuant to Regulation S of the
Securities Act of 1933, as amended. For more details, please see note 1c.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zccM6tKvs1Bj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes information of outstanding warrants as of December 31, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zrVZiiruvAs1" style="display: none"&gt;SUMMARY OF OUTSTANDING WARRANTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Warrant Term&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Exercisable&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 22%; text-align: left"&gt;Class J Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zrl8C6d2l38h" style="width: 16%; text-align: right" title="Warrants"&gt;3,649,318&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--WarrantTerm_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zWfllLCfmrV9" title="Warrant Term"&gt;July 2029&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zT6hlD65nrpe" style="width: 16%; text-align: right" title="Exercise Price"&gt;0.48&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--WarrantExercisable_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zxVMLW21XTb5" style="width: 16%; text-align: right" title="Exercisable"&gt;3,649,318&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Class K Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zxZZJ6hPxAHj" style="text-align: right" title="Warrants"&gt;3,649,318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--WarrantTerm_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_z5cdcogI2Dpf" title="Warrant Term"&gt;July 2029&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zGug9JiAUcD7" style="text-align: right" title="Exercise Price"&gt;0.80&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WarrantExercisable_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zziS5An11jql" style="text-align: right" title="Exercisable"&gt;3,649,318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A4_z6G7X9RSxl2i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additionally,
in connection with the Share Exchange Agreement, upon the earlier of: (a) the launch of a live video product to an American consumer
in the United States by Viewbix Israel, or (b) the launch of an interactive television product to an American consumer in the United
States by Viewbix Israel, the Company will issue to Gix an additional &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20201217__20201218__dei--LegalEntityAxis__custom--GixLtdMember_zW7kAtmAnN8i" title="Number of restricted common stock shares issued"&gt;1,642,193&lt;/span&gt; shares of restricted common stock of the Company. All
of the Company&#x2019;s warrants meet the US GAAP criteria for equity classification. During 2020, &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--ClassHWarrantsMember_z3HuFfxJR8p7" title="Number of warrants expired during period"&gt;50,000&lt;/span&gt; class H warrants , &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--ClassIWarrantsMember_z2DpczWovEJl" title="Number of warrants expired during period"&gt;38,095&lt;/span&gt; class
I warrants and &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--ClassGWarrantsMember_zt9opza6H1V5" title="Number of warrants expired during period"&gt;142,857&lt;/span&gt; Class G warrants expired.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Viewbix
Inc. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.S.
dollars in thousands (except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockVotingRights contextRef="From2021-01-01to2021-12-31">Ordinary
shares confer the right to: (i) participate in the general meetings, to one vote per share for any purpose, to an equal part, on share
basis, (ii) in distribution of dividends and (iii) to equally participate, on share basis, in distribution of excess of assets and funds
from the Company and they shall not confer other privileges unless stated hereunder or in the Companies Law otherwise. Some investors
have standard anti-dilutive rights, registration rights, and information and representation rights.</us-gaap:CommonStockVotingRights>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-172020-12-18_custom_StockSubscriptionAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="Shares">3000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2020-12-18_custom_StockSubscriptionAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-12-172020-12-18_custom_StockSubscriptionAgreementMember_us-gaap_InvestorMember"
      decimals="-3"
      unitRef="USD">30000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-12-18_us-gaap_InvestorMember_custom_LoanAgreementMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-172020-12-18_custom_LoanAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="Shares">552000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2020-12-18_us-gaap_InvestorMember_custom_LoanAgreementMember"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zccM6tKvs1Bj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes information of outstanding warrants as of December 31, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zrVZiiruvAs1" style="display: none"&gt;SUMMARY OF OUTSTANDING WARRANTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.75in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Warrant Term&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Exercisable&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 22%; text-align: left"&gt;Class J Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zrl8C6d2l38h" style="width: 16%; text-align: right" title="Warrants"&gt;3,649,318&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--WarrantTerm_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zWfllLCfmrV9" title="Warrant Term"&gt;July 2029&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zT6hlD65nrpe" style="width: 16%; text-align: right" title="Exercise Price"&gt;0.48&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--WarrantExercisable_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassJWarrantsMember_zxVMLW21XTb5" style="width: 16%; text-align: right" title="Exercisable"&gt;3,649,318&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Class K Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zxZZJ6hPxAHj" style="text-align: right" title="Warrants"&gt;3,649,318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--WarrantTerm_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_z5cdcogI2Dpf" title="Warrant Term"&gt;July 2029&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zGug9JiAUcD7" style="text-align: right" title="Exercise Price"&gt;0.80&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WarrantExercisable_iI_c20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassKWarrantsMember_zziS5An11jql" style="text-align: right" title="Exercisable"&gt;3,649,318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2021-12-31_custom_ClassJWarrantsMember"
      decimals="-3"
      unitRef="Shares">3649318000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <VBIX:WarrantTerm contextRef="From2021-01-012021-12-31_custom_ClassJWarrantsMember">July 2029</VBIX:WarrantTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-12-31_custom_ClassJWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">0.48</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <VBIX:WarrantExercisable
      contextRef="AsOf2021-12-31_custom_ClassJWarrantsMember"
      decimals="-3"
      unitRef="Shares">3649318000</VBIX:WarrantExercisable>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2021-12-31_custom_ClassKWarrantsMember"
      decimals="-3"
      unitRef="Shares">3649318000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <VBIX:WarrantTerm contextRef="From2021-01-012021-12-31_custom_ClassKWarrantsMember">July 2029</VBIX:WarrantTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-12-31_custom_ClassKWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">0.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <VBIX:WarrantExercisable
      contextRef="AsOf2021-12-31_custom_ClassKWarrantsMember"
      decimals="-3"
      unitRef="Shares">3649318000</VBIX:WarrantExercisable>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2020-12-172020-12-18_custom_GixLtdMember"
      decimals="INF"
      unitRef="Shares">1642193</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2020-01-012020-12-31_custom_ClassHWarrantsMember"
      decimals="INF"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2020-01-012020-12-31_custom_ClassIWarrantsMember"
      decimals="INF"
      unitRef="Shares">38095</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2020-01-012020-12-31_custom_ClassGWarrantsMember"
      decimals="INF"
      unitRef="Shares">142857</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80D_eus-gaap--RevenueFromContractWithCustomerTextBlock_zVSFdCfTNhqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
7. &lt;span id="xdx_822_z9kqclCBqFM3"&gt;REVENUES&lt;/span&gt;. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--DisaggregationOfRevenueTableTextBlock_z9fAgJq5bob1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8BD_zTSY7UYpc1d9" style="display: none"&gt;SCHEDULE OF REVENUES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Individual Subscriptions&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210101__20211231__srt--ProductOrServiceAxis__custom--IndividualSubscriptionsMember_zgRpownWfmO8" style="width: 16%; text-align: right" title="Revenues"&gt;10&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__custom--IndividualSubscriptionsMember_pn3n3" style="width: 16%; text-align: right" title="Revenues"&gt;13&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Enterprise Subscriptions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210101__20211231__srt--ProductOrServiceAxis__custom--EnterpriseSubscriptionsMember_zImVzQwHevPd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues"&gt;31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__custom--EnterpriseSubscriptionsMember_pn3n3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues"&gt;83&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210101__20211231_zLJeKw9kpbxj" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;41&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;96&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zXnxewyXKoZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_890_eus-gaap--DisaggregationOfRevenueTableTextBlock_z9fAgJq5bob1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8BD_zTSY7UYpc1d9" style="display: none"&gt;SCHEDULE OF REVENUES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Individual Subscriptions&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210101__20211231__srt--ProductOrServiceAxis__custom--IndividualSubscriptionsMember_zgRpownWfmO8" style="width: 16%; text-align: right" title="Revenues"&gt;10&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__custom--IndividualSubscriptionsMember_pn3n3" style="width: 16%; text-align: right" title="Revenues"&gt;13&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Enterprise Subscriptions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210101__20211231__srt--ProductOrServiceAxis__custom--EnterpriseSubscriptionsMember_zImVzQwHevPd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues"&gt;31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__custom--EnterpriseSubscriptionsMember_pn3n3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues"&gt;83&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210101__20211231_zLJeKw9kpbxj" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;41&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;96&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-12-31_custom_IndividualSubscriptionsMember"
      decimals="-3"
      unitRef="USD">10000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-12-31_custom_IndividualSubscriptionsMember"
      decimals="-3"
      unitRef="USD">13000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-12-31_custom_EnterpriseSubscriptionsMember"
      decimals="-3"
      unitRef="USD">31000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-12-31_custom_EnterpriseSubscriptionsMember"
      decimals="-3"
      unitRef="USD">83000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">41000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">96000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_808_eus-gaap--ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_zBBYmsbj4RPa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
8. &lt;span id="xdx_827_z1PTDeJ3JAJg"&gt;RESEARCH AND DEVELOPMENT EXPENSES&lt;/span&gt;. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_ecustom--ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_znRHXTH3Nl92" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8B7_zPjyxqKeCI5" style="display: none"&gt;SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Salaries and related expense&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_zliWUf4uKjLc" style="width: 16%; text-align: right" title="Research and development"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0525"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ResearchAndDevelopmentExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_pn3n3" style="width: 16%; text-align: right" title="Research and development"&gt;55&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Subcontractors&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--SubcontractorsMember_zAFjFZbpJL2a" style="border-bottom: Black 1.5pt solid; text-align: right" title="Research and development"&gt;64&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--SubcontractorsMember_z6hzHijwkhBf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Research and development"&gt;53&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20210101__20211231_zOrZa5RGNRKf" style="border-bottom: Black 2.5pt double; text-align: right" title="Research and development expenses"&gt;64&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ResearchAndDevelopmentExpense_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Research and development expenses"&gt;108&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zGjA47tFMeqj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <VBIX:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_891_ecustom--ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_znRHXTH3Nl92" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8B7_zPjyxqKeCI5" style="display: none"&gt;SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Salaries and related expense&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_zliWUf4uKjLc" style="width: 16%; text-align: right" title="Research and development"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0525"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ResearchAndDevelopmentExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_pn3n3" style="width: 16%; text-align: right" title="Research and development"&gt;55&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Subcontractors&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--SubcontractorsMember_zAFjFZbpJL2a" style="border-bottom: Black 1.5pt solid; text-align: right" title="Research and development"&gt;64&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--SubcontractorsMember_z6hzHijwkhBf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Research and development"&gt;53&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20210101__20211231_zOrZa5RGNRKf" style="border-bottom: Black 2.5pt double; text-align: right" title="Research and development expenses"&gt;64&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ResearchAndDevelopmentExpense_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Research and development expenses"&gt;108&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</VBIX:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-01-012020-12-31_custom_SalariesandRelatedExpenseMember"
      decimals="-3"
      unitRef="USD">55000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-01-012021-12-31_custom_SubcontractorsMember"
      decimals="-3"
      unitRef="USD">64000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-01-012020-12-31_custom_SubcontractorsMember"
      decimals="-3"
      unitRef="USD">53000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">64000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">108000</us-gaap:ResearchAndDevelopmentExpense>
    <VBIX:SalesAndMarketingExpensesDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_809_ecustom--SalesAndMarketingExpensesDisclosureTextBlock_zWwpG23gyqK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
9. &lt;span id="xdx_822_zFidS2CnsnAb"&gt;SALES AND MARKTING EXPENSES&lt;/span&gt;. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_ecustom--ScheduleOfSalesAndMarketingExpensesTableTextBlock_z4i5U5icqKJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8B4_zVXGfpuncWSj" style="display: none"&gt;SCHEDULE OF SALES AND MARKETING EXPENSES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Salaries and related expense&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SellingAndMarketingExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_ztS7H3aV0YNj" style="width: 16%; text-align: right" title="Sales and marketing expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0541"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SellingAndMarketingExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_pn3n3" style="width: 16%; text-align: right" title="Sales and marketing expenses"&gt;7&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SellingAndMarketingExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--OtherMember_zrajO4n1V7ll" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sales and marketing expenses"&gt;2&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SellingAndMarketingExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--OtherMember_pn3n3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sales and marketing expenses"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SellingAndMarketingExpense_pn3n3_c20210101__20211231_zbni4G3gDIuj" style="border-bottom: Black 2.5pt double; text-align: right" title="Sales and marketing expenses"&gt;2&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SellingAndMarketingExpense_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Sales and marketing expenses"&gt;8&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zHOfDjpvapX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</VBIX:SalesAndMarketingExpensesDisclosureTextBlock>
    <VBIX:ScheduleOfSalesAndMarketingExpensesTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_894_ecustom--ScheduleOfSalesAndMarketingExpensesTableTextBlock_z4i5U5icqKJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8B4_zVXGfpuncWSj" style="display: none"&gt;SCHEDULE OF SALES AND MARKETING EXPENSES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Salaries and related expense&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SellingAndMarketingExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_ztS7H3aV0YNj" style="width: 16%; text-align: right" title="Sales and marketing expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0541"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SellingAndMarketingExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--SalariesandRelatedExpenseMember_pn3n3" style="width: 16%; text-align: right" title="Sales and marketing expenses"&gt;7&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SellingAndMarketingExpense_pn3n3_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--OtherMember_zrajO4n1V7ll" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sales and marketing expenses"&gt;2&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SellingAndMarketingExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--OtherMember_pn3n3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sales and marketing expenses"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SellingAndMarketingExpense_pn3n3_c20210101__20211231_zbni4G3gDIuj" style="border-bottom: Black 2.5pt double; text-align: right" title="Sales and marketing expenses"&gt;2&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SellingAndMarketingExpense_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Sales and marketing expenses"&gt;8&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</VBIX:ScheduleOfSalesAndMarketingExpensesTableTextBlock>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2020-01-012020-12-31_custom_SalariesandRelatedExpenseMember"
      decimals="-3"
      unitRef="USD">7000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2021-01-012021-12-31_custom_OtherMember"
      decimals="-3"
      unitRef="USD">2000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2020-01-012020-12-31_custom_OtherMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">2000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">8000</us-gaap:SellingAndMarketingExpense>
    <VBIX:GeneralAndAdministrativeExpensesDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_803_ecustom--GeneralAndAdministrativeExpensesDisclosureTextBlock_zbAqzzgNhD0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -68.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
10. &lt;span id="xdx_82F_zL6gfEEaNEph"&gt;GENERAL AND ADMINISTRATIVE EXPENSES&lt;/span&gt;. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock_zEaN69G9yuA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -68.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zMqHY6TgQw99" style="display: none"&gt;SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20210101__20211231_zAZ2mliSYmT3" style="font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20200101__20201231_zmhcRID8cdU6" style="font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LaborAndRelatedExpense_maGAAEzPpY_zQOJZP2z8m7c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-left: 5.4pt"&gt;Wages, salaries and related expenses&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;140&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;214&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ProfessionalFees_maGAAEzPpY_zc0ClPWTwc7g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Professional fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;150&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;176&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--Depreciation_maGAAEzPpY_zVX3ifbAcxe5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0563"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--OtherGeneralAndAdministrativeExpense_maGAAEzPpY_zjDEsA4HkMah" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 5.4pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;14&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;42&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--GeneralAndAdministrativeExpense_iT_pn3n3_mtGAAEzPpY_zeqITNovxt82" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; font-size: 11pt; padding-left: 5.4pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;General
    and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;304&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;437&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zmkCbEforcHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -68.05pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Viewbix
Inc. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.S.
dollars in thousands (except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</VBIX:GeneralAndAdministrativeExpensesDisclosureTextBlock>
    <VBIX:ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89B_ecustom--ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock_zEaN69G9yuA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -68.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zMqHY6TgQw99" style="display: none"&gt;SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20210101__20211231_zAZ2mliSYmT3" style="font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20200101__20201231_zmhcRID8cdU6" style="font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LaborAndRelatedExpense_maGAAEzPpY_zQOJZP2z8m7c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-left: 5.4pt"&gt;Wages, salaries and related expenses&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;140&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;214&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ProfessionalFees_maGAAEzPpY_zc0ClPWTwc7g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Professional fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;150&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;176&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--Depreciation_maGAAEzPpY_zVX3ifbAcxe5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0563"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--OtherGeneralAndAdministrativeExpense_maGAAEzPpY_zjDEsA4HkMah" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 5.4pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;14&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;42&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--GeneralAndAdministrativeExpense_iT_pn3n3_mtGAAEzPpY_zeqITNovxt82" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; font-size: 11pt; padding-left: 5.4pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;General
    and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;304&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;437&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</VBIX:ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">140000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">214000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:ProfessionalFees
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">150000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">176000</us-gaap:ProfessionalFees>
    <us-gaap:Depreciation
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">5000</us-gaap:Depreciation>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">14000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">42000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">304000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">437000</us-gaap:GeneralAndAdministrativeExpense>
    <VBIX:FinancingIncomeExpensesTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_802_ecustom--FinancingIncomeExpensesTextBlock_zBG0lVKmv1E3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
11. &lt;span id="xdx_82D_zEi2bv2PU0pg"&gt;FINANCIAL EXPENSES (INCOME), NET&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;b&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_89C_ecustom--ScheduleFinancingIncomeExpensesNetTableTextBlock_zYpwyV7G9z6i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;span id="xdx_8BA_zVFOB9kDoaW" style="display: none"&gt;SCHEDULE
OF FINANCIAL (EXPENSES) INCOME, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Bank fees&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231__us-gaap--CreditFacilityAxis__custom--BankFeesMember_zobzR3SUeKne" style="width: 16%; text-align: right" title="Financing (income) expenses, net"&gt;3&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231__us-gaap--CreditFacilityAxis__custom--BankFeesMember_zPkZh1iklpL" style="width: 16%; text-align: right" title="Financing (income) expenses, net"&gt;1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exchange rate differences&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231__us-gaap--CreditFacilityAxis__custom--ExchangeRateDifferencesMember_zqa4iX1UmPFe" style="text-align: right" title="Financing (income) expenses, net"&gt;(1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231__us-gaap--CreditFacilityAxis__custom--ExchangeRateDifferencesMember_zPlbcOUnCZ28" style="text-align: right" title="Financing (income) expenses, net"&gt;(14&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Interest expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231__us-gaap--CreditFacilityAxis__custom--InterestExpensesMember_zVEpoYWkl0I4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Financing (income) expenses, net"&gt;28&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231__us-gaap--CreditFacilityAxis__custom--InterestExpensesMember_zswxfj2aAOAh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Financing (income) expenses, net"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0586"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231_zA9OXsD3KgS" style="border-bottom: Black 2.5pt double; text-align: right" title="Financing expenses (income), net"&gt;30&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231_zv4LOjkgX4zk" style="border-bottom: Black 2.5pt double; text-align: right" title="Financing expenses (income), net"&gt;(13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zhGq7Kv1uEt9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</VBIX:FinancingIncomeExpensesTextBlock>
    <VBIX:ScheduleFinancingIncomeExpensesNetTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89C_ecustom--ScheduleFinancingIncomeExpensesNetTableTextBlock_zYpwyV7G9z6i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;span id="xdx_8BA_zVFOB9kDoaW" style="display: none"&gt;SCHEDULE
OF FINANCIAL (EXPENSES) INCOME, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Bank fees&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231__us-gaap--CreditFacilityAxis__custom--BankFeesMember_zobzR3SUeKne" style="width: 16%; text-align: right" title="Financing (income) expenses, net"&gt;3&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231__us-gaap--CreditFacilityAxis__custom--BankFeesMember_zPkZh1iklpL" style="width: 16%; text-align: right" title="Financing (income) expenses, net"&gt;1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exchange rate differences&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231__us-gaap--CreditFacilityAxis__custom--ExchangeRateDifferencesMember_zqa4iX1UmPFe" style="text-align: right" title="Financing (income) expenses, net"&gt;(1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231__us-gaap--CreditFacilityAxis__custom--ExchangeRateDifferencesMember_zPlbcOUnCZ28" style="text-align: right" title="Financing (income) expenses, net"&gt;(14&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Interest expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231__us-gaap--CreditFacilityAxis__custom--InterestExpensesMember_zVEpoYWkl0I4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Financing (income) expenses, net"&gt;28&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231__us-gaap--CreditFacilityAxis__custom--InterestExpensesMember_zswxfj2aAOAh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Financing (income) expenses, net"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0586"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--FinancingIncomeExpensesNet_pn3n3_c20210101__20211231_zA9OXsD3KgS" style="border-bottom: Black 2.5pt double; text-align: right" title="Financing expenses (income), net"&gt;30&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--FinancingIncomeExpensesNet_pn3n3_c20200101__20201231_zv4LOjkgX4zk" style="border-bottom: Black 2.5pt double; text-align: right" title="Financing expenses (income), net"&gt;(13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</VBIX:ScheduleFinancingIncomeExpensesNetTableTextBlock>
    <VBIX:FinancingIncomeExpensesNet
      contextRef="From2021-01-012021-12-31_custom_BankFeesMember"
      decimals="-3"
      unitRef="USD">3000</VBIX:FinancingIncomeExpensesNet>
    <VBIX:FinancingIncomeExpensesNet
      contextRef="From2020-01-012020-12-31_custom_BankFeesMember"
      decimals="-3"
      unitRef="USD">1000</VBIX:FinancingIncomeExpensesNet>
    <VBIX:FinancingIncomeExpensesNet
      contextRef="From2021-01-012021-12-31_custom_ExchangeRateDifferencesMember"
      decimals="-3"
      unitRef="USD">-1000</VBIX:FinancingIncomeExpensesNet>
    <VBIX:FinancingIncomeExpensesNet
      contextRef="From2020-01-012020-12-31_custom_ExchangeRateDifferencesMember"
      decimals="-3"
      unitRef="USD">-14000</VBIX:FinancingIncomeExpensesNet>
    <VBIX:FinancingIncomeExpensesNet
      contextRef="From2021-01-012021-12-31_custom_InterestExpensesMember"
      decimals="-3"
      unitRef="USD">28000</VBIX:FinancingIncomeExpensesNet>
    <VBIX:FinancingIncomeExpensesNet
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">30000</VBIX:FinancingIncomeExpensesNet>
    <VBIX:FinancingIncomeExpensesNet
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-13000</VBIX:FinancingIncomeExpensesNet>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80D_eus-gaap--IncomeTaxDisclosureTextBlock_zFHs1Da3HR4g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
12. &lt;span id="xdx_82E_zu67r7UMr1ik"&gt;INCOME TAXES&lt;/span&gt;.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is subject to income taxes under the Israeli and U.S. tax laws&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Tax
rates applicable to the income of the Company:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Viewbix
Inc. is taxed according to U.S. tax laws. &lt;span id="xdx_908_eus-gaap--IncomeTaxExaminationDescription_c20210101__20211231_zR1cNqgHN7Mk" title="Income tax examination description"&gt;On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the &#x201c;Act&#x201d;), which
among other provisions, reduced the U.S. corporate tax rate from 35% to 21%, effective January 1, 2018.Viewbix Israel and Israeli subsidiaries
are taxed according to Israeli tax laws.&lt;/span&gt; The Israeli corporate tax rate is &lt;span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_c20210101__20211231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zUnonec9e9hf" title="Corporate tax rate"&gt;&lt;span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_c20200101__20201231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_z9kh0037ylf1" title="Corporate tax rate"&gt;23&lt;/span&gt;&lt;/span&gt;% in the years 2021, 2020 and onwards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Deferred
income taxes:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zdpdxmzeWya8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#x2019;s deferred tax assets are
as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_zYDTPzqvw8Cd" style="display: none"&gt;SCHEDULE OF DEFERRED INCOME TAXES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.75in"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="display: none"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20211231_zsrOcfIccJT5" style="display: none; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="display: none; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20201231_z2WokoXqd0Md" style="display: none; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="display: none; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December 31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December 31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_iI_pn3n3_maDTAOLz7uk_zKXf5q76a4J9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Deferred R&amp;amp;D expenses&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;167&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;114&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_maDTAOLz7uk_zSofonZhDJH4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Operating loss carryforward&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,256&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DifferencesBetweenTaxBasisAndCarryingValuesOfLoans_iI_pn3n3_maDTAOLz7uk_zlZRqYGItht1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Differences between tax basis and carrying values of loans &lt;br/&gt;(see notes 4
    and 5)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(184&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(18&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_mtDTAOLz7uk_zvzwlSFFD2b5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;33,038&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;32,352&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsGross_iI_pn3n3_maDTANzK9I_zkejzdb3WPrb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Net deferred tax asset before valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;7,230&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;7,072&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzK9I_zWWrvOpzvKH8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(7,230&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(7,072&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzK9I_zOpGXZvjhlSl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax asset&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0620"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0621"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zSqfHsMUoC4l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Viewbix
Inc. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.S.
dollars in thousands (except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
12. INCOME TAXES. (Cont.)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2021, the Company has provided valuation allowances of $&lt;span id="xdx_909_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pn3n3_c20210101__20211231_zFZBbcDnlHJc" title="Valuation allowances, deferred tax assets"&gt;3,909&lt;/span&gt; in respect of deferred tax assets resulting from tax loss
carryforward and other temporary differences. Management currently believes that because the Company has a history of losses, it is more
likely than not that the deferred tax regarding the loss carryforward and other temporary differences will not be realized in the foreseeable
future.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Available
carryforward tax losses:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2021, Viewbix Israel incurred operating losses in Israel of approximately $&lt;span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20211231__us-gaap--IncomeStatementLocationAxis__custom--ViewbixIsraelMember_zzuPrEmrnGB9" title="Operating loss carryforwards"&gt;14,624&lt;/span&gt; which may be carried forward and offset
against taxable income in the future for an indefinite period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2021 the Company generated net operating losses in the U.S. of approximately $&lt;span id="xdx_90A_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20211231__srt--StatementGeographicalAxis__country--US_z5W6h3WCd6Qc" title="Operating loss carryforwards"&gt;18,615&lt;/span&gt; &lt;span id="xdx_90F_eus-gaap--IncomeTaxExaminationDescription_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_z46VBCwh4JY4" title="Income tax examination description"&gt;Net operating losses in the U.S.
are available through 2035.&lt;/span&gt; Utilization of U.S. net operating losses may be subject to substantial annual limitation due to the &#x201c;change
in ownership&#x201d; provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in
the expiration of net operating losses before utilization.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zosicShTX6t5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Loss
from continuing operations, before taxes on income, consists of the following:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zmHjQOwPMaa2" style="display: none"&gt;SCHEDULE OF LOSS (INCOME) FROM CONTINUING OPERATIONS, BEFORE TAXES ON INCOME&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;USA&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zVnolIGZwVTc" style="width: 16%; text-align: right" title="Total loss before taxes on income"&gt;164&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zIVBw2hl00Ik" style="width: 16%; text-align: right" title="Total loss before taxes on income"&gt;65&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Israel&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zB1yXc9iqkOd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total loss before taxes on income"&gt;220&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_ztMaWEjR5s1f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total loss before taxes on income"&gt;376&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20210101__20211231_zxNRkT9b7U1e" style="border-bottom: Black 2.5pt double; text-align: right" title="Total loss before taxes on income"&gt;384&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20200101__20201231_zxRjGkRQRXR8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total loss before taxes on income"&gt;441&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A3_zx4VNY24DFUg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExaminationDescription contextRef="From2021-01-01to2021-12-31">On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the &#x201c;Act&#x201d;), which
among other provisions, reduced the U.S. corporate tax rate from 35% to 21%, effective January 1, 2018.Viewbix Israel and Israeli subsidiaries
are taxed according to Israeli tax laws.</us-gaap:IncomeTaxExaminationDescription>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2021-01-012021-12-31_us-gaap_IsraelTaxAuthorityMember"
      decimals="INF"
      unitRef="Pure">0.23</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2020-01-012020-12-31_us-gaap_IsraelTaxAuthorityMember"
      decimals="INF"
      unitRef="Pure">0.23</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_892_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zdpdxmzeWya8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#x2019;s deferred tax assets are
as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_zYDTPzqvw8Cd" style="display: none"&gt;SCHEDULE OF DEFERRED INCOME TAXES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.75in"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="display: none"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20211231_zsrOcfIccJT5" style="display: none; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="display: none; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20201231_z2WokoXqd0Md" style="display: none; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="display: none; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December 31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December 31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_iI_pn3n3_maDTAOLz7uk_zKXf5q76a4J9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Deferred R&amp;amp;D expenses&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;167&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;114&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_maDTAOLz7uk_zSofonZhDJH4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Operating loss carryforward&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,256&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DifferencesBetweenTaxBasisAndCarryingValuesOfLoans_iI_pn3n3_maDTAOLz7uk_zlZRqYGItht1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Differences between tax basis and carrying values of loans &lt;br/&gt;(see notes 4
    and 5)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(184&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(18&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_mtDTAOLz7uk_zvzwlSFFD2b5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;33,038&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;32,352&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsGross_iI_pn3n3_maDTANzK9I_zkejzdb3WPrb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Net deferred tax asset before valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;7,230&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;7,072&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzK9I_zWWrvOpzvKH8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(7,230&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(7,072&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzK9I_zOpGXZvjhlSl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax asset&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0620"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0621"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">167000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">114000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">33055000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">32256000</us-gaap:OperatingLossCarryforwards>
    <VBIX:DifferencesBetweenTaxBasisAndCarryingValuesOfLoans contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">-184000</VBIX:DifferencesBetweenTaxBasisAndCarryingValuesOfLoans>
    <VBIX:DifferencesBetweenTaxBasisAndCarryingValuesOfLoans contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">-18000</VBIX:DifferencesBetweenTaxBasisAndCarryingValuesOfLoans>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">33038000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">32352000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">7230000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">7072000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">7230000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">7072000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">3909000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2021-12-31_custom_ViewbixIsraelMember"
      decimals="-3"
      unitRef="USD">14624000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2021-12-31_country_US"
      decimals="-3"
      unitRef="USD">18615000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:IncomeTaxExaminationDescription contextRef="From2021-01-012021-12-31_us-gaap_DomesticCountryMember">Net operating losses in the U.S.
are available through 2035.</us-gaap:IncomeTaxExaminationDescription>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_895_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zosicShTX6t5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Loss
from continuing operations, before taxes on income, consists of the following:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zmHjQOwPMaa2" style="display: none"&gt;SCHEDULE OF LOSS (INCOME) FROM CONTINUING OPERATIONS, BEFORE TAXES ON INCOME&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;USA&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zVnolIGZwVTc" style="width: 16%; text-align: right" title="Total loss before taxes on income"&gt;164&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zIVBw2hl00Ik" style="width: 16%; text-align: right" title="Total loss before taxes on income"&gt;65&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Israel&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zB1yXc9iqkOd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total loss before taxes on income"&gt;220&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_ztMaWEjR5s1f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total loss before taxes on income"&gt;376&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20210101__20211231_zxNRkT9b7U1e" style="border-bottom: Black 2.5pt double; text-align: right" title="Total loss before taxes on income"&gt;384&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iN_pn3n3_di_c20200101__20201231_zxRjGkRQRXR8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total loss before taxes on income"&gt;441&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-012021-12-31_us-gaap_DomesticCountryMember"
      decimals="-3"
      unitRef="USD">-164000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-01-012020-12-31_us-gaap_DomesticCountryMember"
      decimals="-3"
      unitRef="USD">-65000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-012021-12-31_us-gaap_ForeignCountryMember"
      decimals="-3"
      unitRef="USD">-220000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-01-012020-12-31_us-gaap_ForeignCountryMember"
      decimals="-3"
      unitRef="USD">-376000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-384000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-441000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_807_eus-gaap--EarningsPerShareTextBlock_zloGIVs67Un6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
13. &lt;span id="xdx_822_zHuUie6lRNv5"&gt;LOSS PER SHARE-BASIC AND DILUTED&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Composition:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zUKTfWJQj9V2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8BD_zMZyTVCSIeb4" style="display: none"&gt;SCHEDULE OF LOSS PER SHARE-BASIC AND DILUTED&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-size: 11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 60%; font-weight: bold; text-align: left"&gt;Net loss attributable to ordinary stockholders&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20210101__20211231_zjW4NEGZ1iP9" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Net loss attributable to ordinary stockholders"&gt;386&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20200101__20201231_zsEM81j00iQc" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Net loss attributable to ordinary stockholders"&gt;443&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted-average ordinary shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20210101__20211231_zkxW0dRbDh3b" style="text-align: right" title="Weighted-average ordinary shares"&gt;34,753,669&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20200101__20201231_zhI5LPxGTgjf" style="text-align: right" title="Weighted-average ordinary shares"&gt;31,201,669&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;Loss per share-basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20210101__20211231_zPhJIGOAsdk2" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss per share-basic and diluted"&gt;0.011&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200101__20201231_zb8UYTUc6Xq8" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss per share-basic and diluted"&gt;0.014&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A1_zqk4oAGz3Zy8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Viewbix
Inc. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.S.
dollars in thousands (except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_899_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zUKTfWJQj9V2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8BD_zMZyTVCSIeb4" style="display: none"&gt;SCHEDULE OF LOSS PER SHARE-BASIC AND DILUTED&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 1in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-size: 11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 60%; font-weight: bold; text-align: left"&gt;Net loss attributable to ordinary stockholders&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20210101__20211231_zjW4NEGZ1iP9" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Net loss attributable to ordinary stockholders"&gt;386&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20200101__20201231_zsEM81j00iQc" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Net loss attributable to ordinary stockholders"&gt;443&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Weighted-average ordinary shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20210101__20211231_zkxW0dRbDh3b" style="text-align: right" title="Weighted-average ordinary shares"&gt;34,753,669&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_c20200101__20201231_zhI5LPxGTgjf" style="text-align: right" title="Weighted-average ordinary shares"&gt;31,201,669&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;Loss per share-basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20210101__20211231_zPhJIGOAsdk2" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss per share-basic and diluted"&gt;0.011&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareBasicAndDiluted_pid_c20200101__20201231_zb8UYTUc6Xq8" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss per share-basic and diluted"&gt;0.014&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="USD">-386000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-443000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">34753669</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">31201669</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.011</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.014</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:UnusualRisksAndUncertaintiesTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80B_eus-gaap--UnusualRisksAndUncertaintiesTextBlock_zoJaaR3xEK6h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
14. &lt;span id="xdx_821_zUYpnaqMDd2g"&gt;COVID-19 PANDEMIC IMPLICATIONS&lt;/span&gt;.&lt;/b&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
COVID-19 pandemic which originated in China in late 2019, has resulted in a widespread health crisis that has adversely affected businesses,
economies and financial markets worldwide, placed constraints on the operations of businesses, decreased consumer mobility and activity,
and caused significant economic volatility in the United States, Israel and international capital markets. The COVID-19 pandemic has
caused an economic recession, high unemployment rates and other disruptions, both in the United States, Israel and the rest of the world.
The Company is actively monitoring the pandemic and is taking any necessary measures to respond to the situation in cooperation with
the various stakeholders. Due to the uncertainty surrounding the COVID-19 pandemic, the Company will continue to assess the situation,
including government-imposed restrictions, market by market. The COVID-19 pandemic has not yet currently adversely affected our business,
however, it is not possible at this time to estimate the full impact that the COVID-19 pandemic, the continued spread of COVID-19, and
any additional measures taken by governments, health officials or by the Company in response to such spread, could have on the Company&#x2019;s
business, results of operations and financial condition.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UnusualRisksAndUncertaintiesTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zL1eT7AiJfbh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
15. &lt;span id="xdx_828_zNSmj9f7p7r4"&gt;SUBSEQUENT EVENTS&lt;/span&gt;.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Loan
Agreement &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
January 2022, the Investors under the Loan Agreement expressed their intention to convert the Principal Amount to the Company&#x2019;s
shares of Common Stock, and accordingly, the Company agreed to extend the repayment date (see note 5).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Gix
Merger&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.5pt; text-align: justify; text-indent: 35.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 5, 2021, the Company entered into the Merger Agreement with Gix Media and Merger Sub, pursuant to which, following the Gix Merger,
and upon satisfaction of additional closing conditions, Merger Sub will merge with and into Gix Media, with Gix Media being the surviving
entity and wholly-owned subsidiary of the Company. As of the reporting date, the closing conditions of the Merger Agreement have not
been fulfilled yet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subject
to the terms and conditions of the Merger Agreement, at the Merger Effective Date (as defined in the Merger Agreement) all outstanding
ordinary shares of Gix Media, having no par value (the &#x201c;Gix Media Shares&#x201d;) will be converted into shares of Common Stock,
such that immediately following the Gix Merger, holders of Gix Media Shares will hold 90% of the Company&#x2019;s capital stock on a fully
diluted basis. The Merger Agreement contains customary representations, warranties and covenants made by each of the Company, Gix Media
and Merger Sub.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 21, 2021, the shareholders of each of Gix Media and Merger Sub approved the Merger Agreement. Consummation of the Gix Merger
is subject to certain additional closing conditions, including, among other things, (i) the Company filing an amendment to its certificate
of incorporation to change the Company&#x2019;s name to &#x201c;Gix Media, Inc.&#x201d;, (ii) obtaining approval from certain third parties,
including the approval of Bank Leumi due to certain liens registered in its favor against ordinary shares of Gix Media; (iii) conversion
of the Company&#x2019;s outstanding convertible instruments into restricted shares of Common Stock and (iv) obtaining a tax pre-ruling
from the Israeli Tax Authority relating to the Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Viewbix
Inc. &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.S.
dollars in thousands (except share and per share data)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
15. SUBSEQUENT EVENTS. (Cont.)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reverse
Stock Split&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Gix Merger, on February 13, 2022, the requisite majority of the Company&#x2019;s stockholders approved certain amendments
to the Company&#x2019;s certificate of incorporation, including, but not limited to (i) a name change from &#x201c;Viewbix Inc.&#x201d;
to &#x201c;Gix Media, Inc.&#x201d;, (ii) a reverse stock split of the Company&#x2019;s common Stock at a ratio of 1-for-28 (the &#x201c;Planned
Reverse Split&#x201d;), (iii) a staggered board structure, and (iv) certain other provisions therein. Pursuant to the Planned Reverse
Stock Split, each twenty-eight (28) shares of the Company&#x2019;s common stock will be automatically converted, without any further action
by the stockholders, into one share of the Company&#x2019;s common stock. No fractional shares will be issued as the result of the reverse
stock split. Instead, each stockholder will be entitled to receive one share of common stock in lieu of the fractional share that would
have resulted from the reverse stock split.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company intends to effect the foregoing amended and restated certificate of incorporation upon the closing of the Gix Merger, thus, as
of the reporting date the Planned Reverse Stock Split has not been effected.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#xdx2ixbrl0230"
          xlink:label="xdx2ixbrl0230"
          xlink:type="locator"/>
        <link:footnote id="Footnote000255" xlink:label="Footnote000255" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents an amount
less than $1.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0230"
          xlink:to="Footnote000255"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>64
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( *Z <50'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "N@'%4)"A/1>X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:L,P#(9?9?B>R$[H!B;-I:.G#@8K;.QF;+4UBQ-C:R1]^SE>FS*V!]C1TN]/
MGT"-]E(/ 9_#X#&0Q7@WN:Z/4OLU.Q%Y"1#U"9V*94KTJ7D8@E.4GN$(7ND/
M=42H.+\'AZ2,(@4SL/ +D;6-T5('5#2$"][H!>\_0Y=A1@-VZ+"G"*(4P-IY
MHC]/70,WP PC#"Y^%] LQ%S]$YL[P"[)*=HE-8YC.=8YEW80\/:T>\GK%K:/
MI'J-Z5>TDLX>U^PZ^;7>/.ZWK*UX516\+L3#ON*2KZ18O<^N/_QNPFXP]F#_
ML?%5L&W@UUVT7U!+ P04    " "N@'%4F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M *Z <51P5)Y1^04  $(9   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
ME9G;<MLV$(:OXZ? :#*=9&I9)*AC*FM&!RM5$SL>RW&:='H!D9#$,0FH(&C9
M;]\%18F*"RW97,0\[<\/"_!? .IOI7I,UIQK\AQ'(KFLK;7>?&@T$G_-8Y9<
MR T7<&<I5<PTG*I5(]DHSH(L*(X:U'':C9B%HC;H9]=NU: O4QV%@M\JDJ1Q
MS-3+B$=R>UES:_L+=^%JK<V%QJ"_82L^Y_KKYE;!6>.@$H0Q%TDH!5%\>5D;
MNA\F7M<$9$\\A'R;'!T3TY2%E(_F9!9<UAQ#Q"/N:R/!X,\3'_,H,DK \4\N
M6CN\TP0>'^_5IUGCH3$+EO"QC+Z%@5Y?UKHU$O E2R-])[>_\[Q!+:/GRRC)
M_B?;W;/-9HWX::)EG <#01R*W5_VG"?B*,!KGPB@>0!]%>">>H.7!WA5 YIY
M0#/+S*XI61XF3+-!7\DM4>9I4#,'63*S:&A^*$R_S[6"NR'$Z<%8/G%%ZN3K
M?$+>O7W?;V@0-;<:?BXPV@G0$P(N)==2Z'5"KD3 @Y\%&D!S0*)[I!%%%2?<
MOR">>TZH0UT+T!@/OV;J@KB=+)Q:PB=X^!^I@+<[MK?_U!KOD& OT_/0!/\U
M7"1:P2#_&Y%L'B2;F63S5(*DG\*GI\G]RX;;>@P/=YWZ)X2B=:!HH3)#0 @R
MC&G$5C8,/'[)HH0C'.T#1[M:-H9"I"PB=WPCE;;QX#I:I1A.YX#3J=@YBH$[
M9N9V&@G7*DM1]\#4K<9TRU4H _.E$G +Z]@I4<J_S;,W;TJ^C]Z!K5>-;1HF
M/G1?CCB%RXF-#U>;?D>07*<P1>=_07WG3)U&*A$K291[9-4N*C1.E7H-A75E
MB5R][M*ZAZ+1 HVB6E="A_H%R").;M)XP945"!=Q'*?NMCK--H94^*[K54&Z
MXZO06"_D[8;%]CSA0@^SJV^CV9]GLYOQ!496V+>+&W!.-H:^5-"/,ZB;S^03
M?[&RX5*0,J?3Z[2:%",K+-W%/3DGNV?/9!8 7K@,?999&-*IN&2[6W><KM-V
MT(%6F+V+NW1..!.^5&"J&=PYF6OX!(A49"Q32"KD5@;VKBZI)5<89%$"7-RW
M<\AA$"B>).?[ _(9GB-?A)T,EW3=,P+_)EQQ?TVNN6!F!4!&,+H%-%_!_ ]#
M+RJ%BQO\:_2Q.8/$WLNML&+C<G<,IN;D(Q,87%$J7-S=_P.WZVTK%ZXT^XQ-
M5(LZ07%K?PUT*Q,-7_2/<'-R!)8HMFB[ZSI-C*ZH%[2D7F1LL!H\#8,+_-KK
M8+Y"B_) <6?_++/2OI8"*P\E(KUZI].$ N&T,*:B/E#<UN]##<5*+HE+WRW>
MDSGW4P4)LX+A2F,9QU)DW^=<2_\1Q@%4Y@<6I9R\=2[ HC'OHT7=H+C9PXPR
M",6*S%_BA8RLH+C  Y0QC*2H$[12G?@&R_7ZHP!K@/2Q!'HW(+,D24]T+ZYY
M(S&THD#02@7B04;@#4SMYB3*.F\K4<*!BF) *Q6#_>1MMQ;(NA&*EGU"6:+X
MG2<86>'UM)+7SX3F:K?_8J:2;(]J)<,5\905/D\K^7S6<V0,I7TE[2Y?HG,C
M19WY/@<9$ EV@MB:OC!^KY+QSV,61624)G [L79EB4[)HM,KO-[#K3H'NHJY
M6IG!]1$4]!J,/]XP8<U=B6#9VM,KS-^KM#:8K\$M4"!<IA3H:$>FTLK@-EU$
MH4^FD62VL3[)55J9BMD_?1ITW1;M=/J-)]O["Q_WJLW_L[*Q+QGS-8,Y!/F2
M:IA""./SMJVO7+E]Q.0U.RVOW>Z=H"H\W</]=S:>WI%A&H0:IGM#K3EP9%/_
M4]L[)7IE0[MP= _WX3W3-%0QF4VL*+B"Z_8Z&$KAY1[NO'N44RO)DO"1,KO0
M,1-D&,4,3(W\D-#MY!<6;WZ#\8 M+[W"UCW<A/>09M)E.M *BDO<\^AL^!0^
MG4,Y5XQ'-J[&T::S<9UL\SXAOIF3[_:?#U<//Q ,LVWQ1O'X[M>%:V9,*R$1
M7T*H<]&!D:5V&_:[$RTWV1;V0FHMX^QPS5G E7D [B^EU/L3\X+#SR:#?P%0
M2P,$%     @ KH!Q5+,^P-!+!   0 \  !@   !X;"]W;W)K<VAE971S+W-H
M965T,BYX;6R5EVU3XS80@/^*)F4Z[4S DFS'R1$R ^%NRLRU90BTGQ5;8 VV
ME9-D OWU73G&,;%L<A\@LKV[>E;2OFB^E>I9IYP;])IGA;X8I<9LOGB>CE.>
M,WTF-[R +X]2Y<S HWKR]$9QEE1*>>91C"=>SD0Q6LRK=[=J,9>ER43!;Q72
M99XS]7;%,[F]&)'1^XL[\90:^\);S#?LB:^X>=C<*GCR&BN)R'FAA2R0XH\7
MHTOR94FQ5:@D_A%\JUMC9%U92_EL'VZ2BQ&V1#SCL;$F&/R\\"7/,FL).'[4
M1D?-G%:Q/7ZW_JUR'IQ9,\V7,OM7)":]&$U'*.&/K,S,G=S^P6N'0FLOEIFN
M_J-M+8M'*"ZUD7FM# 2Y*':_[+5>B)8""7H4:*U CU7P:P6_<G1'5KEUS0Q;
MS)7<(F6EP9H=5&M3:8,WHK#;N#(*O@K0,XNE++3,1,(,3] 5RU@1<[2RYC0Z
M10^K:_3;R>_H!(D"W:>RU*Q(]-PS,+/5]^)ZEJO=++1GEFL>GR&?C!'%E#C4
ME\>KXX_J'OC;.$T;IVEES^]S^N'N[NM?]^ARM?IZOQHPZ#<&_<I@T&>0Z13!
MTJ#8#OB/4KRPC!?&N50[4V%ERD;9RR(*YMY+>SFZ(B28-C(?$(,&,1A$O%<L
MX1!X,0>V=<:=:#L3D]:\TP.RK@0)W6!A Q8.@OUM4JX@G&-9PH*U"%V 86=Z
M'Q\0=D4H=A-.&L+)(.&MXALF$L1?(7EJ]\I-.K,&AYOJ$*%NL*@!BX;W5!J6
M0990"LX:8EIS]XF+')LV.:#KRE#:L[/3!F]Z!%X_UO0(K*Y,+]:LP9H=%?W?
M;RZO;K[?W-]\'4H!!.\S*3XBPC;LK3>\:@-M;V8'_CI$:,\I(:T<3WXFQ&K$
M*F'!2U5"ZL\$6XM,&-%#3KI8K=-;LW>%2!3UP.]S-:'#T<>JTQW+?,.*-R<<
M[<(1<GB27%(X#'KP]IF?#*?^52J508:K'&62%4X^OS/SI+/O79FP)VV1?<HG
MG^3\#_GALRWNIG8:^)U5=$CYV.\AW=< $@[&Y"J%749+MA% /!2-^YQ-AI/V
M4N8YM(G00,7/8W2"SS#&!(Z^0E":2WZ.@AD>PSO[A[2=7B-6&MA-\1]/SI$?
MC*/0'T\FL_>O0FL;*39JH!_6!@:B>$+,(.A/>+Z&$'MO<7:AU?V G0O?+0S^
MX:H/B7Q<H'WM(,/%XS))A.VDX838ZG8*'5[L6O\:TE%#?!I&AZ N,1SUP>XK
M"1DN)9=Q7.9E5G6IT*2+6!@G9;=<G)(P# Y[!+<<Z<T&^])"9D=$7'7H4IDE
M7.E??YE2$IT/4L^Z-)1..] N,1SU](5T7[?H)W6K8FYEAS&DLWPC%5SKJE[6
MO%7G^2>]JF<-!\N[0ZA;W[W6]<;>+?]DZDD4&F7\$;3P603J:G==VST8N:EN
M/&MIX/Y4#5.XXG)E!>#[HY3F_<%>HII+\^)_4$L#!!0    ( *Z <5165!@0
M9P(  )8&   8    >&PO=V]R:W-H965T<R]S:&5E=#,N>&ULE55-C]HP$/TK
M5M1#*VU)2"!T5Q!IE]6J/51"B]H>JAY,,A!K'3NU!]CVUW?LA BVT&8Y$'_,
M>_/>V)E,]]H\V1( V7,EE9T%)6)]$X8V+Z'B=J!K4+2SUJ;B2%.S"6UM@!<>
M5,DPCJ(TK+A003;U:PN33?46I5"P,,QNJXJ;7W<@]7X6#(/#PJ/8E.@6PFQ:
M\PTL ;_4"T.SL&,I1 7*"JV8@?4LN!W>S%,7[P.^"MC;HS%S3E9:/[G)IV(6
M1$X02,C1,7!Z[& .4CHBDO&SY0RZE YX/#ZP/WCOY&7%+<RU_"8*+&?!AX 5
ML.9;B8]Z_Q%:/V/'EVMI_3_;-['C2<#RK45=M6!24 G5//ES6X<CP'!T 1"W
M@+@O(&D!B3?:*/.V[CGR;&KTGAD736QNX&OCT>1&*'>*2S2T*PB'V5PKJZ4H
M.$+![KCD*@>V='26O5UP PI+0)%S^8Z]9V]8R&Q)JW8:(F5W'&'>9KIK,L47
M,MU#/F#)\(K%43P\ Y_WAT>G\) \=\;CSGCL^9(+?$LDRW0=D>DU>Q"*C LN
MV4);X>_7]]N514.W[,<_DB5=LL0G&UVL<E41)YUF_L2N6,T-VW&YA7-5;)@F
MGLF]@[LL&D111"7;'5?KOV$G0D>=T%%OH5?M43.^Q5(;\1N*<WH;PO1(R.@Z
M:GXO)/>)/%$][E2/7Z]:6+L]KWC\EXYD-!DG:7K]0G"/P!.]::<W?;U>:K$6
MN2J$VIP3G?85W2.P$1T>=0W7L3]SLQ'*,@EK@D:#"=DW31=L)JAKWTA6&JDM
M^6%)'PXP+H#VUUKC8>)Z4_<IROX 4$L#!!0    ( *Z <53 G]/X=@0  !H0
M   8    >&PO=V]R:W-H965T<R]S:&5E=#0N>&ULE5A;<Z,V%/XK&F8?VIDF
M(,#8SMB>B9W=MC/=W4R2[3YT^J" ;)B Y$JRG?[['@D"V AM^A(N/I?O7#B?
M3A8G+EYD3JE"KU7)Y-++E=K?^+Y,<UH1><WWE,$O6RXJHN!1['RY%Y1D1JDJ
M_3 ($K\B!?-6"_/N7JP6_*#*@M%[@>2AJHCX=TU+?EIZV'M[\5#L<J5?^*O%
MGNSH(U7?]O<"GOS62E94E,F",R3H=NG=XIM-:!2,Q)\%/<G>/=*A/'/^HA]^
MSY9>H!'1DJ9*FR!P.=(-+4MM"7#\TQCU6I]:L7__9OV3"1Z">2:2;GCYO<A4
MOO1F'LKHEAQ*]<!/O]$FH(FVE_)2FK_H5,M.P6-ZD(I7C3(\5P6KK^2U241/
M 2<C"F&C$%XJQ",*4:,0F4!K9":L.Z+(:B'X"0DM#=;TC<F-T89H"J;+^*@$
M_%J GEIM.).\+#*B:(8>%5R@1DHBOD4;7D%GY+ID1XK^X%*B*_3M\0[]].%G
M] $5##WE_" )R^3"5X!%6_33QN^Z]AN.^,4A^LR9RB7ZR#*:G1OP(8@VDO M
MDG7HM'A'TVL4X5]0&(38 FCS?O7  2=J$QL9>]&(O0=ZI.Q T5;P"E+)E(".
MA>*J'&U,6:E ?]T^2_/^;X?#N'48&X>QVZ&U%K7FQ&CJ#_NXBB%%QWYVAB+S
MI!4Y S1I 4V<@#9<*MU'P@',:4&/L!NY)RE=>M")DHHC]5;(5MO:3M)#/[&#
M3UKPB1/\KT+W^U[P;:%LP).!PT%&AR)S; <U;4%-G3WU\16FMZ3RQM$NL];6
M[ ?M(BD1:8[@^X6Y=X2!OM>?OBW8V2"2)+X(=BB"@YD]VGF+<.Y$^$A**@T\
M()@7J@JVLX&;#SR'%]B&$B/(<-!-S<#='I1104J#CF0PEPO](6M&LH["8( @
M"BXS:!&*H^D(T-YXQTZ@7U4.@X8VC6,%AX<)G%QB<SIYUW=ZCC_L\(?N1,-)
MI)ZA$MI!CQ,"1XYG660%G#JL\3@-_H^9TACJ)^9JK'$Z5L"1,YXGKJ!MX!2F
MNX7MW)6)AFTS'Y1F*#2)1X8?[K@$N\G$L+U)>P,5C@E6B/$P1]%DT-H6J;@G
M=0ZRXQ?L)IA/!2,LI7 228%.K?"&O' YI2TBFO^MR#KRP&[V>$/65-<*;4@/
M5]$ G$5H;"1T)(*G/Z[MFL(*0)$BKS!CX3CMR.'4 G0V*+%%*HY'^ YW)(7=
M+/7T#GQ#ZKDD *?(.;*.G+";G;[ BJ4S:84T'QRF(&7))2J+5!Q'=F!A1TVA
MFYK61!9IS>I%>=#'>@902W.< 2J0.1'TQH:ZL3OKXPFN WS9E&-R(]]SV'%5
MZ.:J[V;G L#D"#-G1VNL4/Z#D@H"TO/R2B]MY_%98QF26A1/)U&2S"^CL4CB
M,,!]R3H>O[=EP>E]9Y9/B5)^8*I>4]JW[8)[:]:ZB_=K6'SK-;4S4V_-GXG8
M%4RBDF[!9' ]A>80]2):/RB^-[O<,U>P0IC;')9W*K0 _+[E7+T]: ?MOP-6
M_P%02P,$%     @ KH!Q5)8MD&@<!   K \  !@   !X;"]W;W)K<VAE971S
M+W-H965T-2YX;6RM5TUOVS@0O>^O((0 VP)Q).K3#FP#B6-C>^@B2-KMH=@#
M(]$6$8G4DK3=_/L=2HIBR[*<I+G8(CGS^.:10W+&6R$?54JI1K_RC*N)E6I=
M7-JVBE.:$W4A"LIA9"ED3C0TY<I6A:0D*9WRS'8=)[1SPK@U'9=]MW(Z%FN=
M,4YO)5+K/"?RZ9IF8CNQL/7<<<=6J38=]G1<D!6]I_I[<2NA93<H"<LI5TQP
M).ER8EWARP7VC4-I\0^C6[7SC4PH#T(\FL:79&(YAA'-:*P-!(&_#9W1+#-(
MP.._&M1JYC2.N]_/Z(LR> CF@2@Z$]D/ENAT8@TME- E66?Z3FS_HG5 @<&+
M1:;*7[2M;1T+Q6NE15X[ X.<\>J?_*J%V''P@B,.;NW@MARP=\3!JQV\]@SA
M$0>_=O!;#FYTQ"&H'8+74@IKA[#4OA*K5/J&:#(=2[%%TE@#FODHEZOT!H$9
M-SOK7DL89>"GIS/!E<A80C1-T+V&/]@V6B&Q1+.4\!55B'$8$/%C*K*$2O4G
MNJ%+%C.-!NC[_0WZ=/89G1FC;ZE8*\(3-;8U,#/X=ERSN*Y8N$=9Y+FHIT$_
MO]+\@<I_.V!N^F&NDH29_4HR=$M8,@!2,U(P#>T>T'D_Z!W5D*"@SIQ(SOA*
M]6$M^K&^">"R[V;#@C6KYC:KYI8X_A&<:Y(1'E-$-"Q&?($\?(Y<!X^ZE*^0
M@A+)G#.;J3>V-[NB'EI@S\'!OM7\T&J _0CC?;-%EUDX>IER+UZOB==[3;SG
M2*5$PI9\3=P58K@;-P;;,!QU<_$;+GXOER]*K4OQ(44J.EVS]V*8Z^)2%22F
M$PON T7EAEI3U($SZ^?R$W=FB7\0>C!LK>8'\5OT3K6G;]#H&[Q1W_,>G8/#
M50X"N%:=;A)A0R+L)?$WW.F94 K!W8UT2E%!)1-)%X->H-<K>?-!.//P0)&!
M[[=2?G'":$^SJ-$L>L>AY#I=HD4G#Z7H@"$<2E'+:GYH-< !#OQ6N!UFKA,=
MV:C#)M[A;QQ*W7$/#[>K'P7>T4-IU' 9]7)9, Y<X'9"A10;EL!U]?!4;MQ;
MX,8U@ANV(/P)?5*4(BXT1?[G+H*]T[QA-X\.EV_87I5^FST=L//RGG$^*G/[
MD=X0[$<!S6N@O8WJ#<.6;J>L]I7;>0GB]^0O[I0.GTS@#A/LN4'4RN .,TCA
MP'?:07?8N>[PR#F/7UY2^%5/J6-9W!V]^\8TQN:AL]_S\MS [[GCKT]XW=%R
MJYFG/('Z+1=KKO_(*.2%AF<].L,77<]0>Z>0R*E<E26?0K'QKEYK36]55E[C
MRUE9?;7ZK[ ']:;7,0+$GRM1^V6*JH[]2N2*<84RNH3IG(L(5EM6I6'5T*(H
M2YD'H:$P*C]3**>I- 8POA1PLM4-,T%3H$__!U!+ P04    " "N@'%4007+
MUV8%  "^%@  &    'AL+W=O<FMS:&5E=',O<VAE970V+GAM;*U8VY+:.!#]
M%165AZ1J9T#"W*88JC*PV9V'I%*9S>ZSL 76QI:())C)WV]+-C;8LF"R>0%;
M5G>?OJB/I/FS5-]TRIA!+WDF]'TO-69WU^_K.&4YU;=RQP1\V4B54P.O:MO7
M.\5HXH3RK$\&@W$_IUST%G,W]EDMYG)O,B[89X7T/L^I^O' ,OE\W\.]X\ 7
MODV-'>@OYCNZ94_,?-U]5O#6K[0D/&="<RF08IO[WGM\MR(S*^!F_,W9LSYY
M1M:5M93?[,MC<M\;6$0L8[&Q*BC\'=B299G5!#B^ETI[E4TK>/I\U/[!.0_.
MK*EF2YG]PQ.3WO>F/92P#=UGYHM\_I.5#HVLOEAFVOVBYV+N9-)#\5X;F9?"
M@"#GHOBG+V4@3@3PN$. E *D*1!U" Q+@>&U E$I$+G(%*ZX.*RHH8NYDL](
MV=F@S3ZX8#II<)\+F_<GH^ K!SFS6$JA9<83:EB"G@S\05*-1G*#EE2GZ ,4
MAD8WZ.O3"KU]\PZ]05R@OU*YUU0D>MXW@,%JZL>EO8?"'NFPAPGZ*(5)-?I=
M)"PY5] '\)4'Y.C! PEJ7+'X%@WQ;X@,"/8 6EXO/O"(K\+B']CZ%F'B$S_S
M9ECE8^CT#;OR88.^<4'?*)DC6."*&BZVQ0KAAC,=,!-59B)G)NHP\PDZ2B8U
M&)$*F90A,,-EXLMGH6CD%-DN<EC<#*?C>?]P&F//I"@:5I/.,(XJC*-@*-XG
M_T+]%^5H)#296(J89PR)(W@8M<^QC=E>0P%#;?H"=A>(V+A",PY&[ _HH45*
M- 4,L#XH-,NUY@F'?ND+7%"?[>=W>D=C=M^#AJV9.K#> OGJM] S/HWMU!_9
M2>7+).C+BH')F%/;>7W(@]*O0#YI(1_Y@4\KX-/PZDBIV#+=R+/6#$H$^A'*
M.%WS[&+.9Y6YV84XQ<"EFJ&WCZ)X>F=-&T439NN1\0-=9ZRP#;'849X@]@*<
MK)NKM CL+!"0(F3M&3?1P!\T/*A[_.!G_)"P\!4LDUCN[1JK'?*V]4$;&1XT
MT'LFX4$7_!.*PD'X1]#H;<)::=C1'RX'7LRX'6_2A-R><S/J*%-,:LCD.LB
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M-$;F[C%E</)2=@)\WTAICB_60'5EO?@/4$L#!!0    ( *Z <51O8;'-$@H
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M^8[$2MW SUK74E<FB[$==4=RJMQ*T.0"'Z3^LS4WJF(=:2=)%YID2@2S5-#
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MM0?[M+ 1X;50Y0WG(Y=OXJIUW1(SSP4$QT7+8.G:UL."9@7U,S@A/#">S/9
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M1\^?'83KV_0%'N-WGN?6 RWYXTHK% 4:@-\7%D4U?J$%NI?@W_X/4$L#!!0
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M0M@HA,[OVI#S<LD,BR9*'D%9-+'9@PO5:9-SA;!%28RBUX+T3+2)DWBV6=S
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MZ$6.F@7H^T+1T%0;=K![XU__#5!+ P04    " "N@'%4,97S\>@"   0!@
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MHXN1R-1"-H5_9]8_J]:><]*7FL+Q7[$.9Z<_CD3:.&_*5A@(2EV%__*A]<-
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MJ$*2-'N]WFE/TZ& BJ0:H6=%,854M1472L.D8W(U.AV/3B\NA^+VT%?X/\&
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M-D(;@[IM9EY$E#;!W&^%T,>#):C?V/X_4$L#!!0    ( *Z <50W,-8!50(
M /T$   9    >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;'U4VVX:,1!]YRM&
M;E6U4I2] &F:PDK+)4VD7!"05E75![,[L*OXLK5-"']?VPM;*@5>UAY[YIPS
MLS/N;:1ZU@6B@5?.A.Z3PICJ*@AT5B"G^EQ6*.S-4BI.C375*M"50IK[(,Z"
M. PO DY+09*>/YNHI"?7AI4")PKTFG.JM@-D<M,G$=D?3,M58=Q!D/0JNL(9
MFJ=JHJP5-"AYR5'H4@I0N.R3-+H:=)R_=_A>XD8?[,%ELI#RV1FW>9^$3A R
MS(Q#H'9YP2$RYH"LC#\[3-)0NL##_1[]VN=N<UE0C4/)?I2Y*?KDDD".2[IF
M9BHW-[C+I^OP,LFT_\*F]FU_(9"MM9%\%VP5\%+4*WW=U>$@X#(\$A#O F*O
MNR;R*D?4T*2GY :4\[9H;N-3]=%67"G<3YD996]+&V>2Z?@NG8]',$FG\Y\P
MGZ8/LW0XOWU\F,''.5TPU)]Z@;%$SCW(=J"#&C0^ AK%<"^%*32,18[Y_P"!
M5=C(C/<R!_%)Q!%FY]".SB .X^@$7KM)N^WQVL?21D8-YC"ARFQAKJC0U+>)
MAE_I0AMEK=\G>#H-3\?S=([PS(8WX]'3W1@>K^%XJ=^J\$E<-ZI7NJ(9]HF=
M18WJ!4D">[;62;:6+2;R!:J6*^BAT7+5=24.6]_*U]:'=Y=Q%'V%H>05%5M;
MK*WK"'@/\5D47?@U[';@K3H%!RW)4:W\X&G(Y%J8NCN;TV:VT[JE_[G7#\,]
M5:O2_AB&2QL:GG_N$E#UL-6&D95O\(4T=ES\MK#O$RKG8.^74IJ]X0B:%R_Y
M"U!+ P04    " "N@'%47*X]EU0#  !Z!P  &0   'AL+W=O<FMS:&5E=',O
M<VAE970R-2YX;6RE56%OXC@0_<ZO&$5::5=") 32+14@A4+52!0X CV=3O?!
M) .QUHFSME-V__W:#N38JJ"33FK#V)YY?O/&'@^/7'R3&:*"'SDKY,C)E"H?
M7%<F&>9$=GB)A5[9<Y$3I8?BX,I2($EM4,Y<W_/NW)S0PAD/[=Q*C(>\4HP6
MN!(@JSPGXN<$&3^.G*YSGEC30Z;,A#L>EN2 ,:IMN1)ZY#8H*<VQD)07(' _
M<L+NPR0P_M;AE>)17MA@,MEQ_LT,HG3D>(80,DR402#ZYPT?D3$#I&E\/V$Z
MS98F\-(^HS_9W'4N.R+QD;,_::JRD7/O0(I[4C&UYL=G/.5C"2:<2?N%8^W[
M5>^85%+Q_!2LQSDMZE_RXZ3#1<"]=R7 /P7XEG>]D64Y)8J,AX(?01AOC68,
MFZJ-UN1H88H2*Z%7J8Y3X_AYN=[ 9K9^@?DR7$"XF$(4Q]M9#,LGB)_#M;8^
M;\B.H?PR=)7>T@2ZR0E^4L/[5^"[/KSP0F429D6*Z>\ KN;:$/;/A"?^3<0I
M)AWH==O@>W[W!EZO$:!G\7I7\78*IE0FC,M*(/P=[J02^K#\<P.\WX#W+7C_
MFKJ/S[/I=CXS6CZ%T1I>P_EV!M,HWJRCR783+1=F:1Z%DV@>;?ZR\L_^V!KS
M<?FR6BYFBTW\D>PW]S4W^4&6),&1HZ^J1/&&SGB388LPQA-B[P/?@\H02L$3
MQ%2"XG:\)U3 &V$50DJU$G177;HS2G:44?432)$"?J^,F?"\Y 462H+V-&Y:
MP4(2>_$DI$0A'(D$_;?GFL%1/L!9FM;_DJ85%9ICI;N$@B?#_-4R_V3I<D58
MG4]8IXTID)Q7A6K-.2D@"-JZ=T%_T.D'^MOV^W>M."-:, CZ;4\O!5XG"/2W
MW>M[K8W%ZWH#&]75_X-!.[B_@QL')6@.2O"?#XK-+H[."KR[H1\=AIO8UP^#
M+9NDY_+*C L%"D4.S,BS(XP4"9JJG8I_456@U\MY.X'62M BH:76LBX&W U:
MY@):6R/'[WA\[@[@2^O=;!L6^L4*O _%=R_Z88[B8+N^!+M#W1J;V>9A">M^
M^J][_2J]$'&@^@PSW.M0K_-5:RWJ3E\/%"]M=]UQI7NU-3/].*(P#GI]S[DZ
M#\P&S7,[_@502P,$%     @ KH!Q5$ZK5M*5 @  @ 4  !D   !X;"]W;W)K
M<VAE971S+W-H965T,C8N>&ULA51=;]HP%'WOK[C*I&F3*A(";2F#2'QUI1T%
M0;IJFO9@D@NQZMBI;4J[7S\["2F3"GV)?7WO.??#.>YLA7Q4":*&EY1QU742
MK;.VZZHHP92HFLB0&\]*R)1H8\JUJS*)),Y!*7-]SSMW4T*Y$W3RLYD,.F*C
M&>4XDZ V:4KD:Q^9V':=NK,[F--UHNV!&W0RLL8%ZOML)HWE5BPQ39$K*CA(
M7'6=7KW=;]KX/. GQ:W:VX/M9"G$HS7&<=?Q;$'(,-*6@9CE&0?(F"4R93R5
MG$Z5T@+W]SOVJ[QWT\N2*!P(]D!CG72=E@,QKLB&Z;G87F/9SYGEBP13^1>V
M16S#=R#:*"W2$FPJ2"DO5O)2SF$/T/(. /P2X.=U%XGR*H=$DZ CQ1:DC39L
M=I.WFJ--<93;2UEH:;S4X'2P"*>#V^OIC^%HOOC\J>77+[[!<'0U'HQ#^!*2
M)4/UM>-JD\G&NU')VB]8_0.L=1\F@NM$P8C'&/]/X)H2JSK]79U]_RCC$*,:
M-.JGX'M^_0A?H^J[D?,U#O"-GC94O\+OWE)I:7Z-/T<XFQ5G,^=L'IKE_632
MF_^"Z15,[\-%V+L;CN^^PT-O/N_=A8OWQGB4T JRK3(28=<QBE,HG]$)P@1/
M5H(9-5&^!FVOJ)04_8L**"^4:G]YL0*C0Z4)CVWLEDA)N%9 E'69D6*Z1%F-
MM0T?='#RL&,H-Q"B3&'T@C*B"F$F:80[TQ9V,F!$*;B!"M@X/6]>GC;J+;C9
ML%>;]A*\6K/UYB@QMQ]A6MZ>X[W;<_=4D:)<Y]I7$(D-UX5 JM/J>>D5JGH+
M+]ZF"9%KRA4P7!FH5[LX<T 6>B\,+;)<8TNAC6+S;6*>2)0VP/A70NB=81-4
MCV[P#U!+ P04    " "N@'%4T!G.8E "  #F!   &0   'AL+W=O<FMS:&5E
M=',O<VAE970R-RYX;6Q]5-MNVS ,?<]7$'[:@*&^I9<5B8$F==$"ZU8T:X=A
MV(-L,[%06?(D.>G^?I2<>-G0Y,42;X?D,:G)1ND74R-:>&V$--.@MK:]#$-3
MUM@P<Z):E&19*MTP2Z)>A:;5R"H?U(@PB:*SL&%<!MG$ZQYT-E&=%5SB@P;3
M-0W3OV<HU&8:Q,%.\<A7M76*,)NT;(4+M$_M@R8I'% JWJ T7$G0N)P&5_'E
M;.S\O<,SQXW9NX/KI%#JQ0EWU32(7$$HL+0.@=&QQCD*X8"HC%];S&!(Z0+W
M[SOT&]\[]5(P@W,EOO'*UM/@(H *EZP3]E%M;G';SZG#*Y4P_@N;WG=\'D#9
M&:N:;3!5T'#9G^QUR\->P$5T("#9!B2^[CZ1K_*:699-M-J =MZ$YBZ^51]-
MQ7'I?LK":K)RBK/98_Z<?W[*%_#N*RL$FO>3T!*L,X;E%F+60R0'(.($[I6T
MM8%<5EC]"Q!2/4-1R:ZH67(4\1K+$TCC#Y!$27P$+QV:3#U>>JA)7*/L$)9:
M-3"G6C4- Q%M:YA[BE'#CZO">/W/(PG'0\*Q3S@^D' QO\VOGS[E\.4&=@R_
M1>Q1%+>/EZ9E)4X#6CB#>HU!!F]AC[XCTX".?B#RL"FH(R)PY AT+$:C.UGQ
M-:\Z)F#1%:;4O'5K82".($Y'N;2H6\T-_F=.8[A(1^,8/I[!6\R$>[-'/*[\
MAADH52=M/X:#=ECBJWYV_[KW+\ ]TRM.*04N*30Z.3\-0/=;U0M6M7Z2"V7I
MI_EK30\1:N= ]J52=B>X!,/3EOT!4$L#!!0    ( *Z <53()]DB9@(  " %
M   9    >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;)54VV[;, Q]SU<0>MJ
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ME76@\Y64YF#8 .VC&/X&4$L#!!0    ( *Z <50]7EY\3@(  /H$   9
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MO5/HDYMT^GR7PL,UO&4X?4/Q>\R>178[VC<5RW 8T!(:U*\8)/"_^5J_D&E
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MI0F@\Z40>K\P NVS&_T!4$L#!!0    ( *Z <51A3]'J<P(  "L%   9
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M^<#6UZ1:D*OY A:+XAO6U5AS $$N)$LJL%*0T+3\Q2_51FP![%$+P*H U@[
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M%0$_'/"'B62;Y%!=,*F.Z&3HJY\BX'J#6E\Q)E\G^IS.?K.:OP%02P,$%
M  @ KH!Q5 E#A*)= @  _P4  !D   !X;"]W;W)K<VAE971S+W-H965T,SDN
M>&ULC51=3^,P$/PKJX@'D(!\M 4.I9&@ 8$$M&K+W</I'MQTVU@X=LYV*/S[
MLYT0]>[2JB^)U]Z9G=ED'6^$?%,YHH:/@G$U]'*MRVO?5UF.!5'GHD1N3E9"
M%D2;4*Y]54HD2P<JF!\%P85?$,J])'9[$YG$HM*,<IQ(4%51$/EYBTQLAE[H
M?6U,Z3K7=L-/XI*L<8;ZM9Q($_DMRY(6R!45'"2NAMY->)T.;+Y+^$YQH[;6
M8)TLA'BSP>-RZ 56$#+,M&4@YO6.(V3,$AD9OQM.KRUI@=OK+_9[Y]UX61"%
M(\%^T*7.A]Z5!TM<D8KIJ=@\8./'"<P$4^X)FSKWTB1GE=*B:,!&04%Y_28?
M31^V &%_!R!J -&A@%X#Z!T*Z#> ONM,;<7U(26:)+$4&Y VV[#9A6NF0QO[
ME-O//M/2G%*#T\EL]'"7OC[=P?@>1N/GR7CV.'\<O]AP]C">SF%^-WV&I_'-
M"QRGJ EEZ@3.X'66PO'1"1P!Y3#/1:4(7ZK8UT:2)?:SIOQM73[:43[%[!QZ
MX2E$011VP$>'PX,.>'H /+SJ@ONFCVTSH[:9D>/K[>1;:$BIRIA0E43X>;-0
M6II?^]<>\EY+WG/D_1WD$TEY1DO"@!2BXKK+;LTP< QVX-^3BV^Q_]Y1M=]6
M[>^M:MW8:F!F=)8+J4&C+( )PKL$U&076P+.PAT*!JV"P5X%_U0]A1?L\GX[
MV.>]_IG^3QD$?Z>D>U-J_?[6M-FK\9G(->4*&*X,*#B_-&A97S=UH$7I!G A
MM!EGM\S-#8W2)ICSE1#Z*[ SW=[YR1]02P,$%     @ KH!Q5#3%T,RE P
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M$6&"D;$0C'[6.,$DL4@4Q]<2M%/YM(;;UP_HKUWRE,R<:9S(Y!./S>JB,^Q
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M*4KO[%P)XO7(J#>2E:;K+IE4/=PL,S5F@>L =;]B3&XW.H$=W-$?4$L#!!0
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MTY=$K.P<Y430M2Z^'U3(4JZ'B6RVR)2!_+ZD5.PG:H.Z?7M_ 5!+ P04
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MZ-;LABD];%#9#?1]+J793*R"^JDT^!=02P,$%     @ KH!Q5,&0-970 @
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MV2)+0_&M[3(KKG3/LL-,_U6P, YZ?<VY.AAF@_H_-?@#4$L#!!0    ( *Z
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MAEW4,+X4^7)6D?9C__N*=]Y.@*[O\SR L:2(2K$ZO.IP>$WCX_]02P,$%
M  @ KH!Q5*&7ZI3) 0  H!X  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<\W9N6["0!2%X5=!?@"&NY@L@E1ITD:\@$6&12RV/!,%WCX("G*L%&FB
M.94UMGS]R\4G:SQ[C_LF;]MCVFR[-#H=]L<TKS8Y=\\AI.4F'IHT;KMXO%Q9
MM?VAR9=EOPY=L]PUZQAT,IF&_N>,ZF7V<^9H<>[B7R:VJ]5V&5_;Y><A'O,O
M@\-7V^_2)L9<C19-OXYY7H73_GXZA>M!QI?)U>CM8U[U;Q]2A=)!"D%:/L@@
MR,H'.01Y^: :@NKR05,(FI8/>H"@A_)!CQ#T6#[H"8*>R@?)!&6<$"0-L";0
M6I!K(?!:$&PA$%N0;"$P6Q!M(5!;D&TA<%L0;B&06Y!N(;!;$&\AT%M1;R70
M6U%O)=!;!Q_;!'HKZJT$>BOJK01Z*^JM!'HKZJT$>BOJK01Z*^JM!'HKZJT$
M>AOJ;01Z&^IM!'H;ZFT$>MM@LX1 ;T.]C4!O0[V-0&]#O8U ;T.]C4!O0[V-
M0&]#O8U ;T>]G4!O1[V=0&]'O9U ;T>]G4!O'VQV$^CMJ+<3Z.VHMQ/H[:BW
M$^CMJ+<3Z.VHMQ/H7:/>-8'>->I=_Z?>*9_W,=U[;FM\_G]2G2_WQOOCK\O;
MR<%+N.(<X(?TRS=02P,$%     @ KH!Q5"BT:!/# 0  B1X  !,   !;0V]N
M=&5N=%]4>7!E<UTN>&ULS=G);L(P% 707T'95L1X@ X"-FVW+8O^@)L\("*)
M+=M0^/LZ89!:T:B(2KV;1(GM=U]LZ6PR?MM9\KUM5=9^DBQ#L ^,^6Q)E?:I
ML53'D;EQE0[QT2V8U=E*+XB)P6#$,E,'JD,_-#62Z?B)YGI=AM[S-K[VA:DG
MB:/2)[W'_<0F:Y)H:\LBTR&.LTV=?TOI'Q+2N+*=XY>%]3=Q0L+.)C0C/P<<
MUKUNR+DBI]Y,N_"BJSB+;4OFPZXDGW:7.-.CF<^+C'*3K:NX)/76D<[]DBA4
M9;HO>M.='.(.T_[*K\YORW0%QIDS9ZR/)^;H\KCCD32K^S86(A>*[D\\)<;2
M5W\?-:>=4_[+[+B]'\:MVO/PK+U=O\=?S_A4_\(^!$@?$J0/!=+'$*2/$4@?
MMR!]W('T<0_2!Q^@-((B*D<AE:.8RE%0Y2BJ<A16.8JK' 56CB*K0)%5H,@J
M4&05*+(*%%D%BJP"15:!(JM D56@R"I19)4HLDH4626*K!)%5HDBJT215:+(
M*E%DE2BR*A19%8JL"D56A2*K0I%5H<BJ4&15*+(J%%D5BJQ#%%F'_RGKNS&K
MO_XYVMS32A?U,9^U?Z"GGU!+ 0(4 Q0    ( *Z <50'04UB@0   +$    0
M              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @
MKH!Q5"0H3T7N    *P(  !$              ( !KP   &1O8U!R;W!S+V-O
M<F4N>&UL4$L! A0#%     @ KH!Q5)E<G",0!@  G"<  !,
M ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " "N@'%4<%2>
M4?D%  !"&0  &               @($-"   >&PO=V]R:W-H965T<R]S:&5E
M=#$N>&UL4$L! A0#%     @ KH!Q5+,^P-!+!   0 \  !@
M ("!/ X  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( *Z
M<5165!@09P(  )8&   8              " @;T2  !X;"]W;W)K<VAE971S
M+W-H965T,RYX;6Q02P$"% ,4    " "N@'%4P)_3^'8$   :$   &
M        @(%:%0  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%
M  @ KH!Q5)8MD&@<!   K \  !@              ("!!AH  'AL+W=O<FMS
M:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( *Z <51!!<O79@4  +X6   8
M              " @5@>  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"
M% ,4    " "N@'%4;V&QS1(*  "E&@  &               @('T(P  >&PO
M=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ KH!Q5 .P9@+0$
M$"\  !@              ("!/"X  'AL+W=O<FMS:&5E=',O<VAE970X+GAM
M;%!+ 0(4 Q0    ( *Z <52@D7S.OP(  /L%   8              " @4(_
M  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " "N@'%4#S4(
M8E\%  #:"P  &0              @($W0@  >&PO=V]R:W-H965T<R]S:&5E
M=#$P+GAM;%!+ 0(4 Q0    ( *Z <52 KK8&: 0  /8(   9
M  " @<U'  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @
MKH!Q5![LK,?_!   JPH  !D              ("!;$P  'AL+W=O<FMS:&5E
M=',O<VAE970Q,BYX;6Q02P$"% ,4    " "N@'%4*.>2#DL"  #A!   &0
M            @(&B40  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4
M Q0    ( *Z <52A'EQ^8 (  #0%   9              " @214  !X;"]W
M;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ KH!Q5&I>,-E* @
M!P4  !D              ("!NU8  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX
M;6Q02P$"% ,4    " "N@'%4IU5X+=$"   -!@  &0              @($\
M60  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( *Z <50_
MPMJN;P(  $(%   9              " @41<  !X;"]W;W)K<VAE971S+W-H
M965T,3<N>&UL4$L! A0#%     @ KH!Q5.%_23A^!0  [PL  !D
M     ("!ZEX  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *Z <51??.J-?0(  &\%   9              "
M@9^%  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ KH!Q
M5#<PU@%5 @  _00  !D              ("!4X@  'AL+W=O<FMS:&5E=',O
M<VAE970R-"YX;6Q02P$"% ,4    " "N@'%47*X]EU0#  !Z!P  &0
M        @('?B@  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0
M   ( *Z <51.JU;2E0(  ( %   9              " @6J.  !X;"]W;W)K
M<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ KH!Q5- 9SF)0 @  Y@0
M !D              ("!-I$  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q0
M2P$"% ,4    " "N@'%4R"?9(F8"   @!0  &0              @(&]DP
M>&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( *Z <50]7EY\
M3@(  /H$   9              " @5J6  !X;"]W;W)K<VAE971S+W-H965T
M,CDN>&UL4$L! A0#%     @ KH!Q5#RPDPF* @  @@4  !D
M ("!WY@  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " "N
M@'%484_1ZG,"   K!0  &0              @(&@FP  >&PO=V]R:W-H965T
M<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( *Z <529#N2D\P,  -<(   9
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M970S-BYX;6Q02P$"% ,4    " "N@'%490*QE7,"  #$!0  &0
M    @('DK@  >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    (
M *Z <53$@!6=Z (  '()   9              " @8ZQ  !X;"]W;W)K<VAE
M971S+W-H965T,S@N>&UL4$L! A0#%     @ KH!Q5 E#A*)= @  _P4  !D
M             ("!K;0  'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"
M% ,4    " "N@'%4-,70S*4#   /#@  &0              @(%!MP  >&PO
M=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( *Z <53R1KM$Z (
M $,)   9              " @1V[  !X;"]W;W)K<VAE971S+W-H965T-#$N
M>&UL4$L! A0#%     @ KH!Q5*/U,J'V!   [!$  !D              ("!
M/+X  'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " "N@'%4
MJ@]B*Z("  #$!P  &0              @(%IPP  >&PO=V]R:W-H965T<R]S
M:&5E=#0S+GAM;%!+ 0(4 Q0    ( *Z <51H'PU8J0(   @'   9
M      " @4+&  !X;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%
M  @ KH!Q5"7)4&>4 @  Y08  !D              ("!(LD  'AL+W=O<FMS
M:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " "N@'%4@$6E/^8"  #*!P
M&0              @('MRP  >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+
M 0(4 Q0    ( *Z <51V[!L#!P,  *H)   9              " @0K/  !X
M;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ KH!Q5/%[$\(9
M P  V0@  !D              ("!2-(  'AL+W=O<FMS:&5E=',O<VAE970T
M."YX;6Q02P$"% ,4    " "N@'%4E'9UV.X"  !0"   &0
M@(&8U0  >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( *Z
M<51_06[2& 0  #8-   9              " @;W8  !X;"]W;W)K<VAE971S
M+W-H965T-3 N>&UL4$L! A0#%     @ KH!Q5,&0-970 @  LP8  !D
M         ("!#-T  'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q02P$"% ,4
M    " "N@'%4]2K=:34#   R$P  #0              @ $3X   >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( *Z <527BKL<P    !,"   +
M  "  7/C  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( *Z <52>BR)ULP0  "HB
M   /              "  5SD  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" "N@'%4H9?JE,D!  "@'@  &@              @ $\Z0  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "N@'%4*+1H$\,!  ")'@
M$P              @ $]ZP  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
...P [ !00   Q[0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>70</ContextCount>
  <ElementCount>265</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>34</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/StatementsOfComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Changes in Stockholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit</Role>
      <ShortName>Consolidated Statements of Changes in Stockholders' Deficit</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - GENEREL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/Generel</Role>
      <ShortName>GENEREL</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilities</Role>
      <ShortName>OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - SHORT TERM LOAN AND ISSUES OF SHARES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfShares</Role>
      <ShortName>SHORT TERM LOAN AND ISSUES OF SHARES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - STOCKHOLDERS??? DEFICIT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/StockholdersDeficit</Role>
      <ShortName>STOCKHOLDERS??? DEFICIT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - REVENUES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/Revenues</Role>
      <ShortName>REVENUES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/ResearchAndDevelopmentExpenses</Role>
      <ShortName>RESEARCH AND DEVELOPMENT EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - SALES AND MARKTING EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/SalesAndMarktingExpenses</Role>
      <ShortName>SALES AND MARKTING EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/GeneralAndAdministrativeExpenses</Role>
      <ShortName>GENERAL AND ADMINISTRATIVE EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - FINANCIAL EXPENSES (INCOME), NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/FinancialExpensesIncomeNet</Role>
      <ShortName>FINANCIAL EXPENSES (INCOME), NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - LOSS PER SHARE-BASIC AND DILUTED</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/LossPerShare-basicAndDiluted</Role>
      <ShortName>LOSS PER SHARE-BASIC AND DILUTED</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - COVID-19 PANDEMIC IMPLICATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/Covid-19PandemicImplications</Role>
      <ShortName>COVID-19 PANDEMIC IMPLICATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilitiesTables</Role>
      <ShortName>OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilities</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/RelatedPartyTransactionsTables</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://corp.viewbix.com/role/RelatedPartyTransactions</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - SHORT TERM LOAN AND ISSUES OF SHARES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesTables</Role>
      <ShortName>SHORT TERM LOAN AND ISSUES OF SHARES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfShares</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - STOCKHOLDERS??? DEFICIT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/StockholdersDeficitTables</Role>
      <ShortName>STOCKHOLDERS??? DEFICIT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://corp.viewbix.com/role/StockholdersDeficit</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - REVENUES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/RevenuesTables</Role>
      <ShortName>REVENUES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://corp.viewbix.com/role/Revenues</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/ResearchAndDevelopmentExpensesTables</Role>
      <ShortName>RESEARCH AND DEVELOPMENT EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://corp.viewbix.com/role/ResearchAndDevelopmentExpenses</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - SALES AND MARKTING EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/SalesAndMarktingExpensesTables</Role>
      <ShortName>SALES AND MARKTING EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://corp.viewbix.com/role/SalesAndMarktingExpenses</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/GeneralAndAdministrativeExpensesTables</Role>
      <ShortName>GENERAL AND ADMINISTRATIVE EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://corp.viewbix.com/role/GeneralAndAdministrativeExpenses</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - FINANCIAL EXPENSES (INCOME), NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/FinancialExpensesIncomeNetTables</Role>
      <ShortName>FINANCIAL EXPENSES (INCOME), NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://corp.viewbix.com/role/FinancialExpensesIncomeNet</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/IncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://corp.viewbix.com/role/IncomeTaxes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - LOSS PER SHARE-BASIC AND DILUTED (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/LossPerShare-basicAndDilutedTables</Role>
      <ShortName>LOSS PER SHARE-BASIC AND DILUTED (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://corp.viewbix.com/role/LossPerShare-basicAndDiluted</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - GENEREL (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/GenerelDetailsNarrative</Role>
      <ShortName>GENEREL (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://corp.viewbix.com/role/Generel</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - SCHEDULE OF OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/ScheduleOfOtherAccountsPayableAndAccruedLiabilitiesDetails</Role>
      <ShortName>SCHEDULE OF OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/ScheduleOfRelatedPartyTransactionsDetails</Role>
      <ShortName>SCHEDULE OF RELATED PARTY TRANSACTIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://corp.viewbix.com/role/RelatedPartyTransactionsTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - SCHEDULE OF FAIR VALUE DISTRIBUTION OF LIABILITY AND EQUITY COMPONENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails</Role>
      <ShortName>SCHEDULE OF FAIR VALUE DISTRIBUTION OF LIABILITY AND EQUITY COMPONENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - SCHEDULE OF COMPOSITION OF SHORT TERM LOAN (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/ScheduleOfCompositionOfShortTermLoanDetails</Role>
      <ShortName>SCHEDULE OF COMPOSITION OF SHORT TERM LOAN (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - SHORT TERM LOAN AND ISSUES OF SHARES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative</Role>
      <ShortName>SHORT TERM LOAN AND ISSUES OF SHARES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - SUMMARY OF OUTSTANDING WARRANTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/SummaryOfOutstandingWarrantsDetails</Role>
      <ShortName>SUMMARY OF OUTSTANDING WARRANTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - STOCKHOLDERS??? DEFICIT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative</Role>
      <ShortName>STOCKHOLDERS??? DEFICIT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://corp.viewbix.com/role/StockholdersDeficitTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - SCHEDULE OF REVENUES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/ScheduleOfRevenuesDetails</Role>
      <ShortName>SCHEDULE OF REVENUES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails</Role>
      <ShortName>SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - SCHEDULE OF SALES AND MARKETING EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/ScheduleOfSalesAndMarketingExpensesDetails</Role>
      <ShortName>SCHEDULE OF SALES AND MARKETING EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails</Role>
      <ShortName>SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - SCHEDULE OF FINANCIAL (EXPENSES) INCOME, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/ScheduleOfFinancialExpensesIncomeNetDetails</Role>
      <ShortName>SCHEDULE OF FINANCIAL (EXPENSES) INCOME, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - SCHEDULE OF DEFERRED INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails</Role>
      <ShortName>SCHEDULE OF DEFERRED INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - SCHEDULE OF LOSS (INCOME) FROM CONTINUING OPERATIONS, BEFORE TAXES ON INCOME (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails</Role>
      <ShortName>SCHEDULE OF LOSS (INCOME) FROM CONTINUING OPERATIONS, BEFORE TAXES ON INCOME (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://corp.viewbix.com/role/IncomeTaxesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - SCHEDULE OF LOSS PER SHARE-BASIC AND DILUTED (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corp.viewbix.com/role/ScheduleOfLossPerShare-basicAndDilutedDetails</Role>
      <ShortName>SCHEDULE OF LOSS PER SHARE-BASIC AND DILUTED (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="form10-k.htm">form10-k.htm</File>
    <File>ex21-1.htm</File>
    <File>ex31-1.htm</File>
    <File>ex32-1.htm</File>
    <File>vbix-20211231.xsd</File>
    <File>vbix-20211231_cal.xml</File>
    <File>vbix-20211231_def.xml</File>
    <File>vbix-20211231_lab.xml</File>
    <File>vbix-20211231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>fin_001.jpg</File>
    <File>fin_002.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="286">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="35">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>69
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form10-k.htm": {
   "axisCustom": 0,
   "axisStandard": 12,
   "contextCount": 70,
   "dts": {
    "calculationLink": {
     "local": [
      "vbix-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "vbix-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "form10-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "vbix-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vbix-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "vbix-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 307,
   "entityCount": 1,
   "hidden": {
    "http://corp.viewbix.com/20211231": 3,
    "http://fasb.org/us-gaap/2021-01-31": 20,
    "http://xbrl.sec.gov/dei/2021q4": 3,
    "total": 26
   },
   "keyCustom": 28,
   "keyStandard": 237,
   "memberCustom": 25,
   "memberStandard": 9,
   "nsprefix": "VBIX",
   "nsuri": "http://corp.viewbix.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://corp.viewbix.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - RELATED PARTY TRANSACTIONS",
     "role": "http://corp.viewbix.com/role/RelatedPartyTransactions",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - SHORT TERM LOAN AND ISSUES OF SHARES",
     "role": "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfShares",
     "shortName": "SHORT TERM LOAN AND ISSUES OF SHARES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - STOCKHOLDERS\u2019 DEFICIT",
     "role": "http://corp.viewbix.com/role/StockholdersDeficit",
     "shortName": "STOCKHOLDERS\u2019 DEFICIT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - REVENUES",
     "role": "http://corp.viewbix.com/role/Revenues",
     "shortName": "REVENUES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES",
     "role": "http://corp.viewbix.com/role/ResearchAndDevelopmentExpenses",
     "shortName": "RESEARCH AND DEVELOPMENT EXPENSES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VBIX:SalesAndMarketingExpensesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - SALES AND MARKTING EXPENSES",
     "role": "http://corp.viewbix.com/role/SalesAndMarktingExpenses",
     "shortName": "SALES AND MARKTING EXPENSES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VBIX:SalesAndMarketingExpensesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VBIX:GeneralAndAdministrativeExpensesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES",
     "role": "http://corp.viewbix.com/role/GeneralAndAdministrativeExpenses",
     "shortName": "GENERAL AND ADMINISTRATIVE EXPENSES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VBIX:GeneralAndAdministrativeExpensesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VBIX:FinancingIncomeExpensesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - FINANCIAL EXPENSES (INCOME), NET",
     "role": "http://corp.viewbix.com/role/FinancialExpensesIncomeNet",
     "shortName": "FINANCIAL EXPENSES (INCOME), NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VBIX:FinancingIncomeExpensesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - INCOME TAXES",
     "role": "http://corp.viewbix.com/role/IncomeTaxes",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - LOSS PER SHARE-BASIC AND DILUTED",
     "role": "http://corp.viewbix.com/role/LossPerShare-basicAndDiluted",
     "shortName": "LOSS PER SHARE-BASIC AND DILUTED",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - Consolidated Balance Sheets",
     "role": "http://corp.viewbix.com/role/BalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnusualRisksAndUncertaintiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - COVID-19 PANDEMIC IMPLICATIONS",
     "role": "http://corp.viewbix.com/role/Covid-19PandemicImplications",
     "shortName": "COVID-19 PANDEMIC IMPLICATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnusualRisksAndUncertaintiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://corp.viewbix.com/role/SubsequentEvents",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)",
     "role": "http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilitiesTables",
     "shortName": "OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)",
     "role": "http://corp.viewbix.com/role/RelatedPartyTransactionsTables",
     "shortName": "RELATED PARTY TRANSACTIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ShortTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VBIX:ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - SHORT TERM LOAN AND ISSUES OF SHARES (Tables)",
     "role": "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesTables",
     "shortName": "SHORT TERM LOAN AND ISSUES OF SHARES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ShortTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VBIX:ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - STOCKHOLDERS\u2019 DEFICIT (Tables)",
     "role": "http://corp.viewbix.com/role/StockholdersDeficitTables",
     "shortName": "STOCKHOLDERS\u2019 DEFICIT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - REVENUES (Tables)",
     "role": "http://corp.viewbix.com/role/RevenuesTables",
     "shortName": "REVENUES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VBIX:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES (Tables)",
     "role": "http://corp.viewbix.com/role/ResearchAndDevelopmentExpensesTables",
     "shortName": "RESEARCH AND DEVELOPMENT EXPENSES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VBIX:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "VBIX:SalesAndMarketingExpensesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VBIX:ScheduleOfSalesAndMarketingExpensesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - SALES AND MARKTING EXPENSES (Tables)",
     "role": "http://corp.viewbix.com/role/SalesAndMarktingExpensesTables",
     "shortName": "SALES AND MARKTING EXPENSES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "VBIX:SalesAndMarketingExpensesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VBIX:ScheduleOfSalesAndMarketingExpensesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://corp.viewbix.com/role/BalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "VBIX:GeneralAndAdministrativeExpensesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VBIX:ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables)",
     "role": "http://corp.viewbix.com/role/GeneralAndAdministrativeExpensesTables",
     "shortName": "GENERAL AND ADMINISTRATIVE EXPENSES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "VBIX:GeneralAndAdministrativeExpensesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VBIX:ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "VBIX:FinancingIncomeExpensesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VBIX:ScheduleFinancingIncomeExpensesNetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - FINANCIAL EXPENSES (INCOME), NET (Tables)",
     "role": "http://corp.viewbix.com/role/FinancialExpensesIncomeNetTables",
     "shortName": "FINANCIAL EXPENSES (INCOME), NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "VBIX:FinancingIncomeExpensesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VBIX:ScheduleFinancingIncomeExpensesNetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://corp.viewbix.com/role/IncomeTaxesTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - LOSS PER SHARE-BASIC AND DILUTED (Tables)",
     "role": "http://corp.viewbix.com/role/LossPerShare-basicAndDilutedTables",
     "shortName": "LOSS PER SHARE-BASIC AND DILUTED (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - GENEREL (Details Narrative)",
     "role": "http://corp.viewbix.com/role/GenerelDetailsNarrative",
     "shortName": "GENEREL (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2019-02-07_custom_ShareExchangeAgreementMember_custom_ViewbixLtdMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableOtherCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - SCHEDULE OF OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)",
     "role": "http://corp.viewbix.com/role/ScheduleOfOtherAccountsPayableAndAccruedLiabilitiesDetails",
     "shortName": "SCHEDULE OF OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableOtherCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DueToAffiliateCurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTIONS (Details)",
     "role": "http://corp.viewbix.com/role/ScheduleOfRelatedPartyTransactionsDetails",
     "shortName": "SCHEDULE OF RELATED PARTY TRANSACTIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-02-122022-02-13_custom_GixLoanMember_us-gaap_SubsequentEventMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtConversionOriginalDebtAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)",
     "role": "http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative",
     "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-02-122022-02-13_custom_GixLoanMember_us-gaap_SubsequentEventMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtConversionOriginalDebtAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "VBIX:ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock",
       "us-gaap:ShortTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-18",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShorttermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - SCHEDULE OF FAIR VALUE DISTRIBUTION OF LIABILITY AND EQUITY COMPONENTS (Details)",
     "role": "http://corp.viewbix.com/role/ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails",
     "shortName": "SCHEDULE OF FAIR VALUE DISTRIBUTION OF LIABILITY AND EQUITY COMPONENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "VBIX:ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock",
       "us-gaap:ShortTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-18",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShorttermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "us-gaap:ShortTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-18",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "VBIX:ShortTermPrincipalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - SCHEDULE OF COMPOSITION OF SHORT TERM LOAN (Details)",
     "role": "http://corp.viewbix.com/role/ScheduleOfCompositionOfShortTermLoanDetails",
     "shortName": "SCHEDULE OF COMPOSITION OF SHORT TERM LOAN (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "us-gaap:ShortTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-18",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "VBIX:ShortTermPrincipalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - Consolidated Statements of Comprehensive Loss",
     "role": "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - SHORT TERM LOAN AND ISSUES OF SHARES (Details Narrative)",
     "role": "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative",
     "shortName": "SHORT TERM LOAN AND ISSUES OF SHARES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShortTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-18_custom_LoanAndStockSubscriptionAgreementMember_us-gaap_InvestorMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31_custom_ClassJWarrantsMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - SUMMARY OF OUTSTANDING WARRANTS (Details)",
     "role": "http://corp.viewbix.com/role/SummaryOfOutstandingWarrantsDetails",
     "shortName": "SUMMARY OF OUTSTANDING WARRANTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31_custom_ClassJWarrantsMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockVotingRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - STOCKHOLDERS\u2019 DEFICIT (Details Narrative)",
     "role": "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative",
     "shortName": "STOCKHOLDERS\u2019 DEFICIT (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockVotingRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - SCHEDULE OF REVENUES (Details)",
     "role": "http://corp.viewbix.com/role/ScheduleOfRevenuesDetails",
     "shortName": "SCHEDULE OF REVENUES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-012021-12-31_custom_IndividualSubscriptionsMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES (Details)",
     "role": "http://corp.viewbix.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails",
     "shortName": "SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "VBIX:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock",
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-012020-12-31_custom_SalariesandRelatedExpenseMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:SellingAndMarketingExpense",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000045 - Disclosure - SCHEDULE OF SALES AND MARKETING EXPENSES (Details)",
     "role": "http://corp.viewbix.com/role/ScheduleOfSalesAndMarketingExpensesDetails",
     "shortName": "SCHEDULE OF SALES AND MARKETING EXPENSES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "VBIX:ScheduleOfSalesAndMarketingExpensesTableTextBlock",
       "VBIX:SalesAndMarketingExpensesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-012020-12-31_custom_SalariesandRelatedExpenseMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:SellingAndMarketingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "VBIX:ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock",
       "VBIX:GeneralAndAdministrativeExpensesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LaborAndRelatedExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000046 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)",
     "role": "http://corp.viewbix.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails",
     "shortName": "SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "VBIX:ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock",
       "VBIX:GeneralAndAdministrativeExpensesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LaborAndRelatedExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "VBIX:ScheduleFinancingIncomeExpensesNetTableTextBlock",
       "VBIX:FinancingIncomeExpensesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "VBIX:FinancingIncomeExpensesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000047 - Disclosure - SCHEDULE OF FINANCIAL (EXPENSES) INCOME, NET (Details)",
     "role": "http://corp.viewbix.com/role/ScheduleOfFinancialExpensesIncomeNetDetails",
     "shortName": "SCHEDULE OF FINANCIAL (EXPENSES) INCOME, NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "VBIX:ScheduleFinancingIncomeExpensesNetTableTextBlock",
       "VBIX:FinancingIncomeExpensesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "VBIX:FinancingIncomeExpensesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000048 - Disclosure - SCHEDULE OF DEFERRED INCOME TAXES (Details)",
     "role": "http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails",
     "shortName": "SCHEDULE OF DEFERRED INCOME TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000049 - Disclosure - SCHEDULE OF LOSS (INCOME) FROM CONTINUING OPERATIONS, BEFORE TAXES ON INCOME (Details)",
     "role": "http://corp.viewbix.com/role/ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails",
     "shortName": "SCHEDULE OF LOSS (INCOME) FROM CONTINUING OPERATIONS, BEFORE TAXES ON INCOME (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-012021-12-31_us-gaap_DomesticCountryMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - Consolidated Statements of Changes in Stockholders' Deficit",
     "role": "http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit",
     "shortName": "Consolidated Statements of Changes in Stockholders' Deficit",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExaminationDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000050 - Disclosure - INCOME TAXES (Details Narrative)",
     "role": "http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative",
     "shortName": "INCOME TAXES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExaminationDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000051 - Disclosure - SCHEDULE OF LOSS PER SHARE-BASIC AND DILUTED (Details)",
     "role": "http://corp.viewbix.com/role/ScheduleOfLossPerShare-basicAndDilutedDetails",
     "shortName": "SCHEDULE OF LOSS PER SHARE-BASIC AND DILUTED (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://corp.viewbix.com/role/StatementsOfCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "VBIX:GainFromSaleOfSubsidiary",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000007 - Disclosure - GENEREL",
     "role": "http://corp.viewbix.com/role/Generel",
     "shortName": "GENEREL",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://corp.viewbix.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES",
     "role": "http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilities",
     "shortName": "OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 34,
   "tag": {
    "VBIX_AccountingForIncomeTaxesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting for Income Taxes [Policy Text Block]",
        "label": "Accounting for Income Taxes"
       }
      }
     },
     "localname": "AccountingForIncomeTaxesPolicyTextBlock",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "VBIX_BankFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bank Fees [Member]",
        "label": "Bank Fees [Member]"
       }
      }
     },
     "localname": "BankFeesMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfFinancialExpensesIncomeNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_ClassGWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class G Warrants [Member]",
        "label": "Class G Warrants [Member]"
       }
      }
     },
     "localname": "ClassGWarrantsMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_ClassHWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class H Warrants [Member]",
        "label": "Class H Warrants [Member]"
       }
      }
     },
     "localname": "ClassHWarrantsMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_ClassIWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class I Warrants [Member]",
        "label": "Class I Warrants [Member]"
       }
      }
     },
     "localname": "ClassIWarrantsMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_ClassJWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class J Warrants [Member]",
        "label": "Class J Warrants [Member]"
       }
      }
     },
     "localname": "ClassJWarrantsMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfOutstandingWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_ClassKWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class K Warrants [Member]",
        "label": "Class K Warrants [Member]"
       }
      }
     },
     "localname": "ClassKWarrantsMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfOutstandingWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_CurrentAssetsExcludingCashAndCashEquivalent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current assets excluding cash and cash equivalent.",
        "label": "Current assets excluding cash and cash equivalents"
       }
      }
     },
     "localname": "CurrentAssetsExcludingCashAndCashEquivalent",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VBIX_DifferencesBetweenTaxBasisAndCarryingValuesOfLoans": {
     "auth_ref": [],
     "calculation": {
      "http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Differences between tax basis and carrying values of loans.",
        "label": "Differences between tax basis and carrying values of loans (see notes 4 and 5)"
       }
      }
     },
     "localname": "DifferencesBetweenTaxBasisAndCarryingValuesOfLoans",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VBIX_DisclosureFinancialExpensesIncomeNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Expenses Income Net"
       }
      }
     },
     "localname": "DisclosureFinancialExpensesIncomeNetAbstract",
     "nsuri": "http://corp.viewbix.com/20211231",
     "xbrltype": "stringItemType"
    },
    "VBIX_DisclosureGeneralAndAdministrativeExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General And Administrative Expenses",
        "verboseLabel": "Schedule Of General And Administrative Expenses"
       }
      }
     },
     "localname": "DisclosureGeneralAndAdministrativeExpensesAbstract",
     "nsuri": "http://corp.viewbix.com/20211231",
     "xbrltype": "stringItemType"
    },
    "VBIX_DisclosureSalesAndMarktingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales And Markting Expenses"
       }
      }
     },
     "localname": "DisclosureSalesAndMarktingExpensesAbstract",
     "nsuri": "http://corp.viewbix.com/20211231",
     "xbrltype": "stringItemType"
    },
    "VBIX_DiscountOnShortTermLoan": {
     "auth_ref": [],
     "calculation": {
      "http://corp.viewbix.com/role/ScheduleOfCompositionOfShortTermLoanDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ShortTermBorrowings",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount on Short term loan.",
        "label": "Discount on Short term loan"
       }
      }
     },
     "localname": "DiscountOnShortTermLoan",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfCompositionOfShortTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VBIX_EnterpriseSubscriptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Enterprise Subscriptions [Member]",
        "label": "Enterprise Subscriptions [Member]"
       }
      }
     },
     "localname": "EnterpriseSubscriptionsMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_ExchangeRateDifferencesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exchange Rate Differences [Member]",
        "label": "Exchange Rate Differences [Member]"
       }
      }
     },
     "localname": "ExchangeRateDifferencesMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfFinancialExpensesIncomeNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_FinanceExpense": {
     "auth_ref": [],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance expense.",
        "label": "Finance expense",
        "negatedLabel": "Finance expense"
       }
      }
     },
     "localname": "FinanceExpense",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VBIX_FinanceIncome": {
     "auth_ref": [],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance income.",
        "label": "Finance income"
       }
      }
     },
     "localname": "FinanceIncome",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VBIX_FinancingIncomeExpensesNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing (Income) Expenses, Net.",
        "label": "Financing expenses (income), net"
       }
      }
     },
     "localname": "FinancingIncomeExpensesNet",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfFinancialExpensesIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VBIX_FinancingIncomeExpensesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Income Expenses [Text Block]",
        "label": "FINANCIAL EXPENSES (INCOME), NET"
       }
      }
     },
     "localname": "FinancingIncomeExpensesTextBlock",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/FinancialExpensesIncomeNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "VBIX_FinancingProvidedByParentCompanyAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing provided by parent company acquisition.",
        "label": "Financing provided by the Parent Company (see note 4)"
       }
      }
     },
     "localname": "FinancingProvidedByParentCompanyAcquisition",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VBIX_GainFromSaleOfSubsidiary": {
     "auth_ref": [],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain from sale of subsidiary.",
        "label": "Gain from sale of subsidiary",
        "negatedLabel": "Gain from sale of a subsidiary"
       }
      }
     },
     "localname": "GainFromSaleOfSubsidiary",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VBIX_GeneralAndAdministrativeExpensesDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General and Administrative Expenses Disclosure [Text Block]",
        "label": "GENERAL AND ADMINISTRATIVE EXPENSES"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpensesDisclosureTextBlock",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/GeneralAndAdministrativeExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "VBIX_GixLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gix Loan [Member]",
        "label": "Gix Loan [Member]"
       }
      }
     },
     "localname": "GixLoanMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_GixLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gix Ltd [Member]",
        "label": "Gix Ltd [Member]"
       }
      }
     },
     "localname": "GixLtdMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_IndividualSubscriptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Subscriptions [Member]",
        "label": "Individual Subscriptions [Member]"
       }
      }
     },
     "localname": "IndividualSubscriptionsMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_InterestExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Expenses [Member]",
        "label": "Interest Expenses [Member]"
       }
      }
     },
     "localname": "InterestExpensesMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfFinancialExpensesIncomeNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_InvestorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investors [Member]",
        "label": "Investors [Member]"
       }
      }
     },
     "localname": "InvestorsMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_LiabilitiesCurrentOne": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liabilities current one.",
        "label": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentOne",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VBIX_LoanAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan Agreement [Member]",
        "label": "Loan Agreement [Member]"
       }
      }
     },
     "localname": "LoanAgreementMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_LoanAndStockSubscriptionAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan And Stock Subscription Agreement [Member]",
        "label": "Loan And Stock Subscription Agreement [Member]"
       }
      }
     },
     "localname": "LoanAndStockSubscriptionAgreementMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_LoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan [Member]",
        "label": "Loan [Member]"
       }
      }
     },
     "localname": "LoanMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_ModificationOfParentCompanyPayableIntoLoan": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Modification of parent company payable into a loan.",
        "label": "Modification of parent company payable into a loan"
       }
      }
     },
     "localname": "ModificationOfParentCompanyPayableIntoLoan",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VBIX_OperationsCostsIncurredPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operations costs incurred, percentage.",
        "label": "Operations costs incurred, percentage"
       }
      }
     },
     "localname": "OperationsCostsIncurredPercentage",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "pureItemType"
    },
    "VBIX_OtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other [Member]",
        "label": "Other [Member]"
       }
      }
     },
     "localname": "OtherMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfSalesAndMarketingExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_PercentageOfFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of fair value.",
        "label": "Percentage of fair value"
       }
      }
     },
     "localname": "PercentageOfFairValue",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "VBIX_SalariesandRelatedExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Salaries and Related Expense [Member]",
        "label": "Salaries and Related Expense [Member]"
       }
      }
     },
     "localname": "SalariesandRelatedExpenseMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails",
      "http://corp.viewbix.com/role/ScheduleOfSalesAndMarketingExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_SalesAndMarketingExpensesDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales and Marketing Expenses Disclosure [Text Block]",
        "label": "SALES AND MARKTING EXPENSES"
       }
      }
     },
     "localname": "SalesAndMarketingExpensesDisclosureTextBlock",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/SalesAndMarktingExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "VBIX_ScheduleFinancingIncomeExpensesNetTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Financing Income (Expenses) [Table Text Block]",
        "label": "SCHEDULE OF FINANCIAL (EXPENSES) INCOME, NET"
       }
      }
     },
     "localname": "ScheduleFinancingIncomeExpensesNetTableTextBlock",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/FinancialExpensesIncomeNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "VBIX_ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of fair value distribution of liability and equity components on transactions date [Table Text Block]",
        "label": "SCHEDULE OF FAIR VALUE DISTRIBUTION OF LIABILITY AND EQUITY COMPONENTS"
       }
      }
     },
     "localname": "ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsOnTransactionsDateTableTextBlock",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "VBIX_ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of General and Administrative Expenses [Table Text Block]",
        "label": "SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES"
       }
      }
     },
     "localname": "ScheduleOfGeneralAndAdministrativeExpensesTableTextBlock",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/GeneralAndAdministrativeExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "VBIX_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Research And Development Expenses [Table Text Block]",
        "label": "SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES"
       }
      }
     },
     "localname": "ScheduleOfResearchAndDevelopmentExpensesTableTextBlock",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ResearchAndDevelopmentExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "VBIX_ScheduleOfSalesAndMarketingExpensesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Sales and Marketing Expenses [Table Text Block]",
        "label": "SCHEDULE OF SALES AND MARKETING EXPENSES"
       }
      }
     },
     "localname": "ScheduleOfSalesAndMarketingExpensesTableTextBlock",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/SalesAndMarktingExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "VBIX_ShareCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Capital Abstract.",
        "label": "Share Capital"
       }
      }
     },
     "localname": "ShareCapitalAbstract",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "VBIX_ShareExchangeAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Exchange Agreement [Member]",
        "label": "Share Exchange Agreement [Member]"
       }
      }
     },
     "localname": "ShareExchangeAgreementMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_SharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares [Member]",
        "label": "Shares [Member]"
       }
      }
     },
     "localname": "SharesMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_ShortTermDebtAllocatedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocated amount.",
        "label": "Allocated amount"
       }
      }
     },
     "localname": "ShortTermDebtAllocatedAmount",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VBIX_ShortTermPrincipalAmount": {
     "auth_ref": [],
     "calculation": {
      "http://corp.viewbix.com/role/ScheduleOfCompositionOfShortTermLoanDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ShortTermBorrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short Term Principal Amount.",
        "label": "Principal amount"
       }
      }
     },
     "localname": "ShortTermPrincipalAmount",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfCompositionOfShortTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VBIX_StockSubscriptionAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Subscription Agreement [Member]",
        "label": "Stock Subscription Agreement [Member]"
       }
      }
     },
     "localname": "StockSubscriptionAgreementMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative",
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_SubcontractorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subcontractors [Member]",
        "label": "Subcontractors [Member]"
       }
      }
     },
     "localname": "SubcontractorsMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_SupplementalCashReceivedFromSaleOfSubsidiaries": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental cash received from sale of subsidiaries.",
        "label": "Supplemental cash received from sale of subsidiaries",
        "verboseLabel": "Cash received from the sale of a subsidiary"
       }
      }
     },
     "localname": "SupplementalCashReceivedFromSaleOfSubsidiaries",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VBIX_SupplementalGainFromSalesOfSubsidiary": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental gain from sales of subsidiary.",
        "label": "Gain from sale of a subsidiary"
       }
      }
     },
     "localname": "SupplementalGainFromSalesOfSubsidiary",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VBIX_ViewbixIsraelMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Viewbix Israel [Member]",
        "label": "Viewbix Israel [Member]"
       }
      }
     },
     "localname": "ViewbixIsraelMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_ViewbixLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Viewbix Ltd [Member]",
        "label": "Viewbix Ltd [Member]"
       }
      }
     },
     "localname": "ViewbixLtdMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_VirtualCryptoIsraelMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Virtual Crypto Israel [Member]",
        "label": "Virtual Crypto Israel [Member]"
       }
      }
     },
     "localname": "VirtualCryptoIsraelMember",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VBIX_WarrantExercisable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant Exercisable.",
        "label": "Exercisable"
       }
      }
     },
     "localname": "WarrantExercisable",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfOutstandingWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "VBIX_WarrantTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant term.",
        "label": "Warrant Term"
       }
      }
     },
     "localname": "WarrantTerm",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfOutstandingWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "VBIX_WarrantsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants [Policy Text Block]",
        "label": "Warrants"
       }
      }
     },
     "localname": "WarrantsPolicyTextBlock",
     "nsuri": "http://corp.viewbix.com/20211231",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r339",
      "r341",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r339",
      "r341",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r339",
      "r341",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r339",
      "r341",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r339",
      "r341",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://corp.viewbix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r106",
      "r183",
      "r185",
      "r269",
      "r304",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r106",
      "r183",
      "r185",
      "r269",
      "r304",
      "r305"
     ],
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r107",
      "r108",
      "r183",
      "r186",
      "r306",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325"
     ],
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r107",
      "r108",
      "r183",
      "r186",
      "r306",
      "r315",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsAndOtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://corp.viewbix.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.",
        "label": "Other accounts receivable"
       }
      }
     },
     "localname": "AccountsAndOtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r287",
      "r299"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/ScheduleOfOtherAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.",
        "label": "Accounts Payable and Accrued Liabilities",
        "totalLabel": "Total other accounts payables"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfOtherAccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://corp.viewbix.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Other accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableOtherCurrentAndNoncurrent": {
     "auth_ref": [
      "r289",
      "r298"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/ScheduleOfOtherAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligations incurred and payable classified as other.",
        "label": "Other payables and deferred revenues"
       }
      }
     },
     "localname": "AccountsPayableOtherCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfOtherAccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r9",
      "r25"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Trade payables"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r18",
      "r110",
      "r111"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Trade receivables"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r289",
      "r298"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/ScheduleOfOtherAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.",
        "label": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfOtherAccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative",
      "http://corp.viewbix.com/role/SummaryOfOutstandingWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r37",
      "r38",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative",
      "http://corp.viewbix.com/role/SummaryOfOutstandingWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r72",
      "r73",
      "r74",
      "r196",
      "r197",
      "r198",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative",
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r66",
      "r96",
      "r99",
      "r104",
      "r114",
      "r122",
      "r123",
      "r124",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r133",
      "r134",
      "r231",
      "r235",
      "r241",
      "r262",
      "r264",
      "r283",
      "r294"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r8",
      "r33",
      "r66",
      "r114",
      "r122",
      "r123",
      "r124",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r133",
      "r134",
      "r231",
      "r235",
      "r241",
      "r262",
      "r264"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT ASSETS"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combination"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r2",
      "r71",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "GENEREL"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/Generel"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r24",
      "r55"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r10",
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r50",
      "r55",
      "r59"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash and cash equivalents and restricted cash at the end of the period",
        "periodStartLabel": "Cash and cash equivalents and restricted cash at the beginning of the period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r50",
      "r242"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase (decrease) in cash and cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Exercise Price"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfOutstandingWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "verboseLabel": "Warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfOutstandingWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r121",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r72",
      "r73",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock , par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r17",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r17",
      "r264"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock, $0.0001 par value; 490,000,000 shares authorized; 34,753,669 shares issued and outstanding at December 31, 2021 and at December 31, 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockVotingRights": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.",
        "label": "Common stock, voting rights"
       }
      }
     },
     "localname": "CommonStockVotingRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r61",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Principles of consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r44",
      "r66",
      "r114",
      "r122",
      "r123",
      "r124",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r133",
      "r134",
      "r241"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of revenues"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfFinancialExpensesIncomeNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfFinancialExpensesIncomeNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r57",
      "r58"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt conversion amount"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionOriginalDebtAmount1": {
     "auth_ref": [
      "r57",
      "r58"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt modification original debt, amount"
       }
      }
     },
     "localname": "DebtConversionOriginalDebtAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r65",
      "r70",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r253",
      "r284",
      "r285",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://corp.viewbix.com/role/ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r135",
      "r152",
      "r153",
      "r252",
      "r253",
      "r254"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r30",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt instrument interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative",
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r31",
      "r65",
      "r70",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://corp.viewbix.com/role/ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r142",
      "r251",
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Loan discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Net deferred tax asset before valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "auth_ref": [
      "r217",
      "r218"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.",
        "label": "Deferred R&amp;D expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r217",
      "r218"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Total"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r211"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r53",
      "r118"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      },
      "http://corp.viewbix.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails",
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r183",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "SCHEDULE OF REVENUES"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/RevenuesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative",
      "http://corp.viewbix.com/role/ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueToAffiliateCurrent": {
     "auth_ref": [
      "r11",
      "r69",
      "r258",
      "r312"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Parent company",
        "verboseLabel": "Gix \u2013 Company Payable"
       }
      }
     },
     "localname": "DueToAffiliateCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets",
      "http://corp.viewbix.com/role/ScheduleOfRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r69",
      "r125",
      "r127",
      "r128",
      "r132",
      "r133",
      "r134",
      "r258",
      "r288",
      "r300"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.",
        "label": "Due to related party"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Loss per share-basic and diluted",
        "negatedLabel": "Basic and diluted net loss per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfLossPerShare-basicAndDilutedDetails",
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r87",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings per Common Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r87",
      "r88",
      "r89",
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "LOSS PER SHARE-BASIC AND DILUTED"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/LossPerShare-basicAndDiluted"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Corporate tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r37",
      "r38",
      "r39",
      "r72",
      "r73",
      "r74",
      "r76",
      "r81",
      "r83",
      "r91",
      "r115",
      "r169",
      "r171",
      "r196",
      "r197",
      "r198",
      "r220",
      "r221",
      "r237",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r307",
      "r308",
      "r309",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit",
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative",
      "http://corp.viewbix.com/role/SummaryOfOutstandingWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r239",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair value of financial instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Functional currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r53",
      "r234"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedLabel": "Gain from sale of a subsidiary"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and administrative",
        "totalLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails",
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r43",
      "r66",
      "r96",
      "r98",
      "r100",
      "r103",
      "r105",
      "r114",
      "r122",
      "r123",
      "r124",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r133",
      "r134",
      "r241"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r40",
      "r96",
      "r98",
      "r100",
      "r103",
      "r105",
      "r282",
      "r290",
      "r292",
      "r302"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "negatedLabel": "Total loss before taxes on income",
        "totalLabel": "Loss Before taxes on income"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails",
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r119",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative",
      "http://corp.viewbix.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails",
      "http://corp.viewbix.com/role/ScheduleOfSalesAndMarketingExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement."
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative",
      "http://corp.viewbix.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails",
      "http://corp.viewbix.com/role/ScheduleOfSalesAndMarketingExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative",
      "http://corp.viewbix.com/role/ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative",
      "http://corp.viewbix.com/role/ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r67",
      "r205",
      "r208",
      "r214",
      "r222",
      "r224",
      "r226",
      "r227",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationDescription": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.",
        "label": "Income tax examination description"
       }
      }
     },
     "localname": "IncomeTaxExaminationDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r68",
      "r82",
      "r83",
      "r95",
      "r203",
      "r223",
      "r225",
      "r303"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Taxes on income"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r36",
      "r201",
      "r202",
      "r208",
      "r209",
      "r213",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (decrease) in other accounts payables and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Increase (decrease) in trade payables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDueToAffiliatesCurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in current obligations (due within one year or one operating cycle) owed to an entity that is controlling, under the control of, or within the same control group as the reporting entity by means of direct or indirect ownership.",
        "label": "Increase in payable to parent company"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueToAffiliatesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables classified as other.",
        "label": "Increase (Decrease) in Other Receivables",
        "negatedLabel": "Decrease (Increase) in other accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Decrease (Increase) in trade receivables and prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestorMember": {
     "auth_ref": [
      "r257",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.",
        "label": "Investor [Member]"
       }
      }
     },
     "localname": "InvestorMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative",
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IsraelTaxAuthorityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of Israel.",
        "label": "Israel Tax Authority [Member]"
       }
      }
     },
     "localname": "IsraelTaxAuthorityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LaborAndRelatedExpense": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.",
        "label": "Wages, salaries and related expenses"
       }
      }
     },
     "localname": "LaborAndRelatedExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r23",
      "r66",
      "r114",
      "r241",
      "r264",
      "r286",
      "r297"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, temporary equity and stockholders\u2019 deficit"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS\u2019 DEFICIT"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r29",
      "r66",
      "r114",
      "r122",
      "r123",
      "r124",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r133",
      "r134",
      "r232",
      "r235",
      "r236",
      "r241",
      "r262",
      "r263",
      "r264"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfFinancialExpensesIncomeNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r27",
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfFinancialExpensesIncomeNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r50",
      "r51",
      "r54"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "negatedLabel": "Cash flows from operations",
        "totalLabel": "Net cash used by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r34",
      "r35",
      "r39",
      "r41",
      "r54",
      "r66",
      "r75",
      "r77",
      "r78",
      "r79",
      "r80",
      "r82",
      "r83",
      "r84",
      "r96",
      "r98",
      "r100",
      "r103",
      "r105",
      "r114",
      "r122",
      "r123",
      "r124",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r133",
      "r134",
      "r238",
      "r241",
      "r291",
      "r301"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net loss for the period",
        "negatedLabel": "Net Income (Loss) Attributable to Parent",
        "negatedTerseLabel": "Net loss attributable to ordinary stockholders",
        "totalLabel": "Net Loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/ScheduleOfLossPerShare-basicAndDilutedDetails",
      "http://corp.viewbix.com/role/StatementsOfCashFlows",
      "http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit",
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recently issued accounting pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r96",
      "r98",
      "r100",
      "r103",
      "r105"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r215"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating loss carryforward",
        "verboseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative",
      "http://corp.viewbix.com/role/ScheduleOfDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative",
      "http://corp.viewbix.com/role/ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative",
      "http://corp.viewbix.com/role/ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of general and administrative expense classified as other.",
        "label": "Other"
       }
      }
     },
     "localname": "OtherGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherGeneralExpense": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of general expenses not normally included in Other Operating Costs and Expenses.",
        "label": "Other expenses"
       }
      }
     },
     "localname": "OtherGeneralExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r5",
      "r7",
      "r116",
      "r117"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Cash received from the sale of a subsidiary"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from issuance of common stock",
        "verboseLabel": "Issuance of shares"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative",
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Short term loan received"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfessionalFees": {
     "auth_ref": [
      "r313",
      "r314"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
        "label": "Professional fees"
       }
      }
     },
     "localname": "ProfessionalFees",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r193",
      "r257",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative",
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r193",
      "r257",
      "r259",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative",
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r255",
      "r256",
      "r258",
      "r260",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development [Abstract]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r200",
      "r268",
      "r326"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and development",
        "verboseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails",
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.",
        "label": "RESEARCH AND DEVELOPMENT EXPENSES"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ResearchAndDevelopmentExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r20",
      "r171",
      "r199",
      "r264",
      "r296",
      "r310",
      "r311"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r72",
      "r73",
      "r74",
      "r76",
      "r81",
      "r83",
      "r115",
      "r196",
      "r197",
      "r198",
      "r220",
      "r221",
      "r237",
      "r307",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r93",
      "r94",
      "r97",
      "r101",
      "r102",
      "r106",
      "r107",
      "r109",
      "r182",
      "r183",
      "r269"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfRevenuesDetails",
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r184",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "REVENUES"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/Revenues"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r62",
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of stock, price per share",
        "verboseLabel": "Stock issued price per share"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative",
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "SCHEDULE OF OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/OtherAccountsPayableAndAccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "SCHEDULE OF LOSS (INCOME) FROM CONTINUING OPERATIONS, BEFORE TAXES ON INCOME"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "SCHEDULE OF DEFERRED INCOME TAXES"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "SCHEDULE OF LOSS PER SHARE-BASIC AND DILUTED"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/LossPerShare-basicAndDilutedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.",
        "label": "SCHEDULE OF RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/RelatedPartyTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTextBlock": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "SCHEDULE OF COMPOSITION OF SHORT TERM LOAN"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "auth_ref": [
      "r172",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "SUMMARY OF OUTSTANDING WARRANTS"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StockholdersDeficitTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Sales and marketing",
        "verboseLabel": "Sales and marketing expenses"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfSalesAndMarketingExpensesDetails",
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.",
        "label": "Number of warrants expired during period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares issued, price per share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance, shares",
        "periodStartLabel": "Balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r12",
      "r264",
      "r284",
      "r295"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://corp.viewbix.com/role/ScheduleOfCompositionOfShortTermLoanDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short term loan",
        "totalLabel": "Short term loan, Net"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets",
      "http://corp.viewbix.com/role/ScheduleOfCompositionOfShortTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTextBlock": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for short-term debt.",
        "label": "SHORT TERM LOAN AND ISSUES OF SHARES"
       }
      }
     },
     "localname": "ShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfShares"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShorttermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.",
        "label": "Fair Value"
       }
      }
     },
     "localname": "ShorttermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r60",
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r32",
      "r37",
      "r38",
      "r39",
      "r72",
      "r73",
      "r74",
      "r76",
      "r81",
      "r83",
      "r91",
      "r115",
      "r169",
      "r171",
      "r196",
      "r197",
      "r198",
      "r220",
      "r221",
      "r237",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r307",
      "r308",
      "r309",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit",
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative",
      "http://corp.viewbix.com/role/SummaryOfOutstandingWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://corp.viewbix.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails",
      "http://corp.viewbix.com/role/ScheduleOfSalesAndMarketingExpensesDetails",
      "http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r72",
      "r73",
      "r74",
      "r91",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://corp.viewbix.com/role/ScheduleOfResearchAndDevelopmentExpensesDetails",
      "http://corp.viewbix.com/role/ScheduleOfSalesAndMarketingExpensesDetails",
      "http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r16",
      "r17",
      "r169",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Number of share issued",
        "verboseLabel": "Stock issued during period, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative",
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued attributable to transactions classified as other.",
        "label": "Issuance of shares, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r169",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Number of restricted common stock shares issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r16",
      "r17",
      "r169",
      "r171"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock issued during period value"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued attributable to transactions classified as other.",
        "label": "Issuance of shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r17",
      "r21",
      "r22",
      "r66",
      "r112",
      "r114",
      "r241",
      "r264"
     ],
     "calculation": {
      "http://corp.viewbix.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "negatedLabel": "Stockholders' deficit",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders\u2019 deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets",
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "STOCKHOLDERS\u2019 DEFICIT"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r64",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r171",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "STOCKHOLDERS\u2019 DEFICIT"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/StockholdersDeficit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r249",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r249",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r249",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r265",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/GenerelDetailsNarrative",
      "http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative",
      "http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualRisksAndUncertaintiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of the unusual risk or uncertainty, if estimable, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.",
        "label": "COVID-19 PANDEMIC IMPLICATIONS"
       }
      }
     },
     "localname": "UnusualRisksAndUncertaintiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/Covid-19PandemicImplications"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r212"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation allowances, deferred tax assets"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted average shares outstanding - basic and diluted",
        "verboseLabel": "Weighted-average ordinary shares"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://corp.viewbix.com/role/ScheduleOfLossPerShare-basicAndDilutedDetails",
      "http://corp.viewbix.com/role/StatementsOfComprehensiveLoss"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(1),(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(3),(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(k)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "730",
   "Topic": "985",
   "URI": "http://asc.fasb.org/subtopic&trid=2197926"
  },
  "r328": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r329": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r331": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r332": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r333": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r334": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r335": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r336": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r337": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r338": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r339": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r340": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r341": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r342": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r343": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r344": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r345": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r346": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r347": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.6)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>70
<FILENAME>0001493152-22-007150-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-22-007150-xbrl.zip
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M+3MD&HK-DK'_KHKV0AKJ16/YYE&]H/P+4$L#!!0    ( *Z <50PL(#<9#D
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M7'S"XY0G3U/3GJ5GO,[.>9.;]S:_H+2LO**RJKJFMJ&QJ;FEM>U+>T]O7__
MX-#PR#AU8G)J>N;7[!Q]>65UC;$.;6S^L8L+X.;ZC^/?VB6,V+7ESQ[P_;&+
M:TO@GPN$M_+L/\HK<LJ*[ZJ?Z(%C][:)G7[TJJ1^NYR&-4W\VJUN_MWRFN,'
MZ7],^]NR_S/#(OX_6?:?AOV772/ #FXN9/.XA0$TP&:]3E "7B=LN,#\GAR
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MMX@#N)*&.,"EO@Z_DE@'*+K(U%U2A\).[>KXKC'4\3S$=CS+8*ZN!"'D'Y+
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MJL>RMK\+MCO2GJ%+M[P!FA'>'V?MG64*PMW..WM6A4;*FBHYP#96Z%1<A5)
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M0CA\WBPT3AEW%+73%[ZG6Y?*SWV)5X_]E,1?-TH@S1W:B$M@6;5D66C\M=U
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M6+H)*IWF [Y\L9K/A%(-'MQI?3!OT'=[2<M?Q?J$\<"JL(/O$=38N:&]1_O
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MXGL$-!5"E_V?=6G=*3OEE<A9?!(HCO_7C?#T[0-B3 5095531PY%M_C\[;%
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MJN=H?TX.K=8$"#W-W=%Z_0$C<$A?"$L+WXO'\**-04,R1-%?4>+S>G7X/B"
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M,QZS"_1,(]R2Y_T7'>?UF\<Z6I0SBT-^7Q,Q\\LXQ2/P!QN/W\N1A=Q7L#N
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M3&Y@*2JAZU@YBOBYB1CG?GT\1FKD5^=^%9A=SL?5*RAWAAE40D24+L4SS4P
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MT(DU&FU#,F+-*;9'!QH?-Q)49E\TXP/_WM0+^M*>*?V.?5Z*_93O 9SE[0?
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M>D)1B37)S&J['E7<U*KD3IN\LS(E7XXWGD5KY6\P:"X&#Z7!=9"T.L32,M=
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M<#TZJ%ZU/&6,.;="8'@GMOW5\?X8\ZDKC2MEIA]J=IKFSNDI%%1@Q3*^EI?
M]T+;=,\H<*7NFUL^$MBQ,LQ[7KL'R=JY6:4_/Y;R<_X5VO"FU/&-&#<QGD#'
M8/2J*,AK?(\+R09S2%@4AMDYKIKLV\PAID=.9SCM(DV'1QW1H1"TPZ>Y=S^6
M:APZK,*&-*!Z( F/&\OID/@[JSW@C%_H2HR%PHLB>4#E)8(:X'Z%<4DM*IMJ
M&:2OD*F&>:E>1;<>Q=\15N&"Y95Y-<*B-G?^(0#?$^7K3DA]Q6HJ//TF53-$
MTEV[Y*&-QD!@=71%+VY2K??Q4%\AG KGX83E5O!D[)Z<3FOL-NZF7K(XE*4C
M_:'4J,>J(3^W+17XNH*N1V^1V+BK0^H]01)J*/JR!M*&72)FTF2A4D "TW$U
MA:2#0?L;.S=QHU)*&[@)P,4SE(4Y=YNED6NDE=EF[[E0C8Y(B3B/FM%.J*V0
M$(F:HK%6$^T5N7C60ZQ5(V#\"I9"4A/<XEXICXXM=^3M[FB];SSW0.7*!XWJ
M;^A4]7<'^YHP$/'\ABT2ZIKN8O5"(!M@5\45*%1W.Q#'ZN&&ES 7A=8?_GT+
MT JY^%3W8."^]]J4[0/6E0@+Z7-[&%0U@3+>G[NYB64.$0TCZF=:6415=!VC
M>C6N.A*UY.<.E3=P:YD)6JEF?S;^X)^@H9VSDJBN?4JJ[ZR83Q/X-F)ZK=1F
MP;^)-N 1@4IP)@;"F7":L&R'@K6^.A<_2GY0>?F?;]8U;K3[F]2C2S=[ZP9C
M;;A@WCT@C3,JDKW!8N\0G'[IC_;KAM4.]J4R.<1I;>HA@6;FB?ZM?X^]NON<
M;K/U1D N:PT$&,TE8/5PG7;3(IFO.);P),T!M9&*O@;<UT(/TG)!*3*-D)SH
M%8KS2>1SW)1REQJD053.]Z<MKJJIM51T7Z1/$\&#81H-2$2C7,[N U\&X!_.
M"5I=B\$$,KT(44?,)$$Q6X!@/@IS2UA-,EN8V<M->AK,;!V$G !2HX(8\YYS
MJ]Q)LX(-<K@=VR/3JW9?V1.U]4XT>&D3?P="@&X15K;YUXB&:<H"FXM(_EGT
M/WFUXQQP9OCO ^P*O]<CYUUY3@[7!Q]U^,AM3P$"7&%NF'7CW6B,I_ 1T9(L
M@5$0-MI[E N,AQNNM(QB(8@05;7!L&NC&GYPMQ]9%:I_KVS(7E#8(/L;-87G
M.7!6E]Z78ER&Z\W59A92N09,;#O+[WM;W%;J^:O9QN_#"[&_0YMDX4;M((S)
M&JC>F7V#&\$S%>)KVFSX1Q<U(??;8KG'Y[I$.[GN;83VMKJ,/UI&1>?XV1^W
M)P_Z?SC+EJWQVB#UA70 \.HEU,)[<%--#%PW#0]3LG*#J A0!1C7""9->^9J
MOFVZ:=EY2)VKX4?XU&I7IIYZ!B(")+.SE2#FHYW[VC;1"4FX35@-*N;D^,X$
M.C$SO,V]S-\5I1[K%#K;^J![K_8><,/K#RNWM_RQ^H*=A-3*5[ ]&,M;&@NY
M-AZ<X/OVRLP4S!&ZN';/\[CN.Q*7KKZ+<MR[;U"KM,7V@%X2[*A$CP GEDIA
M4B+98/Y!P?YA^S <LF1Q!LR=I9"?^0783M-<4:I9O-"=*3JUZ@,YUTR@_NS,
MYVV%(IEH3C]SF2W'6,13@UEDM@?7R)O@"!0RW<SE@/ ABIIGR_G;UO]R>W;E
M/W#J0-CT=SRL?7;/ [1EH@JS_C8I$IWF*JS$&/,O8ZZ)/]U80UIHOR.?;R%1
M#:&W\ZPAEUID^/5-38[>4S[^ P5FLQV!C98>OY>G;'@7/L$NTQ+K,":<N=2:
M/\C0-K>7R)T+_[:Y;LQORO;??_% 5WWBD87#Q>"3&1HGW6W_SQ4G$K5"*D-<
M90LP$39Q*!H3DG#MM[$X.]PQQTV77H6-'_CV1G.64]NBC]Y_WC=:3>&KS_<K
M%V2VMZ8>WIT0$,$W":4JY')HY^HY<ST^]J?#:8KV_I:/'][_<*$YI^=.>LZD
MX MSQ#-[0/=1HSIKF\2/_VKGR5UF2\SB 9.A)='(EC50[QMNTI?B VL@?, W
M+N7.'?Z3V,0 #Q9A"G&8V\<.I..H77.]7GG_\'$"V,M0ZY83I\US(G7F\1%V
ML4O$O+VVVK^'+"5^0=CZG,#S@#B[-V5P*A+"2&9H0I?M<8'$YXKQ&GM(%?3I
MBX >JYA3>3\B(<MZ1Y=>#6H9,_<6WZ6\=5O&T]3(%]JC>&2.4RK7H7?&=ABK
M)K 8;?.A>V.B:^"O D)7\STCPN]]/3%HF==UV4?VK9T375J2U-\LS*_7(E(7
M1GFM.;UJ!*HG5K*94W\'ED<.WML?I3+\J&EF1E.O^4>"=S[D]5RW.Y+EU0M/
M@YI_-K.*@:61%&HYM-0VFTC9--2;SBVO:^.;K_PRR,V-8X]F[MI 1VP0G!!6
M_Y:W8P3WXN,18-BU(46 NMASQ[T/7\B4M)Q1&[_57P%GR^<]YS(:/)S,-QS1
MW";[]L [(A%&;[!=3L>($75C)<"H%,#>-J>=$DN9G=[V_>=_\BUK^U2&B)NE
M'NY;*GM,YJ!XVL)2D:P_&M4ITA6'8SRZ9;E#5ZVE@0]._ .1_1'A#P_<4&IZ
MKVE0,??9+M+I"QL+P0I@J]_FZ1@P Y4"51ZSEV.%;1X]-_RG&HK4\3I!NNNZ
MZ6O]BS,N96>[#8Q5]J#U/DE9\.W07HR^>)$D8-.U!I*J9E_B5!,2EP(YJU.!
M<EH^T;*7L!9/WSDHYV3W9+N^_TNF_%O-Q&['=3I"33&@,>AN]//N+C;??@KA
M-SG?\GN<?*DEYD?N3[U)7*2%GNQE_^K,_7<RS$&X3AM<".)NBZ3 1/AXW0)'
M9,WINQOFZ@[NOM.4=&OP2JP2S3 M!EG57#" ['!\"!WN.Z"RV**VE,;X"N&5
MC9.ONI'5%]2H2>V<?Q-=^53_'A=]](6GY<IYYY4-4!=B0.B^XR#!'V&&2!IS
M"EC?\.'$P;-A?*@@#,@CF7&^$]9 ,CO(26L@ADU;OEM+T^NQBNSOG=?Z4\:,
M&GT>UNP]'W^$ OY<BXGA&K']^#<$.IS\3GA*2V+^W=^P9'>N&L6T].H91]W7
M^=R_FNX/I_>1ME.0\:^N8S]ND)3W!>PX"0RR0"F*OC2C#@SQ+UG2I!C(#+M.
MD3;W=L[5C NC;:L95YL4*PK1O8Z4R4FE<]K@A[)S.'HRK997)9[H:*X4!:42
M8MN8_P)SG&O5RXLK77S+#\AB/-)A#"\1[&NF+QCV22F]N*"N"?HD+ ZK7P,I
MXCHODR3147U'+H_\)B=A=X^UF:)NWNV*+-E1YKX]^-5[I&'O]?TJDYGW\%68
M&*8W1IF>@:3@+ZUN<!ZI,7\\H]+_87LJX>I=&</$WN@F-HZ_#0WFM0U;ROQ!
MJ"W.*'.#$QHNOD0;]T%56K=>M;4:MWYS](B/P:V_AJF=SF<\XC;>K^"8\VX*
M7PAD6'#V&BB#W*3[1JQ>W#2J)[I_ >9NHR4%3T [\]Q"[B5^WG"WW.N[_:UB
M\"!!&OL)T;A.DZ=L^W@O #_Z\K2<-S!1(]W 5@VSMD9)#E N>'::.,X]X.W4
M[FOK_I[SZYN-U>\_'PG<)EZI. M*@!SZT'W2(<%1#B)NB20=HBDJ%U</6:"(
MY5X0>;"BP+J\!_S],&A_-.FTTX.RPV\\.G\3-N,Z#T(M!<HC-$;^TC ?#51U
MPA3$5+J>+./,\#?[YZZI<3D8Z>=6^,@G>ZOWDA?X]?4#(+ ?9VZI@K$L+YH@
M[102JP4>,3LKF:A-D^B;<\[95GS[?;Y#AE5[FF9,*$>E[;?<. R1$'VR5<L(
M)P?"IP-YE[F(/D2*YO<T3@W3#B^[\'@B+;AY3),:N]TN[\W;UIM!;YN4WO5=
M2[_9>H[SK&6(.D$I@JXWS+MLG@"3Q\IAC@*MKVB84.[SY-*KU(RBMV9U-3^H
MT:-%,2FWXFXR+A2,[S@&>G'*_^%F6>>Q.V2!,I_1E.K%:B"D"DY7^OM@[GA[
M]:B^K(1,JMIMK)-4W6 T>_COM5]]Q[^'D^E/[DSTP*9J:6+Z6X(+#4/U3I!T
MQNN%9QG+&6&W[$QMSG!ZO][?V-A\KZ/0\*'\PD!_LH^.2[<FB(N:DJ/@ZN')
MN&O&.#FT&H/(/HCD5/AP3/]R=PSU+::B8'56:$FK^O%\BZ_P/3)G!YSQU\],
MNVS(M@4#AE%=R^D(+9$T ./U"(MA5_$I,]O'80U6+^H1"GW,Z2KQP.PB$DVW
M^D\;;/J\\^^6HLO\QGV.YZ4_$XJA4M@A7#TQK@T>_0J#%-9'XB"A*Z'[?:CS
MV8#SR=$2YTN$'V8\;JKNJ6TO)'+W&6#:]WW"OB/4!23RMV.'_D&6Q'E/5/RZ
M,'Y'>V+$X07"J<J$'-I>]"-.KH,ZFBL&%J/LD TCV\^D-F38_O<K]R7JPE?\
MKGYC']!M>"^0PJFX<1"=O]#+7;Q_NLTS*J,?WY1.=;WI#HSBA0@6;SGN\%!<
MB3O2(0MBJ8R=9RV-A!_0]7G?UW #4>=1E%.!'8)*K!N'A-J[7431V\WLS!7?
MO=+R2 PSD+GM<'/+RXU/?OV*.*PS^%\K'KKY.($Y,&'>"T\@-QAUXI(BT-_A
MB22]ST83]FI!L5O4\AMM\L)0AN-%,67P&VJ; F_[,PJ.;(R'%M5 6'-WQ6CM
MR/'B&742,N#T0Q?.BPE%F%D"ZL5W>VW*)<)LIZ'V'_758G"Z0(7KQ9*BX !3
MFSB!,Q&C\!FJ.T45R(_WM,!2S$UIOLVO;7A=NY>51GQ*D@PBFAT@CP?YE8]8
M-ZMOPSC>RTD!:L"0U-(<!T\9=XJ%]-#J/8H*7E J<K;,Z$X$7CHD+?\@]C#Q
MJO Q+/ 0A*Z6WN;.S>DE*#40=#''N ]O<X T"DDO<]=WI+=-M.IU!]E7M\?G
M_1\YW94<\$FU:N([8 ?N@-GR1('5Q!^RLO^/%8P5D(%B\J79%YW\^E.N_60?
MVQ_.?^')+C1X4JPC4PR^]]L\ [=5L-[?YQ]G6:#LU@O5ST:E10B.K8$2S5^Y
M2_W[_KIVH$F3:.+M1+5TTWN8'?7QGG!A1IAD'\M)YF&$>%QH(Y#/-?+DX)*O
MD:^BM.>M;9N2J4Z?PYIHCDBD_(,,?RJN.>OE;KVXN#X(/(3 .;D&2O U9Z^^
MQ'4>*6UOR^^AYB?"WDRXY(?6-C[Z&[I#$*BA!MZXK\-/%!UOJWM0'B>2<>2,
M!@ &+.(]&*?>JC^&J"I D8#R,K'N"8$.%R^>G:FF2GL\?)5%.=>7K''YBE11
M"*22@9 0[01*&?F";4@&N!LF01.-6(N4@40&^X[\S3X6J3TR!AEE6E[0$K\P
M;/9S1YY&W%'M32DJ#RYKWQC%=5J3= 1!PHIEC ^WGU7!AG.WKXQV$K0BV;!.
MDL:(?6!DT)6P,*L->FH_E!,PY5]Z]!\\RI/.DER96N_E@NNTQP2(10?A[AH(
M"<$C&A I;9',99!#I5_HOO?/J*$\2%!;/3+:8,7TL_Q?U-YWKI<.!VR[U()+
M(,N)Y,58+)(%6CVX^;UH-L8BFA7FUO.OL9UIE#ECO#M2JSQ0:V_7/27;9SGQ
M-Z7.7U8<P'4:D[8#?&94A[D*.H%IE-Y@>G-EE"659LE'5GMRY[*-0R(/!B:I
M!!O>.R;A<6>7NK:7/N=N"ZX3A;70FVX@;0*\9M]+O(F^8ZL @SJAAZS>B*,!
MF1E#GK+QYN[W_=""2R$9 W7>PV9EB0_\)X=>#GSZHG=!H0]1X*=^X8C&1LT_
M0[+8]R)=#H&=R*1-RX[V-HU<Q9IQP@L9BX.:+J-+G+Y@RUK##]W?S69"I0Z"
M%/8=ACPE<TY"IMPH+32!HD,WKEXAAW]!X/$)<[H,@)P;PYBK)6-N1(:6_<!=
MSEMPH>? ,Q+;N^I*->QG;U\0'@9Y198+K@F+<6'P#'+MSGRC/H(*&N(,5'+
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M.Y%I*@C#K/K^J:E43ON=9_VP4W?%1O^^Y<KKC3'.&S?\[AF8[.A%&[%1_!M
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M',BZD=_YJVL@I3_5#KU4.'MW$)W/OL0Z5\AW^M5]G#R-" V54-K3_@0E5?#
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MDA2I'T"1.RL HCR3BY;S#@)GJLAFANV#O!I<5GF[D(>PW1?-_I4!W*76Q9/
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MUCY((!R: 3_,O,P937Y]1?<1_G_SVQI2GGD/7.OR7Y"O405]_/2I2T()54;
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MG-CW:Y>B&O4BFF;ZA(2G"?2+[Y <+!QQ26.+"ET9-+M8]9'AG?RXI"KHWOC
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M\E( (AA&T"TIQB64^R[IJ8A5B975=)UJ6UM+_LOC"N\8NJ'ZXPK/5+/"=&^
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ML929N-\WH1I!?CM(2.1[Q)PJ_3JP1Y0 6 P+]I#7B;9V()[FT7M?)Y_4 1-
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M_]Z!BFR2ZA78%7Z)'YI+F!.<; #%>R,R\))U_\SN 6[OZB#W_#ZQ#8ME3YN
M&GMALVJ=+9\<[_>WYD[>LOYQJFCQGT_Z#<2L!_W-C#Y>DND+!.X5?<FZ->T>
MTEBYX5+T8%+R37\1E_J;^CP9M=S:G&'NBU3D[(X]#9H&.\X>0U O[:1A%2-V
M("CP.>IVB1 ^-:+F56)UI9#SM'=HY5"$Z.N/M+H9Z]O"-2>V%_>RCC,<T/K
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M"=$?.OP]O=5B'Y\&TC\.^01P93M@0,#R4B!7"Z,.#%&)4FCLV".4::S&E?0
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M99:[VSLAH1<4-7ENMX;Z3#$G>/O5#L@7-=NZ-7,&8+)M ?ONYL*,C@GX=,3
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M/":UN'&52J#P'J[O2$-1P8!#(T$.EE Z67/@JH&:SJ%#="_M>/W/1U>B/25
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M_M*CI@$<7:9K])L5B><6$"XVU1(BYAN"COK'A*GO@=XX)9^KPS^ "S[FV"&
MZW+J4.$X KJ,^QA/IC;GH#(>[,F1';N>ZOGUCJ67R=AZY*:!/EVV;/CY]R+8
MX5//%6]4E\(_:%#-R9N4[RRW[2<-,.D/<P%W*GI1"FL(QC\88W=%_<\,M<>L
M<UVJ#;6G4^T&MI9; H\+1%T;S#:*Y>]%"'*MD82&$@*/5._?3K1V7AJ^ X%@
MCD[\P$FBX?VYGFZ]4?XRN1Z4>;=YFWNL+?S1?!IZ]JPQV5^1U2$/M+!%./+
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M3!K'W)<Z;&[+./:HQ\TEY2EEV+3[N.9K;_T>HFE/KG5F%=]-OF80*)I /\;
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MW>V&ZLF"G)N(,-2X%'"CZ6Y->_G5Z]_+E4_&O?ZX)%V@V EX+T,RL<>V2;@
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M'+>#Z3?]U3H Z(6I7/?/:]4J.0&I/.%J\:WHX]-=5K\_/=@E'@=SP^UZPDI
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MN8=%]ZIH,AW(F2W%1:] ^2X]OV!?UL6/TOX9\(5$':?IUZL!KZ/\/R-W<H)
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M7S53G[[V7(2]J0\NK$M!7D!UN24H3\P._"BZ?AN2@H?X'])2&>W)U9R^OU5
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M3LTI;;GOS\"K<4Z/:M]W&9NSU_*F4<(%#YU0?2C6,KIV*? -! )5X;BP8O#
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M%_XB]\DM FVH2^%?6I\D7W'>('I!DL9JH8PJTHNUIR8P4.[-U[@;CW6#BJY
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MGB,SWSO?''N7')2%W\&;\%6:-*MQ/@6XE8?3]3GG&6)&%R_"H!M$#[&.8JO
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MN8QR<](I]&:AQ=A.!4\=C<^&V,W&DD,TS Z69;_)]-AY,*D*U&-?GJPM _,
MT8U^+\;*O%03T0/U,YP9/G?$MO7^]1U&6AJ(.Q%!.N^Z(% SCC@@DHX]B!V
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M%3+Y$^(249<(ET*+6CLP@T[%I#UN37LVH#DHD+H<=IK 2<XY=S[W1;XH3]A
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M@X_JF?BAGC3XTBK'+N2Y N^#%*82C$LP?LYJU;<[&E8/[$MX?\+P/EM4>1Z
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MH<#I^>4'V"D-B6('2 .?#VJ-S]*3_N;F<>12,4PLV/O91>6L!O_S^3/^J]X
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M9_*QOC9./WC)ABK(Y"5+ \Y,>>!X+-[<G L>BT+(Z10@OKWY:[@=_O%7-K]
MK^GSWR$=.*5PL%+;_DI20$IJ (N7CG!=( 4Q=@HGU$ --9SZ% 3R<'/J#\D
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M+P+4-C +#5_&CFF>B+W$P7H'OC<K>'CKA7@Y52>VO6_K:]HLO3 +50G/BS%
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MFC0AO1?C?0HTJ4#\L'A1L7 1T3XQ&=PS'@&:$R@[".9.$B;@") J2*55),/
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M#%.5XVO)RKF('#DW44S^W4&4H"DH!(%Y&/N<!J;?2W1"DQVR<X<-J:+YA6:
MBMO LCLQLUN/JOFH-Q+S09JE$99KQU+LQ&Q)I%1<3'&=)(4G V15+V05A.P!
M2 $NRLQH4F$FF.BZ)5S<_F5%KV3,L4S%40#KJ\Y'P_NTS*XWK[YUD$&2(\Y5
MJD@/HW#AB*]1-4B<+OQ,$O6X+@'S)$/IDK$'<SO)*$/GIU.,=77SP'>_Z!0R
M.-6434X8U1#[:+3"6F=HX'<S+&;.@DA%AWKUD%WSC'AX7Z22N1(D(RHVR$D
M1E-*A\?_@RE],+2\MC*?4U0=;''$R#*H&.0J#:?]&-$?="*JP80:F" ++ \8
M1R! )'E=)EM*XI>QF!.K+V1ZT@_AY2XJ-[G>QI)01#5ILE )<5YT$P:1<EAJ
MV<A2/FP=+(GTH!S,D)>H&JJR%2AW%8! N"[L!5L3A+# 6 5/V/.8];+F8Y0>
M+J #MY9PT(IV%_%6EEQ@:NQ5ZZ4:]+U;/HM25$GR8**"T;08MTG%BHQAF.L-
M) A-F-R.N&,4=J5N=/T$RQ.-I(@WV;R<%UED?VRM4/A,/</LV<E8&6.,5>7-
MCOJ^[#HG5-0.R?!Y%X@7TA\ :O[MG--T82'Z-S2"D]K"I ^6"F?-A-;1OC=^
M/I1*/1M&"3MDJ\X'.);H&ATHRB<Y=77"#[!=!_P\D#+ERIS<"@.=@R) RPK<
MO$R1YA"=(XV03=DSJH=4"N7U'&M \CW"^3.BX\UJ$X^:"M@0%VU"<GOC)U*5
M.?E?X'=OCOEW+J0)S,3-JWPBRZ'[W<PSF:E@09!BXL?ZVA7U8O& :20YHU*]
M2LQ3=EGJ4!,8;!)8*@[V5/%A9^R5F#A12QU.R*Z5E_T"'@4[-=7!=(PN+X)V
MC<21&B^A P(GRINMW#5G7GW0I'HODX^U)'H_QL"O:Y>MKSTIPW[)&N>CI9 X
MGEO98SF@*- HE)HW=462@O3D]&*.<?498*B:Q#C]P="[W(8%?X/@>>-IBHMV
M=Y@&0;#J-/57G!>5I)D',#C,.H&?]#FN[@AX*PC1G1&Y40O*C)( 38BJL]_X
MMV4@,V5GTE@@7ZPZ[X*HPR[:M \<!T7Y(" :[8<99MN_B&)@YL !!OS#^AKR
M].0ECJHT#^4.H)E9HK:5,391#N"EOEZRKC7K*S?%WYE_#2PKY+9CU;J>RRS"
MS,7*%?K185E:N(930:<ZYEA@$%4IO*X AAHTH?".8M4CPAFG@#(8.^"#I M8
MB>JWY+BNL8#8I!_=T%#< @L1&V V5B$0]?J_*TI]4N6OA.Y:A_#(M,*YCH*,
M*X[_J[[;J#2V&P:8&?AWJ9J5,;^C@HX:,.GWB>QQIH"?%M>&2O:_ZEN[E>W]
M73.>#L_MR5!2QJTQH^OBI%RB:[=$B!5 B <+-D<YMWD2$DWI\IS#EG]'-QII
MDJ@=Q1CW%(YLAS]2&+(^.?THR4LL&UNFLD4E>;$ JG@ER?;*40QDT+R% 9$A
M<[)1T:K$L\0H#V"IZ(X<1<H.-WU.8]_-K61H-4Z0V0-]YMP (SU1DD >5OR+
M&([$%RUIL"XG46'4"9G7OG!N9 >CP!)5^J85AK@1_9&U0TVE57_,L>@VIN1Z
M$^94*Z;WY>]8_(CM<"!:CD0,<P"0]-61:YO*5.>PZ0Z95R>K.K]$-Y+,$5:'
M$=)>;?LX+@0$UI"8"5>'QR)ED3V13HVD>!,T%E*N1D+EU-A2B/9D@AO1A8\H
MR8/MB\JH.:2NHB6/60$J\A7*<RK)])YAGN]%C.BG .V<@E8O+#"]I!BGDA>M
M"A2=9S'&J \&6#,,Q?7,Q?9%0()0+B<B3GXDBAJV4B:H4X ?ZK^Q8:\J&,"!
MT+X%=$0'">;@'ZKOADGD+Q1;9<KOVXV!D*3KKAVI5242@UHHZ013X+3EL>K\
MCO$J(;H8.Y1W+IG/4:G?+K]+2TWLA#JU>>!#,&@WP^*IH5DKANADL>42K3IP
M:,Z4,R.OD3HX?6YT;/!Z&(5PB5TTQ[/O2ADN]&JBN, M8D)#%0=M)>NHR#P^
M;6,2)[8 6^G#5[B)T(3_TVF"&G3-B8.!O.72P_@(=Q;(GF!+;E?UT/X[4UZH
M)6<BJXG]C7F+HA*=_]>2,TDU,!+*T...E"'HWB)46GEFC/L?J^VJ$LUNI*DP
M:<SZ^#(.:0SX'&^F'4$*92P947N\5%KMZQ+Z<-=Y()$=.#0>6/35)U.(*YH9
M?[1!43Y6E-'#)Y@2C[2A8X;R&*2O7C CP(]VQ:3>4UKZP>[>P;S6_LB+11K"
MJ[M@CG865>&GRO;N7F5W?_LU$1I-?1338T<FQ4B ?B@#9LP^LBUT)+*>QG9&
MK:?J7H>(2[E+D<< PM7U>QF6K,9UV&']0XJWYVB,O)3>F+K6!6:K H2T?HF1
M.T!T-H7^82)A0%E#M2"E^BN,*+ZJBW&\A?NCZ+NEP<2GA'HEKMV#:_N5O=IN
M96>W<1^J,=S*327U2B>4*4(KQ:8,(DP19!8_D&D_\I1T;N.724O!4#)<!J)7
M@"4ON%1-8K49H0DY7R4/L]*>+<]/"#--91X;6VF<40AGY'+Y%Q:,18;E8E(5
M5,?58[!7"Z_$)!200*X\%8!JH)B4B/@48/O9(.+._IV(^-58B$&/C"X6^AG,
MTRQO"OJ9Y*[OQ+]9B%? .44/BHB'GY?(]P3@^>DCWT%E[Z!1V=W>F8I\)BM4
M.!G)F0J[$$U,&TR-!48X1*M,![!34J9D#MMD?<%ZC EPMPHOA3%6A6R:.&&V
M:9'#F?W(C*CY!-7IZ*'2-%959;X[L6JW3*R::V+5;IE85296/0.[ZB.85<D;
MH)P(VDEA[/MCQ0C@)Y=,$I:_I3-BY0F7Z(M ^X;]$-.4*.>8.C9R=4P=H)YP
M$"-.)P?#(!I)\J?G >-HIW Q  !3C-"3[B>ZPB [;E#,0P8#3\G9D$A[=(S<
M!GVJPW$#'@>;WTAZCDX7,AH+#^@ \L188OU1R6W713A:7^,/R4U#YQ-C:5*4
M F,LSIE04S%N?U@\.&K;YV)NA(>2L.5S)]],X6M<"^T%H^RQ?T(TD*J99X0N
M<_3NL)>&NQ!Y&,')DF]G9$<PP/XYMP!@A3*J*2ZC<+3.O2<+4TX<+')_7,4T
M%QG70^ZH+6ASNQ]S\AWWN:^0$$[!F+A9@?4@J<P$+S?6=2I,U'\46\%R>!2;
M'%WGX2H4/)4.GQ4@3 \.&KA@G,/*C526 =&_C I8%3 QB<$ZZ@H#EG2JDNQV
MJ6R+[ON*468Z.]7G^CBF< 4EYKIBR+E#R J(Q :Z-R0-,);0B32.PM1A8JX*
MR2F3JN8BUNUC$P4-SA%J5A"[\ =LPY!A'[-M=<";BLIRNE)Z-$;$!2MY )J5
MHL PA=A)_8&T$ZGXI?4U53%#E 1S13#AP03S1,L$)95<%=AH<H#.>"YMO5*(
MD,5:VD9@1*&,\\--@Y6N'Q*9RAMRC06TZL&PWZ[/A25-!#"%$=U$ZVN:..LT
M=66U6E29Q%IU>V=1D/A3QP!C9T%U^Q=3+K&C!O.]GS?$YUIM:T-OOW5U\F%]
MK=ZL.I>M]F_.:?/HZORRO;CSJ>[-.*&2(GT?"/C8/6-]+:]]C>IJL?YU;.($
M,;F>^N5>$_4)!9>VU0&#@MYS/(GJ/S6K]Q.NGYWTHRSPT!"@.^.B*P=&!.$.
MM-@$C=\W?2KF$CH"Q442R((HD4J91943?<(#JIB!.FB2YAXE>\%6$B820Z!K
MNB: ^@SU:;4@%S9'G4=,/%K%$4&$P65L%B%%?"#2%#5K>%?&RM_%M7HK3B$&
MC3?<53H[-E7&1 IA0D)-;!M;+?5A<%C':$8!\NKZ6JNKXU$GITL<CL-$LXCK
M9IA&84]54>P"(^Q,C7JR,9C0.I,JH._(RK2GS(D$;2Z"B@E(#Y<3<NB**[ H
MP2C*R*A EX6E6M!A2(&L7?PM5J?.]?;_A)=GGKVR1>">/)FXL=]!PP8HDS>F
MPIZ.%3859"CR-NV#&'^A+CHSQ\L3JW2_<;A>8/.Z!;*ZI2NU/F=^UL9F#ICV
M?XF8>,J8N#BV5=PR&_>?RW4N,O_ $-)B?XX0L^,C( "*,*+;5(>V4^<*QVY<
M@?2*&!M:/W->HNM)I7Z*)<U5^2P;GDQI^EGMLOS$L)T,%T@PJ8WCO#9>B"QT
M"$G&V,EB0II_@"NG#%*>$ND+Q_X4[[<8RS'4Q_$4MS(&JDL>F?*["H.:7MQK
M2KTFNY;P,);7/E)*J]*7-HFR'$B..12%-[%DE18$5?'>1&<I:4*<QZ58OCTT
MC/JJDITIQR1(0,R%THX,99?26[&,%X=$<SC,TH92KF[@UOA:G^^M/*$0M2L=
M$'ET_JEUO%D_<"B+'R,JR=D[IL+=KQYBR;F_,]_3$01:043K@*FJMB)P4&+G
M,M[*$\).TE=P<;,3I?.&3/"Q'V98]E\.N$RMKC-D>I3TL'B&MJ_D249YL3,K
M(3J@I.,LQ$90B+,FCR),C$4EGU-53*(H;%CJ,"4O@UY"@FO(*TJ*0*5<7W.^
M!T;4Z I.5CW_J-NE?^?+TYG7N<2@71,K KLE15G&6WE"%.4XT[F'G#%M<O/'
M.I80ZQ9#WU.M]DPFMJGMIVD &_*IE; I%,1%S#P?"PT"]Z< "K0OL[4#B^/Z
MKDH(P46HL >KGY$J^4#A?X5A5"E%20W[@/*H4@:@!*B"L2L"<B4A6,9;>4*$
MP(@6G":%+BK$-U56&DN@4+%I% _8B68(!,=&@430]X<< )PECJIZDL*D5:?5
MM48U!4FY/1=&$5/# 2HI$K,;A@@!NP\U7L]>R+3YB>18M@>1EX8H&A_&;0\5
M2T%1ZS!:BA4P45!Q5@282Q*SC+?RA$C,>RQXGXOJV%]6UV7U"U)$GIXPI8#>
MNRCJ!2P0G I7=J+H2\512:9)UL$>!IBQX,01ESVEE#:_!P)!8%=8Y76H4JU:
MNK"(D:H,#_0%R8-5?5[5#W2TJU@5>RX%C64#MY(*+.6U& NCA8RO<I5>HQ,J
M#"I2R!1%OV99XL946>-?K"Z B+4*+WG(BBU$)!1_A"TPL+E1Q,OPI(M6A1F
M\H/S61_?7WIWANI>F:$ZUPS5O3)#M<Q0_18T+<,:9H0U+"73G.>Z6DKOS+F<
MQ A%90.S,U.GIW!R_F4Q<#,/QYR,P5P1"6EN<FLIHCXG;-.!+]1]K- XK",K
M=CB@&PA_0&[KZ6A7**]+N=J,<W=ZS%?DZDO<*W%ORKJX"))R/TELWJL\/'YH
MBCB,%6.P5$%3@%K5=\@+/ZB\#LQP@ 6LR!67.%;BV#W\3=6E)\5B#*^249+*
M <:,%TO#(%<321IG+O%$"JMT1QVT@*:@^9<,;*F6]7PO8#F1R_A,C9ZE^R\H
MKZ+E-E!E)SB/))&JP0[W A]Q1WK!Z70Z?(O+5$2A^83;,21<IX*ERX+#0MDS
M8:C03_I<'9-Z+^G>$ZJ)DJI-BT-FB4F-S#VT'*9)%M,5 :\2OTO\GK(N:L2=
MF'"$0B:SGR09<5([X!)5/56+YD;$6,F395K++TD>"A6S1.%2&55OP'"IJ1F[
MCK@6?H S\3I0V,6FWEI;I>*>KNW(]"C (E&I&;XKIV5BKPA<E8A=(O;,&S#L
M^R(0(=:]NY0<&M0> M>V,H\P(,AT>55!2B+(\5BC(E:/1B0NT:Y$NQ+M9BNC
MB"*V:15[@_D4YDOA>XETLYCKM07B1F<2RMMAA,7@6&0=1BE7)@71V91WLU.R
M\Q< ?UV?:KDIW\B*P$")A"42WAE_PX(E:ZC JP1@6]RS)5*1I?THYHX)68H%
MZ$'HE=XL21489IY_Y,<L(@-65YQ "H_;0019J@1D>>M3/165T(0C]*, BX:M
M"'B4^%GBYQU,DN+60Y1(G:' O!N1] &!,'\.+4RDZ44DH*)BZ?K8, *>4'_#
MR/@R(XRUEZ2HLE]S1>ZV1*X2N>ZRV([9<FQQ%/%&%>JYD&$XXI=4G1XGIC9'
MJGI:^^3(Y+U1TBH@G[+$J"IAB9Z ++S2-)0?B"_:L@0?AHGNVE+XS"5.G$2#
M//]-I<$4;+N4S*O+HJT(>)7X7>+W-(LM*( R3R0=Q_*T[V.A2.K8 *A(=E1=
M61"%3\9?> &PTQ&FEB"QSS*J8%DNN42S1:_K+L>(A$/T2=Z,3"8W(=K4^C'(
MR)ACKLB%EAA58M3=4=]=X5,#^P$6FL02;'FA%*L42YC&40""*.J'>4YR+,D]
M@1TY[W3_Z4B[,AQ\F8"@1,-%K\OV4,3R[\R/=2/IP1"0A-P3NC(B-3E(2&L#
M#&NK8)WMVK;1#D7<$:%,-L]O SERFBY)CXU:K<&Q=5T;V]4,Y&5$ 5.'\PS0
M-1G/2N< /HS]9J@ZDE$;&>OYG;NS&Y\;4)5876+U758?P"5,VD!T^3L3,3#3
M8&0*?B!+[ 88Z2I2F=MI1BI4SJXMH%^S338%]DHHN")W7B)=B733*HO)0-P
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MI(;9P!/C;$AG47$ KOKW+Y9Z<<LDU9$1=.1W+1)DQ_6UD4RUHV9J]_"QQ@W
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MB>QH1%&RG&/!\1@I/0))T*=N/10#KLT)7BRZJ<41=-(NA8]=<W(429F$ EU
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M1S6>]>I):#S!T,>-I$#>I[>(K5*>[!:!F7^..9;."_44Z C5D SO0_8$LA9
MH(WGVD> 7*@T9Z1I-T/ 2T96B$B<'#1MY+1^H+L4M%QZN=A&L1/75D6BX!(!
MXJ05R]E,-HO_'PGX%<T<\#*0C($N%#.'I4+FX* \2CX92:\:8%2T^QBA1F9]
M)OE-QDG2=(#J Z@$D(T-[14WH8+U01%JR5O'6Y?R8X&H+_7(>6$85"%8UX';
MT7(>HE'S3+S_@"QH4V+F*BR5A? 9?(XE#>+#].(,#F*@GC9ZH(GK-1\8)CWQ
MVW3B,75] K@.= %QRVMVRW'[#O<OI2[PZ%<2- !U,JEW"NZIQY0 ]3YY![(_
MLOOTL[DHT)\Y63;TJ4#G,81S1P[]* W"(P+#)YL>M*C:$@Q3PMV3P$X)0$^P
ME'(VW-YAFM3&RGC&!P,=3WDI)'U'VWQ,SH_PWT.78;<':2%Y>4&R;G@)L251
MD@OT$*2#]<S8^3@:L&:(\80Y(_84M7-L%Y1<#RN% J4#U;&CU4,DV<;)@$-P
M/;@&B/X3BE/U$1)TU&O3$A.P=L44:[=8K%TQQ=JE6+NI+E%BUNN\KZP]%\4"
MSA!VH1)N0A]0KTM5.-A'"+M@N>I0HRD#&\Y[CBQ7&&J7E5X#MU)N8A(#R!;=
M9>#]).GA21-Q2T"/@G%0RA8*0'S-+D"\M=I (SKVB/"8&V6C9X947*[SX'?Y
MU4-IL$O=T:Z TX!WASP4ZCCVJ7T8R%05=ON*CC-2=2/X]B#S(V:0T#E%]'Q@
M-;UAQ)%WTV4 JBBKA9+DBN)O# +]YB&P2.XA:#CREOKJO*?M/DX*2#A6$J.&
MDY6H[S6QJ?3BAWCT5W,#*^2FJU=/9!=/W]59BPUV;Q<MBL0+D.@(P]C\0O +
M266!-))3^D2_TF)7 VRTRXO;%"(DV5A:)DM YE,KL)5BB]%G$#6U#0TK_BIU
M]LH"L(*]<4RORRZOT"H+(:B\XYL0Z3Z*-(L0")D6%W-9%BDU(Q+$,40!6 JJ
M7?V!TB.(MU3QL*5A-%QE\7X3MO9':3\;X1AP&>Y&8228XFN9A'ZO4!;+*\YX
M!R(8I7*FX&PXUCU&,31UYEI@XYM8YHGW/<63S4W(^U=WA,*+E7J1BE^T9EZ$
MR#UKY'WL#=YZE%O7]"](N)^]$7>H\$XV\X"S^WEZC%>P%^6#PW*X&?1*^(RQ
M+WFP#7K<V>B [-SY!8$V\$IU2P;MR7!/&;V%K,9,R\3LG7(F/:0^41<"[\8;
M(Q>K/90;+0?#8WUE6_6BSBQA@QLZL!SRID .):!&UQZH??<)O2!V +I";.D9
M*R<8VD#[B+R#'@&L#@IN>+X@W/\-.$>>+??%.)0CSZGH!6I(Z8\4$2D>'7L-
M1GBK_=@:XIQXI=NSS05SVH:D&GJ:I,Y;ZKRESEL\P=QD5R887QA?4T#!G/1>
M!!.P$XQKLM(XO'FAL>"1#W9H4Y<M==E>R%:]H)-ZH?\BXIH%M=&.C=I=0!CT
MD&$GYI -V4B-E3Z9OJ!*95]CAU=&+OE?(8[C!>TV\+G3XP_M/"UB=,10>&\H
MKA$ RBN5"-4?/F?]AG;U>A]?!YA%B%/JLA.0),T;-^;4"=QJ)Q#O(XE>&ZN<
MYLV&,KQ< 7LIQ6-Z\6">KC2NT[Q6EQ@0' 6*.TY4Q9'?$$-5VE(P-(]Z'V%!
MS(S 3M(W=<U.U\)2!["3:W(L4_]Q+?[CJS5 =0)I5G04Y<6>E9C1X\>R#<EW
M+]W@E3-H<AA2/F*V-MIA3'W#[=^5%W0*PVA[XF%3*E:A  I3RT-!N^'0GC2K
M,=\Q=;NVVNWZ0&QLG0089B9*LJ@1$Z$ PN'-NL@C:2&/<,Q)5XK=DM$2BB<5
M04L 4MQDKP/8 ]3U 80;:,#AM@&%&&W98L9A]PCJT/5Y7?I0.3U#_ #_B1YG
M(N)9: F/2(LFMEJJ3Z7;O[N#MP>XP[);*/HBV/LI>O7DC8RP'CYZ5Z9_IS/L
M"L;=L*B?-X.D\N_8!I"\":@/$N3+5[1DZ:@'#?0&HD\#/C14X7LB7\IOWZP.
M&,N*7<)IN76(M65DA\C?@<.Z8'D2JN%%ZU?#H@;>,@WXS)!47C9*P9M4: =D
M5TNZ)FU7#XS8>D2._[YV9O**7GJ4_*X%'Y*-Q5A-.*XZ#%Y<QECI,0"@1<,)
M-=@H,2?**[LDY#T6:0"V^.'W>&4UAU,I:*OD&$)ZS+?@F/.F0R8K APFM*82
M8=H6.Y?@!PGNZP%\%@IA&"Z/?@#,CR[[*N.YT'LH9X(H+X70;:,$3:!NQS@I
M$Z(])D1"SUPU3KX<<V+&#+3GM5DPDP=?PW(SP4<C:D8)4Z@LM2U:9[-W[N[(
M'D%4"=K0H;QI&H+>D1/,=$SH,@@B*?PT%KD"ZC;-@T;S^&7'WL/"<$!_:A6/
M"S>OPA']5_@#&$TCJS8CV$F3NF#ZP),U==AW1!HWUN-O(&&I;/7 D3-MLZ</
MO1]A@L@<Z?+N[?0U$+V&I8#:.)?'#AA@D%7 ,2X%HAN#W9U[QPIZA,>'HV/
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M&6$-!IAX.(A[G6I41"E\W-_=J8BW*F\:_0K^=+DZS V'-DVVS:DTX,R_!27
M*H"4Z-.[S)AA,>Y-ZEY#\$>MS:17%3O2 )A[[DFT_XD["--B#1\UT4<^P=</
M-9+2\C0-"6^UDF(6#3@O'X D%1J).IIHE<!E@Q'$4K&Q686Q[SKTC@7<Z@JH
MR278I<+N9";T[^!J+FX/$<Z>FL'MDS!L$8-E#FT3TZ]2 SW0>P*6R/.0">^+
M@1290:)L@2D"QLY][0H;4D1E<J1(2OVWNS/T<IX1"","*I<G5\+T;RZ4N&-
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M:+7*B"+!E(CSPE)2'CZ<&B#/UP57A@]H)>5-?"[L"U++PTH"9Q%\0L%P<)>
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M]6KZS#B]@V%GA#7DT4SLU:M><-"89H333$VIQ1UKIB5@&OR:XH'O3'BEALL
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M^J+OKU"?TG)LF_<##ZDN$=\BR'&TBNAIFM&P5RL"4737,A$D\EY[J[_C&/[
M;F%D2]>@@:P&031'-EX%FCM;J_3H8%JZS1B5>TB^P= EMS:V5T6>3>R&^M4D
M#TWS49:Q.*[VMCGT*IM1)',&/9]8A'57F>*]VM!KL3XE_MX'SG_'NB[1QWV
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M\GA[)I4QW15A!88?@.;$^'@F$'3&0(L6FY#H839FO>(D9#PZR!JQ,:GA/V.
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M@<A[5*R.TZ.?<#'OEPC:B]A!EAW<(/%)!67I*4,A*]$8JNT K-U0PJX>5 U
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M$$(@Z.3B9X4="E]^%OQU/.'LL="$DBZ,1R\#ON,.8L6CL-:1CIP0>@AL&?+
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MIZ/U"&$-7QR\ U'EY&&XW4/:'W%T/8AYLRNCX2"1L[@T8B[, %EAO\9<+-Z
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M+(44R9(B65*C%)UPS=[=N3?IQR7.H:?[5 X\;-ZD1G\!^?@3_"S'5: G@O.
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MC$?,%G!-7'<)0NEO[8HEY]_#F^H$$;<R3)U+P]2QZ.G9WCR!ZMS(.'4:H=Z
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MNCHV=@P#LT;7U/-9V7Y&(]AYJP7GLZ.C%*ML[,,L%'%VWLBEYRK4P'AO"D?
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M\)AG<_2@5_-Z_]_@W\:/EK6<DSY!W['YG-S>W #S>WK.UR@R!XK(0#>BBFW
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M'SO?+CM&W(!.F6,2H_Y!=%<CMD$E(M*#NNEJ?_VC3=TU=Q$9T^0%J&)+:KD
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M-!R:4>C%@C>CJTIWCH:D)N,O'7NP8VL3<QL8L/<&Z)Z([4<P5J(X5'9"3?B
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M$N"B'%N4=ZV<"2XZ/_3M.Y!%5T%-BZ$;C9W@J!]_[L;5V]35W=-6H8B&DU8
MJRBXE*U #'7,#)R*T+T64<7B'Z"*A5'%BME=M7G=-RX&Y8>+Q!9J7V$;L :%
M:SYP4,)'6Q(=]/2=^M;',Z.R<?.F&><)ZR7[D2K66GG/$MB?=0^+;XPZ>/==
MH31,,",_]'N5=6V5NQ]J0D(>'M18"VZ1A>Z0/(?]2^12J1BU$NL3OM^Q= Y*
M7%_'6 D#&U4%TWF@8D]4R63,09G_)/!IN^2G^%_E^X.,EPM#=LHG=!JM-?<]
M- #E[&?%X'[:J*3X;'A2_&)C-D:MUG76^OEB)L[>'=K:>*X\3W1'$X6G7IAV
M'R8$OS(#OD]@*+IMD1<5?_LJ-B.J9_/*\^8_@(K'<NFSC9%Q_T=1#/LE;R8B
M<^GOKJ_SU=^8.E^YJ]?J^9MB^>9">LA7JWD//FYK,N=/,ZL&C@L]FYW#0O,8
M\E;!OZUIF1*F3^[0Z93>P/)43#+U6_\FB#ZQ<.06JUGUW"7BOIL^5UU+R"[,
M+$Q9MF!FYF ;F-:[!]X0 %XR''ZNH,JF*?V0HOC>&@IDO&I<OZ.8)E+IB'D(
M7:OB:1Y.3PR>#>!KE^VDO8VC" =M51K^A[-*QU@UU--"MIU44Z<>RHWSFU"L
MIX63U&<M*]2(%:JP8ZV&S?U]#EHO@I1-YV*I1)C+;,G2GZ5))VI[QSPDOD(T
ML2,HPT)31E9$) \=5;TJ=/K&?6Z<2$A^+I!I,N_9^DIP?(O\\OV'K0Y1S<Y%
MYAULT^UUI#4):_=+UXY*^!U9*SVQ>K:G%K,9S1AX;4*"JL,:+_>L5:_YQD]S
M4*6WX9XO1F1G$]?=IPJM12:\W5]?/203O^K-S#CQX#O?1SG^*QT8])-)@0U!
M_''MY>>$]K*:DNO<:6'#"LK/"6+\\^='MG?[EK]\C%90/DXI^?FQY+BRROL(
M7:.X;EUCXKPSK79+[Y:3Q4%G3;K&Q)&]5]=8U5T[VQ9U8N)0+NQN[H>2OVL5
M3V:I$UNF0BQW/Z>I$*>S2V W@X<10"I<CVHP00@CI9;):XG$X[,Z5378F#JP
MU?PW#.YI1KURNC'*7IS\RE5K;VI267=(17RH:&V&XQ_!3[V*A7V($E>0;[<)
M30DS96*'!Q$YRT0Y4NFMU<-$ 7\K2WL@<K.8;*@*)8O\+7V5O_$V1K*MM7J4
M5".IF)2/!0HZ-D-JVRU+U#KDB4QD>K&)-$.SP,?O@'!9F]<]FE)S*(DZ3ZEL
M&C)38U@R\+4Y\2J-YT(A2;]@NIG*7A03ES/CO5+@M8<'T>_U5SZ\*JK*@_LX
M[@7\"A.(W%V=2!]*SYL^5&58C]&"J=#/\J^RT;XP=#.B-W&;*4='5ZPKJR7-
M4L;;V<&\KJRVZ_ X><I;_;QV<ZJ$Y/H8[HL##3:#G0;?E004N;3%DH+\BWI7
MVD\"&&(RELBEYLBSCMH=D= HR.)8RJNJVT=1?"AJ"$TOQHKE09SF:M)%/G\K
MM0R@/4.1*2W7Z?N%@D#I*+RCV+'$]U/4/(1XSWQ )S#I,^S]B!-@FDD#^+)]
MSH;>3V[E(24 X5G<Z%J%<DFY#/4R!<W2VT#AM32"#%TM.?X..7PY+H=3E_9Y
MY^U']71P$D*@[O8QG,UX)NYL5)%U[DH$!3L*>SQ$QE^N0(=S$]BFEPL0*4F7
MW@Y.$E!B%PFH/$Y 8%^U1@_Z2^F'^OD)J+Q" DJ=QN*Y,+!S'P$='I1]:2):
M^W,PH8MQ&K)R^F D9R\3]YG/3T,7*Z2A! C3TTQTBVKNU+N8V,*59RAN"B-E
M 0BCY![":-401J=["*,]A-%Z+/$]=M$>NVB/7;11[*(J>V&:S?!QH"4+=8<'
MQ>H52%=A1A1TD1_@<]XA&J/[VGF[T*G?])[;NX-<=#*)7)1LC')/SRVU</9\
M?IWZ\KU:NB_=W)5J;G5*& FN_NR*BNF4SE$/>'$04WO*^\OIYGH>EMK)=W\\
M9YIZ,[$2#W(FBW[A<6<Q_W0]*N18 GJQ,:K7?I_<_1ZT$NW<+#!WS$ ?.^"P
MX_W(EN6+)YFO.6,WN_J,W=],-B2JOPH426Q-]NX.)#TC7_D7Y7BCZ;UA\GA?
M2G$VO*=V62.H*82H\@,/;#:U^&Q^@5\BHP5V.6^:#/Y?NRZ_^1 I)C(]3,,Z
M.KKEP:** 7SO16FQH,?(VX+ #KA0-M6!_JH]=/J54]=U)":YHK3C)98<ZA6*
MS"69NL*5]!G;N53%W#M)+M17^6YB(T+><BJ+]#VNG<K"0GK;FO(XJTM%"<7(
MP,"DI*E\]V-:5&P+:_9V*90UE_OWHW]>+]G+;3OZTBS59^.#&?;4=:\"[B<,
M_&#)7AWAS/NCZ?;D@_C[=(J=P=^WF%0CN?ZZ2?5T-M=?BE37K7;/;N'R\?U>
M-L'F1U<_V,_7W-.@Z6N_.A_EO[/ES(JY=-!U]FZZ3B_.@N=J3[-%1+6 'W=N
M'KP,!]T2.II@H:OH_CJ[\^N*FAS-2 8^:8Q^:6_L=?CKI_XGMZ.NW!#/ZR:"
M)":3C5:O"&2FZ@/*#M$HE<0&R5K3.]:K;,S1\.$T<-N6'+,Q.CO[W3>;C^GJ
MK;QKI\A#*J>3(14@SL1MO<A^I'[D?W0QI%(KY:N%2RE_4Y2*I?O25>7VNG13
METJ_;DLWM8W%6G@'21?1R#DU."K?P97>,*>(F5,C+PE?Q\^EQFN,M.KEK_IE
MZD;-)7?MX,,C,7#JMX_#M^>?K%#.S!>(F8\L]A&:?81F'Z'9@>5N.D*S-? [
MNX)S$Q&4JLFJ;"!()N_E05BHF%B*<FNC48)TB$X5*DVG^3E]T*TM,!C<]*DK
MG5>!C$&CB[7#T@4*K'B%X_14E8>[3MK^^7C5\ME!?&ZT86UO=G-'#OS2^,AD
MK2/E[:BGM$%H_RW!5B25MZ:AQC/)S)?O1]/A2[8FPG,V]]E-SSM?R:F-FZWO
M/*X9]NJ4Q2[FW)NQK%5TZ0VK3]BFH$Z$.*O9S99P!NC&UD5MXA_ MP(;XC"K
M_/GC^9_FX,=54IZ?^M?B!E_T3D3&9L(6NH*+D$U_]I!,80FB?"];#B7*;&]T
MJ3R^/O7..CM&E-&,>CU$F=D'7S;@)S]? ;<>58P_<J9Z<5/].9NH'5UZW7[S
M)7GNBB,M2W#678NTA/E^Y]=UYU-.MY5HUA%62<1GXZEL)JZ2;(PN'O/I$^O\
MFCV_&[?^$X1-N,\<CLT$$KF6C2=JRNHXM6>'27(^3_D"HS1&#Z^#BV2J.WS^
MF=VR8^!QCUQH*<FYTJXE"YJIY9M@M.2O2C7R;E_GJS_K"'G_L1&/R!.8&NQ(
MAP4[YARJ,4HKF;N,TGK^^>/=<8Z-A#'2C=']KXO.P-9:#[7'>>(8P6,NA9WS
M/H2Q#V'L0Q@[L-Q]"&,?PEA9H4,->#DF*DU*R0W&+ZS:R65*OH__OGD,])SC
M6]5W)C9I;JPHAI%.[$X,HS3?X6T\@+&2\YH.JA.YVFV+8(1AX^Q  *-B]=CV
M!2X2&^96M MN@Q'YL9+6$O<GJKH8I:_!-[P@_4=&*WP+7 &M)S][C&).^EL!
MP_53WA+,]>-)+I+EKI;DUE2IM(] 1&7J+\5V1TU-25^DNL6RO:!6MPXG\G+,
M<\5AA\5YY:Y%'<Z69Y:KXGB;)91UA!JV)=!PWAA=5CK%Q\&+//BU2BR>70:R
M(G?U!=.8(:M )/EV7]$4TT)HSA<V?\PAY3FLEQ@,F&O^>33JWO2*<;:2@\F>
M'L<G:"@"9U_\=BTABT1\,F8!='B5[79*)?FF-.A]^7Y1NBE5\U?DSLX7K\LW
MY5J]FJ^7[TL?'+N8=9)30QAG82&,Q49LC&"+LKF+W-#.KZ9BXX/)(CS\D6N,
MKI\O?V?KW7]><W/A:<U/,5L= 0FL\#_2W*V=_?N:&#]-Q[,\IRM\#I^W<U+I
MW&DC3#',_TGV5:7VNU]/?8E\S_S>_N7=^@NM)=<(45I&_5ZK6BZ>MMIWV276
M,N'*7X//?IXHP7*TL53<X5\:6-O^4]B1V-QV+_<#8W.K8O;>H_-OX9K>N<U3
M\Q^1*R0"K1&N9*"L_'B0H=&7+_+YTNAV\+LQ^J?RX\]M<G3:/VE]F7[0:XA(
M>D%M_-??4N8XC8M\D+NHJ)A3HI6;@ )<1<0H_ 0VZ/!)I'<%!F_#V[T.MTDR
M,3NK=ZFXFW>]D[[K?6OH'6::U ;LG#$S<+%;\8)Z^U!_;9UTE[C8\S;0C;C!
M_IE)'<96U%8W.N5B.EF,;]0F[U_FH]M=KG73UI+G?#(;/V:9J^.O:"BR@0&3
MH1!8X-K<_THIG6:^]<8RZY&'H??%/YTE3WW>3)-L:L)C.9-0CG:#8OV[N#%J
MG5TJN@RM9GVT2J'+&6ZX  T_%DMF/GWY="WW5LCZ(^R(4'JF*:\@C/[.P/T:
MXM'S',9&U;LM3'[X1*>V#HZ17E/"2C@GR?@XR2PFHM1%-+UO>=R$/9?K-_K+
MFW6:7*]$' LE3IC-H9PF(/;&O-/O<OR+O>*S10M4#FR9SQ -E:)+Q,'?&7E?
M1RAZ>QA=*KZ-!9.?Y,C6PN52LW-0-X8"V7\J-$NPI-9E\P.#DL':Q(4[.Z;V
MG1T]C^EJ.COF]IT=%]CD\5L8NC/[SH[[SH[[SH[;W-GQL]3;"Q+1NCRUW4U(
MBLAW2WK93;.>;(S.+N+J_<_^2Z*4>J_"L)XDM<1DDEJQ,2HIR>9+\O8N/NB"
M3"S?Y&\*Y?R5FV$D?2W?%"K7I6\QZ:94#ZFZ;JYPKL>!\=>;^!9QH#?,FIKP
M5IA,>)MWI,;H]^!U>']RD1MEE:UO[<GO:'@N6[XQNC^OG.6>BKK\,"N5[?"@
M<BYYA/75H:QO$J>L(&%M<2+;1]>A_QLRCG:RMGU?RK^MI?SO+-C?WK+\,UE[
M"D3)UYAEX17*I&;J0R#TYBIJ+1BLK5CGP,-5Q1H&*PIQ;1@]=LI9]>:HFJK=
ML9\@59Q*&_?UTE>%)O#-]:[&)(V]$X%VFJYX@X,O4KD:7,XJ_)H[DIT3*/]?
MB&ZB2U(7H9O;IS^]A/*D#JZVF&PBJT]73C:S"U"WI^LD?V7IK=63M2Z3###G
MI;;2Z3 #G6TK2@WRZ'.VG;<*ON8LIPJK*7J+<<CU64XKOQ)W_=OS)=A<"(U^
MW0!OF[JDI6C6A"7 9XL3[^1Q?ULUF9QLA(W-()-;M=FJW&F%/\G3;2.3Z-Z*
M&R.3V1&_2#I9MT(7G0<YIM.74=-FIA69N/S1X!*YC;!+9QN<,9T+<%\:Z+\?
MGM1X.;WX!5AAHLA*&6GX8E>17[QX7?:.09UD-\*5HZC1?'WK/";E?"7?VQ0U
MSIFU>9J-Q@?;/-3(O"F"VXTO4G@GYQOE<Y5?9C'ULUL+H1:'2%RRF8-:EDS]
M> ?S6GF6SA8FZ:P<E>9='&KTDKZJ/#YU?Z5'3YLBFW6JA2O5^!;O[!!)/N.*
MX +90KV+YY.?+PF[9+V[9^S:(SL?W">6$TU=?IN--^*'<YKV6&-T?FDFBG+J
MLIKN[L+^BXAL<C(B6VJ,[.R)<7)W;204V \>(Y/J^5\>/LCZDQK6%D]<];2=
M_W^<4;2U+Z'>@T/#YL.R-I044S+MYB-K69*E2YSS2I;\!B."VL,,R>HQJ6P:
M,E,52M/ G [\@:3*K^;^^#9VUX!E'!Z@!]&4Y,% !7458\IP9GA XMST#OU+
MG.W?Z[A@@DZ3FR#43W#7@HEJ<-GP:K4EN=4"=0:U'CC P(T:9Z6Y0"-Q5WJ4
MWF!"&M5[%4%*&<J ZOE"E?5JHG7SW+V\.;GVU*ZR>]%![W*' JW%'>O+LD(S
M0DR&S_C+]XKFQ>R3R9@$RN))C,B8]H5IH [!CN$',(I4L"U>%O]#;YI2'MC6
M5_SJO__?:3(9_P_\F_Y*_ >TQ]>>TNH='LA]'?99QSH8:6#H+PH6=L*1@95L
MM\3(]"HXDH%./GK<%OJC ^N44IF_\)B2B;]B$NMT@%5B%<0/6;-E8R@E:,JG
MQ^*D!:^D*3IL$QBLJ;05*NF'^1@LC J<'[N$,*'#\'L@U7T,.63*0&/C%.2'
MK2XY"W /!KV9!3A;1;-A*I4!,^B0S$9[T+!O03^9"]@7!LK;5D\W%&N(R<;<
M[>#]B";L_Y'C>;C#-)M6CN5Z7J.LPL2RG#OI+2JS@D7-PHQ=>E&YIUX\GCH9
MJIW$]$5-+6B8?UES>NG$P(VHB<]IT91OSEV3YBCI,V5P8]>\J$GG_&86E0PS
MT"8^\&=__<437IDT9)C]BL> K"(9)]Z@:Z^RT3:/=U$5B3:[=F'V1=9A!C#_
MPP._MKMN96G]>M'J35P/"M'9,[Q=ILDL[.QTI<A-]# K,[ 5_;@=2X[8&+4'
M[;?^B#T,Y=/W&L8;U?_"B0UTCXY*)A>P!XU97 \CQFB2$L_Z*"I N_!E"TA-
M9KTRQGE*2S:,(6H.H-W8&G]*IGTD[J)Z.XG<3^HX-05@0C 8FB!]!S8()%.@
M#.&@SEBV"<H)/N;-V?WQL52#O5(Z8']H%E 93%1C8@(^VP.UL,3)?TQ@L'P#
M:!!GA@88H#+.3%7U5[QZ:]+P3S9HI8SE%A<:H]_%^NWH^>7UM-">!R>S6#HO
M5:NEHA3B*]FFA&*WQHM7(_-=7AE<YM@&A;O"PZJ=E\:6+/A,)=.HM#KE5NM'
M/1-^9._*IUUHVFM=KG#()Q_T)_W7<SM^'4&A[\JG76RYW%W]N9.L\\0F_[=I
M2/_SW9^I_B]*O%[O%NQS]3\AR>QS]>>&O9S0JLO:K:&#\FB&-W)N*&4']T0N
MUO.5J]&)#=KVSU^=S/-)5D[_\,* &ZP*<%8A5?];[@_^4UPK].5_1:4/+P7#
MN.@!!'T<>;/262U(4G:%[= ^_;ZO$,AO_7"8?DP_X3/3NE>Z:1;0-(05D'\I
MXH+7=."4?WK%'Y?I-4)D?OGN3DQ286;<:A536TU6<W1"\ Q8K,@=6_.-3*5B
M\<Q[D?-V9-=6=Y]229 D:\/&=+*:?#G=9]S7 NSD3#85=$X5A,>%@&A@?5>Z
MK$5=+_5/]?GW1=GJ68GUR,^YD["+8?XC^0W>"JLBQX_K27JAA:%VKN+2A([^
MU60,##@,.Z<]1+#,M[D4LM6GSTY(C:5R3Z=EA2U.!"OG&%$Y8J<KA#S<'^",
M UQ'DM\*D]A#JCT\GG8ZS2282UFP?-SL9?2JUL[/B\GF,L# "V9,KP;5\,OW
MNF[)ZNH0"I?*I)V/UM^)>K? ^6Y M4FMJ7_>_O#6KV&E,FOJD;FNDK0-Z<2S
M?[A)#7V9V81+B;-I4N+"  (<4V]O1C]SY<;HB3V.VLW4PZW17*OQ>,.LD/"A
MQ/$&25WE26LR1A%ED/=+;OW$37__-:;=6S.[/8$KL?$."QO=J]5QMY-8_&0V
M<UOF$DWUOMX[-)IW2+2AW#A7JJTT^J9WJQX>C)?*8/3R\_+T@VW&^^B;];'%
MDFNP&"*I<O+HMN(Z;[U]M_U'MFFNLAJ3KCB-SV#=G5(/&&^"JU0&%[_^O#SV
MU)JZ0ED](W 7SEV$HAXNU7==RY^OF#F;C,]?S/S)[:)Y=RRQXAU;N"RRU!C5
MGCN7YO6=7DBK[\T^_(#,M&#NV *PZ^D][+J7A[ 2V/5D? ^[OL F?U+8]0VF
MT._1U_?HZ_\Z]/5=J$+Q2N?]Z=['TE>LA#I>R_[3_R9VOVYW([I3'GB#W@G
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MCR($F>G#^6PKIF$/'# 6^&SV9/%;S%9VH%EHRT&TU7UH9]@[%K<*#[*OPU!
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MN"S@_E>.=P2W9<(+,?]%:SJF?LM0R)[W!"B7>*"&.8J6&PR0CDCYZAH\>]\
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M1M#_#-ZE*#IFVV OWT4]F#U?. C4X"R\R:.*B4IEEOHZXLGOX)"(",$^Q5S
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M*='GLX\; ZP*(R*GF8[@'^;OQ]XQ$=Z<F&,VT[ZP$1LE&@"^?RE79"V21<Q
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M)6EUAU4SSF/&>1)SWO34+S&3X>#-T1;!AR5Z9*/<[ZE[POJ!%EQ#VQTZ>#V
M*^!95*5O'K#0"D&S);D WT*7#5NR 0:LT&(T_H%M.W2:T+D:EK"RS0;1>4 +
M_G+!!LPY=BPXIPI([(%.T.+V&4&G[]"%IB4A\[(5/+*6:+M^6R9<(1OY'8:S
ML2NUV=SSF(+TT6>YZ&2)$TUX!)J:_8O_O,&04#Y?@Q$M"!E#D@(F UB&9^W'
MLQ,EER4LB"SU;-OU@,7FFWX'H4L"&Z:+Q+8\H09DRQZ,C6D3QT(F+3&EL"$I
M:*DQ,;/"%&"JVQUT$94XQ][I>K'Q3ZL;7WJ3:OCMP8(1VXMH*^8^8'@';8*V
M<.20</R+2<20O!-!LFM8<E92JFF)M=V PBQ^!^Q;2%1;=QWC_LZQ3.K:T7<0
M,I";@X^(6@S5^SV@"GJ1D"TE^_F7%/;4 ,>@ .1N:#D/>;,HKA)#\F$/2&B3
MDM_FP1K?CXM@^!*)?H@-_!-S?6B883G$PY#^N%(FRDP9':P-=6^]!OA)6^GH
MUJ;.K0%L5S8,Q[-=&JE.Z> S$(Q&=#5:,0(?LPCHB_%8GGV5M*&DJU<3=:CV
MY<E<DOM];3&9JY,K::J-U+ZJZ <+DD;=%AQ:FCI(3V!I0=DV:0GVH#E"8(DL
M*D6$4W5R,51G6:BT^;4RBY#1I:G\5>Z-%$F>#%CA;*$,I)$J]]21.C]DN&;0
M8@LV=3C=ISD&-@$&ZS-$I[!6"$;W. L&7;7D.;7X5)[-OTKSF3S1Y?Y<U2:'
M:WC]SL'N'.+UR $V'?$J(1ZDKU_]COK^T2(FIA&#T.46KVMM-I?FRFPLC31Y
MXD\%5=<7BNZO9]?R[(#G@<"!W=-7[9YPAI]K_4_7VFB@S/1__N/C2?>GGZ6!
M0M\=ZOQ@[3V#6VA[,%YGPE]BRY[RZ\J-,ED<\+"=474 -N[HXC"@-K2<#7.Z
ME<<-C51WQA72B$W^CC>YKLBS_K6_? RH_4?:=*Q0)TCY,E4F^@%CH0,+$FKD
M,<#WS,E,HU!8*[;_>VXQD4=TP6;&IY[H)]_G/'C+!YM.%O,;S37MD+B8RKF%
M:01*J<1(?,@-Q^11X%(.QNI$U:EG,U=OE :1(;*!;2!@1<95;5H')S!\JPKJ
MQ2AP0?%0G<B3ODIQB(PNO5$G?6VLO/U1FBB'^X8-+#H'C]'X3Q:(C<S%O8%!
MI;G\Y8#'-,OZ3B'VG>_V$A!DL#<JLCR7[;(Q"PLIQ";GXM>1IM.HE8:POF/>
M[LFZV@_>N>IH06.I@X6A[VR1V>Z>38%MPC4RU/7&0@9(1*U""B$,)USDVM=N
MU %MBX:NDX$RIABHX^E([<L''KUZ2P*_><R/W+(L;Y1TRY2*C<U'J(N>KORV
M\+U)ZMC/#]F^5=*7STEY5DM]GO!!;.74I_0FZN-P=RXKIS7GK&;?7&C()$:0
M"Y;WRXA*;X)>#A?#HN1G$K(2&C%".;%U49JT04.<"TUB4HE2C P?=5?(G388
MY>1*4\ 45HO1X")O04*U 2'*I::7J529V-Q<B!UE61O;BE.I:8M7H!3CP$7A
MI:G7!J"B+&MJ&1+3B$'AXG1!/K:!HRSEFH2E(JT0GE,N?J^0I&U@*L[&)@$J
MI1)#PT7[99G;!I=$QC8)!%\LMCP7RR?3N8V515G;I-DKT(EQX"+RLAQO@TUX
M4G( 78 L,@$X>">DCE%RE6(4N*@[/%8IO0D;DN*6#M?N[!,ST[.@MJJ<E JM
M%_I8S^<7H\='YOUK9; 8*2P.WS?#%7;9P*RMBA)9!:B6D8M!Y /Z!(BB)-C!
M U9B]\P"69E:#%=.0J 4HF813<ZN(4#8_U9XP,(:M/18W]HJ6OV>Z(*H?//H
M _O.R+'9WEG!Q/N.EL0@\V?=$W-R**LSZ48>+13JFM  2NTM&-RL*EI0O_K+
MK/+;@CU2]W*J3=@.7C-G$\/ QX2@ +)4FKH [7(&,:A\MB(!J@^2KD9 9E/<
M#7#BC83\)7=/'B%\[[AL1K5MB&8)YO?1-<]EEQ6P*RT^,[-P*VP%0C%8.:<9
MXAUS;3'7YQ0LEAW\+,_H"[-9&?/WBPIF505",3K[',IO9E!!B!!L(A6&!.EJ
M,1Y<+B0= D0;3LT42=A7M*-4"$H5)C%47,(D#57IGE2#80Q'<NL))O>>"N K
MI1<C)TR6I#>NE,S.50-:#$+9QE0!=E79Q! *4R65-K<:)'?!<^$.5E&T7<H@
M1H_+G*2"ZGC_ZTV$UMMP:R;<_VJ@BY&@7A_$&)J)O:\"S 248K"$&1#J&BJS
MF3+([)TU",5V9]MC@<V'V%GW'7;JV*.O+&W#+@1D:<<>7#DX0$2S ]("#+^K
M+3'*PI2(OR$7;4)+PYDVEOH:.]V\8&]';:K,@G/_/TH]9:C-HF&@3:)AT0P(
M?MIE8CD1@1"Z]UPZ)'<N-D%;=E86;5H+)E\9BQ@H/A62G6/"3>__OSG$_L-N
MUIS!E>3?R'G.KGR\;!'$[D1MA65W&*XN6UN*9#NZBO%WJMK1X]J*2%C3@ALY
M??"SU@@[CIJ@X2#7"G=C*&W$H6LMVY?M1,)'#;C(9>S31#<2ZX<.I,Y+J&R!
MY;XJ4Q9HO:*N(];^BRI)1]^^2F8&["NIVM_U\J(*TZFSK\+IV?9*^@[B3I+J
MAI>==G:WG8:_LS>B7E#%'>Q*-G>]JNB^W."FWY$3?)0H8&&_VA%?FQ6UNR?M
MT^[1(S%WDNXCQ,X,^PD1\3U#B,);>_,D(,4,[+$=/%;M6G@#L+#[7,X.M%P2
ME;1W;3U''/Z^X.^0QV_L&0*57T5<)%09I_^;/&N(^&>%\).O8<5!DF2)?OCF
MV!N9[-W/U4")N ) V'70WS$X\F^3?JX@)4,CO#S:]P'9A=._WR#L>L#JXZ>-
MZZ@$ VB-X7K)+FUF,E,J 0&R+'; Z[+E8H^MM.P&\7.Z B/'G/LO"M,+ KB6
M%+PXXMNQSTUG#9"MNG#-**F^WI+0-=H_X'"%'6]SV0J:0Y1$I(#ON"J/AG\/
MJ'R+H5^?UJ&$I@YJW 1._<@UL^;GRNL@KK]%QSX -S#:,.XBRY?3U4$=?_L^
M7X/\JCH(?94S7*[J-U282-2&O)S)PCH(&I[AJ#JTJY/703G5WD+B.IBDE>"+
MZR L/UYJ-UB"$SXYKYEZ6;)O 4*NHZ,M:7$+ZFHCMBH0FZ^KC=A7 K'YNMJ(
M_6^!V'Q=;<3^)!";KZN#V*IMHBTRJ4^=?&MPZ[*8J Z**+8+\08C @6*E!'5
M01$=6  C2(!MAF?HPPW@S/)>2E8+9;REX=" &!C\V[Z@K@YB^Q\.I:5-%]5!
MR!ZP[X<P^]KG2NL@:A3MSN@X':#5"F)H&UG)RXCJH(C*%A#JHT9G,K+K9$%M
M'40/8_?\K$I>51V$]IW8/M@@%UCRDOB+1<K!Y>I ^!2)O;\: 07[PL6^?0$5
M@G,\,-AZCF3/%NXA9%"W#/YJTV7+P-!D]X4G95\[-G0!?GHYZ<,1G1%_5_I\
M^4VX?'7QV15TF%W,",W>4_#WK=C7+<!^DHUO'@H^<DGK5I6EML!=T0G(#K"P
M8YS:BKD[R$2TZ3CG45Q?6YW&CNG?+<@8M54*E?#K7KH".RPZC[3<BZ-4[V S
MS/VSU>Y[F,DM$P)=0M^2EL>^$&%_V$BV3?8_]M7=EN)HQVOC?BS/5OQU)V_B
M ^U0'\V.EZ"BRKJ"J'N;35 &K.3<(WF3LRIQ38%+BL\&VPP:$&VAF;/>^#>(
M\DI7XJHKU+OC1T77/65=F7TX:N?@%'\H$&LUAX]NSW*,^T3TN@_/=[BB;M3,
MBP);=L"^&.#JG+4#NO2K@F*\G\=:.]B+S^07 UZ%IW90QTYP(&Q\#UH6UPIT
M-0%Q=QOUT,&)<\#^?=%/G&+5R6NB7Y1=+M"GN+HF\G_7-1.:G;IB!+C0O[R*
M?^V\<B>ULV6%JT %1MJ3NW;:%WH998I79ZR=SI6NLA2HOC=_S2Q0\$:*;HHL
MU'P/OIIHO/L@J>\0E[D5+ XVIQ ;+(:ZC4/E*H3/=#@VU,%Y 55VHB16YDC\
MHLKJX5\6A4W0XHODI\,K5P9PZ<J6Q4Y(0E->,]]AEZ<6TM0UBHW%GE*?TD ;
MNB;DJ\77UU4EYI0S$34[=55.TF?/KZYIGB5TZIB@&3\O+/I?AQ&A-,HCG7"(
M,%$R<J9K]IW1H;3^0:?7"WK\/QPG#'<"BMJFS1.;J3WH/D!HTU"F!P@B?C(8
MXR>JD;^J$O8%'K#);D8\@[.FDV6/?1W"X5V-IZ[K7KC5,7=2PG.N4#G9G^[Y
M7'2"3P_HXW\!4$L#!!0    ( *Z <507C%/@Y \  'RX   5    =F)I>"TR
M,#(Q,3(S,5]C86PN>&UL[5UIC]LX$OV^P/X';0\P2(!Q.NX<,[EV(-OJ1!BW
MY?&123X-U#(=$Y'%'DGNX]]O48<CZJ!(VY+8P 9!.FV3I7I5I:K'0^+[W^^W
MKG:+_  3[\-9_]GS,PUY#EEA[]N'L^6\I\^'IGFF!:'MK6R7>.C#F4?.?O_O
MO_^EP9_W_^GUM$N,W-5;;42<GNFMR3MM8F_16^TC\I!OA\1_IWVVW1W]A%QB
M%_G:D&QO7!0B^"*^\%OMU;/^Q;76ZPG(_8R\%?&7,W,O=Q.&-\';\_.[N[MG
M'KFU[XC_/7CFD*V8P'EHA[M@+^WY_?/D3]S]O8N][V_I/]=V@#2PEQ>\O0_P
MAS-ZW>2R=R^>$?_;^<7SY_WS+U?CN;-!6[N'/6HW!YVEO:B4LG[]-V_>G$??
MIDT++>^O?3>]QHOS5)V]9/@6<]IG- GPVR!2;TP<.XS<7GL9K;(%_:V7-NO1
MCWK]B]Z+_K/[8'66&C^RH$]<-$-KC?X$[^VOZA#_YMDM1G?7^)XZ[9PV.!\2
M"$K0-NJZ\='ZP]DM-( K7/3[%['\GYA&X<,-!&> :6R=:>='7'M@N]16\PU"
M85"G0VGCAG29VC[RP@T*L6.[4HJ5]CR=EO060ENX0F"MZ=WMHPWR GR+QB2H
MM:!0YX9TW=C>-Q28WCPDSO<-<5>0D$9HC1T<2JDM(*<A!':PN73)G9R5\YU.
MIUN4]5%M<.::G= VN^W6]A^L]1Q_\S XP/9"W7'(S@NAI$V)"RY!]<:2DG(Z
M[2VX1?WD0G#//MC7+M*]%7SB[]!JC.UK[.)0 ("TH--AF"$7(FT%&2=\6/BV
M%]@.K3*U*M?U.V&,;(@?+I"_'1/; ZN80;!#<%O,-Y EZV-#J/<I[_8#4E,+
M66B&;I&WJ[=7OMTI-0B0[3L;<,((+N*2&YK?C/L;*!\B>HGT/J$?;1<%<+$K
MV_].LXBHGG7]3IR[;9?FB=46>S@(@;]#'1;55+3_Z32^Q!YP'&R[Z25,&+ML
MT035WB+U/4^G92QZ8=_7F["DZ>GTH'QJBOPH4?6 KV.'QCYV=Y!VZQ03Z7LZ
M38'8XU6O_V8*HTZTQ8X)(G$\6JDUH4C?4_*-ZP#]LZ.9XY:2JWIF4=Z^;09T
M6B:D "-:T&].QXM8<<VS(S'UQ7JWQ93$=):1T2AK$E2WKN/I&92H[\M:M\6F
M1'44E]$\LQ)TN%#O]EB6F-9R4MI@7&)ZB_9OA'V)J5C9H1TF)J:DN(23S^V,
M4&AC-YC8?AQR@G,]5=U.F ><#5KM7&2MA<M\HE1MCCA:<A,HJ]B -"A!0<VS
M(-G0DI73A!<N;>Q'2T<CFH3Q]8YJ8*W34'B Z##^V<%_Z-PV\2CIEW;0\==H
M GETL0#'NC T3QJ@L*BVN*UL)!XFK8%1G[4+H\5:8#)_T<M)A)NXB$9YNK3I
MQ44TDX5C7GY UBWMV(R./%Y^@.82XIK D^7L*$O:I:&(2FH"11V'EP8C*;"1
M:EC)[^6+GJBH)G! (D&^CU:9P8 T@'H936A.1P;Q%2]]LAT2.E&W@\"V;NAV
M',J.!FA-_%@?RXN;2F,[Q54:&>/)5@^!KDUYJ6K\=I S!(7QL#BVZ^S<R'MC
M^)WI@>Y#Y*U^S/53.#);>$(<T@[)SJJ^UJ/;L':T;,!_DY:-:E.^3X?1Z@)4
MV6^3B-3R N+B%1UB:$E_+1&0J)HJZQ*'4="E>ZM(;@-3ND\MVD&UMH/K:!O5
M+NA]L^V;<^K;<^2&0?I)Y.W>\WZRF^JGY.._]2  #88[GV[I2:_@VM?(C:[[
M=](NU^R\0XWI?A.(2/J##E-NH>8"I]3#(=QI#Y THJ%--1+![GF$F0#2?4<C
M/A#$#V?]]#I 8)BP*>YM2UJ<!Y084S$]#+&1]E]#WN,9/#$N.01*UC&@Q9EV
MA_"W31AIWZ4CTXF/&7(0*'_MTFI<'XG<7F)NN^C4;2*XU?46!%PT;?5#^T#&
M;37=Q?SW0@G_"5E"/4=.?71CXU7"@VL=5]%<S%$O.W44%ZEZCHDAU=5@54I3
MU<U1ZA?E;)V96Z^] \K:JI")DP6#A6^OZF]C;J>N(ZK:&Q6IEP-=O5@K+O"D
MZSZY51Y9)PI(ZIH/'>I982.IY^[1#BV(OEZ#OC#6J_5I1?.NB9"PX[APU?/.
M?FEE0'R?W,$HB5-Q2QMWS7R$/<.!JJ!?,NLN\>HCQRTE;3N=D2#;+8F?UJF;
M?"BT[+KT5ML]/]E0 5*]4-)7JVCMUW:GP/Y-;VC?X-!V,P X%5:@;]<U5=AE
MXH90SXDS.M/LH95A^Q[-7$ $=MM=M$$C]Q!*T8DB?;NNK\).%#>$>D[,E"H@
M=#(IOKYGUXE3%%O.G<<RV0X)O Q,3D,NS/?G>91C^+VUI9SR)YN9=9T7XNLZ
MVA-&WM.&%Z7$'GUFP+SD@?DA3R-KC9&H12([S"P??;I*Z9,UKPXPC;HM9M'F
MG'1QV[>=\"\<;H:[("1;Y!OWCKNC&Z3HY!G\72WL>UYU.T!8U]FRQ%^%.G>P
MC=0K?$,2A/L]6;SA -.LZUQ?[Z127"7F[W5L_V3C2/'YUJ(/2IIVFRHXN^%X
M28';K>O;O](?A20@@%Z]VWV.7)>FIN+./\XD!J=/UXE U%WUN-7S5<VV1@Z;
MJ.O8]9!2U&N"%E#/==&*0*)]K;M*&W<]=ROJ(@Y2]=SRT<8>'0]8'MW_;*T'
MNP![*.#4W.H>8@YZU;F#ZC"KS(GB3:K902&'%64;*\,BB@CR[BEALDI.KXA#
MJHY,]4+M!QC^?N[,=FGC'JH0F!M[MO]@@LF""8%O82!((HYA>B'R4< 9[3=Z
MT:Y#OP6+5L5;262>K@05-Z)_'IA?_HZ?UDC0E+B<-LJUZ?I.;M%#)>A;=DPU
M^\KHI@PQ[L8U];RMZS0]0:$(%\@UZSH5EFJ=2UYM>%PY'KX'DT3> ,8/W/GQ
MR@Y=YU)Q%U>BK;G=VE]GDG[#*[-0\TIBH286KF%/RXK_V;XAP3NML #>/-C"
M^V$99*\ED($D+1;5;=:DBL#HXA:#508/RX ^E;GG2[H3XEOF=:BE*558QO\K
MQ 'I0])#N=Q2GG\:)U=T4H'6JWA*@;[<#Z\P5*,*FE7=7('\?: #^+B495(C
M=.,C!T>FJ;Y-V%9=L^*C[Y(RT$JR(A_9 1JA^*?IL8\%<>E13<^NIY./=J&H
M<12\Y8JJYQ_&D_%LL6_7,]$-^+;*0(_"NV6/_LAXN+R_F)=?/R8O\PSU&-(S
M^T!)_4-1XA+$G/WK8W(VWUB/P=TRYTH<<)]7R!,+A=\>4RC(']"A4F!4&,3T
M;E%PY*BZ5$:W3^ 3!Z%5-#<YPI%RX<[/K"+S0 IU5G0$SO%FX=%]81,]FEA.
M7D%V5"R7RE EENEK*NG*1[3]O/Y9*X&NBL8QQY.<..::1[THSJJ^?Y1TA*ZY
M[PJI[*+HE-1AGBPUAWH>I(!S+X>:(?K*7R=$J^3E4>P'F993Y&.R*M*,9!N^
M<>]$ZPPSH)W&>HT<3EBTK4?76:,;NQ?GL&49II([I%0V)H_/'&',YN9\538F
M+Q4K]LQ@_L!)9D'S5_HZ2APX+@F L<(O'XV),3/&32^YRITRR:C\6U[E^?+J
M2I]]U:Q+;6Y^G)B7YE"?+#1].+26DX4Y^:A-K;$Y-(UYPZCDCYYD@+W) [,6
MGXQ9BF.N3?6O^F!L:/ID1#^<+8V1-C;U@3DV%\V#JSVD,HNE_SR/!6)*7X#"
M4WVV^*HM9OIDK@\7IC5I6F_!0RL9[?N%$/MDS1;:PIA=:6-+GT0N,.?SI3&/
MHNZ3/FO<_J*[+_H7!>47UO"/3]9X9,SF/__TVT7_UW?:R("[Q%PT'C.Y S 9
M15\48^2S,5FV$,E"QU\RNKXLZCHW]-GP4Q0*(U!\;$VO#$@[QI>I,9DW'PYU
M9V,RZK\JQ(0^AMBEND/J_"-*DBTI+GQ4)@/@=6F=TL=Q,AQ=F1-S#DEE87XV
MV@(B<(XF Z%0:B_-B3X9F@ BU5A[8DZ&UI7Q]!=M8C1]<Y8=N,DH7"BTL7+:
M0O_2N'&%#MUDM"U4S[$UAYH)!31*S[V!/C>'\=UJCI=0BII_!WC]89Q9!!>%
MFCFT/ILC$ %%<S(RKD!]\VH*3$9OI6Y6'=?)Z%RLE,O!W/AS&65"R.:+YM4\
MZ)1.!D2Q8@HS2NU)*KKI%V8<>GXG@[10<N4HIO8D%MXT5L'#/AEH)16ZBG&V
M!4/J_$\&3+%>"Q#0UF#5GA/*8"F4;@X?;2_ 2D\49?0NU.N4GK:GI,21HHSJ
MA<I=RU9;BQVQ(T<9-(7*SB&O;>&0/(0TB^=%H<X+<-FV< D?4LH@*K" .FK;
M%ISJ TT9_0L$(,MTV])5XEQ31OE"3:\COJW>(YS33QD4A?*=3$1J3Y+^VEY
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MI:.6+E9F>%MJ>9Y\55Q-RWN2N[^6]502Y/0?T '!)_\#4$L#!!0    ( *Z
M<53*S04OS!D  "R+ 0 5    =F)I>"TR,#(Q,3(S,5]D968N>&UL[5UK<Z-&
ML_Y^JLY_X#A5J4U5M%YY[;TE>]["$O+R1@:_NCB;3ZXQC"1J$3B ?#F__LP
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MFK@HE.V?XB6[2G.8G'5QQ2P*D&(ELV!3+-#:1E=N]8 4[,PJO35(:\-8H'I
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MH[DUS(20' 9%/Z$:[$0 4TL!"#BW E#0[ I@"E8 <F9R 4S="N#<4@ "SJT
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M*OG))XQY"UZ/[6'IQ[3!NN.^+*PM\5VVPF'ISI*M7(6MY8HC5.![=KZ<//,
MY^*9C_#@Z[0U3K@*R(SP$TD1'S=?8<(G4.9AMMK2TZ3%5!7%/$9E!J:CM>>J
MF^V@H^TT!YX,RWPAHV:F97X4HH4GV:FH*^36AT.4F8*C?C(MS):AJHS?RV&M
ML!KM55U=REIEE5"XJNKPLU)4N<("54WJU%5V)EYUI4A;98.'JS!SRBJIS+(#
MY:IZR5K( TXW^(RVX3A+^9KW+W%Q-]Y0XO>8&#:EK*W=KHH,JE)W:<3*%(PN
MA_'M2[2R1NSQH=H>/<8LFWI5 KQ$ 88J3Y["9,/>+Q;Z3O\O6@9/NST\>4F
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MH&ZDO6RS#-R!SF&\9;$XV\7TFV?(6U^*RD[3!YP/VMC:I2  6K:HJ(6F-:6
M\=\[4S=M[,9U"?#432L;8ASQ5!*G,:=9;$@KLYO2)5M9NM3O@*JT!6MA!D:A
M]EREDBS7'JC'Y:ID,9" MZCLW\87O\Y0_>S+_.M7,690\]:/&>(4LE=55+8Y
M"//2,8.V( !:MJBHA:8UI8#QR#M3-XT95LVA*7#J;O="]2F&V:IU:9M%[Z6P
M\S5>T%9#-5J0&CE5Y@,F-UF.=7[7EO!7<S2J7:'%74:*)2;WI_A&Y4(U>%]J
MD])6J:P#!N/W3 R%6'&&004%H20+TF8H"D14]F[\Q?T U [Z91WS5S'85/-6
M#C;;)Y8!=\FLMNS_V?&K!SJG2XM\3@?') X+'+$O1FG4_:"%+$\LBJO7U65_
MDZ>0AP;-@P)/5BNL'*RZ)N'TACXO#[AS!:!3!K#>9R]UM]R1X6Z";;_P/_#V
M=_F'I&'%O_^OX"Z:)W<:Y^LL#Y)SDFW6/ E9'I:G8'"T/01SB"8=3.&K<14[
M/MR].8J!OP\Q 8Z'^DLG\[8^ 04%7XN]P;=QRA):LBF7]P/J_T^I&. );R_U
MWXN.,?W*6L$O.!3U,8OB51SR*LQ6G9Q$5;S%-"VR"SK;[#WBP=;.#DX-KU)S
ME,K>U/L:PFY\^]IL%\#TU@T&:\+$8EH*"OBBPX%T6(6NC?A1B>:*].H5[;Z8
ML@<QR-R9$G>H5"/% ;8PM#B<L. HRQ+J\S*X+D,].SB0&%N!916G62J]QD8!
M="8P+=%&2E(4#-'HJ*GDL<?(/$7[+S;K=<*3<M!.OW5P-3<=&[8T=*:/015I
M]&)E!4,_0ZBZ/6-L(2WF%.?5$K[D;+2X3KY3"5[$9E\UJ>K,YE!V"'>G_O4'
M%U6!V2Q=7Y;$H456$HV!T]PB1N*=#"%*M'<?:$U1R-;1&*#: E[&J3H>[Q3G
M(8G7;(Y"AY+LM@;JWJ_H,V0O'/MTB9^*DT0=,[%+02[UN'M%VSH=7@H8_>Y,
M7>C3)Y>3^>0"B( 7\6W*I]=T6B2\H2;1VAH[3=HWJ$*=]'U6EF $.8BN$*9Q
M_?'C:/XKFIVAQ?3\<GHV'8\NEV@T'L^N+Y?3RW-T-;N8CJ>3!1"=5FM%>7VT
M*DA,/;G6PFE$D)EZ)R9(#0>C/3/'ON"NV@?8:AMX_;G-03ZVMIYD^89@DW_<
MN30/(\U=JRP9A@XM"HRL7\:_+_G9\J?)O':I"W0U^G5T<C%!H\M3]N'\>G**
M+J:CD^G%= G'S\YQPA)G7 6D>%Z2(,U9")0Y.:K9S*6D;2O1UJ[)!HQ(+8GV
MU5B9(6Z'VH;PO+"JBO:>=U )$*1IZ6$'F(,7K+TGI=.ET9*ZRZO1?/DK6LY'
MEXO1>#F=74+QFBP@>EL=@Z]4@=VF7M01[B9AE"'!B$M+3\S<=%.@+1J>X^M$
MV!MGWPJPV^O4=(2[URW(D&!TI*4GS)Y_FLV7:#F9?T07L]$E'])-%XOKR8)/
MJ'\:S<&,Y\I[.@P>J0]R>GVUE&#GMNH. HQBI+3Z2BE! !V-<)7+959@^_'5
M 'OGMU -J9;^$AZ%,92-O5V)"^YL.1O__-/LXG0R7_SQ#W]]_^XO/Z+3R=ET
M/%T"D>L</^!T@]EF);M_@;U)O\3%W7B3%]D])N;9@*VYVZG L$IUYP%VMF"\
MY4#"X@S@T^3R&DRO.L<YI@^2A8V=THHEV9KMK!O72/1&;K5G4X&NXG06@'1F
M05-<&RF-^.)TRPQ>OUTS;=<MC5@\[:; 9)&MBL> #.C'7U">#[GN7&V9D@<7
M!D[DN]9 ]*Z+R6@^_HE/9$ZIJ[V877V<7"[1Y%]7D\O%R]VN(M)LRY 'Q-$Z
M? S(EX(?UBN3>RM<ZF!K9Q%FPZO41)?9FWH7XFY\A7$G,T/4#M6&:+*GI.ZJ
MT,864=QF:O:8.]B["VO<H5K;H,8!QC"$MP-C07JCB\F"N[N/H_G//.#!F:\[
MQRDF0<)V%Z/[.(W9.U+$#WB8S[,OQ8/O&UI%B0^T+0*&)'?F+42'E>;<*W8+
M.+1O-!&W=)$[%>/NQK+=*[F]S&QX&3!$NCMQ:0SCZ**,93C].+V<+I;ST7+Z
M:>+.C59)7H*DIE]>&'B)5?/P'>P]N$[[:DF<IMD8AA)W8-R78&/8^$54FB)J
M>R#Q-7F%RE^J?UCK#\TVSD1F2[\1ELD AI@L60H"FEZ.+L=3ZL5JEX6^F5Z.
M9Q\GKX_0Y03*TG=9J67P9!U?H+5P?&&$B7KO5@@5W+O0[#E*L@DQIT1-0$<>
M2"IF6CO4FW@6FG8%4(>'+#632RO=%UJ._@5FIV02$);JAB7G6K#LHJ9(!"7<
M:4R"@70G.D&!!:,C T$A8J&"(XI'W ">L^I7R>2I-'B?LM+Z*"48K+!,WNEB
MMEB@J\F\#) Z/ADMIN-RQV%Z<;V<G (1USS.O[#5Q6O:GJ0(XM0B?;O!QNE6
MF0W]SG:8S@",V&Q8"MM:S(;OZ7:LX/FSZW23;X)$6D>3;[.T=2G!0=5I2]'*
M$(PDA[ 5,BG,/DU/C]]]CZZH YQ\I(YP^O'J8CH>08IJ9QDA\.\;G!:3!Y;*
MR. $U7"G(8 &TIV(/P46C,0,!(5=K0:.2CP\5]>OD3'05(WWJ2I](*D*#%97
MYN/B)XO)/Z]Y2,@G^M]0/-191G!\FY9IM\+N<;@TXO],RM27_&#\LTEM+RC/
MI1I?7.VV6G<N#(R:7UH#865XDW+K($%A5280O8]I'6@5(EX;.TGK39SFR[8@
MW\D,K,&#T9X%22$5 HG3,%ZSV*=LA<)V 5!D)LN(:>E"+6U=)VJWKDX_-[71
M$-IID"&DK?-  Q'F61"33T&RP;-5L_\[3>D(=W._K:2JE["S==J/#ZE.I\^V
M,03C(X>P%?IB:HL>F#%SEJMFTS_>V@/19G\YU,Y=&JU\+E!;N$B#"1@-VO%4
M;H:L,4'E77KEG@@0S56GJN8XS&[3V'Y0:&'GX22<N1J2(W!J(S#:LV4J'DOB
M=BSC:FT(1G>R4U95Y(VV%[:R]'\23EH5\W&XCAD@_=ERU1Z,BUH'X_">8I'W
M';UBY_[4<"]1*Q;.3H4%HS$#0754%!@-L>X]+OB(DA^FX_DT<<JR:=JNM-@7
MX';=96C%NJLPMM9@M#B8LC -;IL<*)9XF[/U+"/-VV/2VC!39Y'% RO3!!A;
MVGE7U@YD->G,5QE! !W@)7YL)1(F64K_#'%KBF[G!H<7X_:>Y-TJV;TM>5@9
MWN7[0N+BJ#"D)LDSBO-\@R,4;*6][A0*1-AUZG;:+]S$:7LG2/&<= 8^DNZK
MB<N2ZXMH, (T4NQ+K39 +8L#=<B_!(0$QFT./=19AVL@VW2P"IQW05B0ZTNA
M1@-Q*HOP#D<;=G&.3=;H)?O&&.ORHB*=AL/LH?*=B)D7E.==RWNLA!!W,_YI
M<GI],6%I);_*=.+;9Z+* CSPS; MQL_;,*R2\C? K@R JA]$7*?TPZ5[5J6%
M:>K0;%6>LM/Q\<VFO+:V?F^?Z:M<9EADR9:RE UR9VDGJ35]!%I)N_A!=XEG
M7#RX;:::0_Z:]Q?*615UK][9:#I'GT87UQ-TRG(Z3$^NV8O'OJH[EU]YES/Y
MYS7[<SS[>#6[!!01NGV PW)I&\W\="@#\FL;;+SK>R!1G4JYZA;36IF]=-SP
ME"C-SUO/9V9D'M_>643"[UZ>)^WN5FV%J(<5!E'M.]5 <W';['JY6%)?S)*7
M_3*:TV$2&"],^ZS@]I;@VZ#LM:I(!JNQOJ6MT]LRAE2G<WF&C2$8K0YAJQ^_
M[R=9LW&TK@ULT,\L7U22A_'U+E65#)R'%.-=ER_GKE>IGZ2WK1Y!E<=RB'*M
M"_$@VH$5E.C5L@1H4AU&6Z?2;J+2B8M,I=MJF!(&#M'IT+(\R'6WZDI4.ZP@
M:.+=B;U.P_ZR1=:54J2(N\2%O83MRW NW:'5$R1K6P LJ0YDK5WW:I(!?E-+
M\C4JTVE!2@:X?4E/\0H3@J-E\#3*<\PCW7;?;QQ8FI_UA)VJ+%]-&%24=]'O
MA[]._J>3L\E\/CE% #/(;6O=6NE>-?%WU5M_0CNM5:QWYWLIT8_V=ZZZ7/^#
MBP/X#NQ:!]U[P%.4U5E@T=E\]A&-9Y=TT'W-QMVSJ\F\3-!SA$XF9[-Y]:*@
MV67UXH![9?K'WDZ"/ [9!#I.-@7S'X->EX&E^7E5=JJR_#495!3 5V07_L;7
M WX&O],-7F:M: 3:(Y:Y0=@M29=42^4_5*N@MM9.5Z"'5:FS!FUG"D:^P_@*
M5SQO,"HR1*K;[M<L& 6(+,M-GX^XN,NB:?J <WY$9?9(9]OY7;RF+RD+JPYN
ML>+!#+!W?X'O@&J)=_M:&(.1YU#&?8$V2':FO(("$2C?H9SRF/[3#6%'!#")
MLXAW'716_<B_RE6]CJ6Q\^N K2LDW 5LM 0CRD%T^XJ\W-S?8,+2:^0\W7-Y
MJ@.*)H-F[_R*Q"&NAS*J!Z&$.]6=@71':0HL'&WI"<HN]>-:8@9':,U,>/J,
M'%#>#,7[PN/M=G1T?5L ?DY>'0LWUS6$H\0!; 59,MOZP%K$K9DJJ7F970B(
M,%DDW#8UTED0XM$].TJ@&BLKX4XG)P;2G=F( @M&9 :"PGR#PEO)J([0BEJ@
M@)N U-0T+3!]9L6<SH\6!9]DF28>0PKPISN;BJF5J+,&JDT+R@:UTC_+(A"A
MYD#D6@Y:2S=O->13XYWVP2;:G7Y7!08C-1-#H7_E^*J#'33L.V";7.*BW!FX
MR'+I^*<#^/S!S=/_OGSZ*8NSQ-&%IA'D](3Y&R[J=!+?,.!K-"K*$R-L?9>M
MAET%;,7,4R.(<<_*D6@']?D[:,VAX2@=;E;0?T,17L5A[*L!J#Y87M<KDCW$
M$8Y.GJ]S'$W3&7T[ Q:;-@J+^('O&RM>$4OKS^^A-=@.W*49<5=)]I@C]E11
M5MIF*91SZ+VSQK/B#I,!NQWVYBX[TZ&5:@O6UA9,5SN0L+"@S/!H71KG5::^
M,CP$D3*"'Y!6>Z?@ARG5RMBQ3@=4J*=2"TM(&K6G*TE]Q8Q1LK6&(TACHH;=
MG>F XCPZU\&5UCA;Z[*<"KO(BB#1C1->6(N^WI?L]U#&_7*5&RMO'+2G02#?
M51^M5K0V=-0T-H0+](&NAG;VMQSH:?9;Y#Q^0G_\PU_?OWOW(\LDM0[29U0U
M]H$BSV?-.'&<Y06[U9Y15*^UV1HYBRVWKD 33&ZT\-Z;#:(IC+,:.Q0R0Q17
MED?P=O+9.M\X2^E[E+.3G"2^C=,@89^6B]GO- N,!CO7"[Q6U>BOZVJ-O,MP
M*%/I*NY]%L6K..2*1%EE2T?^-\41O.V';2W+OPHV#:]7H8=(4F?N3YGF2JD%
MJK8%JE,C8:E<P\8>ECI5V4C8T$"U#*@U@9 GIDW>)D<,PX-1FP5)8;6U,F%Q
M)]SHN*!6B OO-VX(YOK3=I4NXA1/"WROC#11@-UN:^D(=_>T9$@XLM+1$W>S
M>B)B!HA;@%)24=6G21:FJ[P$[%Q)2L*"D@0D+"6IZ$GO+_NTCP@CQ41S.V]I
MY8R3S7L40&<32BW19A(I17EO>B,UX8[/!LNOK6LNL3O4.?>V<QLEW!1'TM Q
M"[R[\^L6M+=GU35@& *Q8"@LC=>H/8V*3?JH[IX-$@MM"%CWNE#0%371 P+3
M@YR=XEY@.HL_J!9.XYPO2<_2AM]%%J2R"BBASI1@(-L(08&#H0,].6&Z7*$1
MOVN2XA$?AR;4PE<$3\WZ)",D>V0G2K43@"W,\;Z!<:-'1U$Z!]@^^R-TB>$M
M6HRSA)+)R@0](Y9*\A;7%U^Q?2K%UT)Z;N-<?'\_Y"N!PGX?E"JOPGY^Q;O?
M.GC5Q"O76O:H50 /:&G_NXQW*>Z"%'6-8*WT[.%YF=:']OL3;J\DW/_#Z5Y:
MN+_RP;R+!ZC4(=Y"RZ6R0WK]0Q_[!1<-,9"W_>&XHS)^WU?4REX.TL)K+1-3
M;?O .%IQ1;(0XR@_HY\R=074@N=DNL]23E?61$8CQVVE\[;V7,5Y?&E9!HS'
ME2U;!PRY=7DT&L@PI7ND[#H-[NFL)_Y/ZD>J::AF3]A@Y^\HH*8:ZA. $B,P
M8K1EVI<B6V9 484!HKA1&&[N-SP]3QGJGMVO";[#:4Z'#]OC3KIIZ; B',?6
M#JY<+Y[6VAZ,.G<@+0D1KXNHAI:=0GKGVV#-]"RK;YK-#2\&H+"UL[*A97QM
M C?-K@:*W'(BY7)-(PGR?+:J[JRIKJR9;8J\H--#.FE035R-9D[7'BPKT5E/
M,-A FV%8\CW4%;OZ&Y;9^KMLFZ3SM>N;E-ND^K<GL^^\^R(%(443(@:![#4F
M3YB$<8[Y!+CYLKD&2Q4-O&-9WOV+;76-3L=4D'>=[H-]7]2U&>)VA_5.U6])
M9A]*E&M?):'8=UDMB'=%Z'DIVGH?1[/VMI/3K/E\REC:@%*LRE5Z!=KM_HJ6
M<G>K1 KUKAH[?N(&QG:%[0@]< -$N 40-6F7ZN>8W?4;T@D"AXT> Q*=DU;R
MFB'K_IK" "0GM*RP]>Z,LB0P2GX1?7725M)8=M:7JXT;8-E<JRST.&(S7SKM
MY<?76ON*)\];R%7PS \7L4=QF:6S-<.6>7>V:Z'YY&D=5^<RE4$_A_U1YUG&
M#OX A51E!_M%."^GBVJJ7^+':B2,,#/J[\(">7MU]\.J-BZT)E#N\)5N#FGP
M8%1K05(27MHR8=JKC("MJBNJ)BPPVSV1"S^KYK:5L!!>?W$9K/CZ1 <(\,)[
MZ)#VCF%9:VD-X(6>V-'M-UEM5247:^Q8;\6O7/05'H23A*7Q$R_:E8YDE&AX
M[63!599XOTS_=E^;^&J?YM1#DN4;@DT7RHYNV">A>+QG>!%P6O*E%5"><9^M
M4%48&K&@S$YQ:&+1X@Y[\0L6&$II5O<Y]=[.GNA58)<]MIYPVYW(D6!Z9RT]
M<=?H%N='* ^2@,25%ZFOT++Q(0X5=46R%<Y9(I$@.</*6SI$F$L5J4CV@B$[
M&##*41"3A#DV,+3"8 3"(RL,[E91<SM3ET(:4IFVN&SLP AN %EI\EM/H\\=
MFL5426#')6WI"ND6J_$)ZT:"[O@$6&_"9IRSU9C@*&9WO;!<G\^Z]2P-WNDH
MQ42[,U!1@<$X !-#(:R9K1-D*U1:H-H$V J6K%:FY2N#C6^-:1>NM :@M=9G
M::VWB_V%:"JB4L[B-$A#.I<O@T/KZ=TEEN;NT*&=1:F8*3<3?#74NU[L^ GI
MGFJ#IJ-#W\3<]O412L$D$#BM+@A8!D^C/,<L"RX_M93G\@5"U0KPX&+<G@G:
MK9+=(T+#RO NVQ<2%W-W5C=)S/\8W*]_/(4V?FNN<F$Q\^. D.=51MBVK*J#
MU1DXG=@9B7>F<THT&,$9*2KR:5-7F5 +%+9,#I;Y:$75C&G;Y">X>,0XI6_'
M29#'[ 0]ITS9\*QN^6S%CL[U1;1S*0[S)>U:Q=:B^] BO&OP9;S%#<JF('13
MEH2*X G=L++XG#:L2BMS^N5L:,A2!-&^/L<8I5E!/_N.(__T&HBC%/J#P9YS
M4 E>^_EAOG6 N7>A[\Y9>D<)5&WJ0EY58*^*4X:LRI%P=:0-.<7%]F8QYA #
M9D)=))4:YJZPC.@(DB1[9"D/H,KK4TUU5#.U?3PR2Z_"4U=%JT+1#-K5C?:4
M^S+]]/4(45S%T4.]2JVW?J/#P=K%T#"T<W% Y*/NXW4[%D8K&+->Y>Z%P01,
M5VK'4ST)9F:H8P=L.T-=P0O#IH:5)0P9"E6QD^(%N&T.>Z[#)'GA/41WFV^#
MI>8:9RGENJ%TM_>SG? 1:8FC3A_GDZ>"!!F)XC0@SYP\SY>8%O0W$[ZZ7V!V
MC$K6Z ?\.7@79KNHK/RV3+X&6$TE"E8N2W]=[IP \7]-G2=/P3VM+7L<IS@/
M2<R/_VB?J,;*I=^SK((H?Z4)&']GQ[.OO2KC#AOIX:T='0(VAD#$-UFM,+NL
M?OOFS=FUIY(75/%\AA3@4I+#*]96I[TU&*$.IBP><2=KEFRWE"W[ XA&Q1EZ
M?^8UOF.G*:>I]/*1W8MQJ===*]E6[= RP&AW1^(6*S3YD63>[>M8T=[V9L$<
M1AG =< VK:_VN<3%=J J:Y(.X/-W/D;92TST32'G*%N0XL\]* H2WVP*MB*
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MP:@.![F%VO2LFH0M4M%WS*YEVA]=T+_HQ_5']+]NZ"R??O)_ 5!+ P04
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MGD2Z]X-UQD)/@=#<S3^ 9X;L#&SF+B'S))Z^YR6SCM<TEVA(MB6 .J.G'#@
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M8KZY81@3K6-*8PAD&0)6-='DR NX'LU*-@F.K7=E7?*S/;S&/9HTJTQ5:5?
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MBRY;=QZOJ.WY7ORDN(J7=#'J5AZ.7E$I%1-HRA5]U11+-C,,NH%I%_?*)0F
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MDWS1*=$QJTHCFPV)8L_MANL@ID^J8HV"YL9<P@D665%-E1%MB EYR?1';QD
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M+FAT;5!+ 0(4 Q0    ( *Z <50PL(#<9#D  &T]   +              "
M 7$0  !F:6Y?,# Q+FIP9U!+ 0(4 Q0    ( *Z <51ISQ921LX! *[J 0 +
M              "  ?Y)  !F:6Y?,# R+FIP9U!+ 0(4 Q0    ( *Z <50T
MH'HK+5T! $'4#  ,              "  6T8 @!F;W)M,3 M:RYH=&U02P$"
M% ,4    " "N@'%4Q.U10$,.   JC@  $0              @ '$=0, =F)I
M>"TR,#(Q,3(S,2YX<V102P$"% ,4    " "N@'%4%XQ3X.0/  !\N   %0
M            @ $VA , =F)I>"TR,#(Q,3(S,5]C86PN>&UL4$L! A0#%
M  @ KH!Q5,K-!2_,&0  +(L! !4              ( !390# '9B:7@M,C R
M,3$R,S%?9&5F+GAM;%!+ 0(4 Q0    ( *Z <53=?F!GTC\  "=Y P 5
M          "  4RN P!V8FEX+3(P,C$Q,C,Q7VQA8BYX;6Q02P$"% ,4
M" "N@'%4WU@DU]0N   ,Y@( %0              @ %1[@, =F)I>"TR,#(Q
B,3(S,5]P<F4N>&UL4$L%!@     +  L GP(  %@=!     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
